CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tunicamycin B3
Accession: CHEBI:64255
browse the term
Definition: A nucleoside that is one of the homologues in the mixture that is tunicamycin, characterised by an 13-methyltetradecanoyl fatty acyl substituent on the amino group of the tunicamine moiety.
Synonyms: exact_synonym: (2E)-N-[(2S,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-6-{(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-2-hydroxyethyl}-4,5-dihydroxytetrahydro-2H-pyran-3-yl]-13-methyltetradecanamide; (5'R)-5'-[2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1<->1)-2,6-dideoxy-2-(13-methyltetradecanamido)-beta-D-galactopyranos-6-yl]uridine
related_synonym: Formula=C38H64N4O16; InChI=1S/C38H64N4O16/c1-19(2)13-11-9-7-5-4-6-8-10-12-14-24(46)40-27-31(51)28(48)22(55-37(27)58-36-26(39-20(3)44)30(50)29(49)23(18-43)56-36)17-21(45)34-32(52)33(53)35(57-34)42-16-15-25(47)41-38(42)54/h15-16,19,21-23,26-37,43,45,48-53H,4-14,17-18H2,1-3H3,(H,39,44)(H,40,46)(H,41,47,54)/t21-,22-,23-,26-,27-,28+,29-,30-,31-,32+,33-,34-,35-,36-,37+/m1/s1; InChIKey=XAFNQFHOQPRGAK-KTVOANSYSA-N; SMILES=[H][C@@](O)(C[C@H]1O[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@H](NC(=O)CCCCCCCCCCCC(C)C)[C@@H](O)[C@H]1O)[C@@]1([H])O[C@H]([C@H](O)[C@@H]1O)n1ccc(=O)[nH]c1=O; tunicamycin VI
xref: PMID:7061468
G
Aars1
alanyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of AARS1 mRNA; Tunicamycin results in increased expression of AARS1 protein
CTD
PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
G
Aarsd1
alanyl-tRNA synthetase domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of AARSD1 mRNA
CTD
PMID:29453283
NCBI chr10:86,340,625...86,353,732
Ensembl chr10:86,340,626...86,353,729
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression decreases expression multiple interactions
ISO
Tunicamycin results in increased expression of ABCB1 mRNA Tunicamycin results in decreased expression of ABCB1 protein 1-(4-chlorophenyl)-3-(3-(4-chlorophenyl)-5,5-dimethyl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-1-hydroxyurea inhibits the reaction [Tunicamycin results in decreased expression of ABCB1 protein]
CTD
PMID:29453283 PMID:34915026
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
increases expression
ISO
Tunicamycin results in increased expression of ABCB1B mRNA
CTD
PMID:17127020
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:25,242,798...25,325,199
G
Abcb7
ATP binding cassette subfamily B member 7
increases expression
ISO
Tunicamycin results in increased expression of ABCB7 mRNA
CTD
PMID:22378314
NCBI chr X:73,361,296...73,502,464
Ensembl chr X:69,295,552...69,436,858
G
Abcc1
ATP binding cassette subfamily C member 1
increases expression
ISO
Tunicamycin results in increased expression of ABCC1 mRNA
CTD
PMID:17127020
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
G
Abcc3
ATP binding cassette subfamily C member 3
decreases expression
ISO
Tunicamycin results in decreased expression of ABCC3 mRNA
CTD
PMID:17127020
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
G
Abce1
ATP binding cassette subfamily E member 1
increases expression
ISO
Tunicamycin results in increased expression of ABCE1 mRNA
CTD
PMID:17127020
NCBI chr19:45,109,880...45,134,819
Ensembl chr19:28,205,555...28,230,489
G
Abitram
actin binding transcription modulator
increases expression
ISO
Tunicamycin results in increased expression of ABITRAM mRNA
CTD
PMID:22378314
NCBI chr 5:71,505,848...71,524,224
Ensembl chr 5:71,505,813...71,511,890
G
Abtb1
ankyrin repeat and BTB domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of ABTB1 mRNA
CTD
PMID:22378314
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
G
Acaa2
acetyl-CoA acyltransferase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ACAA2 mRNA
CTD
PMID:17127020
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:68,345,012...68,373,249
G
Acaca
acetyl-CoA carboxylase alpha
increases expression decreases expression
ISO
Tunicamycin results in increased expression of ACACA mRNA Tunicamycin results in decreased expression of ACACA mRNA
CTD
PMID:22378314 PMID:22414386
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acacb
acetyl-CoA carboxylase beta
decreases expression
ISO
Tunicamycin results in decreased expression of ACACB mRNA
CTD
PMID:17127020
NCBI chr12:48,026,394...48,138,214
Ensembl chr12:42,366,548...42,457,655
G
Acad10
acyl-CoA dehydrogenase family, member 10
increases expression
ISO
Tunicamycin results in increased expression of ACAD10 mRNA
CTD
PMID:29453283
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
G
Acad11
acyl-CoA dehydrogenase family, member 11
increases expression
ISO
Tunicamycin results in increased expression of ACAD11 mRNA
CTD
PMID:22378314
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
G
Acad9
acyl-CoA dehydrogenase family, member 9
decreases expression
ISO
Tunicamycin results in decreased expression of ACAD9 mRNA
CTD
PMID:22378314
NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:118,943,174...118,966,547
G
Acadvl
acyl-CoA dehydrogenase, very long chain
increases expression
ISO
Tunicamycin results in increased expression of ACADVL mRNA
CTD
PMID:22378314
NCBI chr10:55,231,558...55,236,786
Ensembl chr10:54,732,469...54,738,075
G
Acat1
acetyl-CoA acetyltransferase 1
decreases expression decreases expression multiple interactions
ISO
Tunicamycin results in decreased expression of ACAT1 mRNA tunicamycin decreases expression of Acat1 mRNA in liver naltrexone inhibits the reaction [tunicamycin decreases expression of Acat1 mRNA in liver]
CTD RGD
PMID:22378314 PMID:27813192 PMID:27813192
RGD:401842386 , RGD:401842386
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:53,979,813...54,008,855
G
Acat2
acetyl-CoA acetyltransferase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ACAT2 mRNA
CTD
PMID:22378314
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Acbd3
acyl-CoA binding domain containing 3
increases expression
ISO
Tunicamycin results in increased expression of ACBD3 mRNA
CTD
PMID:22378314
NCBI chr13:92,455,813...92,484,556
Ensembl chr13:92,455,655...92,483,380
G
Acer3
alkaline ceramidase 3
increases expression
ISO
Tunicamycin results in increased expression of ACER3 mRNA
CTD
PMID:17127020
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
G
Acly
ATP citrate lyase
decreases expression
ISO
Tunicamycin results in decreased expression of ACLY mRNA
CTD
PMID:29453283
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,412,049...85,463,320
G
Acot13
acyl-CoA thioesterase 13
decreases expression
ISO
Tunicamycin results in decreased expression of ACOT13 mRNA
CTD
PMID:22378314
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
G
Acot7
acyl-CoA thioesterase 7
decreases expression
ISO
Tunicamycin results in decreased expression of ACOT7 mRNA
CTD
PMID:22378314
NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:162,684,645...162,779,309
G
Acox1
acyl-CoA oxidase 1
decreases expression
ISO
Tunicamycin results in decreased expression of ACOX1 mRNA
CTD
PMID:22414386
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,406,197...101,431,232
G
Acp6
acid phosphatase 6, lysophosphatidic
increases expression
ISO
Tunicamycin results in increased expression of ACP6 mRNA
CTD
PMID:29453283
NCBI chr 2:184,711,975...184,733,067
Ensembl chr 2:184,711,619...184,733,017
G
Acsl5
acyl-CoA synthetase long-chain family member 5
increases expression
ISO
Tunicamycin results in increased expression of ACSL5 mRNA
CTD
PMID:17127020
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:254,292,521...254,336,607
G
Acta2
actin alpha 2, smooth muscle
increases expression
ISO
Tunicamycin results in increased expression of ACTA2 mRNA
CTD
PMID:22378314
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Actb
actin, beta
decreases expression
ISO
Tunicamycin results in decreased expression of ACTB mRNA
CTD
PMID:29453283
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
G
Actg1
actin, gamma 1
decreases expression
ISO
Tunicamycin results in decreased expression of ACTG1 mRNA
CTD
PMID:22378314
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Acvr1
activin A receptor type 1
increases expression
ISO
Tunicamycin results in increased expression of ACVR1 mRNA
CTD
PMID:22378314
NCBI chr 3:63,387,378...63,506,980
Ensembl chr 3:42,978,561...43,098,241
G
Acvr1c
activin A receptor type 1C
increases expression
ISO
Tunicamycin results in increased expression of ACVR1C mRNA
CTD
PMID:17127020
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
G
Acy1
aminoacylase 1
increases expression
ISO
Tunicamycin results in increased expression of ACY1 mRNA
CTD
PMID:29453283
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Adam23
ADAM metallopeptidase domain 23
decreases expression
ISO
Tunicamycin results in decreased expression of ADAM23 mRNA
CTD
PMID:17127020
NCBI chr 9:64,862,649...65,009,718
Ensembl chr 9:64,862,878...65,006,515
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
decreases expression
ISO
Tunicamycin results in decreased expression of ADAMTS1 mRNA
CTD
PMID:22378314
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
decreases expression
ISO
Tunicamycin results in decreased expression of ADAMTS9 mRNA
CTD
PMID:22378314
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression
ISO
Tunicamycin results in increased expression of ADIPOQ mRNA
CTD
PMID:17127020
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
increases expression
ISO
Tunicamycin results in increased expression of ADM mRNA
CTD
PMID:33545341
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adm2
adrenomedullin 2
increases expression
ISO
Tunicamycin results in increased expression of ADM2 mRNA
CTD
PMID:22378314
NCBI chr 7:122,272,808...122,274,594
Ensembl chr 7:120,393,179...120,396,331
G
Adora2b
adenosine A2B receptor
decreases expression
ISO
Tunicamycin results in decreased expression of ADORA2B mRNA
CTD
PMID:22378314
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Adprm
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent
increases expression
ISO
Tunicamycin results in increased expression of ADPRM mRNA
CTD
PMID:22378314
NCBI chr10:51,732,073...51,744,635
Ensembl chr10:51,731,993...51,744,635
G
Adrm1
ADRM1 26S proteasome ubiquitin receptor
decreases expression
ISO
Tunicamycin results in decreased expression of ADRM1 mRNA
CTD
PMID:29453283
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:167,265,296...167,270,195
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
Tunicamycin results in increased expression of AEN mRNA
CTD
PMID:22378314
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
G
Aga
aspartylglucosaminidase
increases expression
ISO
Tunicamycin results in increased expression of AGA mRNA
CTD
PMID:29453283
NCBI chr16:38,504,661...38,516,607
Ensembl chr16:38,504,663...38,516,606
G
Agap1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
decreases expression
ISO
Tunicamycin results in decreased expression of AGAP1 mRNA
CTD
PMID:22378314
NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958
G
Agk
acylglycerol kinase
decreases expression
ISO
Tunicamycin results in decreased expression of AGK mRNA
CTD
PMID:17127020
NCBI chr 4:69,114,850...69,193,989
Ensembl chr 4:69,114,269...69,193,934
G
Agtpbp1
ATP/GTP binding carboxypeptidase 1
increases expression
ISO
Tunicamycin results in increased expression of AGTPBP1 mRNA
CTD
PMID:29453283
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
G
Ahcyl2
adenosylhomocysteinase-like 2
increases expression
ISO
Tunicamycin results in increased expression of AHCYL2 mRNA
CTD
PMID:22378314
NCBI chr 4:58,381,290...58,531,061
Ensembl chr 4:58,381,218...58,531,060
G
Ahi1
Abelson helper integration site 1
increases expression
ISO
Tunicamycin results in increased expression of AHI1 mRNA
CTD
PMID:22378314
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
G
Ahnak
AHNAK nucleoprotein
increases expression
ISO
Tunicamycin results in increased expression of AHNAK mRNA
CTD
PMID:22378314
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
G
Ahsa1
activator of Hsp90 ATPase activity 1
decreases expression
ISO
Tunicamycin results in decreased expression of AHSA1 mRNA
CTD
PMID:17127020
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Aif1
allograft inflammatory factor 1
multiple interactions
ISO
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of AIF1 protein]]
CTD
PMID:37394652
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Ak2
adenylate kinase 2
decreases expression
ISO
Tunicamycin results in decreased expression of AK2 mRNA
CTD
PMID:22378314
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
G
Ak3
adenylate kinase 3
decreases expression
ISO
Tunicamycin results in decreased expression of AK3 mRNA
CTD
PMID:22378314
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
G
Ak4
adenylate kinase 4
decreases expression
ISO
Tunicamycin results in decreased expression of AK4 mRNA
CTD
PMID:22378314
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Ak5
adenylate kinase 5
increases expression
ISO
Tunicamycin results in increased expression of AK5 mRNA
CTD
PMID:17127020
NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458
G
Akap17a
A-kinase anchoring protein 17A
increases expression
ISO
Tunicamycin results in increased expression of AKAP17A mRNA
CTD
PMID:22378314
NCBI chr12:16,310,427...16,315,166
Ensembl chr12:16,310,437...16,314,479
G
Akap8
A-kinase anchoring protein 8
increases expression
ISO
Tunicamycin results in increased expression of AKAP8 mRNA
CTD
PMID:33770205
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
G
Akna
AT-hook transcription factor
increases expression
ISO
Tunicamycin results in increased expression of AKNA mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:81,792,928...81,839,936
Ensembl chr 5:76,777,415...76,816,017
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Tunicamycin results in increased expression of AKR1C21 mRNA
CTD
PMID:17127020
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions increases phosphorylation
ISO EXP
Tunicamycin results in decreased phosphorylation of AKT1 protein [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein] Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein]; MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT1 protein]
CTD
PMID:22378314 PMID:24680926 PMID:24898257 PMID:25398788 PMID:36640941
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
increases phosphorylation multiple interactions
ISO
Tunicamycin results in increased phosphorylation of AKT2 protein Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT2 protein]
CTD
PMID:36640941
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Akt3
AKT serine/threonine kinase 3
increases phosphorylation multiple interactions
ISO
Tunicamycin results in increased phosphorylation of AKT3 protein Curcumin inhibits the reaction [Tunicamycin results in increased phosphorylation of AKT3 protein]
CTD
PMID:36640941
NCBI chr13:91,475,839...91,758,060
Ensembl chr13:88,946,091...89,225,708
G
Alb
albumin
decreases expression
EXP
Tunicamycin results in decreased expression of ALB protein
CTD
PMID:33527851
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
Tunicamycin results in decreased expression of ALDH1A2 mRNA
CTD
PMID:29453283
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
increases expression
ISO
Tunicamycin results in increased expression of ALDH1L2 mRNA
CTD
PMID:29453283
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
decreases expression
ISO
Tunicamycin results in decreased expression of ALDH5A1 mRNA
CTD
PMID:22378314
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
increases expression
ISO
Tunicamycin results in increased expression of ALDH6A1 mRNA
CTD
PMID:22378314
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
decreases expression
ISO
Tunicamycin results in decreased expression of ALDH7A1 mRNA
CTD
PMID:22378314
NCBI chr18:52,208,035...52,240,293
Ensembl chr18:50,009,934...50,042,193
G
Aldoc
aldolase, fructose-bisphosphate C
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of ALDOC mRNA Tunicamycin results in increased expression of ALDOC mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,217,451...63,221,066
G
Alg5
ALG5, dolichyl-phosphate beta-glucosyltransferase
increases expression
ISO
Tunicamycin results in increased expression of ALG5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:138,936,998...138,951,228
Ensembl chr 2:138,936,993...138,951,216
G
Alg9
ALG9, alpha-1,2-mannosyltransferase
increases expression
ISO
Tunicamycin results in increased expression of ALG9 mRNA
CTD
PMID:29453283
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
G
Alkbh3
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase
increases expression
ISO
Tunicamycin results in increased expression of ALKBH3 mRNA
CTD
PMID:29453283
NCBI chr 3:79,939,515...79,972,820
Ensembl chr 3:79,939,600...79,972,000
G
Alpl
alkaline phosphatase, biomineralization associated
multiple interactions increases degradation
ISO EXP
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; Tretinoin inhibits the reaction [Tunicamycin results in increased degradation of ALPL protein]; Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein] Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]
CTD
PMID:10567916
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
G
Amot
angiomotin
decreases expression
ISO
Tunicamycin results in decreased expression of AMOT mRNA
CTD
PMID:29453283
NCBI chr X:113,778,990...113,837,846
Ensembl chr X:108,984,022...109,041,272
G
Amt
aminomethyltransferase
increases expression
ISO
Tunicamycin results in increased expression of AMT mRNA
CTD
PMID:22378314
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
G
Anapc11
anaphase promoting complex subunit 11
decreases expression
ISO
Tunicamycin results in decreased expression of ANAPC11 mRNA
CTD
PMID:22378314
NCBI chr10:106,373,610...106,384,633
G
Anapc15
anaphase promoting complex subunit 15
decreases expression
ISO
Tunicamycin results in decreased expression of ANAPC15 mRNA
CTD
PMID:22378314
NCBI chr 1:165,650,478...165,678,004
Ensembl chr 1:156,262,841...156,268,145
G
Anapc16
anaphase promoting complex subunit 16
increases expression
ISO
Tunicamycin results in increased expression of ANAPC16 mRNA
CTD
PMID:29453283
NCBI chr20:27,927,334...27,941,644
Ensembl chr20:27,927,334...27,941,984
G
Anapc7
anaphase promoting complex subunit 7
decreases expression
ISO
Tunicamycin results in decreased expression of ANAPC7 mRNA
CTD
PMID:29453283
NCBI chr12:39,793,518...39,821,614
Ensembl chr12:34,133,429...34,160,005
G
Angptl3
angiopoietin-like 3
decreases expression
ISO
Tunicamycin results in decreased expression of ANGPTL3 mRNA
CTD
PMID:32535746
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Ank2
ankyrin 2
increases expression
ISO
Tunicamycin results in increased expression of ANK2 mRNA
CTD
PMID:17127020
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:215,379,680...215,862,923
G
Ankrd1
ankyrin repeat domain 1
increases expression
ISO
Tunicamycin results in increased expression of ANKRD1 mRNA
CTD
PMID:29453283
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Ankrd12
ankyrin repeat domain 12
increases expression
ISO
Tunicamycin results in increased expression of ANKRD12 mRNA
CTD
PMID:22378314
NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:105,584,065...105,687,911
G
Ankrd39
ankyrin repeat domain 39
decreases expression
ISO
Tunicamycin results in decreased expression of ANKRD39 mRNA
CTD
PMID:22378314
NCBI chr 9:38,780,291...38,790,177
Ensembl chr 9:38,781,785...38,790,201
G
Ano10
anoctamin 10
increases expression
ISO
Tunicamycin results in increased expression of ANO10 mRNA
CTD
PMID:38498338
NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:121,841,665...121,962,670
G
Anxa1
annexin A1
increases expression
ISO
Tunicamycin results in increased expression of ANXA1 mRNA
CTD
PMID:29453283
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Anxa3
annexin A3
increases expression
ISO
Tunicamycin results in increased expression of ANXA3 mRNA
CTD
PMID:29453283
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
G
Anxa4
annexin A4
increases expression
ISO
Tunicamycin results in increased expression of ANXA4 mRNA
CTD
PMID:17127020
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:119,184,374...119,241,161
G
Anxa6
annexin A6
decreases expression
ISO
Tunicamycin results in decreased expression of ANXA6 mRNA
CTD
PMID:17127020
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
G
Ap1b1
adaptor related protein complex 1 subunit beta 1
decreases expression
ISO
Tunicamycin results in decreased expression of AP1B1 mRNA
CTD
PMID:17127020
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
increases expression
ISO
Tunicamycin results in increased expression of AP3D1 mRNA
CTD
PMID:22378314
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:8,970,291...9,005,643
G
Ap3m2
adaptor related protein complex 3 subunit mu 2
increases expression
ISO
Tunicamycin results in increased expression of AP3M2 mRNA
CTD
PMID:29453283
NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431
G
Ap3s2
adaptor related protein complex 3 subunit sigma 2
increases expression
ISO
Tunicamycin results in increased expression of AP3S2 mRNA
CTD
PMID:22378314
NCBI chr 1:133,818,825...133,859,269
Ensembl chr 1:133,818,825...133,859,322
G
Ap5s1
adaptor related protein complex 5 subunit sigma 1
increases expression
ISO
Tunicamycin results in increased expression of AP5S1 mRNA
CTD
PMID:33770205
NCBI chr 3:138,882,634...138,885,940
Ensembl chr 3:118,429,637...118,432,926
G
Apcs
amyloid P component, serum
increases expression
ISO
Tunicamycin results in increased expression of APCS mRNA
CTD
PMID:22414386
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:85,373,220...85,374,298
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
decreases expression
ISO
Tunicamycin results in decreased expression of APEX2 mRNA
CTD
PMID:22378314
NCBI chr X:19,425,684...19,508,459
Ensembl chr X:19,487,419...19,508,439
G
Apob
apolipoprotein B
decreases secretion multiple interactions
ISO
Tunicamycin results in decreased secretion of APOB protein [ursodoxicoltaurine co-treated with Tunicamycin] results in increased expression of APOB mRNA; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in decreased secretion of APOB protein]
CTD
PMID:32535746
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc2
apolipoprotein C2
decreases expression
ISO
Tunicamycin results in decreased expression of APOC2 mRNA
CTD
PMID:17127020 PMID:22414386
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apoc3
apolipoprotein C3
decreases expression
ISO
Tunicamycin results in decreased expression of APOC3 mRNA
CTD
PMID:32535746
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
App
amyloid beta precursor protein
multiple interactions increases secretion
ISO
[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA; ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form]; Quercetin inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form]
CTD
PMID:22115781
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Arcn1
archain 1
increases expression
ISO
Tunicamycin results in increased expression of ARCN1 mRNA
CTD
PMID:22378314
NCBI chr 8:45,057,617...45,082,224
Ensembl chr 8:45,057,619...45,082,247
G
Arf4
ARF GTPase 4
increases expression
ISO
Tunicamycin results in increased expression of ARF4 mRNA
CTD
PMID:22378314
NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,896,546...1,913,261
G
Arfgap3
ARF GTPase activating protein 3
increases expression
ISO
Tunicamycin results in increased expression of ARFGAP3 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 7:114,432,873...114,479,206
Ensembl chr 7:114,432,873...114,479,208
G
Arg2
arginase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ARG2 mRNA
CTD
PMID:22378314
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgap45
Rho GTPase activating protein 45
decreases expression
ISO
Tunicamycin results in decreased expression of ARHGAP45 mRNA
CTD
PMID:29453283
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
Tunicamycin results in decreased expression of ARHGDIA mRNA
CTD
PMID:29453283
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Arhgef2
Rho/Rac guanine nucleotide exchange factor 2
increases expression
ISO
Tunicamycin results in increased expression of ARHGEF2 mRNA; Tunicamycin results in increased expression of ARHGEF2 protein
CTD
PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:174,062,976...174,118,355
G
Arid3b
AT-rich interaction domain 3B
decreases expression
ISO
Tunicamycin results in decreased expression of ARID3B mRNA
CTD
PMID:29453283
NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318
G
Arid5b
AT-rich interaction domain 5B
decreases expression
ISO
Tunicamycin results in decreased expression of ARID5B mRNA
CTD
PMID:29453283
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
increases expression
ISO
Tunicamycin results in increased expression of ARIH2 mRNA
CTD
PMID:29453283
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
G
Arl1
ARF like GTPase 1
increases expression
ISO
Tunicamycin results in increased expression of ARL1 mRNA
CTD
PMID:22378314
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
G
Armcx1
armadillo repeat containing, X-linked 1
increases expression
ISO
Tunicamycin results in increased expression of ARMCX1 mRNA
CTD
PMID:22378314
NCBI chr X:102,192,225...102,196,130
Ensembl chr X:97,898,883...97,903,299
G
Armcx3
armadillo repeat containing, X-linked 3
increases expression
ISO
Tunicamycin results in increased expression of ARMCX3 mRNA
CTD
PMID:22378314
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
G
Arrb1
arrestin, beta 1
decreases expression
ISO
Tunicamycin results in decreased expression of ARRB1 mRNA
CTD
PMID:17127020
NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:153,838,078...153,904,061
G
Arrdc4
arrestin domain containing 4
increases expression
ISO
Tunicamycin results in increased expression of ARRDC4 mRNA
CTD
PMID:29453283
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Asb3
ankyrin repeat and SOCS box-containing 3
increases expression
ISO
Tunicamycin results in increased expression of ASB3 mRNA
CTD
PMID:22378314
NCBI chr14:104,659,406...104,788,032
Ensembl chr14:104,611,010...104,788,028
G
Ascc2
activating signal cointegrator 1 complex subunit 2
increases expression
ISO
Tunicamycin results in increased expression of ASCC2 mRNA
CTD
PMID:17127020
NCBI chr14:79,503,449...79,547,801
Ensembl chr14:79,503,517...79,545,494
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression
ISO
Tunicamycin results in decreased expression of ASF1B mRNA
CTD
PMID:22378314
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:24,181,028...24,195,549
G
Asgr1
asialoglycoprotein receptor 1
increases expression
ISO
Tunicamycin results in increased expression of ASGR1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of ASNS mRNA Luteolin inhibits the reaction [Tunicamycin results in increased expression of ASNS mRNA]
CTD
PMID:22378314 PMID:29453283 PMID:32407927 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Ass1
argininosuccinate synthase 1
increases expression
ISO
Tunicamycin results in increased expression of ASS1 mRNA
CTD
PMID:29453283
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atad3a
ATPase family, AAA domain containing 3A
increases expression
ISO
Tunicamycin results in increased expression of ATAD3A mRNA
CTD
PMID:29453283
NCBI chr 5:166,350,302...166,370,492
Ensembl chr 5:166,350,304...166,370,482
G
Atf3
activating transcription factor 3
increases expression
ISO
Tunicamycin results in increased expression of ATF3 mRNA
CTD
PMID:17127020 PMID:22935518 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases phosphorylation increases expression multiple interactions
ISO EXP
Tunicamycin results in increased phosphorylation of ATF4 protein Tunicamycin results in increased expression of ATF4 mRNA; Tunicamycin results in increased expression of ATF4 protein 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA]; ATF4 protein affects the reaction [Tunicamycin results in increased expression of PHGDH protein]; Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; leonurine inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; rosamultin inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; ATF4 protein affects the reaction [Tunicamycin results in increased expression of SESN2 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of ATF4 protein]
CTD
PMID:14604972 PMID:22001960 PMID:22115781 PMID:22378314 PMID:22959463 PMID:22959925 PMID:23741617 PMID:24291486 PMID:24312631 PMID:24648495 PMID:24892553 PMID:27358234 PMID:28688763 PMID:28743512 PMID:28844859 PMID:29453283 PMID:29793971 PMID:30592132 PMID:32357311 PMID:32578922 PMID:32740777 PMID:34533242 PMID:36030031 PMID:36473502 PMID:36586010 PMID:36640941 PMID:38670420 PMID:39427783 More...
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
increases expression
ISO
Tunicamycin results in increased expression of ATF5 mRNA
CTD
PMID:22378314 PMID:28942281 PMID:29453283
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
multiple interactions increases expression decreases cleavage increases cleavage increases expression
EXP ISO
ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein] Tunicamycin results in decreased cleavage of ATF6 protein Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein; Tunicamycin results in increased expression of ATF6 protein modified form 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]; 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein] Tunicamycin results in increased cleavage of ATF6 protein Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form] tunicamycin increases expression of Atf6 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Atf6 mRNA in liver]
CTD RGD
PMID:18477628 PMID:22001960 PMID:22378314 PMID:22959463 PMID:22959925 PMID:24648495 PMID:25160872 PMID:26551149 PMID:28399139 PMID:29723631 PMID:29894845 PMID:30592132 PMID:32407927 PMID:32740777 PMID:36030031 PMID:27813192 PMID:27813192 More...
RGD:401842386 , RGD:401842386
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg13
autophagy related 13
increases expression
ISO
Tunicamycin results in increased expression of ATG13 mRNA
CTD
PMID:22378314
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
G
Atg4b
autophagy related 4B, cysteine peptidase
multiple interactions increases expression
ISO
Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG4B protein]
CTD
PMID:36640941
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
G
Atg5
autophagy related 5
multiple interactions increases response to substance increases expression
ISO EXP
[ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DDIT3 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DNAJB9 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of EIF2AK3 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of HSPA5 mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of PPP1R15A mRNA; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of SQSTM1 protein; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of XBP1 mRNA; ATG5 protein mutant form inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein] Tunicamycin results in increased expression of ATG5 mRNA Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] Tunicamycin results in increased expression of ATG5 mRNA; Tunicamycin results in increased expression of ATG5 protein
CTD
PMID:29793971 PMID:36640941 PMID:37654027
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
G
Atl2
atlastin GTPase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ATL2 mRNA
CTD
PMID:29453283
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
G
Atp11b
ATPase phospholipid transporting 11B (putative)
increases expression
ISO
Tunicamycin results in increased expression of ATP11B mRNA
CTD
PMID:38498338
NCBI chr 2:118,585,348...118,691,076
Ensembl chr 2:118,585,342...118,690,232
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
increases expression
ISO
Tunicamycin results in increased expression of ATP2A2 mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
G
Atp5mc1
ATP synthase membrane subunit c locus 1
decreases expression
ISO
Tunicamycin results in decreased expression of ATP5MC1 mRNA
CTD
PMID:22378314
NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
G
Atp5mc3
ATP synthase membrane subunit c locus 3
decreases expression
ISO
Tunicamycin results in decreased expression of ATP5MC3 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:79,218,014...79,220,664
Ensembl chr 3:58,810,535...58,814,279
G
Atp5mf
ATP synthase membrane subunit f
decreases expression
ISO
Tunicamycin results in decreased expression of ATP5MF mRNA
CTD
PMID:22378314
NCBI chr12:14,535,435...14,542,007
Ensembl chr12:9,421,579...9,428,236
G
Atp5pd
ATP synthase peripheral stalk subunit d
decreases expression
ISO
Tunicamycin results in decreased expression of ATP5PD mRNA
CTD
PMID:22378314
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:100,657,708...100,663,479
G
Atp6v0a1
ATPase H+ transporting V0 subunit a1
increases expression
ISO
Tunicamycin results in increased expression of ATP6V0A1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:86,436,089...86,490,185
Ensembl chr10:85,935,854...85,989,895
G
Atp6v0a2
ATPase H+ transporting V0 subunit a2
increases expression
ISO
Tunicamycin results in increased expression of ATP6V0A2 mRNA
CTD
PMID:29453283
NCBI chr12:37,608,211...37,640,860
Ensembl chr12:31,822,733...32,007,069
G
Atp6v0e1
ATPase H+ transporting V0 subunit e1
decreases expression
ISO
Tunicamycin results in decreased expression of ATP6V0E1 mRNA
CTD
PMID:22378314
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,479,567...16,524,434
G
Atp6v1d
ATPase H+ transporting V1 subunit D
decreases expression
ISO
Tunicamycin results in decreased expression of ATP6V1D mRNA
CTD
PMID:29453283
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:97,656,576...97,672,303
G
Atp6v1g1
ATPase H+ transporting V1 subunit G1
decreases expression
ISO
Tunicamycin results in decreased expression of ATP6V1G1 mRNA
CTD
PMID:17127020
NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:76,961,499...76,969,463
G
Atp6v1g2
ATPase H+ transporting V1 subunit G2
increases expression
ISO
Tunicamycin results in increased expression of ATP6V1G2 mRNA
CTD
PMID:17127020
NCBI chr20:3,592,374...3,595,986
Ensembl chr20:3,587,686...3,590,481
G
Atp7b
ATPase copper transporting beta
increases expression
ISO
Tunicamycin results in increased expression of ATP7B mRNA
CTD
PMID:17127020
NCBI chr16:76,654,725...76,726,092
Ensembl chr16:69,951,778...70,023,636
G
Atp8a1
ATPase phospholipid transporting 8A1
decreases expression
ISO
Tunicamycin results in decreased expression of ATP8A1 mRNA
CTD
PMID:17127020
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
G
Auh
AU RNA binding methylglutaconyl-CoA hydratase
increases expression
ISO
Tunicamycin results in increased expression of AUH mRNA
CTD
PMID:22378314
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
G
Aurka
aurora kinase A
decreases expression
ISO
Tunicamycin results in decreased expression of AURKA mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression
ISO
Tunicamycin results in decreased expression of AURKB mRNA
CTD
PMID:22378314
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:53,745,142...53,750,837
G
B3galt1
Beta-1,3-galactosyltransferase 1
increases expression
ISO
Tunicamycin results in increased expression of B3GALT1 mRNA
CTD
PMID:17127020
NCBI chr 3:72,661,410...73,234,447
Ensembl chr 3:52,253,618...52,825,313
G
B4galt1
beta-1,4-galactosyltransferase 1
increases expression
ISO
Tunicamycin results in increased expression of B4GALT1 mRNA
CTD
PMID:29453283
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:55,935,615...55,982,461
G
B4galt5
beta-1,4-galactosyltransferase 5
decreases expression
ISO
Tunicamycin results in decreased expression of B4GALT5 mRNA
CTD
PMID:22378314
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
G
B9d1
B9 domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of B9D1 mRNA
CTD
PMID:29453283
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
G
Bacc1
BPTF associated chromatin complex component 1
decreases expression
ISO
Tunicamycin results in decreased expression of BACC1 mRNA
CTD
PMID:22378314
NCBI chr10:54,951,991...54,954,756
Ensembl chr10:54,951,991...54,956,601
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
Tunicamycin results in increased expression of BAD mRNA
CTD
PMID:22378314
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
increases activity
ISO
Tunicamycin results in increased activity of BAK1 protein
CTD
PMID:17553788
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression
ISO
Tunicamycin results in decreased expression of BAMBI mRNA
CTD
PMID:29453283
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Banf1
barrier to autointegration nuclear assembly factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of BANF1 mRNA
CTD
PMID:22378314
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
G
Basp1
brain abundant, membrane attached signal protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of BASP1 mRNA
CTD
PMID:22378314
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Bax
BCL2 associated X, apoptosis regulator
increases activity
ISO
Tunicamycin results in increased activity of BAX protein
CTD
PMID:17553788
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
increases expression
ISO
Tunicamycin results in increased expression of BBC3 mRNA
CTD
PMID:22378314 PMID:33545341 PMID:38498338
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Bcat1
branched chain amino acid transaminase 1
increases expression
ISO
Tunicamycin results in increased expression of BCAT1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Bckdha
branched chain keto acid dehydrogenase E1 subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of BCKDHA mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
G
Bckdhb
branched chain keto acid dehydrogenase E1 subunit beta
decreases expression
ISO
Tunicamycin results in decreased expression of BCKDHB mRNA
CTD
PMID:22378314
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
G
Bckdk
branched chain ketoacid dehydrogenase kinase
decreases expression
ISO
Tunicamycin results in decreased expression of BCKDK mRNA
CTD
PMID:22378314
NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:182,515,327...182,536,633
G
Bcl11a
BCL11 transcription factor A
increases expression
ISO
Tunicamycin results in increased expression of BCL11A mRNA
CTD
PMID:17127020
NCBI chr14:102,230,147...102,325,289
Ensembl chr14:98,030,461...98,124,180
G
Bcl2
BCL2, apoptosis regulator
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of BCL2 mRNA Tunicamycin results in increased expression of BCL2 mRNA
CTD
PMID:17127020 PMID:33545341
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
Tunicamycin results in decreased expression of BCL2L1 mRNA
CTD
PMID:22378314
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of BCL2L11 protein Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased expression of BCL2L11 protein]
CTD
PMID:36509116
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:115,366,646...115,404,068
G
Bcl2l2
Bcl2-like 2
increases expression
ISO
Tunicamycin results in increased expression of BCL2L2 mRNA
CTD
PMID:22378314
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:28,356,807...28,361,624
G
Bcl3
BCL3, transcription coactivator
increases expression
ISO
Tunicamycin results in increased expression of BCL3 mRNA
CTD
PMID:17127020
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:79,471,369...79,485,607
G
Bcl6
BCL6, transcription repressor
increases expression
ISO
Tunicamycin results in increased expression of BCL6 mRNA
CTD
PMID:17127020
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:76,854,090...76,877,389
G
Bcs1l
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
increases expression
ISO
Tunicamycin results in increased expression of BCS1L mRNA
CTD
PMID:22378314
NCBI chr 9:76,164,925...76,168,940
Ensembl chr 9:76,164,932...76,168,938
G
Becn1
beclin 1
increases expression
EXP
Tunicamycin results in increased expression of BECN1 mRNA; Tunicamycin results in increased expression of BECN1 protein
CTD
PMID:37654027
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Begain
brain-enriched guanylate kinase-associated
decreases expression
ISO
Tunicamycin results in decreased expression of BEGAIN mRNA
CTD
PMID:22378314
NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841
G
Bend6
BEN domain containing 6
increases expression
ISO
Tunicamycin results in increased expression of BEND6 mRNA
CTD
PMID:22378314
NCBI chr 9:36,081,033...36,135,309
Ensembl chr 9:36,081,484...36,135,228
G
Best1
bestrophin 1
increases expression
ISO
Tunicamycin results in increased expression of BEST1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:216,054,395...216,071,012
Ensembl chr 1:206,629,500...206,646,063
G
Bet1
Bet1 golgi vesicular membrane trafficking protein
increases expression
ISO
Tunicamycin results in increased expression of BET1 mRNA
CTD
PMID:22378314
NCBI chr 4:32,116,232...32,126,592
Ensembl chr 4:32,116,235...32,126,617
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
increases expression
ISO
Tunicamycin results in increased expression of BET1L mRNA
CTD
PMID:22378314
NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:195,931,411...195,935,040
G
Bex1
brain expressed X-linked 1
increases expression
ISO
Tunicamycin results in increased expression of BEX2 mRNA
CTD
PMID:29453283
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
G
Bex2
brain expressed X-linked 2
decreases expression
ISO
Tunicamycin results in decreased expression of BEX1 mRNA
CTD
PMID:22378314
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
G
Bhlhe40
basic helix-loop-helix family, member e40
decreases expression
ISO
Tunicamycin results in decreased expression of BHLHE40 mRNA
CTD
PMID:22378314
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:141,618,476...141,624,774
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
Tunicamycin results in decreased expression of BID mRNA
CTD
PMID:22378314
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
Tunicamycin results in decreased expression of BIRC5 mRNA
CTD
PMID:29453283
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Birc6
baculoviral IAP repeat-containing 6
decreases expression
ISO
Tunicamycin results in decreased expression of BIRC6 mRNA
CTD
PMID:17127020
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
G
Bloc1s1
biogenesis of lysosomal organelles complex-1, subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of BLOC1S1 mRNA
CTD
PMID:22378314
NCBI chr 7:1,347,495...1,351,103
Ensembl chr 7:1,340,934...1,351,558
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
increases expression
ISO
Tunicamycin results in increased expression of BLOC1S2 mRNA
CTD
PMID:22378314
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
G
Blzf1
basic leucine zipper nuclear factor 1
increases expression
ISO
Tunicamycin results in increased expression of BLZF1 mRNA
CTD
PMID:17127020
NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
G
Bmp1
bone morphogenetic protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of BMP1 mRNA
CTD
PMID:17127020
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
G
Bmp2
bone morphogenetic protein 2
increases expression
ISO
Tunicamycin results in increased expression of BMP2 mRNA
CTD
PMID:17127020
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397
G
Bmp8a
bone morphogenetic protein 8a
increases expression
ISO
Tunicamycin results in increased expression of BMP8A mRNA
CTD
PMID:17127020
NCBI chr 5:140,874,942...140,902,881
Ensembl chr 5:135,591,716...135,617,785
G
Bnc2
basonuclin zinc finger protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of BNC2 mRNA
CTD
PMID:22378314
NCBI chr 5:98,679,071...99,016,044
Ensembl chr 5:98,687,410...99,079,426
G
Bnip1
BCL2 interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of BNIP1 mRNA
CTD
PMID:22378314
NCBI chr10:16,891,317...16,903,561
Ensembl chr10:16,386,841...16,399,157
G
Bnip3
BCL2 interacting protein 3
decreases expression
ISO
Tunicamycin results in decreased expression of BNIP3 mRNA
CTD
PMID:22378314
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Bnip3l
BCL2 interacting protein 3 like
decreases expression
ISO
Tunicamycin results in decreased expression of BNIP3L mRNA
CTD
PMID:22378314
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:41,174,594...41,197,803
G
Bola3
bolA family member 3
decreases expression
ISO
Tunicamycin results in decreased expression of BOLA3 mRNA
CTD
PMID:22378314
NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:115,853,350...115,862,797
G
Bphl
biphenyl hydrolase like
decreases expression
ISO
Tunicamycin results in decreased expression of BPHL mRNA
CTD
PMID:22378314
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
G
Brca1
BRCA1, DNA repair associated
increases expression
ISO
Tunicamycin results in increased expression of BRCA1 protein
CTD
PMID:16434996
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
increases expression
ISO
Tunicamycin results in increased expression of BRCA2 protein
CTD
PMID:16434996
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567
G
Brd2
bromodomain containing 2
increases expression
ISO
Tunicamycin results in increased expression of BRD2 mRNA
CTD
PMID:22378314
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,151...4,735,388
G
Brinp1
BMP/retinoic acid inducible neural specific 1
decreases expression
ISO
Tunicamycin results in decreased expression of BRINP1 mRNA
CTD
PMID:22378314
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
G
Brix1
biogenesis of ribosomes BRX1
increases expression
ISO
Tunicamycin results in increased expression of BRIX1 mRNA
CTD
PMID:17127020
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495
G
Bsg
basigin
decreases expression
ISO
Tunicamycin results in decreased expression of BSG mRNA
CTD
PMID:22378314
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
G
Bsn
bassoon (presynaptic cytomatrix protein)
increases expression
ISO
Tunicamycin results in increased expression of BSN mRNA
CTD
PMID:29453283
NCBI chr 8:108,784,849...108,875,819
Ensembl chr 8:108,788,542...108,875,819
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO
Tunicamycin results in decreased expression of BUB1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:115,020,254...115,051,650
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
Tunicamycin results in decreased expression of BUB1B mRNA
CTD
PMID:22378314
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:105,563,138...105,615,547
G
Bud31
BUD31 homolog
increases expression
ISO
Tunicamycin results in increased expression of BUD31 mRNA
CTD
PMID:29453283
NCBI chr12:9,462,838...9,470,387
Ensembl chr12:9,462,441...9,470,509
G
C10h17orf100
similar to human chromosome 17 open reading frame 100
increases expression
ISO
Tunicamycin results in increased expression of C17ORF100 mRNA
CTD
PMID:29453283
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
G
C10h17orf58
similar to human chromosome 17 open reading frame 58
decreases expression
ISO
Tunicamycin results in decreased expression of C17ORF58 mRNA
CTD
PMID:22378314
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
G
C11h3orf52
similar to human chromosome 3 open reading frame 52
decreases expression
ISO
Tunicamycin results in decreased expression of C3ORF52 mRNA
CTD
PMID:29453283
NCBI chr11:55,166,986...55,192,273
Ensembl chr11:55,166,678...55,192,292
G
C1qbp
complement C1q binding protein
decreases expression
ISO
Tunicamycin results in decreased expression of C1QBP mRNA
CTD
PMID:22378314
NCBI chr10:56,198,534...56,203,185
Ensembl chr10:55,699,954...55,704,649
G
C2h1orf162
similar to human chromosome 1 open reading frame 162
increases expression
ISO
Tunicamycin results in increased expression of C1ORF162 mRNA
CTD
PMID:22378314
NCBI chr 2:193,410,730...193,420,824
Ensembl chr 2:193,412,971...193,420,030
G
C3h11orf96
similar to human chromosome 11 open reading frame 96
increases expression
ISO
Tunicamycin results in increased expression of C11ORF96 mRNA
CTD
PMID:29453283
NCBI chr 3:79,920,125...79,921,368
Ensembl chr 3:79,920,129...79,921,523
G
C5h1orf122
similar to human chromosome 1 open reading frame 122
increases expression
ISO
Tunicamycin results in increased expression of C1ORF122 mRNA
CTD
PMID:29453283
NCBI chr 5:137,109,093...137,110,130
Ensembl chr 5:137,108,633...137,110,929
G
C9h6orf141
similar to human chromosome 6 open reading frame 141
increases expression
ISO
Tunicamycin results in increased expression of C6ORF141 mRNA
CTD
PMID:29453283
NCBI chr 9:20,024,916...20,029,094
Ensembl chr 9:20,024,916...20,029,094
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
increases expression
ISO
Tunicamycin results in increased expression of CACNA1C mRNA
CTD
PMID:17127020
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:151,764,138...152,379,648
G
Cacna2d2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
decreases expression
ISO
Tunicamycin results in decreased expression of CACNA2D2 mRNA
CTD
PMID:22378314
NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:108,072,454...108,203,173
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
increases expression
ISO
Tunicamycin results in increased expression of CACNB2 mRNA
CTD
PMID:17127020
NCBI chr17:82,473,097...82,818,564
Ensembl chr17:77,564,460...77,909,106
G
Cacng4
calcium voltage-gated channel auxiliary subunit gamma 4
decreases expression
ISO
Tunicamycin results in decreased expression of CACNG4 mRNA
CTD
PMID:22378314
NCBI chr10:93,183,410...93,245,470
Ensembl chr10:92,683,761...92,746,126
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
increases expression
ISO
Tunicamycin results in increased expression of CAD mRNA
CTD
PMID:17127020
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Cadm1
cell adhesion molecule 1
decreases expression
ISO
Tunicamycin results in decreased expression of CADM1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
G
Calcb
calcitonin-related polypeptide, beta
increases expression
ISO
Tunicamycin results in increased expression of CALCB mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:168,965,383...168,970,259
Ensembl chr 1:168,966,465...168,970,125
G
Calm1
calmodulin 1
decreases expression
ISO
Tunicamycin results in decreased expression of CALM1 mRNA
CTD
PMID:22378314
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:119,487,621...119,498,227
G
Calm2
calmodulin 2
decreases expression
ISO
Tunicamycin results in decreased expression of CALM2 mRNA
CTD
PMID:22378314
NCBI chr 6:12,845,170...12,857,830
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Calm3
calmodulin 3
decreases expression
ISO
Tunicamycin results in decreased expression of CALM3 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207
G
Calr
calreticulin
increases expression
EXP ISO
Tunicamycin results in increased expression of CALR protein Tunicamycin results in increased expression of CALR mRNA Tunicamycin results in increased expression of CALR mRNA; Tunicamycin results in increased expression of CALR protein
CTD
PMID:15049342 PMID:22001960 PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
increases expression multiple interactions decreases expression
ISO EXP
Tunicamycin results in increased expression of CALU mRNA ibutilide inhibits the reaction [Tunicamycin results in decreased expression of CALU mRNA]; ibutilide inhibits the reaction [Tunicamycin results in decreased expression of CALU protein] Tunicamycin results in decreased expression of CALU mRNA; Tunicamycin results in decreased expression of CALU protein
CTD
PMID:22378314 PMID:28399139
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
decreases expression
ISO
Tunicamycin results in decreased expression of CAMK1D mRNA
CTD
PMID:17127020
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
G
Camk1g
calcium/calmodulin-dependent protein kinase IG
increases expression
ISO
Tunicamycin results in increased expression of CAMK1G mRNA
CTD
PMID:17127020
NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases expression
ISO
Tunicamycin results in decreased expression of CAMK4 mRNA
CTD
PMID:17127020
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Canx
calnexin
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of CANX mRNA; Tunicamycin results in increased expression of CANX protein ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of CANX protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of CANX protein]
CTD
PMID:22378314 PMID:27588471 PMID:29453283
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
G
Car10
carbonic anhydrase 10
decreases expression
ISO
Tunicamycin results in decreased expression of CA10 mRNA
CTD
PMID:22378314
NCBI chr10:78,551,067...79,053,421
Ensembl chr10:78,054,114...78,555,834
G
Car2
carbonic anhydrase 2
decreases expression
ISO
Tunicamycin results in decreased expression of CA2 mRNA
CTD
PMID:29453283
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
G
Car5b
carbonic anhydrase 5B
increases expression
ISO
Tunicamycin results in increased expression of CA5B mRNA
CTD
PMID:22378314
NCBI chr X:34,106,553...34,166,651
Ensembl chr X:30,474,784...30,533,837
G
Card9
caspase recruitment domain family, member 9
increases expression
ISO
Tunicamycin results in increased expression of CARD9 mRNA
CTD
PMID:22378314
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of CARHSP1 mRNA
CTD
PMID:22378314
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of CARS1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Casp1
caspase 1
increases activity
EXP
Tunicamycin results in increased activity of CASP1 protein
CTD
PMID:37654027
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
increases cleavage multiple interactions increases activity
ISO EXP
Tunicamycin results in increased cleavage of CASP12 protein Nicotine inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein] resveratrol inhibits the reaction [Tunicamycin results in increased activity of CASP12 protein]
CTD
PMID:17003819 PMID:18477628 PMID:24224909
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp2
caspase 2
multiple interactions increases activity decreases expression
ISO
Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP2 protein] Tunicamycin results in decreased expression of CASP2 mRNA
CTD
PMID:16388830 PMID:22378314
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
multiple interactions increases cleavage increases activity increases expression
ISO EXP
Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein]; Bortezomib promotes the reaction [Tunicamycin results in increased activity of CASP3 protein]; Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form]; [spautin-1 results in decreased susceptibility to Tunicamycin] which results in decreased expression of CASP3 protein modified form; Luteolin inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form]; TRP53 protein affects the reaction [HR protein affects the reaction [Tunicamycin results in increased activity of CASP3 protein]]; Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased cleavage of CASP3 protein]] 1-Deoxynojirimycin inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; HR protein inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]
CTD
PMID:12871656 PMID:14747384 PMID:16357177 PMID:16388830 PMID:17553788 PMID:19028522 PMID:19735704 PMID:20886113 PMID:24680926 PMID:28399139 PMID:29793971 PMID:31330229 PMID:32407927 PMID:36509116 PMID:37394652 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
decreases expression increases cleavage
ISO
Tunicamycin results in decreased expression of CASP4 mRNA Tunicamycin results in increased cleavage of CASP4 protein
CTD
PMID:17127020 PMID:26551149
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp6
caspase 6
decreases expression
ISO
Tunicamycin results in decreased expression of CASP6 mRNA
CTD
PMID:17127020
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
increases activity increases expression
ISO
Tunicamycin results in increased activity of CASP7 protein Tunicamycin results in increased expression of CASP7 protein modified form
CTD
PMID:19139269 PMID:31330229
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
multiple interactions increases activity increases cleavage increases expression
ISO
Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] Tunicamycin results in increased cleavage of CASP9 protein Tunicamycin results in increased expression of CASP9 mRNA Tunicamycin results in increased expression of CASP9 protein modified form
CTD
PMID:14747384 PMID:16388830 PMID:17553788 PMID:22378314 PMID:31330229
Ensembl chr 5:154,109,046...154,126,626
G
Cblb
Cbl proto-oncogene B
increases expression
ISO
Tunicamycin results in increased expression of CBLB mRNA
CTD
PMID:38498338
NCBI chr11:62,058,829...62,225,904
Ensembl chr11:48,592,703...48,756,839
G
Cbln2
cerebellin 2 precursor
decreases expression
ISO
Tunicamycin results in decreased expression of CBLN2 mRNA
CTD
PMID:22378314
NCBI chr18:79,940,412...79,948,766
Ensembl chr18:79,942,590...79,947,855
G
Cbs
cystathionine beta synthase
increases expression
ISO
Tunicamycin results in increased expression of CBS mRNA
CTD
PMID:29453283
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Cbx4
chromobox 4
increases expression
ISO
Tunicamycin results in increased expression of CBX4 mRNA
CTD
PMID:22378314 PMID:33545341 PMID:38498338
NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,336,876...104,356,706
G
Cbx6
chromobox 6
decreases expression
ISO
Tunicamycin results in decreased expression of CBX6 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:111,372,979...111,383,026
Ensembl chr 7:111,372,980...111,383,091
G
Ccar1
cell division cycle and apoptosis regulator 1
increases expression
ISO
Tunicamycin results in increased expression of CCAR1 mRNA
CTD
PMID:17127020
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
G
Ccdc167
coiled-coil domain containing 167
decreases expression
ISO
Tunicamycin results in decreased expression of CCDC167 mRNA
CTD
PMID:22378314
NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613
G
Ccdc171
coiled-coil domain containing 171
decreases expression
ISO
Tunicamycin results in decreased expression of CCDC171 mRNA
CTD
PMID:22378314
NCBI chr 5:97,919,965...98,403,853
Ensembl chr 5:97,920,002...98,282,833
G
Ccdc24
coiled-coil domain containing 24
increases expression decreases expression
ISO
Tunicamycin results in increased expression of CCDC24 mRNA Tunicamycin results in decreased expression of CCDC24 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:131,398,766...131,412,395
Ensembl chr 5:131,408,143...131,412,029
G
Ccdc28a
coiled-coil domain containing 28A
increases expression
ISO
Tunicamycin results in increased expression of CCDC28A mRNA
CTD
PMID:22378314
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases expression increases expression
ISO
Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] Tunicamycin results in decreased expression of CCL2 mRNA Tunicamycin results in increased expression of CCL2 mRNA
CTD
PMID:18799549 PMID:22378314 PMID:38498338
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Tunicamycin results in increased expression of CCL20 mRNA
CTD
PMID:33545341
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
Tunicamycin results in increased expression of CCL3 mRNA
CTD
PMID:38498338
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
Tunicamycin results in increased expression of CCL4 mRNA
CTD
PMID:33545341
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccn1
cellular communication network factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of CYR61 mRNA
CTD
PMID:36586010
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn3
cellular communication network factor 3
increases expression
ISO
Tunicamycin results in increased expression of CCN3 mRNA
CTD
PMID:29453283
NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:86,094,000...86,101,019
G
Ccna1
cyclin A1
decreases expression
ISO
Tunicamycin results in decreased expression of CCNA1 mRNA
CTD
PMID:22378314
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
G
Ccna2
cyclin A2
decreases expression
ISO
Tunicamycin results in decreased expression of CCNA2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
Tunicamycin results in decreased expression of CCNB1 mRNA
CTD
PMID:29453283
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnb1ip1
cyclin B1 interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of CCNB1IP1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:24,014,905...24,031,357
Ensembl chr15:24,014,908...24,028,475
G
Ccnb2
cyclin B2
decreases expression
ISO
Tunicamycin results in decreased expression of CCNB2 mRNA
CTD
PMID:22378314
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
decreases expression
ISO
Tunicamycin results in decreased expression of CCND1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnf
cyclin F
decreases expression
ISO
Tunicamycin results in decreased expression of CCNF mRNA
CTD
PMID:22378314
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,253,380...13,279,101
G
Ccnt2
cyclin T2
increases expression
ISO
Tunicamycin results in increased expression of CCNT2 mRNA
CTD
PMID:17127020
NCBI chr13:39,251,573...39,293,172
Ensembl chr13:39,251,573...39,292,019
G
Ccnyl1
cyclin Y-like 1
decreases expression
ISO
Tunicamycin results in decreased expression of CCNYL1 mRNA
CTD
PMID:29453283
NCBI chr 9:66,071,721...66,121,742
Ensembl chr 9:66,071,543...66,107,999
G
Ccpg1
cell cycle progression 1
increases expression
ISO
Tunicamycin results in increased expression of CCPG1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
G
Cct6a
chaperonin containing TCP1 subunit 6A
decreases expression
ISO
Tunicamycin results in decreased expression of CCT6A mRNA
CTD
PMID:29453283
NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
G
Cd24
CD24 molecule
decreases expression
ISO
Tunicamycin results in decreased expression of CD24 mRNA
CTD
PMID:22378314
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:47,073,512...47,079,662
G
Cd248
CD248 molecule
decreases expression
ISO
Tunicamycin results in decreased expression of CD248 mRNA
CTD
PMID:22378314
NCBI chr 1:202,373,676...202,376,240
Ensembl chr 1:202,373,676...202,376,240
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
Tunicamycin results in increased expression of CD55 mRNA
CTD
PMID:17127020 PMID:29453283 PMID:33545341 PMID:38498338
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:41,857,395...41,885,831
G
Cd69
Cd69 molecule
increases expression
ISO
Tunicamycin results in increased expression of CD69 mRNA
CTD
PMID:33545341
NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:162,725,446...162,733,542
G
Cdc27
cell division cycle 27
increases expression
ISO
Tunicamycin results in increased expression of CDC27 mRNA
CTD
PMID:17127020
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
G
Cdc45
cell division cycle 45
increases expression
ISO
Tunicamycin results in increased expression of CDC45 mRNA
CTD
PMID:17127020
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
G
Cdc6
cell division cycle 6
increases expression
ISO
Tunicamycin results in increased expression of CDC6 mRNA
CTD
PMID:38498338
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:83,864,638...83,878,011
G
Cdc7
cell division cycle 7
decreases expression
ISO
Tunicamycin results in decreased expression of CDC7 mRNA
CTD
PMID:22378314
NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,804,661...2,824,778
G
Cdca2
cell division cycle associated 2
decreases expression
ISO
Tunicamycin results in decreased expression of CDCA2 mRNA
CTD
PMID:22378314
NCBI chr15:46,071,360...46,117,524
Ensembl chr15:41,895,901...41,941,611
G
Cdca3
cell division cycle associated 3
increases expression decreases expression
ISO
Tunicamycin results in increased expression of CDCA3 mRNA Tunicamycin results in decreased expression of CDCA3 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdca7
cell division cycle associated 7
decreases expression
ISO
Tunicamycin results in decreased expression of CDCA7 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
G
Cdca7l
cell division cycle associated 7 like
decreases expression
ISO
Tunicamycin results in decreased expression of CDCA7L mRNA
CTD
PMID:22378314
NCBI chr 6:138,793,953...138,839,889
Ensembl chr 6:138,794,228...138,839,888
G
Cdca8
cell division cycle associated 8
decreases expression
ISO
Tunicamycin results in decreased expression of CDCA8 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:137,176,417...137,198,629
G
Cdh1
cadherin 1
increases expression
ISO
Tunicamycin results in increased expression of CDH1 mRNA
CTD
PMID:17127020
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cdh10
cadherin 10
increases expression
ISO
Tunicamycin results in increased expression of CDH10 mRNA
CTD
PMID:17127020
NCBI chr 2:70,355,521...70,577,880
Ensembl chr 2:68,628,780...68,850,995
G
Cdh13
cadherin 13
multiple interactions
ISO
Tunicamycin promotes the reaction [HSPA5 protein binds to CDH13 protein]
CTD
PMID:23544152
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:46,349,430...47,387,459
G
Cdh15
cadherin 15
increases expression
ISO
Tunicamycin results in increased expression of CDH15 mRNA
CTD
PMID:22378314
NCBI chr19:67,812,169...67,834,986
Ensembl chr19:50,903,638...50,927,105
G
Cdh2
cadherin 2
increases expression
ISO
Tunicamycin results in increased expression of CDH2 mRNA
CTD
PMID:17127020
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:7,776,704...7,990,167
G
Cdh22
cadherin 22
decreases expression
ISO
Tunicamycin results in decreased expression of CDH22 mRNA
CTD
PMID:17127020
NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:153,845,787...153,970,588
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of CDK1 mRNA
CTD
PMID:22378314
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Tunicamycin results in decreased expression of CDK2 mRNA
CTD
PMID:22378314
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
increases expression
ISO
Tunicamycin results in increased expression of CDK2AP2 mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cdk5
cyclin-dependent kinase 5
decreases expression
ISO
Tunicamycin results in decreased expression of CDK5 mRNA
CTD
PMID:22378314
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of CDK5R1 mRNA
CTD
PMID:22378314
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cdk5rap3
CDK5 regulatory subunit associated protein 3
increases expression
ISO
Tunicamycin results in increased expression of CDK5RAP3 mRNA
CTD
PMID:29453283
NCBI chr10:81,894,393...81,903,581
Ensembl chr10:81,894,393...81,903,590
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Tunicamycin results in decreased expression of CDK6 mRNA
CTD
PMID:17127020
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdk7
cyclin-dependent kinase 7
increases expression
ISO
Tunicamycin results in increased expression of CDK7 mRNA
CTD
PMID:17127020
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:31,840,558...31,865,383
G
Cdkl3
cyclin-dependent kinase-like 3
increases expression
ISO
Tunicamycin results in increased expression of CDKL3 mRNA
CTD
PMID:22378314
NCBI chr10:36,755,413...36,850,197
Ensembl chr10:36,266,977...36,349,268
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
Tunicamycin results in decreased expression of CDKN1C mRNA
CTD
PMID:17127020
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdo1
cysteine dioxygenase type 1
increases expression
ISO
Tunicamycin results in increased expression of CDO1 mRNA
CTD
PMID:22378314
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
G
Cdr2
cerebellar degeneration-related protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of CDR2 mRNA
CTD
PMID:22378314
NCBI chr 1:175,502,837...175,527,746
Ensembl chr 1:175,502,838...175,537,472
G
Cdrt4
CMT1A duplicated region transcript 4
increases expression
ISO
Tunicamycin results in increased expression of CDRT4 mRNA
CTD
PMID:29453283
NCBI chr10:48,124,695...48,156,717
Ensembl chr10:47,625,470...47,657,493
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of CEBPB mRNA CEBPB protein inhibits the reaction [Tunicamycin results in decreased expression of PPARGC1A protein]
CTD
PMID:22378314 PMID:28482072 PMID:29453283 PMID:33545341 PMID:36586010
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
G
Cebpg
CCAAT/enhancer binding protein gamma
increases expression
ISO
Tunicamycin results in increased expression of CEBPG mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:87,684,019...87,694,569
G
Celf1
CUGBP, Elav-like family member 1
decreases expression
ISO
Tunicamycin results in decreased expression of CELF1 mRNA
CTD
PMID:29453283
NCBI chr 3:76,924,591...76,999,429
Ensembl chr 3:76,924,613...76,999,426
G
Celsr3
cadherin, EGF LAG seven-pass G-type receptor 3
increases expression
ISO
Tunicamycin results in increased expression of CELSR3 mRNA
CTD
PMID:29453283
NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:109,530,641...109,558,354
G
Cenpa
centromere protein A
decreases expression
ISO
Tunicamycin results in decreased expression of CENPA mRNA
CTD
PMID:22378314
NCBI chr 6:31,420,062...31,431,703
Ensembl chr 6:25,700,142...25,711,675
G
Cenpf
centromere protein F
decreases expression
ISO
Tunicamycin results in decreased expression of CENPF mRNA
CTD
PMID:22378314
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cenpu
centromere protein U
decreases expression
ISO
Tunicamycin results in decreased expression of CENPU mRNA
CTD
PMID:22378314
NCBI chr16:52,448,446...52,471,662
Ensembl chr16:45,714,294...45,738,823
G
Cep44
centrosomal protein 44
decreases expression
ISO
Tunicamycin results in decreased expression of CEP44 mRNA
CTD
PMID:22378314
NCBI chr16:33,711,548...33,733,226
Ensembl chr16:33,711,559...33,733,225
G
Cep55
centrosomal protein 55
decreases expression
ISO
Tunicamycin results in decreased expression of CEP55 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
G
Cep68
centrosomal protein 68
decreases expression
ISO
Tunicamycin results in decreased expression of CEP68 mRNA
CTD
PMID:33770205
NCBI chr14:94,447,973...94,470,533
Ensembl chr14:94,449,055...94,470,517
G
Cep95
centrosomal protein 95
increases expression
ISO
Tunicamycin results in increased expression of CEP95 mRNA
CTD
PMID:22378314
NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092
G
Cfap263
cilia and flagella associated protein 263
increases expression
ISO
Tunicamycin results in increased expression of CFAP263 mRNA
CTD
PMID:22378314
NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,496,886...9,516,923
G
Cfap300
cilia and flagella associated protein 300
increases expression
ISO
Tunicamycin results in increased expression of CFAP300 mRNA
CTD
PMID:29453283
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
G
Cfap61
cilia and flagella associated protein 61
increases expression
ISO
Tunicamycin results in increased expression of CFAP61 mRNA
CTD
PMID:22378314
NCBI chr 3:133,354,400...133,633,310
Ensembl chr 3:133,354,197...133,633,320
G
Cfl1
cofilin 1
decreases expression
ISO
Tunicamycin results in decreased expression of CFL1 mRNA
CTD
PMID:22378314
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:202,786,627...202,817,587
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
Tunicamycin results in increased expression of CFLAR mRNA
CTD
PMID:17127020
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Cgref1
cell growth regulator with EF hand domain 1
decreases expression
ISO
Tunicamycin results in decreased expression of CGREF1 mRNA
CTD
PMID:17127020
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
increases expression
ISO
Tunicamycin results in increased expression of CHAC1 mRNA
CTD
PMID:29453283 PMID:33545341 PMID:36586010
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:106,342,302...106,345,526
G
Chd1l
chromodomain helicase DNA binding protein 1-like
decreases expression
ISO
Tunicamycin results in decreased expression of CHD1L mRNA
CTD
PMID:22378314
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
G
Chd7
chromodomain helicase DNA binding protein 7
decreases expression
ISO
Tunicamycin results in decreased expression of CHD7 mRNA
CTD
PMID:22378314
NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:21,812,070...21,995,358
G
Chga
chromogranin A
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of CHGA mRNA Tunicamycin results in increased expression of CHGA mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Chgb
chromogranin B
increases expression
ISO
Tunicamycin results in increased expression of CHGB mRNA
CTD
PMID:29453283
NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:120,043,738...120,057,166
G
Chpf
chondroitin polymerizing factor
increases expression
ISO
Tunicamycin results in increased expression of CHPF mRNA
CTD
PMID:22378314
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
G
Chpt1
choline phosphotransferase 1
increases expression
ISO
Tunicamycin results in increased expression of CHPT1 mRNA
CTD
PMID:22378314
NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:22,863,027...22,915,103
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
increases expression
ISO
Tunicamycin results in increased expression of CHRNA4 mRNA
CTD
PMID:33545341
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
decreases expression
ISO
Tunicamycin results in decreased expression of CHRNA5 mRNA
CTD
PMID:22378314
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
decreases expression
ISO
Tunicamycin results in decreased expression of CHRNB4 mRNA
CTD
PMID:22378314
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
G
Chst2
carbohydrate sulfotransferase 2
increases expression
ISO
Tunicamycin results in increased expression of CHST2 mRNA
CTD
PMID:17127020
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
G
Cidec
cell death-inducing DFFA-like effector c
increases expression
ISO
Tunicamycin results in increased expression of CIDEC mRNA
CTD
PMID:22414386
NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:146,569,289...146,582,173
G
Cilk1
ciliogenesis associated kinase 1
increases expression
ISO
Tunicamycin results in increased expression of CILK1 mRNA
CTD
PMID:17127020
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
G
Cirbp
cold inducible RNA binding protein
increases expression
ISO
Tunicamycin results in increased expression of CIRBP mRNA
CTD
PMID:29453283
NCBI chr 7:10,184,515...10,189,623
Ensembl chr 7:9,424,178...9,538,818
G
Cisd2
CDGSH iron sulfur domain 2
increases expression
ISO
Tunicamycin results in increased expression of CISD2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
increases expression
ISO
Tunicamycin results in increased expression of CITED1 mRNA
CTD
PMID:22378314
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
G
Ckb
creatine kinase B
decreases expression
ISO
Tunicamycin results in decreased expression of CKB mRNA
CTD
PMID:22378314
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
G
Ckm
creatine kinase, M-type
increases expression
ISO
Tunicamycin results in increased expression of CKM mRNA
CTD
PMID:17127020
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
G
Ckmt2
creatine kinase, mitochondrial 2
increases expression
ISO
Tunicamycin results in increased expression of CKMT2 mRNA
CTD
PMID:17127020
NCBI chr 2:23,079,918...23,110,518
Ensembl chr 2:23,079,918...23,110,430
G
Clcc1
chloride channel CLIC-like 1
increases expression
ISO
Tunicamycin results in increased expression of CLCC1 mRNA
CTD
PMID:22378314
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
G
Cldn3
claudin 3
increases expression
ISO
Tunicamycin results in increased expression of CLDN3 mRNA
CTD
PMID:22378314
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:21,708,398...21,711,001
G
Cldn4
claudin 4
increases expression
ISO
Tunicamycin results in increased expression of CLDN4 mRNA
CTD
PMID:17127020
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:21,751,331...21,753,436
G
Cldn6
claudin 6
increases expression
ISO
Tunicamycin results in increased expression of CLDN6 mRNA
CTD
PMID:17127020
NCBI chr10:13,213,837...13,218,578
Ensembl chr10:12,709,960...12,715,973
G
Cldn7
claudin 7
increases expression
ISO
Tunicamycin results in increased expression of CLDN7 mRNA
CTD
PMID:38498338
NCBI chr10:55,188,670...55,190,871
Ensembl chr10:54,689,987...54,692,171
G
Clec11a
C-type lectin domain containing 11A
decreases expression
ISO
Tunicamycin results in decreased expression of CLEC11A mRNA
CTD
PMID:17127020
NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:94,801,496...94,804,633
G
Clic5
chloride intracellular channel 5
increases expression
ISO
Tunicamycin results in increased expression of CLIC5 mRNA
CTD
PMID:17127020
NCBI chr 9:16,710,980...16,813,502
Ensembl chr 9:16,710,980...16,813,427
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
increases expression
ISO
Tunicamycin results in increased expression of CLN3 mRNA
CTD
PMID:29453283
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
G
Clstn1
calsyntenin 1
decreases expression
ISO
Tunicamycin results in decreased expression of CLSTN1 mRNA
CTD
PMID:17127020
NCBI chr 5:160,031,235...160,094,585
Ensembl chr 5:160,031,308...160,094,583
G
Cmpk2
cytidine/uridine monophosphate kinase 2
increases expression
ISO
Tunicamycin results in increased expression of CMPK2 mRNA
CTD
PMID:38498338
NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:43,073,796...43,085,183
G
Cmss1
cms1 ribosomal small subunit homolog
increases expression
ISO
Tunicamycin results in increased expression of CMSS1 mRNA
CTD
PMID:29453283
NCBI chr11:42,934,390...43,232,624
Ensembl chr11:42,934,440...43,232,624
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
decreases expression
ISO
Tunicamycin results in decreased expression of CMTM6 mRNA
CTD
PMID:29453283
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
G
Cmtm7
CKLF-like MARVEL transmembrane domain containing 7
decreases expression
ISO
Tunicamycin results in decreased expression of CMTM7 mRNA
CTD
PMID:22378314
NCBI chr 8:123,326,233...123,353,148
Ensembl chr 8:114,448,042...114,474,621
G
Cnn3
calponin 3
decreases expression
ISO
Tunicamycin results in decreased expression of CNN3 mRNA
CTD
PMID:22378314
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
G
Cog3
component of oligomeric golgi complex 3
increases expression
ISO
Tunicamycin results in increased expression of COG3 mRNA
CTD
PMID:22378314
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
G
Cog6
component of oligomeric golgi complex 6
increases expression
ISO
Tunicamycin results in increased expression of COG6 mRNA
CTD
PMID:22378314
NCBI chr 2:137,062,127...137,099,176
Ensembl chr 2:137,061,346...137,099,190
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
ISO
Tunicamycin results in decreased expression of COL4A1 mRNA
CTD
PMID:22378314
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
G
Col4a5
collagen type IV alpha 5 chain
increases expression
ISO
Tunicamycin results in increased expression of COL4A5 mRNA
CTD
PMID:17127020
NCBI chr X:105,118,762...105,322,699
Ensembl chr X:105,118,820...105,322,692
G
Col5a1
collagen type V alpha 1 chain
decreases expression
ISO
Tunicamycin results in decreased expression of COL5A1 mRNA
CTD
PMID:29453283
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Colgalt1
collagen beta(1-O)galactosyltransferase 1
decreases expression
ISO
Tunicamycin results in decreased expression of COLGALT1 mRNA
CTD
PMID:22378314
NCBI chr16:18,319,796...18,332,106
Ensembl chr16:18,319,795...18,332,106
G
Colgalt2
collagen beta(1-O)galactosyltransferase 2
increases expression
ISO
Tunicamycin results in increased expression of COLGALT2 mRNA
CTD
PMID:29453283
NCBI chr13:64,523,641...64,628,295
Ensembl chr13:64,523,658...64,627,549
G
Commd5
COMM domain containing 5
increases expression
ISO
Tunicamycin results in increased expression of COMMD5 mRNA
CTD
PMID:22378314
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
G
Comtd1
catechol-O-methyltransferase domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of COMTD1 mRNA
CTD
PMID:29453283
NCBI chr15:2,459,783...2,462,895
Ensembl chr15:2,459,783...2,462,895
G
Cop1
COP1, E3 ubiquitin ligase
increases expression
ISO
Tunicamycin results in increased expression of COP1 mRNA
CTD
PMID:17127020
NCBI chr13:73,954,058...74,095,283
Ensembl chr13:71,429,961...71,538,890
G
Copa
COPI coat complex subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of COPA mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
G
Copb1
COPI coat complex subunit beta 1
increases expression
ISO
Tunicamycin results in increased expression of COPB1 mRNA
CTD
PMID:22378314
NCBI chr 1:168,404,334...168,438,589
Ensembl chr 1:168,404,335...168,438,416
G
Copb2
COPI coat complex subunit beta 2
increases expression
ISO
Tunicamycin results in increased expression of COPB2 mRNA
CTD
PMID:22378314
NCBI chr 8:99,161,324...99,183,452
Ensembl chr 8:99,161,350...99,185,197
G
Cope
COPI coat complex subunit epsilon
increases expression
ISO
Tunicamycin results in increased expression of COPE mRNA
CTD
PMID:29453283
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
G
Copg1
COPI coat complex subunit gamma 1
increases expression
ISO
Tunicamycin results in increased expression of COPG1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
G
Coq10b
coenzyme Q10B
increases expression
ISO
Tunicamycin results in increased expression of COQ10B mRNA
CTD
PMID:22378314
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
G
Coq3
coenzyme Q3 methyltransferase
decreases expression
ISO
Tunicamycin results in decreased expression of COQ3 mRNA
CTD
PMID:22378314
NCBI chr 5:35,429,567...35,460,613
Ensembl chr 5:35,429,574...35,460,607
G
Coq7
coenzyme Q7, hydroxylase
decreases expression
ISO
Tunicamycin results in decreased expression of COQ7 mRNA
CTD
PMID:22378314
NCBI chr 1:172,836,359...172,851,173
Ensembl chr 1:172,835,188...172,851,158
G
Coq8a
coenzyme Q8A
increases expression
ISO
Tunicamycin results in increased expression of COQ8A mRNA
CTD
PMID:22378314
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
G
Coro1a
coronin 1A
decreases expression
ISO
Tunicamycin results in decreased expression of CORO1A mRNA
CTD
PMID:22378314
NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:181,295,562...181,300,534
G
Cox11
cytochrome c oxidase copper chaperone COX11
increases expression
ISO
Tunicamycin results in increased expression of COX11 mRNA
CTD
PMID:22378314
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
G
Cox16
cytochrome c oxidase assembly factor COX16
decreases expression
ISO
Tunicamycin results in decreased expression of COX16 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:101,162,231...101,181,277
Ensembl chr 6:101,019,680...101,181,246
G
Cox19
cytochrome c oxidase assembly factor COX19
increases expression
ISO
Tunicamycin results in increased expression of COX19 mRNA
CTD
PMID:29453283
NCBI chr12:15,303,535...15,313,014
Ensembl chr12:15,303,551...15,313,014
G
Cox4i1
cytochrome c oxidase subunit 4i1
decreases expression
ISO
Tunicamycin results in decreased expression of COX4I1 protein
CTD
PMID:36473502
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:48,721,199...48,727,921
G
Cox6b1
cytochrome c oxidase subunit 6B1
decreases expression
ISO
Tunicamycin results in decreased expression of COX6B1 mRNA
CTD
PMID:22378314
NCBI chr 1:95,002,513...95,011,516
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001 Ensembl chr 5:85,875,109...85,884,001
G
Cox6c
cytochrome c oxidase subunit 6C
decreases expression
ISO
Tunicamycin results in decreased expression of COX6C mRNA
CTD
PMID:22378314
NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:67,111,024...67,141,963
G
Cox7b
cytochrome c oxidase subunit 7B
decreases expression
ISO
Tunicamycin results in decreased expression of COX7B mRNA
CTD
PMID:22378314
NCBI chr X:75,149,036...75,155,285
Ensembl chr X:71,083,456...71,089,732
G
Cox7c
cytochrome c oxidase subunit 7C
decreases expression
ISO
Tunicamycin results in decreased expression of COX7C mRNA
CTD
PMID:22378314
NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:16,840,837...16,843,760
G
Cox8a
cytochrome c oxidase subunit 8A
decreases expression
ISO
Tunicamycin results in decreased expression of COX8A mRNA
CTD
PMID:22378314
NCBI chr 1:213,831,302...213,833,623
G
Cpa4
carboxypeptidase A4
increases expression
ISO
Tunicamycin results in increased expression of CPA4 mRNA
CTD
PMID:17127020
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
G
Cpd
carboxypeptidase D
decreases expression
ISO
Tunicamycin results in decreased expression of CPD mRNA
CTD
PMID:17127020
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
G
Cpe
carboxypeptidase E
increases expression
ISO
Tunicamycin results in increased expression of CPE mRNA
CTD
PMID:29453283
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cpeb3
cytoplasmic polyadenylation element binding protein 3
increases expression
ISO
Tunicamycin results in increased expression of CPEB3 mRNA
CTD
PMID:22378314
NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:234,751,733...234,931,560
G
Cpt1c
carnitine palmitoyltransferase 1c
increases expression
ISO
Tunicamycin results in increased expression of CPT1C mRNA
CTD
PMID:22378314
NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:95,442,817...95,457,342
G
Crabp1
cellular retinoic acid binding protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of CRABP1 mRNA
CTD
PMID:22378314
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
G
Crabp2
cellular retinoic acid binding protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of CRABP2 mRNA
CTD
PMID:22378314
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Cradd
CASP2 and RIPK1 domain containing adaptor with death domain
decreases expression
ISO
Tunicamycin results in decreased expression of CRADD mRNA
CTD
PMID:17127020
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
G
Crat
carnitine O-acetyltransferase
increases expression
ISO
Tunicamycin results in increased expression of CRAT mRNA
CTD
PMID:22378314
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:13,675,684...13,689,255
G
Creb3l2
cAMP responsive element binding protein 3-like 2
increases expression
ISO
Tunicamycin results in increased expression of CREB3L2 mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr 4:65,907,570...66,112,078
Ensembl chr 4:65,907,655...66,023,763
G
Creb3l4
cAMP responsive element binding protein 3-like 4
increases expression
ISO
Tunicamycin results in increased expression of CREB3L4 mRNA
CTD
PMID:29453283
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
G
Crebrf
CREB3 regulatory factor
increases expression
ISO
Tunicamycin results in increased expression of CREBRF mRNA
CTD
PMID:22378314
NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,404,596...16,461,999
G
Creld1
cysteine-rich with EGF-like domains 1
increases expression
ISO
Tunicamycin results in increased expression of CRELD1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
G
Creld2
cysteine-rich with EGF-like domains 2
increases expression
ISO
Tunicamycin results in increased expression of CRELD2 mRNA; Tunicamycin results in increased expression of CRELD2 protein
CTD
PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
G
Crtac1
cartilage acidic protein 1
increases expression
ISO
Tunicamycin results in increased expression of CRTAC1 mRNA
CTD
PMID:29453283
NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421
G
Cry1
cryptochrome circadian regulator 1
decreases expression
ISO
Tunicamycin results in decreased expression of CRY1 mRNA
CTD
PMID:22378314
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:18,529,823...18,594,091
G
Crybb2
crystallin, beta B2
increases expression
ISO
Tunicamycin results in increased expression of CRYBB2 mRNA
CTD
PMID:29453283
NCBI chr12:43,569,747...43,579,671
Ensembl chr12:43,569,747...43,579,671
G
Cse1l
chromosome segregation 1 like
decreases expression
ISO
Tunicamycin results in decreased expression of CSE1L mRNA
CTD
PMID:29453283
NCBI chr 3:155,641,104...155,678,866
Ensembl chr 3:155,641,166...155,678,865
G
Csnk1d
casein kinase 1, delta
increases expression
ISO
Tunicamycin results in increased expression of CSNK1D mRNA
CTD
PMID:17127020
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,221,992...106,256,614
G
Csnk1g1
casein kinase 1, gamma 1
increases expression
ISO
Tunicamycin results in increased expression of CSNK1G1 mRNA
CTD
PMID:22378314
NCBI chr 8:75,334,751...75,472,339
Ensembl chr 8:66,439,864...66,572,826
G
Csnk2a2
casein kinase 2 alpha 2
increases expression
ISO
Tunicamycin results in increased expression of CSNK2A2 mRNA
CTD
PMID:22378314
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression
ISO
Tunicamycin results in increased expression of CSRNP1 mRNA
CTD
PMID:17127020
NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:119,704,713...119,718,183
G
Csrp1
cysteine and glycine-rich protein 1
increases expression
ISO
Tunicamycin results in increased expression of CSRP1 mRNA
CTD
PMID:29453283
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
G
Csrp2
cysteine and glycine-rich protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of CSRP2 mRNA
CTD
PMID:22378314
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
G
Ctcf
CCCTC-binding factor
decreases expression
ISO
Tunicamycin results in decreased expression of CTCF mRNA
CTD
PMID:22378314
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
G
Cth
cystathionine gamma-lyase
increases expression
ISO
Tunicamycin results in increased expression of CTH mRNA; Tunicamycin results in increased expression of CTH protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnna1
catenin alpha 1
decreases expression
ISO
Tunicamycin results in decreased expression of CTNNA1 mRNA
CTD
PMID:17127020
NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,728,485...26,860,910
G
Ctnnbl1
catenin, beta like 1
decreases expression
ISO
Tunicamycin results in decreased expression of CTNNBL1 mRNA
CTD
PMID:17127020
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
G
Ctnnd2
catenin delta 2
decreases expression
ISO
Tunicamycin results in decreased expression of CTNND2 mRNA
CTD
PMID:17127020
NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764
G
Ctps1
CTP synthase 1
decreases expression
ISO
Tunicamycin results in decreased expression of CTPS1 mRNA
CTD
PMID:22378314
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctsd
cathepsin D
increases expression
ISO
Tunicamycin results in increased expression of CTSD mRNA
CTD
PMID:22378314
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
G
Cuedc2
CUE domain containing 2
decreases expression
ISO
Tunicamycin results in decreased expression of CUEDC2 mRNA
CTD
PMID:22378314
NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339
G
Cul4a
cullin 4A
decreases expression
ISO
Tunicamycin results in decreased expression of CUL4A mRNA
CTD
PMID:17127020
NCBI chr16:83,086,688...83,124,503
Ensembl chr16:76,384,546...76,422,330
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
Tunicamycin results in increased expression of CXCL1 mRNA
CTD
PMID:33545341
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
Tunicamycin results in increased expression of CXCL2 mRNA
CTD
PMID:33545341
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
Tunicamycin results in increased expression of CXCL1 mRNA
CTD
PMID:33545341
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyb561d1
cytochrome b561 family, member D1
decreases expression
ISO
Tunicamycin results in decreased expression of CYB561D1 mRNA
CTD
PMID:17127020
NCBI chr 2:195,834,884...195,837,524
Ensembl chr 2:195,834,740...195,838,243
G
Cyb5a
cytochrome b5 type A
decreases expression
ISO
Tunicamycin results in decreased expression of CYB5A mRNA
CTD
PMID:22378314
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyb5b
cytochrome b5 type B
decreases expression
ISO
Tunicamycin results in decreased expression of CYB5B mRNA
CTD
PMID:22378314
NCBI chr19:51,972,611...52,006,477
Ensembl chr19:35,062,813...35,098,249
G
Cyb5r3
cytochrome b5 reductase 3
decreases expression
ISO
Tunicamycin results in decreased expression of CYB5R3 mRNA
CTD
PMID:22378314
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Cycs
cytochrome c, somatic
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of CYCS mRNA Tunicamycin results in increased expression of CYCS mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cygb
cytoglobin
decreases expression
ISO
Tunicamycin results in decreased expression of CYGB mRNA
CTD
PMID:22378314
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:101,877,676...101,887,442
G
Cyp2g1
cytochrome P450, family 2, subfamily g, polypeptide 1
decreases expression
ISO
Tunicamycin results in decreased expression of CYP2G1 mRNA
CTD
PMID:17127020
NCBI chr 1:82,145,635...82,156,862
Ensembl chr 1:82,145,073...82,156,828
G
Cyp39a1
cytochrome P450, family 39, subfamily a, polypeptide 1
decreases expression
ISO
Tunicamycin results in decreased expression of CYP39A1 mRNA
CTD
PMID:17127020
NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:17,230,455...17,306,775
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
ISO
Tunicamycin results in decreased expression of CYP8B1 mRNA
CTD
PMID:17127020
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Dach1
dachshund family transcription factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of DACH1 mRNA
CTD
PMID:22378314
NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922
G
Dap
death-associated protein
increases expression
ISO
Tunicamycin results in increased expression of DAP mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:82,199,280...82,251,752
G
Dbi
diazepam binding inhibitor
decreases expression
ISO
Tunicamycin results in decreased expression of DBI mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Dbnl
drebrin-like
decreases expression
ISO
Tunicamycin results in decreased expression of DBNL mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr14:80,666,115...80,681,155
Ensembl chr14:80,666,124...80,681,155
G
Dbt
dihydrolipoamide branched chain transacylase E2
increases expression
ISO
Tunicamycin results in increased expression of DBT mRNA
CTD
PMID:22378314
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
G
Dctpp1
dCTP pyrophosphatase 1
decreases expression
ISO
Tunicamycin results in decreased expression of DCTPP1 mRNA
CTD
PMID:22378314
NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839
G
Dcx
doublecortin
decreases expression
ISO
Tunicamycin results in decreased expression of DCX mRNA
CTD
PMID:22378314
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:107,430,767...107,507,476
G
Ddc
dopa decarboxylase
decreases expression
ISO
Tunicamycin results in decreased expression of DDC mRNA
CTD
PMID:22378314
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases activity increases expression
ISO EXP
2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Bortezomib inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; leonurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; rosamultin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; SESN2 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; SESN2 protein promotes the reaction [Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DDIT3 mRNA; [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Amiloride inhibits the reaction [Tunicamycin results in increased expression of DDIT3]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; Bortezomib inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Tretinoin promotes the reaction [Tunicamycin results in increased expression of DDIT3 mRNA] Tunicamycin results in increased activity of DDIT3 protein 1-Deoxynojirimycin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Guanabenz inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; GW 506033X inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; salubrinal promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; TGFB1 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] Tunicamycin results in increased expression of DDIT3 mRNA; Tunicamycin results in increased expression of DDIT3 protein Tunicamycin results in increased expression of DDIT3; Tunicamycin results in increased expression of DDIT3 mRNA; Tunicamycin results in increased expression of DDIT3 protein
CTD
PMID:10542372 PMID:14604972 PMID:16330322 PMID:16357177 PMID:17003819 PMID:17127020 PMID:19028522 PMID:19139269 PMID:19428936 PMID:19735704 PMID:20015086 PMID:20196124 PMID:20477944 PMID:20593179 PMID:20626587 PMID:21321189 PMID:22001960 PMID:22215663 PMID:22378314 PMID:22414386 PMID:22509299 PMID:22935518 PMID:22959463 PMID:22959925 PMID:23123503 PMID:23684743 PMID:23741617 PMID:24210820 PMID:24370435 PMID:24648495 PMID:24680926 PMID:24892553 PMID:25160872 PMID:25324550 PMID:27358234 PMID:28399139 PMID:28482072 PMID:28688763 PMID:28698385 PMID:28844859 PMID:28942281 PMID:29027487 PMID:29289645 PMID:29380555 PMID:29453283 PMID:29723631 PMID:29793971 PMID:30253173 PMID:32407927 PMID:32535746 PMID:32574669 PMID:32578922 PMID:32740777 PMID:33127435 PMID:33545341 PMID:34533242 PMID:34626751 PMID:36030031 PMID:36586010 PMID:37654027 PMID:38498338 PMID:38670420 More...
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
Tunicamycin results in increased expression of DDIT4 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
G
Ddost
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
increases expression
ISO
Tunicamycin results in increased expression of DDOST mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
G
Ddx23
DEAD-box helicase 23
decreases expression
ISO
Tunicamycin results in decreased expression of DDX23 mRNA
CTD
PMID:29453283
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
G
Ddx46
DEAD-box helicase 46
decreases expression
ISO
Tunicamycin results in decreased expression of DDX46 mRNA
CTD
PMID:29453283
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
G
Ddx49
DEAD-box helicase 49
increases expression
ISO
Tunicamycin results in increased expression of DDX49 mRNA
CTD
PMID:22378314
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
G
Ddx60
DEXD/H-box helicase 60
increases expression
ISO
Tunicamycin results in increased expression of DDX60 mRNA
CTD
PMID:38498338
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Decr1
2,4-dienoyl-CoA reductase 1
increases expression
ISO
Tunicamycin results in increased expression of DECR1 mRNA
CTD
PMID:22378314
NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:29,411,172...29,439,018
G
Dedd2
death effector domain containing 2
increases expression
ISO
Tunicamycin results in increased expression of DEDD2 mRNA
CTD
PMID:22378314
NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714
G
Depdc1b
DEP domain containing 1B
decreases expression
ISO
Tunicamycin results in decreased expression of DEPDC1B mRNA
CTD
PMID:22378314
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
G
Deptor
DEP domain containing MTOR-interacting protein
increases expression
ISO
Tunicamycin results in increased expression of DEPTOR mRNA
CTD
PMID:22378314
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Derl2
derlin 2
increases expression
ISO
Tunicamycin results in increased expression of DERL2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:56,226,340...56,238,038
Ensembl chr10:55,727,643...55,739,518
G
Derl3
derlin 3
increases expression
ISO
Tunicamycin results in increased expression of DERL3 mRNA
CTD
PMID:29453283
NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,763,543...12,767,027
G
Dgat1
diacylglycerol O-acyltransferase 1
increases expression
ISO
Tunicamycin results in increased expression of DGAT1 mRNA
CTD
PMID:22414386
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:108,218,524...108,234,299
G
Dgkk
diacylglycerol kinase kappa
increases expression
ISO
Tunicamycin results in increased expression of DGKK mRNA
CTD
PMID:17127020
NCBI chr X:18,253,849...18,385,805
Ensembl chr X:15,583,572...15,712,987
G
Dglucy
D-glutamate cyclase
decreases expression
ISO
Tunicamycin results in decreased expression of DGLUCY mRNA
CTD
PMID:22378314
NCBI chr 6:120,055,480...120,130,910
Ensembl chr 6:120,055,460...120,130,910
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
Tunicamycin results in decreased expression of DHCR24 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
decreases expression
ISO
Tunicamycin results in decreased expression of DHCR7 mRNA
CTD
PMID:22378314
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dhrs13
dehydrogenase/reductase 13
increases expression
ISO
Tunicamycin results in increased expression of DHRS13 mRNA
CTD
PMID:29453283
NCBI chr10:62,920,791...62,925,952
G
Dhrs2
dehydrogenase/reductase 2
increases expression
ISO
Tunicamycin results in increased expression of DHRS2 mRNA
CTD
PMID:29453283
NCBI chr15:32,658,855...32,673,591
Ensembl chr15:28,688,940...28,703,644
G
Dhrs3
dehydrogenase/reductase 3
increases expression
ISO
Tunicamycin results in increased expression of DHRS3 mRNA
CTD
PMID:22378314
NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:156,747,962...156,782,417
G
Dhrs7
dehydrogenase/reductase 7
increases expression
ISO
Tunicamycin results in increased expression of DHRS7 mRNA
CTD
PMID:29453283
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Dhrs7b
dehydrogenase/reductase 7B
increases expression
ISO
Tunicamycin results in increased expression of DHRS7B mRNA
CTD
PMID:29453283
NCBI chr10:46,003,845...46,036,498
Ensembl chr10:45,504,426...45,537,076
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
Tunicamycin results in decreased expression of DHX9 mRNA
CTD
PMID:22378314
NCBI chr13:68,152,813...68,189,580
Ensembl chr13:65,602,323...65,639,069
G
Diablo
diablo, IAP-binding mitochondrial protein
increases expression
ISO
Tunicamycin results in increased expression of DIABLO mRNA
CTD
PMID:22378314
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Dicer1
dicer 1 ribonuclease III
decreases expression
ISO
Tunicamycin results in decreased expression of DICER1 mRNA
CTD
PMID:17127020
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:123,631,250...123,693,965
G
Dis3
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease
increases expression
ISO
Tunicamycin results in increased expression of DIS3 mRNA
CTD
PMID:22378314
NCBI chr15:75,820,040...75,850,450
Ensembl chr15:75,823,436...75,850,642
G
Dis3l
DIS3-like exosome 3'-5' exoribonuclease
increases expression
ISO
Tunicamycin results in increased expression of DIS3L mRNA
CTD
PMID:29453283
NCBI chr 8:64,803,925...64,840,306
Ensembl chr 8:64,803,927...64,840,165
G
Disp2
dispatched RND transporter family member 2
decreases expression
ISO
Tunicamycin results in decreased expression of DISP2 mRNA
CTD
PMID:22378314
NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800
G
Dld
dihydrolipoamide dehydrogenase
decreases expression
ISO
Tunicamycin results in decreased expression of DLD mRNA
CTD
PMID:22378314
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
G
Dlg4
discs large MAGUK scaffold protein 4
increases expression
ISO
Tunicamycin results in increased expression of DLG4 mRNA
CTD
PMID:22378314
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:54,739,470...54,767,153
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
Tunicamycin results in decreased expression of DLGAP5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlk1
delta like non-canonical Notch ligand 1
decreases expression
ISO
Tunicamycin results in decreased expression of DLK1 mRNA
CTD
PMID:22378314
NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:128,410,316...128,417,522
G
Dll3
delta like canonical Notch ligand 3
decreases expression
ISO
Tunicamycin results in decreased expression of DLL3 mRNA
CTD
PMID:22378314
NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:83,562,014...83,569,750
G
Dlst
dihydrolipoamide S-succinyltransferase
increases expression
ISO
Tunicamycin results in increased expression of DLST mRNA
CTD
PMID:17127020
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
G
Dlx5
distal-less homeobox 5
decreases expression
ISO
Tunicamycin results in decreased expression of DLX5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
G
Dmac2l
distal membrane arm assembly component 2 like
decreases expression
ISO
Tunicamycin results in decreased expression of DMAC2L mRNA
CTD
PMID:22378314
NCBI chr 6:93,941,605...93,959,932
Ensembl chr 6:88,205,700...88,223,933
G
Dmkn
dermokine
increases expression
ISO
Tunicamycin results in increased expression of DMKN mRNA
CTD
PMID:29453283
NCBI chr 1:86,013,237...86,031,243
Ensembl chr 1:86,014,188...86,030,006
G
Dmrt1
doublesex and mab-3 related transcription factor 1
increases expression
ISO
Tunicamycin results in increased expression of DMRT1 mRNA
CTD
PMID:29453283
NCBI chr 1:232,569,179...232,667,646
Ensembl chr 1:223,142,859...223,241,333
G
Dmtf1
cyclin D binding myb-like transcription factor 1
increases expression
ISO
Tunicamycin results in increased expression of DMTF1 mRNA
CTD
PMID:17127020
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
decreases expression
ISO
Tunicamycin results in decreased expression of DNAJA1 mRNA
CTD
PMID:22378314
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:55,842,426...55,853,967
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
increases expression
ISO
Tunicamycin results in increased expression of DNAJA3 mRNA
CTD
PMID:22378314
NCBI chr10:11,361,168...11,386,599
Ensembl chr10:10,854,732...10,880,161
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
Tunicamycin results in decreased expression of DNAJB1 mRNA
CTD
PMID:20196124
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:24,522,717...24,526,458
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
increases expression
ISO
Tunicamycin results in increased expression of DNAJB11 mRNA; Tunicamycin results in increased expression of DNAJB11 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dnajb2
DnaJ heat shock protein family (Hsp40) member B2
increases expression
ISO
Tunicamycin results in increased expression of DNAJB2 mRNA
CTD
PMID:22378314
NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:76,731,065...76,739,277
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of DNAJB9 mRNA [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of DNAJB9 mRNA Luteolin inhibits the reaction [Tunicamycin results in increased expression of DNAJB9 mRNA]
CTD
PMID:22001960 PMID:22378314 PMID:23123503 PMID:29453283 PMID:29793971 PMID:32407927 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:61,269,913...61,275,063
G
Dnajc10
DnaJ heat shock protein family (Hsp40) member C10
increases expression
ISO
Tunicamycin results in increased expression of DNAJC10 mRNA; Tunicamycin results in increased expression of DNAJC10 protein
CTD
PMID:29453283
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
decreases expression
ISO
Tunicamycin results in decreased expression of DNAJC12 mRNA
CTD
PMID:22378314
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
G
Dnajc15
DnaJ heat shock protein family (Hsp40) member C15
decreases expression
ISO
Tunicamycin results in decreased expression of DNAJC15 mRNA
CTD
PMID:17127020
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
G
Dnajc17
DnaJ heat shock protein family (Hsp40) member C17
decreases expression
ISO
Tunicamycin results in decreased expression of DNAJC17 mRNA
CTD
PMID:17127020
NCBI chr 3:106,162,197...106,195,771
Ensembl chr 3:106,162,197...106,195,751
G
Dnajc25
DnaJ heat shock protein family (Hsp40) member C25
increases expression
ISO
Tunicamycin results in increased expression of DNAJC25 mRNA
CTD
PMID:22378314
NCBI chr 5:73,825,565...73,847,878
Ensembl chr 5:73,825,565...73,845,433
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
increases expression
ISO
Tunicamycin results in increased expression of DNAJC3 mRNA; Tunicamycin results in increased expression of DNAJC3 protein
CTD
PMID:24312631 PMID:29453283
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:96,025,624...96,065,181
G
Dnase2
deoxyribonuclease 2, lysosomal
increases expression
ISO
Tunicamycin results in increased expression of DNASE2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnhd1
dynein heavy chain domain 1
increases expression
ISO
Tunicamycin results in increased expression of DNHD1 mRNA
CTD
PMID:22378314
NCBI chr 1:159,990,785...160,077,990
Ensembl chr 1:159,990,438...160,074,858
G
Dpagt1
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
increases expression
ISO
Tunicamycin results in increased expression of DPAGT1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
G
Dpf1
double PHD fingers 1
decreases expression
ISO
Tunicamycin results in decreased expression of DPF1 mRNA
CTD
PMID:22378314
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Dph5
diphthamide biosynthesis 5
increases expression
ISO
Tunicamycin results in increased expression of DPH5 mRNA
CTD
PMID:22378314
NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433
G
Dpp3
dipeptidylpeptidase 3
decreases expression
ISO
Tunicamycin results in decreased expression of DPP3 mRNA
CTD
PMID:22378314
NCBI chr 1:211,634,067...211,657,898
Ensembl chr 1:202,204,693...202,228,541
G
Dpyd
dihydropyrimidine dehydrogenase
decreases expression
ISO
Tunicamycin results in decreased expression of DPYD mRNA
CTD
PMID:17127020
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dpysl3
dihydropyrimidinase-like 3
decreases expression
ISO
Tunicamycin results in decreased expression of DPYSL3 mRNA
CTD
PMID:22378314
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
G
Dpysl4
dihydropyrimidinase-like 4
increases expression
ISO
Tunicamycin results in increased expression of DPYSL4 mRNA
CTD
PMID:29453283
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
G
Dscam
DS cell adhesion molecule
increases expression
ISO
Tunicamycin results in increased expression of DSCAM mRNA
CTD
PMID:17127020
NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415
G
Dtl
denticleless E3 ubiquitin protein ligase homolog
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of DTL mRNA Tunicamycin results in increased expression of DTL mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr13:105,646,908...105,685,921
Ensembl chr13:103,117,186...103,154,890
G
Dus4l
dihydrouridine synthase 4-like
increases expression
ISO
Tunicamycin results in increased expression of DUS4L mRNA
CTD
PMID:22378314
NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449
G
Dusp1
dual specificity phosphatase 1
decreases expression
ISO
Tunicamycin results in decreased expression of DUSP1 mRNA
CTD
PMID:17127020
NCBI chr10:17,184,853...17,187,646
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
Tunicamycin results in increased expression of DUSP16 mRNA
CTD
PMID:17127020
NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:167,548,155...167,629,980
G
Dusp23
dual specificity phosphatase 23
decreases expression
ISO
Tunicamycin results in decreased expression of DUSP23 mRNA
CTD
PMID:22378314
NCBI chr13:85,097,899...85,100,054
Ensembl chr13:85,097,899...85,100,093
G
Dusp26
dual specificity phosphatase 26
increases expression
ISO
Tunicamycin results in increased expression of DUSP26 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr16:61,041,784...61,049,319
Ensembl chr16:61,041,792...61,049,051
G
Dusp5
dual specificity phosphatase 5
decreases expression
ISO
Tunicamycin results in decreased expression of DUSP5 mRNA
CTD
PMID:29453283
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:252,538,449...252,551,818
G
Dusp6
dual specificity phosphatase 6
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of DUSP6 mRNA Tunicamycin results in increased expression of DUSP6 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:34,092,943...34,097,185
G
Dut
deoxyuridine triphosphatase
decreases expression
ISO
Tunicamycin results in decreased expression of DUT mRNA
CTD
PMID:22378314
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:112,498,982...112,510,771
G
Dxo
decapping exoribonuclease
increases expression
ISO
Tunicamycin results in increased expression of DXO mRNA
CTD
PMID:22378314
NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
G
Dync1i1
dynein cytoplasmic 1 intermediate chain 1
decreases expression
ISO
Tunicamycin results in decreased expression of DYNC1I1 mRNA
CTD
PMID:22378314
NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149
G
Dync2i2
dynein 2 intermediate chain 2
decreases expression
ISO
Tunicamycin results in decreased expression of DYNC2I2 mRNA
CTD
PMID:22378314
NCBI chr 3:13,306,039...13,322,121
Ensembl chr 3:13,306,039...13,322,121
G
Dynll2
dynein light chain LC8-type 2
decreases expression
ISO
Tunicamycin results in decreased expression of DYNLL2 mRNA
CTD
PMID:22378314
NCBI chr10:73,264,260...73,283,042
Ensembl chr10:72,767,035...72,785,805
G
Dyrk4
dual specificity tyrosine phosphorylation regulated kinase 4
increases expression
ISO
Tunicamycin results in increased expression of DYRK4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
G
E2f1
E2F transcription factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of E2F1 mRNA
CTD
PMID:22378314
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
E2f2
E2F transcription factor 2
decreases expression
ISO
Tunicamycin results in decreased expression of E2F2 mRNA
CTD
PMID:22378314
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:148,399,642...148,421,217
G
E2f5
E2F transcription factor 5
decreases expression
ISO
Tunicamycin results in decreased expression of E2F5 mRNA
CTD
PMID:17127020
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
G
E2f8
E2F transcription factor 8
decreases expression
ISO
Tunicamycin results in decreased expression of E2F8 mRNA
CTD
PMID:17127020
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:98,565,717...98,584,098
G
Ebf1
EBF transcription factor 1
increases expression decreases expression
ISO
Tunicamycin results in increased expression of EBF1 mRNA Tunicamycin results in decreased expression of EBF1 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,099,933...29,487,665
G
Ecd
ecdysoneless cell cycle regulator
decreases expression
ISO
Tunicamycin results in decreased expression of ECD mRNA
CTD
PMID:29453283
NCBI chr15:3,967,209...3,998,713
Ensembl chr15:3,967,382...3,998,706
G
Ech1
enoyl-CoA hydratase 1
increases expression
ISO
Tunicamycin results in increased expression of ECH1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
ISO
Tunicamycin results in increased expression of EDEM1 mRNA; Tunicamycin results in increased expression of EDEM1 protein
CTD
PMID:19735704 PMID:22378314 PMID:22414386 PMID:24312631 PMID:29453283 PMID:36586010 More...
NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:141,797,701...141,829,717
G
Edem2
ER degradation enhancing alpha-mannosidase like protein 2
increases expression
ISO
Tunicamycin results in increased expression of EDEM2 mRNA
CTD
PMID:22378314
NCBI chr 3:164,661,741...164,687,559
Ensembl chr 3:144,201,605...144,227,485
G
Edil3
EGF like repeats and discoidin domains 3
increases expression
ISO
Tunicamycin results in increased expression of EDIL3 mRNA
CTD
PMID:17127020
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
increases expression
ISO
Tunicamycin results in increased expression of EEF1A2 mRNA
CTD
PMID:17127020
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
G
Eepd1
endonuclease/exonuclease/phosphatase family domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of EEPD1 mRNA
CTD
PMID:22378314
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
G
Efhc1
EF-hand domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of EFHC1 mRNA
CTD
PMID:22378314
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
G
Efna1
ephrin A1
increases expression
ISO
Tunicamycin results in increased expression of EFNA1 mRNA
CTD
PMID:22378314
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:174,681,682...174,690,866
G
Efnb2
ephrin B2
increases expression decreases expression
ISO
Tunicamycin results in increased expression of EFNB2 mRNA Tunicamycin results in decreased expression of EFNB2 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:80,783,417...80,824,391
G
Efs
embryonal Fyn-associated substrate
decreases expression
ISO
Tunicamycin results in decreased expression of EFS mRNA
CTD
PMID:22378314
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
G
Eftud2
elongation factor Tu GTP binding domain containing 2
decreases expression
ISO
Tunicamycin results in decreased expression of EFTUD2 mRNA
CTD
PMID:22378314
NCBI chr10:87,804,893...87,852,181
Ensembl chr10:87,804,892...87,846,079
G
Egln1
egl-9 family hypoxia-inducible factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of EGLN1 mRNA
CTD
PMID:29453283
NCBI chr19:69,765,276...69,804,681
Ensembl chr19:52,869,486...52,907,777
G
Egr1
early growth response 1
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of EGR1 mRNA Tunicamycin results in increased expression of EGR1 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif1
eukaryotic translation initiation factor 1
increases expression
ISO
Tunicamycin results in increased expression of EIF1 mRNA
CTD
PMID:22378314
NCBI chr10:85,747,064...85,749,447
Ensembl chr10:85,246,764...85,427,327 Ensembl chr 5:85,246,764...85,427,327
G
Eif1b
eukaryotic translation initiation factor 1B
increases expression
ISO
Tunicamycin results in increased expression of EIF1B mRNA
CTD
PMID:29453283
NCBI chr 8:129,080,497...129,083,772
Ensembl chr 8:120,203,451...120,206,176 Ensembl chr 5:120,203,451...120,206,176
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation increases expression
ISO
Tunicamycin results in increased phosphorylation of EIF2A protein Tunicamycin results in increased expression of EIF2A mRNA
CTD
PMID:20015086 PMID:22378314 PMID:22959463
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression multiple interactions increases response to substance increases phosphorylation increases expression
ISO EXP
Tunicamycin results in increased expression of EIF2AK3 mRNA; Tunicamycin results in increased expression of EIF2AK3 protein Tunicamycin results in increased expression of EIF2AK3 mRNA; Tunicamycin results in increased expression of EIF2AK3 protein modified form 1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of EIF2AK3 mRNA; [Tunicamycin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]]; Bortezomib inhibits the reaction [1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 mRNA]]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; Ketoconazole inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to EIF2AK3 protein]; Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein EIF2AK3 gene mutant form results in increased susceptibility to Tunicamycin 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide promotes the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; leonurine inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; rosamultin inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; Tunicamycin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2AK3 protein]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of EIF2AK3 protein] tunicamycin increases expression of Eif2ak3 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Eif2ak3 mRNA in liver]
CTD RGD
PMID:16330322 PMID:22001960 PMID:22378314 PMID:22509299 PMID:22959925 PMID:23741617 PMID:24224909 PMID:24648495 PMID:24898257 PMID:26551149 PMID:28399139 PMID:29449374 PMID:29793971 PMID:29894845 PMID:30253173 PMID:30592132 PMID:32740777 PMID:34533242 PMID:36030031 PMID:37654027 PMID:38670420 PMID:27813192 PMID:27813192 More...
RGD:401842386 , RGD:401842386
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Eif2ak4
eukaryotic translation initiation factor 2 alpha kinase 4
multiple interactions
ISO
Tunicamycin inhibits the reaction [[EIF2AK4 gene mutant form affects the susceptibility to Amino Acids deficiency] which results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:29449374
NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:105,356,261...105,441,630
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
multiple interactions increases phosphorylation increases expression decreases phosphorylation
ISO EXP
[Tunicamycin results in increased phosphorylation of EIF2S1 protein] which results in decreased expression of MCL1 protein; Bortezomib inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; leonurine inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; NDRG1 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; PTPN1 protein affects the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; rosamultin inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Guanabenz promotes the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 mRNA] Tunicamycin results in increased expression of EIF2S1 protein; Tunicamycin results in increased expression of EIF2S1 protein modified form EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of EIF2S1 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; EIF2S1 protein mutant form inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein]; Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein Tunicamycin results in decreased phosphorylation of EIF2S1 protein
CTD
PMID:16330322 PMID:16357177 PMID:17553788 PMID:22509299 PMID:23741617 PMID:24210820 PMID:24224909 PMID:24532803 PMID:24648495 PMID:24892553 PMID:25160872 PMID:28359145 PMID:28844859 PMID:29109149 PMID:29289645 PMID:29449374 PMID:30253173 PMID:30385349 PMID:30592132 PMID:32407927 PMID:32578922 PMID:34533242 PMID:36030031 PMID:38670420 More...
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Eif2s2
eukaryotic translation initiation factor 2 subunit beta
increases expression
ISO
Tunicamycin results in increased expression of EIF2S2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
G
Eif4e
eukaryotic translation initiation factor 4E
increases expression
ISO
Tunicamycin results in increased expression of EIF4E mRNA
CTD
PMID:17127020
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:227,066,673...227,098,683
G
Eif4e2
eukaryotic translation initiation factor 4E family member 2
decreases expression
ISO
Tunicamycin results in decreased expression of EIF4E2 mRNA
CTD
PMID:22378314
NCBI chr 9:95,333,439...95,362,366
Ensembl chr 9:87,878,085...87,914,482
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
increases expression
ISO
Tunicamycin results in increased expression of EIF4EBP1 mRNA; Tunicamycin results in increased expression of EIF4EBP1 protein
CTD
PMID:29453283 PMID:36586010
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of EIF4EBP2 mRNA
CTD
PMID:22378314
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
G
Eif5
eukaryotic translation initiation factor 5
increases expression
ISO
Tunicamycin results in increased expression of EIF5 mRNA
CTD
PMID:17127020
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
G
Eif5b
eukaryotic translation initiation factor 5B
decreases expression
ISO
Tunicamycin results in decreased expression of EIF5B mRNA
CTD
PMID:29453283
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
G
Elf3
E74 like ETS transcription factor 3
decreases expression
ISO
Tunicamycin results in decreased expression of ELF3 mRNA
CTD
PMID:22378314
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression
ISO
Tunicamycin results in decreased expression of ELOVL6 mRNA
CTD
PMID:29453283
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:218,063,804...218,171,186
G
Emc9
ER membrane protein complex subunit 9
increases expression
ISO
Tunicamycin results in increased expression of EMC9 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
G
Eml2
EMAP like 2
increases expression
ISO
Tunicamycin results in increased expression of EML2 mRNA
CTD
PMID:22378314
NCBI chr 1:87,955,924...87,987,366
Ensembl chr 1:78,828,080...78,859,341
G
Emp3
epithelial membrane protein 3
increases expression
ISO
Tunicamycin results in increased expression of EMP3 mRNA
CTD
PMID:29453283
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
G
Enc1
ectodermal-neural cortex 1
decreases expression
ISO
Tunicamycin results in decreased expression of ENC1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Endog
endonuclease G
decreases expression
ISO
Tunicamycin results in decreased expression of ENDOG mRNA
CTD
PMID:22378314
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Enkd1
enkurin domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of ENKD1 mRNA
CTD
PMID:22378314
NCBI chr19:33,592,074...33,596,552
Ensembl chr19:33,592,078...33,596,545
G
Eno2
enolase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ENO2 mRNA
CTD
PMID:22378314
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:157,572,088...157,580,980
G
Enosf1
enolase superfamily member 1
increases expression
ISO
Tunicamycin results in increased expression of ENOSF1 mRNA
CTD
PMID:29453283
NCBI chr 9:113,275,267...113,314,842
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ENPP2 mRNA
CTD
PMID:22378314
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:86,202,350...86,324,827
G
Epas1
endothelial PAS domain protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of EPAS1 mRNA
CTD
PMID:22378314
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
G
Epha1
Eph receptor A1
increases expression
ISO
Tunicamycin results in increased expression of EPHA1 mRNA
CTD
PMID:17127020
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
G
Epha7
Eph receptor A7
decreases expression
ISO
Tunicamycin results in decreased expression of EPHA7 mRNA
CTD
PMID:17127020
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
G
Ephb2
Eph receptor B2
decreases expression
ISO
Tunicamycin results in decreased expression of EPHB2 mRNA
CTD
PMID:22378314
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:148,897,246...149,077,059
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of EPRS1 mRNA; Tunicamycin results in increased expression of EPRS1 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Epsti1
epithelial stromal interaction 1
increases expression
ISO
Tunicamycin results in increased expression of EPSTI1 mRNA
CTD
PMID:38498338
NCBI chr15:59,692,712...59,791,376
Ensembl chr15:53,284,216...53,382,191
G
Erbb3
erb-b2 receptor tyrosine kinase 3
decreases expression
ISO
Tunicamycin results in decreased expression of ERBB3 mRNA
CTD
PMID:17127020
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
G
Erbin
erbb2 interacting protein
increases expression
ISO
Tunicamycin results in increased expression of ERBIN mRNA
CTD
PMID:17127020
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
G
Ercc6l
ERCC excision repair 6 like, spindle assembly checkpoint helicase
decreases expression
ISO
Tunicamycin results in decreased expression of ERCC6L mRNA
CTD
PMID:22378314
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
G
Ereg
epiregulin
increases expression
ISO
Tunicamycin results in increased expression of EREG mRNA
CTD
PMID:17127020
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,027,287...17,041,062
G
Ergic3
ERGIC and golgi 3
multiple interactions decreases expression
ISO
ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of CANX protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in decreased expression of ERGIC3 protein]
CTD
PMID:27588471
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
G
Erlec1
endoplasmic reticulum lectin 1
increases expression
ISO
Tunicamycin results in increased expression of ERLEC1 mRNA
CTD
PMID:22378314
NCBI chr14:108,856,661...108,894,511
Ensembl chr14:104,655,673...104,693,480
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions increases expression increases phosphorylation increases expression decreases sulfation
ISO EXP
[Tunicamycin co-treated with HRAS protein] results in increased expression of ERN1 protein; Amiloride inhibits the reaction [Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to ERN1 protein]; Tunicamycin results in increased phosphorylation of and results in increased activity of ERN1 protein Tunicamycin results in increased expression of ERN1 mRNA; Tunicamycin results in increased expression of ERN1 protein; Tunicamycin results in increased expression of ERN1 protein modified form Guanabenz inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; KIRA6 inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein] ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of ERN1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of and results in increased phosphorylation of ERN1 protein]; toxoflavin inhibits the reaction [Tunicamycin results in decreased sulfation of ERN1 protein]; toxoflavin inhibits the reaction [Tunicamycin results in increased phosphorylation of ERN1 protein]; Tunicamycin results in increased expression of and results in increased phosphorylation of ERN1 protein tunicamycin increases expression of Ern1 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Ern1 mRNA in liver]
CTD RGD
PMID:17127020 PMID:19139269 PMID:20015086 PMID:21432213 PMID:22001960 PMID:22378314 PMID:24224909 PMID:24892553 PMID:24898257 PMID:25160872 PMID:27588471 PMID:29723631 PMID:29894845 PMID:30253173 PMID:32407927 PMID:32535746 PMID:32740777 PMID:35840659 PMID:36030031 PMID:27813192 PMID:27813192 More...
RGD:401842386 , RGD:401842386
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
ISO
Tunicamycin results in increased expression of ERO1A mRNA
CTD
PMID:12752442
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Ero1b
endoplasmic reticulum oxidoreductase 1 beta
increases expression
ISO
Tunicamycin results in increased expression of ERO1B mRNA
CTD
PMID:12752442 PMID:22378314 PMID:29453283 PMID:38498338
NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398
G
Erp29
endoplasmic reticulum protein 29
increases expression
ISO
Tunicamycin results in increased expression of ERP29 mRNA
CTD
PMID:29453283
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Erp44
endoplasmic reticulum protein 44
increases expression
ISO
Tunicamycin results in increased expression of ERP44 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
G
Errfi1
ERBB receptor feedback inhibitor 1
increases expression
ISO
Tunicamycin results in increased expression of ERRFI1 mRNA
CTD
PMID:17127020
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
ISO
Tunicamycin results in decreased expression of ESPL1 mRNA
CTD
PMID:22378314
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Esrp1
epithelial splicing regulatory protein 1
increases expression
ISO
Tunicamycin results in increased expression of ESRP1 mRNA
CTD
PMID:38498338
NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
G
Esrrg
estrogen-related receptor gamma
decreases expression
ISO
Tunicamycin results in decreased expression of ESRRG mRNA
CTD
PMID:22378314
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression
ISO
Tunicamycin results in decreased expression of ETS2 mRNA
CTD
PMID:22378314
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Etv4
ETS variant transcription factor 4
decreases expression
ISO
Tunicamycin results in decreased expression of ETV4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:87,206,977...87,222,202
Ensembl chr10:86,706,749...86,721,974
G
Etv5
ETS variant transcription factor 5
decreases expression
ISO
Tunicamycin results in decreased expression of ETV5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr11:92,113,171...92,170,758
Ensembl chr11:78,608,710...78,666,215
G
Exosc2
exosome component 2
decreases expression
ISO
Tunicamycin results in decreased expression of EXOSC2 mRNA
CTD
PMID:22378314
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
G
Exosc5
exosome component 5
increases expression
ISO
Tunicamycin results in increased expression of EXOSC5 mRNA
CTD
PMID:29453283
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
G
Exosc8
exosome component 8
increases expression
ISO
Tunicamycin results in increased expression of EXOSC8 mRNA
CTD
PMID:22378314
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
Tunicamycin results in decreased expression of F2R mRNA
CTD
PMID:22378314
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870
G
Fabp3
fatty acid binding protein 3
decreases expression
ISO
Tunicamycin results in decreased expression of FABP3 mRNA
CTD
PMID:17127020
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718
G
Fabp4
fatty acid binding protein 4
increases expression
ISO
Tunicamycin results in increased expression of FABP4 mRNA
CTD
PMID:17127020
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Fads3
fatty acid desaturase 3
increases expression
ISO
Tunicamycin results in increased expression of FADS3 mRNA
CTD
PMID:22378314
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
G
Faf1
Fas associated factor 1
increases expression
ISO
Tunicamycin results in increased expression of FAF1 mRNA
CTD
PMID:22378314
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
G
Faim2
Fas apoptotic inhibitory molecule 2
increases expression
ISO
Tunicamycin results in increased expression of FAIM2 mRNA
CTD
PMID:22378314
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
G
Fam110a
family with sequence similarity 110, member A
decreases expression
ISO
Tunicamycin results in decreased expression of FAM110A mRNA
CTD
PMID:22378314
NCBI chr 3:140,474,484...140,485,074
Ensembl chr 3:140,474,249...140,485,093
G
Fam13b
family with sequence similarity 13, member B
increases expression
ISO
Tunicamycin results in increased expression of FAM13B mRNA
CTD
PMID:29453283
NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,040,285...26,106,587
G
Fam167a
family with sequence similarity 167, member A
increases expression
ISO
Tunicamycin results in increased expression of FAM167A mRNA
CTD
PMID:29453283
NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469
G
Fam174b
family with sequence similarity 174, member B
increases expression
ISO
Tunicamycin results in increased expression of FAM174B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:127,515,393...127,618,591
Ensembl chr 1:127,514,041...127,596,128 Ensembl chr 1:127,514,041...127,596,128
G
Fam20b
FAM20B, glycosaminoglycan xylosylkinase
decreases expression
ISO
Tunicamycin results in decreased expression of FAM20B mRNA
CTD
PMID:22378314
NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915
G
Fam210b
family with sequence similarity 210, member B
decreases expression
ISO
Tunicamycin results in decreased expression of FAM210B mRNA
CTD
PMID:22378314
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
G
Fam222b
family with sequence similarity 222, member B
decreases expression
ISO
Tunicamycin results in decreased expression of FAM222B mRNA
CTD
PMID:29453283
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
G
Fam241b
family with sequence similarity 241 member B
decreases expression
ISO
Tunicamycin results in decreased expression of FAM241B mRNA
CTD
PMID:29453283
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084 Ensembl chr 6:30,052,324...30,055,084
G
Fam24b
family with sequence similarity 24 member B
increases expression
ISO
Tunicamycin results in increased expression of FAM24B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:186,112,544...186,115,957
Ensembl chr 1:186,112,551...186,115,899
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
ISO
Tunicamycin results in increased expression of FAM3C mRNA
CTD
PMID:22378314
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
Tunicamycin results in decreased expression of FAM83D mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:147,421,908...147,441,192
G
Fam89a
family with sequence similarity 89, member A
increases expression
ISO
Tunicamycin results in increased expression of FAM89A mRNA
CTD
PMID:22378314
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
G
Fas
Fas cell surface death receptor
increases expression
ISO
Tunicamycin results in increased expression of FAS mRNA
CTD
PMID:33770205
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
increases expression decreases expression multiple interactions
ISO
Tunicamycin results in increased expression of FASN mRNA Tunicamycin results in decreased expression of FASN mRNA 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA]
CTD
PMID:22378314 PMID:22414386 PMID:32407927
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fastkd5
FAST kinase domains 5
decreases expression
ISO
Tunicamycin results in decreased expression of FASTKD5 mRNA
CTD
PMID:29453283
NCBI chr 3:138,283,315...138,300,803
Ensembl chr 3:117,830,083...117,847,820
G
Fbln1
fibulin 1
decreases expression
ISO
Tunicamycin results in decreased expression of FBLN1 mRNA
CTD
PMID:22378314
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:116,310,582...116,390,075
G
Fbp1
fructose-bisphosphatase 1
decreases expression
ISO
Tunicamycin results in decreased expression of FBP1 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,208,031...2,230,071
G
Fbxo16
F-box protein 16
increases expression
ISO
Tunicamycin results in increased expression of FBXO16 mRNA
CTD
PMID:22378314
NCBI chr15:39,492,268...39,541,493
Ensembl chr15:39,492,377...39,541,480
G
Fbxo17
F-box protein 17
increases expression
ISO
Tunicamycin results in increased expression of FBXO17 mRNA
CTD
PMID:29453283
NCBI chr 1:84,002,276...84,024,455
Ensembl chr 1:84,002,267...84,024,453
G
Fbxo32
F-box protein 32
increases expression
ISO
Tunicamycin results in increased expression of FBXO32 mRNA
CTD
PMID:22378314
NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:89,730,232...89,765,436
G
Fbxw11
F-box and WD repeat domain containing 11
decreases expression
ISO
Tunicamycin results in decreased expression of FBXW11 mRNA
CTD
PMID:17127020
NCBI chr10:17,737,181...17,834,834
Ensembl chr10:17,227,181...17,330,571
G
Fcmr
Fc mu receptor
decreases expression
ISO
Tunicamycin results in decreased expression of FCMR mRNA
CTD
PMID:22378314
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
Tunicamycin results in decreased expression of FDFT1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdxr
ferredoxin reductase
increases expression
ISO
Tunicamycin results in increased expression of FDXR mRNA
CTD
PMID:22378314
NCBI chr10:101,006,845...101,015,582
Ensembl chr10:100,507,865...100,516,658
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
Tunicamycin results in decreased expression of FEN1 mRNA
CTD
PMID:29453283
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:206,844,884...206,850,003
G
Fez2
fasciculation and elongation protein zeta 2
decreases expression
ISO
Tunicamycin results in decreased expression of FEZ2 mRNA
CTD
PMID:22378314
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
G
Fgf21
fibroblast growth factor 21
multiple interactions increases expression
ISO
FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]]; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; Tunicamycin inhibits the reaction [FGF21 protein inhibits the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]] FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; FGF21 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Tunicamycin results in increased expression of FGF21 mRNA; Tunicamycin results in increased expression of FGF21 protein
CTD
PMID:23123503 PMID:29289645
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:96,083,441...96,090,454
G
Fgf9
fibroblast growth factor 9
increases expression
ISO
Tunicamycin results in increased expression of FGF9 mRNA
CTD
PMID:29453283
NCBI chr15:36,325,552...36,369,995
Ensembl chr15:32,210,074...32,253,309
G
Fggy
FGGY carbohydrate kinase domain containing
increases expression
ISO
Tunicamycin results in increased expression of FGGY mRNA
CTD
PMID:22378314
NCBI chr 5:110,398,866...110,786,019
Ensembl chr 5:110,398,863...110,786,017
G
Fhit
fragile histidine triad diadenosine triphosphatase
increases expression
ISO
Tunicamycin results in increased expression of FHIT mRNA
CTD
PMID:29453283
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
G
Fibin
fin bud initiation factor homolog
increases expression
ISO
Tunicamycin results in increased expression of FIBIN mRNA
CTD
PMID:33545341 PMID:38498338
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
G
Fibp
FGF1 intracellular binding protein
increases expression
ISO
Tunicamycin results in increased expression of FIBP mRNA
CTD
PMID:29453283
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
G
Ficd
FIC domain protein adenylyltransferase
increases expression
ISO
Tunicamycin results in increased expression of FICD mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
G
Fjx1
four-jointed box kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of FJX1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
G
Fkbp11
FKBP prolyl isomerase 11
increases expression
ISO
Tunicamycin results in increased expression of FKBP11 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
G
Flt1
Fms related receptor tyrosine kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of FLT1 mRNA
CTD
PMID:24370435
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO
Tunicamycin results in decreased expression of FMO1 mRNA
CTD
PMID:17127020
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fndc3b
fibronectin type III domain containing 3B
increases expression
ISO
Tunicamycin results in increased expression of FNDC3B mRNA
CTD
PMID:22378314
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tunicamycin results in increased expression of FOS mRNA
CTD
PMID:33545341
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tunicamycin results in increased expression of FOSB mRNA
CTD
PMID:33545341
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Foxa1
forkhead box A1
decreases expression
ISO
Tunicamycin results in decreased expression of FOXA1 mRNA
CTD
PMID:29453283
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
G
Foxd2
forkhead box D2
decreases expression
ISO
Tunicamycin results in decreased expression of FOXD2 mRNA
CTD
PMID:29453283
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
G
Foxj2
forkhead box J2
increases expression
ISO
Tunicamycin results in increased expression of FOXJ2 mRNA
CTD
PMID:22378314
NCBI chr 4:156,047,043...156,073,540
Ensembl chr 4:156,046,969...156,073,518
G
Foxm1
forkhead box M1
decreases expression
ISO
Tunicamycin results in decreased expression of FOXM1 mRNA
CTD
PMID:22378314
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Foxn4
forkhead box N4
decreases expression
ISO
Tunicamycin results in decreased expression of FOXN4 mRNA
CTD
PMID:22378314
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
G
Foxo1
forkhead box O1
decreases expression
ISO
Tunicamycin results in decreased expression of FOXO1 mRNA
CTD
PMID:36030031
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790
G
Frmd4a
FERM domain containing 4A
decreases expression
ISO
Tunicamycin results in decreased expression of FRMD4A mRNA
CTD
PMID:22378314
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
G
Frzb
frizzled-related protein
decreases expression
ISO
Tunicamycin results in decreased expression of FRZB mRNA
CTD
PMID:22378314
NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:65,332,277...65,365,208
G
Fscn1
fascin actin-bundling protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of FSCN1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:11,597,048...11,610,211
G
Fth1
ferritin heavy chain 1
increases expression decreases expression multiple interactions
ISO
Tunicamycin results in increased expression of FTH1 mRNA Tunicamycin results in decreased expression of FTH1 protein leonurine inhibits the reaction [Tunicamycin results in decreased expression of FTH1 protein]
CTD
PMID:29453283 PMID:38670420
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
G
Fuca2
alpha-L-fucosidase 2
decreases expression
ISO
Tunicamycin results in decreased expression of FUCA2 mRNA
CTD
PMID:17127020
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
G
Fut1
fucosyltransferase 1
increases expression
ISO
Tunicamycin results in increased expression of FUT1 mRNA
CTD
PMID:38498338
NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:96,086,635...96,090,616
G
Fv1
Friend virus susceptibility 1
increases expression
ISO
Tunicamycin results in increased expression of C19ORF48P mRNA
CTD
PMID:29453283
NCBI chr 1:94,730,839...94,736,791
Ensembl chr 1:94,730,606...94,737,594
G
Fxyd6
FXYD domain-containing ion transport regulator 6
decreases expression
ISO
Tunicamycin results in decreased expression of FXYD6 mRNA
CTD
PMID:22378314
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
G
Fzd7
frizzled class receptor 7
decreases expression
ISO
Tunicamycin results in decreased expression of FZD7 mRNA
CTD
PMID:22378314
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:60,930,875...60,935,781
G
G3bp1
G3BP stress granule assembly factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of G3BP1 mRNA
CTD
PMID:22378314
NCBI chr10:40,087,533...40,120,931
Ensembl chr10:39,586,864...39,620,268
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of G6PC1 mRNA
CTD
PMID:17127020
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
ISO
Tunicamycin results in increased expression of GABARAPL1 mRNA
CTD
PMID:22378314 PMID:33545341
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:162,980,249...162,989,450
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Tunicamycin results in increased expression of GADD45A mRNA
CTD
PMID:29453283
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of GADD45B mRNA Tunicamycin results in increased expression of GADD45B mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:8,778,007...8,780,046
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
ISO
Tunicamycin results in increased expression of GADD45G mRNA
CTD
PMID:29453283 PMID:33545341
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,376,839...13,378,610
G
Gadd45gip1
GADD45G interacting protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of GADD45GIP1 mRNA
CTD
PMID:17127020
NCBI chr19:23,320,662...23,323,211
Ensembl chr19:23,320,159...23,323,236
G
Gal
galanin and GMAP prepropeptide
decreases expression
ISO
Tunicamycin results in decreased expression of GAL mRNA
CTD
PMID:22378314
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Galc
galactosylceramidase
increases expression
ISO
Tunicamycin results in increased expression of GALC mRNA
CTD
PMID:17127020
NCBI chr 6:117,452,888...117,522,281
Ensembl chr 6:117,452,895...117,515,830
G
Galk2
galactokinase 2
increases expression
ISO
Tunicamycin results in increased expression of GALK2 mRNA
CTD
PMID:22378314
NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:113,110,030...113,233,306
G
Galnt18
polypeptide N-acetylgalactosaminyltransferase 18
decreases expression
ISO
Tunicamycin results in decreased expression of GALNT18 mRNA
CTD
PMID:22378314
NCBI chr 1:165,593,180...165,904,268
Ensembl chr 1:165,593,187...165,904,268
G
Galr2
galanin receptor 2
increases expression
ISO
Tunicamycin results in increased expression of GALR2 mRNA
CTD
PMID:29453283
NCBI chr10:101,513,689...101,517,176
Ensembl chr10:101,514,471...101,517,176
G
Ganab
glucosidase II alpha subunit
increases expression
ISO
Tunicamycin results in increased expression of GANAB mRNA
CTD
PMID:29453283
NCBI chr 1:205,793,910...205,813,704
Ensembl chr 1:205,793,895...205,813,695
G
Gap43
growth associated protein 43
decreases expression
ISO
Tunicamycin results in decreased expression of GAP43 mRNA
CTD
PMID:22378314
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gars1
glycyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of GARS1 mRNA; Tunicamycin results in increased expression of GARS1 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
increases expression
ISO
Tunicamycin results in increased expression of GAS2 mRNA
CTD
PMID:17127020
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gas2l3
growth arrest-specific 2 like 3
increases expression
ISO
Tunicamycin results in increased expression of GAS2L3 mRNA
CTD
PMID:17127020
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
G
Gata2
GATA binding protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of GATA2 mRNA
CTD
PMID:22378314
NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:120,658,986...120,667,761
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
decreases expression
ISO
Tunicamycin results in decreased expression of GATD3 mRNA
CTD
PMID:22378314
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gatm
glycine amidinotransferase
decreases expression
ISO
Tunicamycin results in decreased expression of GATM mRNA
CTD
PMID:22378314
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gcat
glycine C-acetyltransferase
decreases expression
ISO
Tunicamycin results in decreased expression of GCAT mRNA
CTD
PMID:22378314
NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:110,595,091...110,601,473
G
Gcc1
GRIP and coiled-coil domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of GCC1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:57,030,817...57,042,682
Ensembl chr 4:57,032,314...57,042,663
G
Gcdh
glutaryl-CoA dehydrogenase
decreases expression
ISO
Tunicamycin results in decreased expression of GCDH mRNA
CTD
PMID:22378314
NCBI chr19:40,168,038...40,174,536
Ensembl chr19:23,263,264...23,269,681
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of GCLC mRNA NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA]
CTD
PMID:22959925 PMID:36586010
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of GCLM mRNA Tunicamycin results in increased expression of GCLM mRNA
CTD
PMID:17127020 PMID:29453283 PMID:36586010
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Tunicamycin results in increased expression of GDF15 mRNA
CTD
PMID:22378314
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gdf6
growth differentiation factor 6
increases expression
ISO
Tunicamycin results in increased expression of GDF6 mRNA
CTD
PMID:22378314
NCBI chr 5:22,996,246...23,012,567
Ensembl chr 5:22,996,246...23,012,567
G
Gfod1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of GFOD1 mRNA
CTD
PMID:33545341
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
G
Gfpt1
glutamine fructose-6-phosphate transaminase 1
increases expression
ISO
Tunicamycin results in increased expression of GFPT1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
G
Gga2
golgi associated, gamma adaptin ear containing, ARF binding protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of GGA2 mRNA
CTD
PMID:17127020
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
G
Ggact
gamma-glutamylamine cyclotransferase
increases expression
ISO
Tunicamycin results in increased expression of GGACT mRNA
CTD
PMID:29453283
NCBI chr15:99,969,246...99,998,343
Ensembl chr15:99,968,282...99,993,455
G
Ggh
gamma-glutamyl hydrolase
decreases expression
ISO
Tunicamycin results in decreased expression of GGH mRNA
CTD
PMID:22378314
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
G
Ghitm
growth hormone inducible transmembrane protein
increases expression
ISO
Tunicamycin results in increased expression of GHITM mRNA
CTD
PMID:22378314
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
G
Gins2
GINS complex subunit 2
decreases expression
ISO
Tunicamycin results in decreased expression of GINS2 mRNA
CTD
PMID:22378314
NCBI chr19:65,535,492...65,548,270
Ensembl chr19:48,626,770...48,639,339
G
Gla
galactosidase, alpha
decreases expression
ISO
Tunicamycin results in decreased expression of GLA mRNA
CTD
PMID:22378314
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:97,768,996...97,780,664
G
Glcci1
glucocorticoid induced 1
decreases expression
ISO
Tunicamycin results in decreased expression of GLCCI1 mRNA
CTD
PMID:22378314
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
G
Gldc
glycine decarboxylase
decreases expression
ISO
Tunicamycin results in decreased expression of GLDC mRNA
CTD
PMID:22378314 PMID:33770205
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Glrx
glutaredoxin
decreases expression
ISO
Tunicamycin results in decreased expression of GLRX mRNA
CTD
PMID:29453283
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glrx3
glutaredoxin 3
increases expression
ISO
Tunicamycin results in increased expression of GLRX3 mRNA
CTD
PMID:17127020
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
G
Gls
glutaminase
increases expression
ISO
Tunicamycin results in increased expression of GLS mRNA
CTD
PMID:22378314
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:49,344,781...49,416,900
G
Glt8d1
glycosyltransferase 8 domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of GLT8D1 mRNA
CTD
PMID:17127020
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
G
Gmeb1
glucocorticoid modulatory element binding protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of GMEB1 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 5:144,421,151...144,462,448
Ensembl chr 5:144,420,555...144,462,602
G
Gmppa
GDP-mannose pyrophosphorylase A
increases expression
ISO
Tunicamycin results in increased expression of GMPPA mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
G
Gmppb
GDP-mannose pyrophosphorylase B
increases expression
ISO
Tunicamycin results in increased expression of GMPPB mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:117,616,029...117,622,866
Ensembl chr 8:108,693,060...108,767,286
G
Gmps
guanine monophosphate synthase
decreases expression
ISO
Tunicamycin results in decreased expression of GMPS mRNA
CTD
PMID:29453283
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
G
Gnas
GNAS complex locus
decreases expression
ISO
Tunicamycin results in decreased expression of GNAS mRNA
CTD
PMID:17127020
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnb1
G protein subunit beta 1
decreases expression
ISO
Tunicamycin results in decreased expression of GNB1 mRNA
CTD
PMID:17127020
NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:166,075,629...166,142,124
G
Gng12
G protein subunit gamma 12
decreases expression
ISO
Tunicamycin results in decreased expression of GNG12 mRNA
CTD
PMID:29453283
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:96,010,952...96,134,712
G
Gng2
G protein subunit gamma 2
decreases expression
ISO
Tunicamycin results in decreased expression of GNG2 mRNA
CTD
PMID:22378314
NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,316,059...4,417,183
G
Gng4
G protein subunit gamma 4
decreases expression
ISO
Tunicamycin results in decreased expression of GNG4 mRNA
CTD
PMID:22378314
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
G
Gngt1
G protein subunit gamma transducin 1
increases expression
ISO
Tunicamycin results in increased expression of GNGT1 mRNA
CTD
PMID:17127020
NCBI chr 4:32,006,267...32,009,252
Ensembl chr 4:32,006,267...32,009,252
G
Gngt2
G protein subunit gamma transducin 2
decreases expression
ISO
Tunicamycin results in decreased expression of GNGT2 mRNA
CTD
PMID:17127020
NCBI chr10:80,776,003...80,784,235
G
Gnl3l
G protein nucleolar 3 like
increases expression
ISO
Tunicamycin results in increased expression of GNL3L mRNA
CTD
PMID:22378314
NCBI chr X:19,961,277...19,994,454
Ensembl chr X:19,958,603...19,994,508
G
Gnptg
N-acetylglucosamine-1-phosphate transferase subunit gamma
increases expression
ISO
Tunicamycin results in increased expression of GNPTG mRNA
CTD
PMID:29453283
NCBI chr10:14,252,186...14,257,128
Ensembl chr10:14,251,136...14,257,096
G
Gnrhr
gonadotropin releasing hormone receptor
decreases expression
ISO
Tunicamycin results in decreased expression of GNRHR mRNA
CTD
PMID:17127020
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
G
Gns
glucosamine (N-acetyl)-6-sulfatase
increases expression
ISO
Tunicamycin results in increased expression of GNS mRNA
CTD
PMID:22378314
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
G
Golga2
golgin A2
increases expression
ISO
Tunicamycin results in increased expression of GOLGA2 mRNA
CTD
PMID:22378314
NCBI chr 3:35,981,783...36,002,023
Ensembl chr 3:15,584,039...15,604,279
G
Golga3
golgin A3
increases expression
ISO
Tunicamycin results in increased expression of GOLGA3 mRNA
CTD
PMID:22378314
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509 Ensembl chr 4:46,454,870...46,500,509
G
Golga4
golgin A4
increases expression
ISO
Tunicamycin results in increased expression of GOLGA4 mRNA
CTD
PMID:22378314
NCBI chr 8:118,208,200...118,285,003
G
Golga5
golgin A5
increases expression
ISO
Tunicamycin results in increased expression of GOLGA5 mRNA
CTD
PMID:22378314
NCBI chr 6:121,612,389...121,640,552
Ensembl chr 6:121,612,529...121,640,413
G
Golph3
golgi phosphoprotein 3
increases expression
ISO
Tunicamycin results in increased expression of GOLPH3 mRNA
CTD
PMID:17127020
NCBI chr 2:61,348,030...61,376,051
Ensembl chr 2:61,348,030...61,376,049
G
Golph3l
golgi phosphoprotein 3-like
increases expression
ISO
Tunicamycin results in increased expression of GOLPH3L mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 2:183,151,941...183,183,094
Ensembl chr 2:183,153,301...183,183,083
G
Gorab
golgin, RAB6-interacting
increases expression
ISO
Tunicamycin results in increased expression of GORAB mRNA
CTD
PMID:22378314
NCBI chr13:75,745,678...75,762,307
Ensembl chr13:75,745,680...75,762,298
G
Gorasp2
golgi reassembly stacking protein 2
increases expression
ISO
Tunicamycin results in increased expression of GORASP2 mRNA
CTD
PMID:22378314
NCBI chr 3:55,474,448...55,503,570
Ensembl chr 3:55,474,757...55,503,576
G
Gosr2
golgi SNAP receptor complex member 2
increases expression
ISO
Tunicamycin results in increased expression of GOSR2 mRNA
CTD
PMID:22378314
NCBI chr10:89,085,323...89,105,665
Ensembl chr10:88,586,299...88,605,625
G
Got1
glutamic-oxaloacetic transaminase 1
increases expression
ISO
Tunicamycin results in increased expression of GOT1 mRNA
CTD
PMID:22378314 PMID:33545341
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Got2
glutamic-oxaloacetic transaminase 2
decreases expression
ISO
Tunicamycin results in decreased expression of GOT2 mRNA
CTD
PMID:22378314
NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,174,311...9,199,994
G
Gpc2
glypican 2
decreases expression
ISO
Tunicamycin results in decreased expression of GPC2 mRNA
CTD
PMID:22378314
NCBI chr12:22,391,489...22,397,822
Ensembl chr12:17,277,875...17,284,208
G
Gpi
glucose-6-phosphate isomerase
decreases expression
ISO
Tunicamycin results in decreased expression of GPI1 mRNA Tunicamycin results in decreased expression of GPI mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Gpm6b
glycoprotein m6b
decreases expression
ISO
Tunicamycin results in decreased expression of GPM6B mRNA
CTD
PMID:22378314
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
G
Gpr137b
G protein-coupled receptor 137B
decreases expression
ISO
Tunicamycin results in decreased expression of GPR137B mRNA
CTD
PMID:29453283
NCBI chr17:92,987,792...93,026,003
Ensembl chr17:85,966,921...86,041,835
G
Gpr146
G protein-coupled receptor 146
decreases expression
ISO
Tunicamycin results in decreased expression of GPR146 mRNA
CTD
PMID:17127020
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
G
Gpr183
G protein-coupled receptor 183
increases expression
ISO
Tunicamycin results in increased expression of GPR183 mRNA
CTD
PMID:33770205
NCBI chr15:105,445,129...105,457,192
Ensembl chr15:99,036,367...99,050,559
G
Gpr27
G protein-coupled receptor 27
increases expression
ISO
Tunicamycin results in increased expression of GPR27 mRNA
CTD
PMID:17127020
NCBI chr 4:132,328,364...132,329,497
Ensembl chr 4:132,328,364...132,329,497
G
Gpr85
G protein-coupled receptor 85
increases expression
ISO
Tunicamycin results in increased expression of GPR85 mRNA
CTD
PMID:17127020
NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566
G
Gprc5c
G protein-coupled receptor, class C, group 5, member C
increases expression
ISO
Tunicamycin results in increased expression of GPRC5C mRNA
CTD
PMID:29453283
NCBI chr10:100,385,682...100,407,953
Ensembl chr10:99,887,077...99,908,926
G
Gprin1
G protein-regulated inducer of neurite outgrowth 1
decreases expression
ISO
Tunicamycin results in decreased expression of GPRIN1 mRNA
CTD
PMID:22378314
NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915
G
Gpsm2
G-protein signaling modulator 2
decreases expression
ISO
Tunicamycin results in decreased expression of GPSM2 mRNA
CTD
PMID:22378314
NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:196,327,149...196,375,154
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases expression
EXP
Taurodeoxycholic Acid inhibits the reaction [Tunicamycin results in increased expression of GPT protein]
CTD
PMID:33527851
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpt2
glutamic--pyruvic transaminase 2
increases expression
ISO
Tunicamycin results in increased expression of GPT2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
Tunicamycin results in increased expression of GPX3 mRNA
CTD
PMID:17127020
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gpx4
glutathione peroxidase 4
multiple interactions decreases expression
ISO
leonurine inhibits the reaction [Tunicamycin results in decreased expression of GPX4 protein]
CTD
PMID:38670420
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gpx8
glutathione peroxidase 8
increases expression
ISO
Tunicamycin results in increased expression of GPX8 mRNA
CTD
PMID:29453283
NCBI chr 2:46,409,646...46,413,401
Ensembl chr 2:44,676,454...44,680,195
G
Gramd4
GRAM domain containing 4
decreases expression
ISO
Tunicamycin results in decreased expression of GRAMD4 mRNA
CTD
PMID:22378314
NCBI chr 7:117,150,398...117,224,056
Ensembl chr 7:117,150,374...117,224,053
G
Grcc10
gene rich cluster, C10 gene
increases expression
ISO
Tunicamycin results in increased expression of C12ORF57 mRNA
CTD
PMID:29453283
NCBI chr 4:157,551,276...157,552,924
G
Grm2
glutamate metabotropic receptor 2
increases expression
ISO
Tunicamycin results in increased expression of GRM2 mRNA
CTD
PMID:17127020
NCBI chr 8:107,280,099...107,293,159
Ensembl chr 8:107,280,099...107,293,146
G
Grpel1
GrpE-like 1, mitochondrial
decreases expression
ISO
Tunicamycin results in decreased expression of GRPEL1 mRNA
CTD
PMID:22378314
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
G
Grpel2
GrpE-like 2, mitochondrial
increases expression
ISO
Tunicamycin results in increased expression of GRPEL2 mRNA
CTD
PMID:22378314
NCBI chr18:55,167,831...55,180,073
Ensembl chr18:55,168,209...55,180,180
G
Grpr
gastrin releasing peptide receptor
increases expression
ISO
Tunicamycin results in increased expression of GRPR mRNA
CTD
PMID:17127020
NCBI chr X:30,998,425...31,038,442
Ensembl chr X:30,998,416...31,038,442
G
Gspt2
G1 to S phase transition 2
decreases expression
ISO
Tunicamycin results in decreased expression of GSPT2 mRNA
CTD
PMID:29453283
NCBI chr X:59,587,237...59,589,758
Ensembl chr X:59,587,276...59,594,162
G
Gsr
glutathione-disulfide reductase
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of GSR mRNA NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GSR mRNA]
CTD
PMID:22959925
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gsta4
glutathione S-transferase alpha 4
decreases expression
ISO
Tunicamycin results in decreased expression of GSTA4 mRNA
CTD
PMID:17127020
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182
G
Gstk1
glutathione S-transferase kappa 1
decreases expression
ISO
Tunicamycin results in decreased expression of GSTK1 mRNA
CTD
PMID:17127020
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:71,118,896...71,123,292
G
Gstm5
glutathione S-transferase, mu 5
decreases expression
ISO
Tunicamycin results in decreased expression of GSTM3 mRNA
CTD
PMID:17127020
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gstt1
glutathione S-transferase theta 1
decreases expression
ISO
Tunicamycin results in decreased expression of GSTT1 mRNA
CTD
PMID:17127020
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gtf2h5
general transcription factor IIH subunit 5
decreases expression
ISO
Tunicamycin results in decreased expression of GTF2H5 mRNA
CTD
PMID:22378314
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
G
Gtpbp2
GTP binding protein 2
increases expression
ISO
Tunicamycin results in increased expression of GTPBP2 mRNA
CTD
PMID:22378314
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
G
Gtse1
G-2 and S-phase expressed 1
decreases expression
ISO
Tunicamycin results in decreased expression of GTSE1 mRNA
CTD
PMID:22378314
NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:116,950,053...116,966,806
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
increases expression
ISO
Tunicamycin results in increased expression of GUCY1A1 mRNA
CTD
PMID:17127020
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:167,418,640...167,481,671
G
H1f0
H1.0 linker histone
increases expression
ISO
Tunicamycin results in increased expression of H1-0 mRNA
CTD
PMID:29453283
NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:110,592,208...110,594,694
G
H2ac18
H2A clustered histone 18
increases expression
ISO
Tunicamycin results in increased expression of H2AC18 mRNA
CTD
PMID:22378314
NCBI chr 2:183,808,398...183,808,992
G
H2ac20
H2A clustered histone 20
increases expression
ISO
Tunicamycin results in increased expression of H2AC20 mRNA
CTD
PMID:29453283
NCBI chr 2:183,779,879...183,780,357
G
H2ac25
H2A clustered histone 25
increases expression
ISO
Tunicamycin results in increased expression of H2AC25 mRNA
CTD
PMID:29453283
NCBI chr10:43,733,702...43,735,254
Ensembl chr10:43,733,668...43,744,874
G
H2bc18
H2B clustered histone 18
decreases expression
ISO
Tunicamycin results in decreased expression of H2BC18 mRNA
CTD
PMID:17127020
NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
G
H2bc8
H2B clustered histone 8
increases expression
ISO
Tunicamycin results in increased expression of H2BC8 mRNA
CTD
PMID:33545341
NCBI chr17:42,708,658...42,709,408
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
ISO
Tunicamycin results in decreased expression of HADH mRNA
CTD
PMID:22378314
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:219,787,927...219,830,353
G
Haus4
HAUS augmin-like complex, subunit 4
increases expression
ISO
Tunicamycin results in increased expression of HAUS4 mRNA
CTD
PMID:29453283
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
G
Hax1
HCLS1 associated protein X-1
increases expression
ISO
Tunicamycin results in increased expression of HAX1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
G
Hbp1
HMG-box transcription factor 1
increases expression
ISO
Tunicamycin results in increased expression of HBP1 mRNA
CTD
PMID:22378314
NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:48,529,372...48,555,787
G
Hbq1b
hemoglobin subunit theta 1B
decreases expression
ISO
Tunicamycin results in decreased expression of HBQ1 mRNA
CTD
PMID:22378314
NCBI chr10:15,334,293...15,336,061
Ensembl chr10:15,320,762...15,321,397 Ensembl chr10:15,320,762...15,321,397
G
Hddc3
HD domain containing 3
increases expression
ISO
Tunicamycin results in increased expression of HDDC3 mRNA
CTD
PMID:29453283
NCBI chr 1:134,299,469...134,301,757
Ensembl chr 1:134,299,468...134,301,757
G
Hebp1
heme binding protein 1
increases expression
ISO
Tunicamycin results in increased expression of HEBP1 mRNA
CTD
PMID:22378314
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
G
Heg1
heart development protein with EGF-like domains 1
increases expression
ISO
Tunicamycin results in increased expression of HEG1 mRNA
CTD
PMID:29453283
NCBI chr11:80,512,096...80,600,150
Ensembl chr11:66,957,190...67,095,051
G
Herc3
HECT and RLD domain containing E3 ubiquitin protein ligase 3
decreases expression
ISO
Tunicamycin results in decreased expression of HERC3 mRNA
CTD
PMID:17127020
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
G
Herc6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
increases expression
ISO
Tunicamycin results in increased expression of HERC6 mRNA
CTD
PMID:38498338
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Tunicamycin results in increased expression of HERPUD1 mRNA Tunicamycin results in increased expression of HERPUD1 mRNA; Tunicamycin results in increased expression of HERPUD1 protein
CTD
PMID:20196124 PMID:22001960 PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,598,417...10,618,424
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
Tunicamycin results in increased expression of HES1 mRNA
CTD
PMID:22115781
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
G
Hes6
hes family bHLH transcription factor 6
decreases expression
ISO
Tunicamycin results in decreased expression of HES6 mRNA
CTD
PMID:22378314
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hexim2
HEXIM P-TEFb complex subunit 2
increases expression
ISO
Tunicamycin results in increased expression of HEXIM2 mRNA
CTD
PMID:29453283
NCBI chr10:88,077,870...88,084,776
Ensembl chr10:88,079,014...88,084,775
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of HEY1 mRNA Tunicamycin results in increased expression of HEY1 mRNA
CTD
PMID:22115781 PMID:22378314 PMID:33770205
NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:93,095,498...93,100,312
G
Hgf
hepatocyte growth factor
multiple interactions decreases expression
EXP
4-phenylbutyric acid inhibits the reaction [Tunicamycin results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in decreased expression of HGF protein]; salubrinal inhibits the reaction [Tunicamycin results in decreased expression of HGF mRNA]; salubrinal inhibits the reaction [Tunicamycin results in decreased expression of HGF protein] Tunicamycin results in decreased expression of HGF mRNA; Tunicamycin results in decreased expression of HGF protein
CTD
PMID:28844859
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hid1
HID1 domain containing
increases expression
ISO
Tunicamycin results in increased expression of HID1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:101,088,526...101,109,011
Ensembl chr10:100,589,555...100,610,041
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of HIF1A mRNA
CTD
PMID:24370435
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hif1an
hypoxia inducible factor 1 subunit alpha inhibitor
decreases expression
ISO
Tunicamycin results in decreased expression of HIF1AN mRNA
CTD
PMID:17127020
NCBI chr 1:243,419,175...243,440,464
Ensembl chr 1:243,419,194...243,434,327
G
Hilpda
hypoxia inducible lipid droplet-associated
decreases expression
ISO
Tunicamycin results in decreased expression of HILPDA mRNA
CTD
PMID:22378314
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hint2
histidine triad nucleotide binding protein 2
increases expression
ISO
Tunicamycin results in increased expression of HINT2 mRNA
CTD
PMID:29453283
NCBI chr 5:62,700,383...62,702,638
Ensembl chr 5:57,904,614...57,907,097
G
Hirip3
HIRA interacting protein 3
increases expression
ISO
Tunicamycin results in increased expression of HIRIP3 mRNA
CTD
PMID:29453283
NCBI chr 1:181,472,537...181,475,082
Ensembl chr 1:181,472,056...181,475,079
G
Hist1h2al1
histone cluster 1 H2A family like 1
increases expression
ISO
Tunicamycin results in increased expression of H2AC6 mRNA
CTD
PMID:22378314
NCBI chr17:42,707,954...42,708,420
G
Hk2
hexokinase 2
increases expression decreases expression
ISO
Tunicamycin results in increased expression of HK2 mRNA Tunicamycin results in decreased expression of HK2 mRNA Tunicamycin results in increased expression of HK2 protein
CTD
PMID:17127020 PMID:22378314 PMID:36473502
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:115,234,509...115,283,530
G
Hm13
histocompatibility minor 13
increases expression
ISO
Tunicamycin results in increased expression of HM13 mRNA
CTD
PMID:22378314
NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:141,145,782...141,184,703
G
Hmga2
high mobility group AT-hook 2
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of HMGA2 protein HMGA2 protein affects the reaction [Tunicamycin results in decreased expression of MPC1 protein]
CTD
PMID:36473502 PMID:38992767
NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1-ps33
high-mobility group box 1, pseudogene 33
decreases expression
ISO
Tunicamycin results in decreased expression of HMGB1P1 mRNA
CTD
PMID:22378314
NCBI chr19:55,045,869...55,047,145
Ensembl chr19:55,045,869...55,047,145
G
Hmgb3
high mobility group box 3
decreases expression
ISO
Tunicamycin results in decreased expression of HMGB3 mRNA
CTD
PMID:22378314
NCBI chr X:154,341,106...154,346,087
Ensembl chr X:149,296,375...149,301,292
G
Hmgcl
3-hydroxy-3-methylglutaryl-CoA lyase
increases expression
ISO
Tunicamycin results in increased expression of HMGCL mRNA
CTD
PMID:22378314
NCBI chr 5:153,461,738...153,475,552
Ensembl chr 5:148,178,252...148,192,068
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
decreases expression
ISO
Tunicamycin results in decreased expression of HMGCR mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
decreases expression affects expression
ISO
Tunicamycin results in decreased expression of HMGCS1 mRNA Tunicamycin affects the expression of HMGCS1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100
G
Hmmr
hyaluronan-mediated motility receptor
decreases expression
ISO
Tunicamycin results in decreased expression of HMMR mRNA
CTD
PMID:22378314
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
EXP ISO
Tunicamycin results in increased expression of HMOX1 mRNA Exenatide inhibits the reaction [Tunicamycin results in increased expression of HMOX1 mRNA]
CTD
PMID:24291486 PMID:29453283 PMID:30253173 PMID:36586010
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hmx1
H6 family homeobox 1
decreases expression
ISO
Tunicamycin results in decreased expression of HMX1 mRNA
CTD
PMID:22378314
NCBI chr14:75,361,207...75,364,993
Ensembl chr14:75,361,225...75,364,993
G
Hnrnpa0
heterogeneous nuclear ribonucleoprotein A0
decreases expression
ISO
Tunicamycin results in decreased expression of HNRNPA0 mRNA
CTD
PMID:22378314
NCBI chr17:6,507,728...6,510,385
Ensembl chr17:6,507,275...6,509,375
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
multiple interactions increases activity affects localization
ISO EXP
benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Tunicamycin affects the localization of HNRNPA1 protein]; HNRNPA1 mutant form inhibits the reaction [Tunicamycin results in increased expression of SREBF1 protein]; Tunicamycin promotes the reaction [HNRNPA1 protein binds to SREBF1 5' UTR] Tunicamycin results in increased activity of HNRNPA1 protein
CTD
PMID:23106379
NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
decreases expression
ISO
Tunicamycin results in decreased expression of HNRNPA2B1 mRNA
CTD
PMID:22378314
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
increases expression
ISO
Tunicamycin results in increased expression of HNRNPDL mRNA
CTD
PMID:22378314
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hnrnpm
heterogeneous nuclear ribonucleoprotein M
decreases expression
ISO
Tunicamycin results in decreased expression of HNRNPM mRNA
CTD
PMID:22378314
NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:14,438,688...14,476,762
G
Hnrnpr
heterogeneous nuclear ribonucleoprotein R
decreases expression
ISO
Tunicamycin results in decreased expression of HNRNPR mRNA
CTD
PMID:22378314
NCBI chr 5:148,542,999...148,574,888
Ensembl chr 5:148,543,044...148,574,867
G
Hook1
hook microtubule-tethering protein 1
increases expression
ISO
Tunicamycin results in increased expression of HOOK1 mRNA
CTD
PMID:22378314
NCBI chr 5:110,824,501...110,887,791
Ensembl chr 5:110,824,501...110,887,787
G
Hoxa11-as
HOXA11 antisense RNA
decreases expression
ISO
Tunicamycin results in decreased expression of HOXA11-AS mRNA
CTD
PMID:29453283
NCBI chr 4:81,346,416...81,350,190
Ensembl chr 4:81,346,416...81,350,179
G
Hoxa13
homeo box A13
decreases expression
ISO
Tunicamycin results in decreased expression of HOXA13 mRNA
CTD
PMID:29453283
NCBI chr 4:82,689,566...82,691,701
Ensembl chr 4:81,358,956...81,361,091
G
Hoxb2
homeobox B2
decreases expression
ISO
Tunicamycin results in decreased expression of HOXB2 mRNA
CTD
PMID:29453283
NCBI chr10:81,317,828...81,320,220
Ensembl chr10:81,318,026...81,320,192
G
Hoxb5
homeo box B5
decreases expression
ISO
Tunicamycin results in decreased expression of HOXB5 mRNA
CTD
PMID:29453283
NCBI chr10:81,269,372...81,271,580
Ensembl chr10:81,269,372...81,271,580
G
Hoxb8
homeo box B8
decreases expression
ISO
Tunicamycin results in decreased expression of HOXB8 mRNA
CTD
PMID:29453283
NCBI chr10:81,745,430...81,747,181
Ensembl chr10:81,248,887...81,250,638
G
Hoxc13
homeobox C13
decreases expression
ISO
Tunicamycin results in decreased expression of HOXC13 mRNA
CTD
PMID:29453283
NCBI chr 7:134,058,640...134,065,479
Ensembl chr 7:134,058,640...134,064,800
G
Hoxc9
homeobox C9
decreases expression
ISO
Tunicamycin results in decreased expression of HOXC9 mRNA
CTD
PMID:29453283
NCBI chr 7:134,118,817...134,121,497
Ensembl chr 7:134,118,817...134,121,492
G
Hoxd1
homeo box D1
decreases expression
ISO
Tunicamycin results in decreased expression of HOXD1 mRNA
CTD
PMID:29453283
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hoxd11
homeobox D11
decreases expression
ISO
Tunicamycin results in decreased expression of HOXD11 mRNA
CTD
PMID:29453283
NCBI chr 3:59,584,840...59,587,257
Ensembl chr 3:59,585,039...59,586,783
G
Hoxd9
homeo box D9
decreases expression
ISO
Tunicamycin results in decreased expression of HOXD9 mRNA
CTD
PMID:22378314
NCBI chr 3:59,600,575...59,602,755
Ensembl chr 3:59,600,575...59,602,754
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
decreases expression
ISO
Tunicamycin results in decreased expression of HPRT1 mRNA
CTD
PMID:22378314
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:132,736,096...132,768,154
G
Hr
HR, lysine demethylase and nuclear receptor corepressor
multiple interactions
ISO EXP
TRP53 protein affects the reaction [HR protein affects the reaction [Tunicamycin results in increased activity of CASP3 protein]] HR protein inhibits the reaction [Tunicamycin results in increased activity of CASP3 protein]; HR protein inhibits the reaction [Tunicamycin results in increased expression of TP53 protein]
CTD
PMID:20886113
NCBI chr15:52,036,540...52,056,019
Ensembl chr15:45,626,835...45,646,313
G
Hras
HRas proto-oncogene, GTPase
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein]; [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK1 protein; [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK3 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of ERN1 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of HSPA5 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein; [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein; [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein]; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein]
CTD
PMID:24898257
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
G
Hrk
harakiri, BCL2 interacting protein
increases expression
ISO
Tunicamycin results in increased expression of HRK mRNA
CTD
PMID:29453283
NCBI chr12:44,048,402...44,070,561
G
Hsbp1
heat shock factor binding protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of HSBP1 mRNA
CTD
PMID:17127020
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
G
Hscb
HscB mitochondrial iron-sulfur cluster co-chaperone
increases expression
ISO
Tunicamycin results in increased expression of HSCB mRNA
CTD
PMID:22378314
NCBI chr12:51,481,318...51,491,689
Ensembl chr12:45,821,555...45,831,909
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
increases expression
ISO
Tunicamycin results in increased expression of HSD17B10 mRNA
CTD
PMID:33545341
NCBI chr X:24,568,551...24,571,012
Ensembl chr X:21,089,122...21,109,488
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
increases expression
ISO
Tunicamycin results in increased expression of HSD17B6 mRNA
CTD
PMID:29453283
NCBI chr 7:422,466...442,008
Ensembl chr 7:422,480...442,425
G
Hsd17b8
hydroxysteroid (17-beta) dehydrogenase 8
increases expression
ISO
Tunicamycin results in increased expression of HSD17B8 mRNA
CTD
PMID:29453283
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,822,026...4,828,742
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression
ISO
Tunicamycin results in decreased expression of HSP90AA1 mRNA
CTD
PMID:22378314
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
decreases expression
ISO
Tunicamycin results in decreased expression of HSP90AB1 mRNA
CTD
PMID:29453283
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488
G
Hsp90b1
heat shock protein 90 beta family member 1
increases expression multiple interactions
ISO EXP
Tunicamycin results in increased expression of HSP90B1 mRNA; Tunicamycin results in increased expression of HSP90B1 protein ibutilide inhibits the reaction [Tunicamycin results in increased expression of HSP90B1 mRNA]
CTD
PMID:15049342 PMID:17416481 PMID:20071420 PMID:20477944 PMID:22378314 PMID:28399139 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:21,110,457...21,124,788
G
Hspa13
heat shock protein family A (Hsp70) member 13
increases expression
ISO
Tunicamycin results in increased expression of HSPA13 mRNA
CTD
PMID:17127020 PMID:38498338
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
decreases expression
ISO
Tunicamycin results in decreased expression of HSPA1B mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
decreases expression
ISO
Tunicamycin results in decreased expression of HSPA1L mRNA
CTD
PMID:22378314
NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,848,843...3,855,571
G
Hspa4
heat shock protein family A (Hsp70) member 4
decreases expression
ISO
Tunicamycin results in decreased expression of HSPA4 mRNA
CTD
PMID:29453283
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression increases expression
ISO EXP
Bortezomib inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; Curcumin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; ERGIC3 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; MT2A protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Quercetin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Tunicamycin promotes the reaction [HSPA5 protein binds to CDH13 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of HSPA5 mRNA; [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; [Tunicamycin co-treated with HRAS protein] results in increased expression of HSPA5 protein; Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Amiloride inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein]; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of HSPA5 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to HSPA5 protein] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Guanabenz inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; GW 506033X inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; ibutilide inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Nicotine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; salubrinal inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; Taurodeoxycholic Acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein]; ursodoxicoltaurine inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] Tunicamycin results in increased expression of HSPA5 mRNA; Tunicamycin results in increased expression of HSPA5 protein tunicamycin increases expression of Hspa5 mRNA in liver naltrexone inhibits the reaction [tunicamycin increases expression of Hspa5 mRNA in liver]
CTD RGD
PMID:12147617 PMID:15019097 PMID:15049342 PMID:16357177 PMID:17416481 PMID:18477628 PMID:18799549 PMID:19139269 PMID:19336499 PMID:19383982 PMID:19428936 PMID:19735704 PMID:20015086 PMID:20071420 PMID:20196124 PMID:20477944 PMID:20593179 PMID:20626587 PMID:21320468 PMID:21321189 PMID:22001960 PMID:22378314 PMID:22509299 PMID:22959463 PMID:23544152 PMID:24210820 PMID:24291486 PMID:24312631 PMID:24680926 PMID:24892553 PMID:24898257 PMID:25160872 PMID:25324550 PMID:27358234 PMID:27588471 PMID:28399139 PMID:28688763 PMID:28698385 PMID:28844859 PMID:29027487 PMID:29380555 PMID:29453283 PMID:29723631 PMID:29793971 PMID:29894845 PMID:30253173 PMID:30592132 PMID:32357311 PMID:32407927 PMID:32535746 PMID:32574669 PMID:32740777 PMID:33527851 PMID:33545341 PMID:35341795 PMID:36030031 PMID:36586010 PMID:36640941 PMID:37654027 PMID:38498338 PMID:38992767 PMID:27813192 PMID:27813192 More...
RGD:401842386 , RGD:401842386
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
decreases expression
ISO
Tunicamycin results in decreased expression of HSPA8 mRNA
CTD
PMID:22378314
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Hspa9
heat shock protein family A (Hsp70) member 9
increases expression
ISO
Tunicamycin results in increased expression of HSPA9 mRNA
CTD
PMID:22378314 PMID:28942281
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
G
Hspb3
heat shock protein family B (small) member 3
decreases expression
ISO
Tunicamycin results in decreased expression of HSPB3 mRNA
CTD
PMID:17127020
NCBI chr 2:45,295,285...45,295,999
Ensembl chr 2:45,295,053...45,296,145
G
Hspb6
heat shock protein family B (small) member 6
increases expression
ISO
Tunicamycin results in increased expression of HSPB6 mRNA
CTD
PMID:17127020
NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:85,806,146...85,809,071
G
Hspb7
heat shock protein family B (small) member 7
increases expression
ISO
Tunicamycin results in increased expression of HSPB7 mRNA
CTD
PMID:17127020
NCBI chr 5:159,010,759...159,014,245
Ensembl chr 5:153,727,588...153,731,266
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
Tunicamycin results in increased expression of HSPB8 mRNA
CTD
PMID:29453283
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hspd1
heat shock protein family D (Hsp60) member 1
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of HSPD1 mRNA Tunicamycin results in increased expression of HSPD1 mRNA
CTD
PMID:22378314 PMID:28942281
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Hspe1
heat shock protein family E (Hsp10) member 1
decreases expression
ISO
Tunicamycin results in decreased expression of HSPE1 mRNA
CTD
PMID:22378314
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
G
Hsph1
heat shock protein family H (Hsp110) member 1
decreases expression
ISO
Tunicamycin results in decreased expression of HSPH1 mRNA
CTD
PMID:29453283
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:5,390,922...5,410,224
G
Htr7
5-hydroxytryptamine receptor 7
decreases expression
ISO
Tunicamycin results in decreased expression of HTR7 mRNA
CTD
PMID:17127020
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:233,636,452...233,760,626
G
Htra1
HtrA serine peptidase 1
increases expression
ISO
Tunicamycin results in increased expression of HTRA1 mRNA
CTD
PMID:29453283
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Hyou1
hypoxia up-regulated 1
increases expression
ISO
Tunicamycin results in increased expression of HYOU1 mRNA; Tunicamycin results in increased expression of HYOU1 protein
CTD
PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338
NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
G
Iars1
isoleucyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of IARS1 mRNA; Tunicamycin results in increased expression of IARS1 protein
CTD
PMID:29453283
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Ibtk
inhibitor of Bruton tyrosine kinase
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of IBTK mRNA; Tunicamycin results in increased expression of IBTK protein EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK mRNA]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of IBTK protein]
CTD
PMID:24648495 PMID:29453283
NCBI chr 8:86,625,591...86,698,661
Ensembl chr 8:86,625,597...86,698,260
G
Id1
inhibitor of DNA binding 1
decreases expression
ISO
Tunicamycin results in decreased expression of ID1 mRNA
CTD
PMID:29453283
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419
G
Ide
insulin degrading enzyme
increases expression
ISO
Tunicamycin results in increased expression of IDE mRNA
CTD
PMID:22378314
NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
decreases expression
ISO
Tunicamycin results in decreased expression of IDH1 mRNA
CTD
PMID:29453283
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of IDH2 mRNA Tunicamycin results in increased expression of IDH2 mRNA
CTD
PMID:20196124 PMID:29453283
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Idh3a
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of IDH3A mRNA
CTD
PMID:22378314
NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:54,971,740...54,991,084
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
Tunicamycin results in decreased expression of IDI1 mRNA
CTD
PMID:29453283 PMID:33770205
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
G
Idnk
Idnk, gluconokinase
increases expression
ISO
Tunicamycin results in increased expression of IDNK mRNA
CTD
PMID:29453283
NCBI chr17:6,483,575...6,490,780
Ensembl chr17:6,483,576...6,490,905
G
Ier3
immediate early response 3
decreases expression
ISO
Tunicamycin results in decreased expression of IER3 mRNA
CTD
PMID:29453283
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,928,378...2,929,583
G
Ifi44
interferon-induced protein 44
increases expression
ISO
Tunicamycin results in increased expression of IFI44 mRNA
CTD
PMID:38498338
NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
increases expression
ISO
Tunicamycin results in increased expression of IFI44L mRNA
CTD
PMID:38498338
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
increases expression
ISO
Tunicamycin results in increased expression of IFIT2 mRNA
CTD
PMID:38498338
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
Tunicamycin results in increased expression of IFIT3 mRNA
CTD
PMID:38498338
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifrd1
interferon-related developmental regulator 1
increases expression
ISO
Tunicamycin results in increased expression of IFRD1 mRNA
CTD
PMID:29453283 PMID:33545341
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ift20
intraflagellar transport 20
increases expression
ISO
Tunicamycin results in increased expression of IFT20 mRNA
CTD
PMID:22378314
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
G
Ift43
intraflagellar transport 43
increases expression
ISO
Tunicamycin results in increased expression of IFT43 mRNA
CTD
PMID:29453283
NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257
G
Igdcc4
immunoglobulin superfamily, DCC subclass, member 4
increases expression
ISO
Tunicamycin results in increased expression of IGDCC4 mRNA
CTD
PMID:29453283
NCBI chr 8:65,621,893...65,657,651
Ensembl chr 8:65,621,897...65,657,648
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
Tunicamycin inhibits the reaction [IGF1 protein results in increased N-linked glycosylation of IGFBP3 protein]
CTD
PMID:15277511
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
Tunicamycin results in decreased expression of IGF1R mRNA
CTD
PMID:17127020
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Igf2r
insulin-like growth factor 2 receptor
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of IGF2R mRNA Tunicamycin results in increased expression of IGF2R mRNA
CTD
PMID:17127020
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
ISO
Tunicamycin results in increased expression of IGFBP1 mRNA
CTD
PMID:33545341 PMID:38498338
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of IGFBP2 mRNA
CTD
PMID:22378314
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp3
insulin-like growth factor binding protein 3
decreases N-linked glycosylation multiple interactions increases expression
ISO
Tunicamycin results in decreased N-linked glycosylation of IGFBP3 protein Tunicamycin inhibits the reaction [IGF1 protein results in increased N-linked glycosylation of IGFBP3 protein] Tunicamycin results in increased expression of IGFBP3 mRNA
CTD
PMID:15277511 PMID:22378314 PMID:38498338
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
Tunicamycin results in increased expression of IGFBP5 mRNA
CTD
PMID:22378314
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Igsf9
immunoglobulin superfamily, member 9
decreases expression
ISO
Tunicamycin results in decreased expression of IGSF9 mRNA
CTD
PMID:22378314
NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
decreases expression
ISO
Tunicamycin results in decreased expression of IKBKG mRNA
CTD
PMID:17127020
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:152,216,596...152,239,499
G
Il12a
interleukin 12A
multiple interactions decreases N-linked glycosylation
ISO
Tunicamycin inhibits the reaction [IL12A protein binds to IL12B protein]; Tunicamycin results in decreased secretion of [IL12A protein binds to IL12B protein] Tunicamycin results in decreased N-linked glycosylation of IL12A protein
CTD
PMID:10779781
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
multiple interactions
ISO
Tunicamycin inhibits the reaction [IL12A protein binds to IL12B protein]; Tunicamycin results in decreased secretion of [IL12A protein binds to IL12B protein]
CTD
PMID:10779781
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il17d
interleukin 17D
increases expression
ISO
Tunicamycin results in increased expression of IL17D mRNA
CTD
PMID:29453283
NCBI chr15:31,671,337...31,688,833
G
Il18
interleukin 18
increases secretion
EXP
Tunicamycin results in increased secretion of IL18 protein
CTD
PMID:37654027
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions increases secretion increases expression
ISO EXP
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of IL1B protein]] Tunicamycin results in increased secretion of IL1B protein Tunicamycin results in increased expression of IL1B mRNA
CTD
PMID:37394652 PMID:37654027 PMID:38498338
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of IL23A mRNA
CTD
PMID:33545341 PMID:38498338
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:721,809...723,923
G
Il6
interleukin 6
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of IL6 mRNA Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of IL6 protein]]
CTD
PMID:22414386 PMID:37394652
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ilvbl
ilvB acetolactate synthase like
increases expression
ISO
Tunicamycin results in increased expression of ILVBL mRNA
CTD
PMID:29453283
NCBI chr 7:11,039,870...11,049,924
Ensembl chr 7:11,039,871...11,049,924
G
Ina
internexin neuronal intermediate filament protein, alpha
decreases expression
ISO
Tunicamycin results in decreased expression of INA mRNA
CTD
PMID:22378314
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Inhba
inhibin subunit beta A
increases expression
ISO
Tunicamycin results in increased expression of INHBA mRNA
CTD
PMID:33545341
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Tunicamycin results in increased expression of INHBE mRNA
CTD
PMID:22935518 PMID:29453283 PMID:33545341 PMID:38498338
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:63,176,219...63,179,172
G
Inpp1
inositol polyphosphate-1-phosphatase
increases expression
ISO
Tunicamycin results in increased expression of INPP1 mRNA
CTD
PMID:22378314
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
G
Inpp5b
inositol polyphosphate-5-phosphatase B
increases expression
ISO
Tunicamycin results in increased expression of INPP5B mRNA
CTD
PMID:22378314
NCBI chr 5:136,996,766...137,061,315
Ensembl chr 5:136,996,686...137,061,315
G
Inpp5f
inositol polyphosphate-5-phosphatase F
decreases expression
ISO
Tunicamycin results in decreased expression of INPP5F mRNA
CTD
PMID:33770205
NCBI chr 1:183,190,480...183,270,276
Ensembl chr 1:183,190,480...183,270,276
G
Insig1
insulin induced gene 1
decreases expression
ISO
Tunicamycin results in decreased expression of INSIG1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
G
Insm1
INSM transcriptional repressor 1
increases expression
ISO
Tunicamycin results in increased expression of INSM1 mRNA
CTD
PMID:29453283
NCBI chr 3:133,640,030...133,642,963
Ensembl chr 3:133,639,580...133,643,003
G
Insm2
INSM transcriptional repressor 2
decreases expression
ISO
Tunicamycin results in decreased expression of INSM2 mRNA
CTD
PMID:22378314
NCBI chr 6:72,973,861...72,976,453
G
Iqck
IQ motif containing K
increases expression
ISO
Tunicamycin results in increased expression of IQCK mRNA
CTD
PMID:29453283
NCBI chr 1:173,199,308...173,316,982
Ensembl chr 1:173,199,316...173,316,984
G
Irf1
interferon regulatory factor 1
increases expression
ISO
Tunicamycin results in increased expression of IRF1 mRNA
CTD
PMID:29453283
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
G
Irf2bpl
interferon regulatory factor 2 binding protein-like
decreases expression
ISO
Tunicamycin results in decreased expression of IRF2BPL mRNA
CTD
PMID:29453283
NCBI chr 6:106,527,179...106,531,294
Ensembl chr 6:106,528,053...106,530,401
G
Irf7
interferon regulatory factor 7
increases expression
ISO
Tunicamycin results in increased expression of IRF7 mRNA
CTD
PMID:22378314
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irf8
interferon regulatory factor 8
increases expression
ISO
Tunicamycin results in increased expression of IRF8 mRNA
CTD
PMID:33545341
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:48,790,588...48,811,829
G
Irs1
insulin receptor substrate 1
multiple interactions
ISO
Tunicamycin affects the phosphorylation of and results in decreased expression of IRS1 protein
CTD
PMID:22378314
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
G
Irs2
insulin receptor substrate 2
increases expression
ISO
Tunicamycin results in increased expression of IRS2 mRNA
CTD
PMID:29453283
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:78,485,045...78,512,482
G
Irx5
iroquois homeobox 5
decreases expression
ISO
Tunicamycin results in decreased expression of IRX5 mRNA
CTD
PMID:22378314
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
G
Iscu
iron-sulfur cluster assembly enzyme
increases expression
ISO
Tunicamycin results in increased expression of ISCU mRNA
CTD
PMID:22378314
NCBI chr12:48,512,852...48,518,696
Ensembl chr12:42,852,305...42,858,150
G
Isg15
ISG15 ubiquitin-like modifier
increases expression
ISO
Tunicamycin results in increased expression of ISG15 mRNA
CTD
PMID:29453283
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Islr2
immunoglobulin superfamily containing leucine-rich repeat 2
decreases expression
ISO
Tunicamycin results in decreased expression of ISLR2 mRNA
CTD
PMID:22378314
NCBI chr 8:58,608,165...58,616,246
Ensembl chr 8:58,608,709...58,614,650
G
Isoc1
isochorismatase domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of ISOC1 mRNA
CTD
PMID:22378314
NCBI chr18:52,158,790...52,179,206
Ensembl chr18:52,158,790...52,178,703
G
Isoc2b
isochorismatase domain containing 2b
increases expression
ISO
Tunicamycin results in increased expression of ISOC2 mRNA
CTD
PMID:29453283
NCBI chr 1:68,972,960...68,993,760
Ensembl chr 1:68,972,960...68,993,757
G
Itgam
integrin subunit alpha M
increases expression
ISO
Tunicamycin results in increased expression of ITGAM mRNA
CTD
PMID:17127020
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Itgb1
integrin subunit beta 1
decreases expression
ISO
Tunicamycin results in decreased expression of ITGB1 mRNA
CTD
PMID:17127020
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:56,705,171...56,753,195
G
Itpk1
inositol-tetrakisphosphate 1-kinase
decreases expression
ISO
Tunicamycin results in decreased expression of ITPK1 mRNA
CTD
PMID:22378314
NCBI chr 6:121,710,750...121,844,501
Ensembl chr 6:121,710,755...121,844,107
G
Jagn1
jagunal homolog 1
increases expression
EXP ISO
Tunicamycin results in increased expression of JAGN1 mRNA
CTD
PMID:26882284
NCBI chr 4:146,591,577...146,596,287
Ensembl chr 4:146,591,510...146,596,288
G
Jam3
junctional adhesion molecule 3
increases expression
ISO
Tunicamycin results in increased expression of JAM3 mRNA
CTD
PMID:17127020
NCBI chr 8:33,767,606...33,828,451
Ensembl chr 8:25,507,057...25,569,355
G
Jmjd8
jumonji domain containing 8
increases expression
ISO
Tunicamycin results in increased expression of JMJD8 mRNA
CTD
PMID:29453283
NCBI chr10:14,848,965...14,851,881
Ensembl chr10:14,848,980...14,851,879
G
Jpt1
Jupiter microtubule associated homolog 1
decreases expression
ISO
Tunicamycin results in decreased expression of JPT1 mRNA
CTD
PMID:22378314
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tunicamycin results in increased expression of JUN mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tunicamycin results in increased expression of JUNB mRNA
CTD
PMID:17127020
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tunicamycin results in increased expression of JUND mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
G
Jup
junction plakoglobin
decreases expression
ISO
Tunicamycin results in decreased expression of JUP mRNA
CTD
PMID:22378314
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,300,440...85,327,057
G
Kat2b
lysine acetyltransferase 2B
increases expression decreases expression
ISO
Tunicamycin results in increased expression of KAT2B mRNA Tunicamycin results in decreased expression of KAT2B mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,562,288...6,667,064
G
Kat7
lysine acetyltransferase 7
increases expression
ISO
Tunicamycin results in increased expression of KAT7 mRNA
CTD
PMID:17127020
NCBI chr10:80,718,335...80,752,387
Ensembl chr10:80,221,524...80,255,567
G
Kcnj16
potassium inwardly-rectifying channel, subfamily J, member 16
decreases expression
ISO
Tunicamycin results in decreased expression of KCNJ16 mRNA
CTD
PMID:17127020
NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
G
Kcnk1
potassium two pore domain channel subfamily K member 1
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of KCNK1 mRNA Tunicamycin results in increased expression of KCNK1 mRNA
CTD
PMID:22378314 PMID:33545341
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
G
Kcnk12
potassium two pore domain channel subfamily K member 12
increases expression
ISO
Tunicamycin results in increased expression of KCNK12 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:6,740,147...6,790,664
Ensembl chr 6:6,739,991...6,790,661
G
Kcnmb2
potassium calcium-activated channel subfamily M regulatory beta subunit 2
increases expression
ISO
Tunicamycin results in increased expression of KCNMB2 mRNA
CTD
PMID:17127020
NCBI chr 2:114,670,027...114,975,374
Ensembl chr 2:114,935,976...114,975,173
G
Kcnt2
potassium sodium-activated channel subfamily T member 2
increases expression
ISO
Tunicamycin results in increased expression of KCNT2 mRNA
CTD
PMID:22378314
NCBI chr13:51,664,129...52,059,209
Ensembl chr13:51,664,686...52,056,987
G
Kctd15
potassium channel tetramerization domain containing 15
increases expression
ISO
Tunicamycin results in increased expression of KCTD15 mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr 1:87,258,658...87,271,979
Ensembl chr 1:87,258,658...87,273,497
G
Kctd20
potassium channel tetramerization domain containing 20
increases expression
ISO
Tunicamycin results in increased expression of KCTD20 mRNA
CTD
PMID:29453283
NCBI chr20:7,015,828...7,032,766
Ensembl chr20:7,015,833...7,032,761
G
Kctd7
potassium channel tetramerization domain containing 7
increases expression
ISO
Tunicamycin results in increased expression of KCTD7 mRNA
CTD
PMID:17127020
NCBI chr12:26,520,969...26,532,327
Ensembl chr12:26,523,142...26,532,138
G
Kdelr2
KDEL endoplasmic reticulum protein retention receptor 2
increases expression
ISO
Tunicamycin results in increased expression of KDELR2 mRNA
CTD
PMID:22378314
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
G
Kdr
kinase insert domain receptor
decreases expression
ISO
Tunicamycin results in decreased expression of KDR mRNA
CTD
PMID:24370435
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Khdrbs3
KH RNA binding domain containing, signal transduction associated 3
increases expression
ISO
Tunicamycin results in increased expression of KHDRBS3 mRNA
CTD
PMID:29453283
NCBI chr 7:100,837,707...100,995,644
Ensembl chr 7:100,837,934...100,988,460
G
Khsrp
KH-type splicing regulatory protein
increases expression
ISO
Tunicamycin results in increased expression of KHSRP mRNA
CTD
PMID:17127020
NCBI chr 9:1,862,555...1,872,403
Ensembl chr 9:1,862,899...1,872,451
G
Kif11
kinesin family member 11
decreases expression
ISO
Tunicamycin results in decreased expression of KIF11 mRNA
CTD
PMID:22378314
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:235,124,316...235,176,766
G
Kif14
kinesin family member 14
increases expression
ISO
Tunicamycin results in increased expression of KIF14 mRNA
CTD
PMID:33545341
NCBI chr13:50,478,646...50,542,256
Ensembl chr13:47,927,044...47,989,164
G
Kif20a
kinesin family member 20A
decreases expression
ISO
Tunicamycin results in decreased expression of KIF20A mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,230,230...26,238,780
G
Kif3c
kinesin family member 3C
decreases expression
ISO
Tunicamycin results in decreased expression of KIF3C mRNA
CTD
PMID:22378314
NCBI chr 6:26,367,092...26,406,033
Ensembl chr 6:26,366,531...26,406,130
G
Kif4a
kinesin family member 4A
decreases expression
ISO
Tunicamycin results in decreased expression of KIF4A mRNA
CTD
PMID:22378314
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
G
Kifc1
kinesin family member C1
decreases expression
ISO
Tunicamycin results in decreased expression of KIFC1 mRNA
CTD
PMID:29453283
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:4,999,047...5,017,105
G
Klf10
KLF transcription factor 10
increases expression
ISO
Tunicamycin results in increased expression of KLF10 mRNA
CTD
PMID:22378314
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
G
Klf11
KLF transcription factor 11
increases expression
ISO
Tunicamycin results in increased expression of KLF11 mRNA
CTD
PMID:29453283
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
G
Klf5
KLF transcription factor 5
increases expression
ISO
Tunicamycin results in increased expression of KLF5 mRNA
CTD
PMID:33545341
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Klf9
KLF transcription factor 9
increases expression
ISO
Tunicamycin results in increased expression of KLF9 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc2
kelch domain containing 2
increases expression
ISO
Tunicamycin results in increased expression of KLHDC2 mRNA
CTD
PMID:22378314
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
G
Klhl13
kelch-like family member 13
decreases expression
ISO
Tunicamycin results in decreased expression of KLHL13 mRNA
CTD
PMID:22378314
NCBI chr X:113,942,309...114,107,299
Ensembl chr X:113,942,309...114,107,321
G
Klln
killin, p53-regulated DNA replication inhibitor
increases expression
ISO
Tunicamycin results in increased expression of KLLN mRNA
CTD
PMID:29453283
G
Klrg1
killer cell lectin like receptor G1
decreases expression
ISO
Tunicamycin results in decreased expression of KLRG1 mRNA
CTD
PMID:22378314
NCBI chr 4:155,455,465...155,467,301
Ensembl chr 4:155,455,495...155,467,424
G
Knstrn
kinetochore-localized astrin/SPAG5 binding protein
decreases expression
ISO
Tunicamycin results in decreased expression of KNSTRN mRNA
CTD
PMID:29453283
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Tunicamycin results in decreased expression of KPNA2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Kpna3
karyopherin subunit alpha 3
decreases expression
ISO
Tunicamycin results in decreased expression of KPNA3 mRNA
CTD
PMID:22378314
NCBI chr15:35,536,310...35,610,066
Ensembl chr15:35,536,316...35,610,419
G
Krt8
keratin 8
increases expression
ISO
Tunicamycin results in increased expression of KRT8 mRNA
CTD
PMID:29453283
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Krtcap2
keratinocyte associated protein 2
increases expression
ISO
Tunicamycin results in increased expression of KRTCAP2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:174,654,409...174,658,405
Ensembl chr 2:174,654,219...174,658,405
G
Lama1
laminin subunit alpha 1
decreases expression
ISO
Tunicamycin results in decreased expression of LAMA1 mRNA
CTD
PMID:22378314
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:107,692,770...107,817,478
G
Lama5
laminin subunit alpha 5
decreases expression
ISO
Tunicamycin results in decreased expression of LAMA5 mRNA
CTD
PMID:29453283
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
G
Lamb2
laminin subunit beta 2
increases expression
ISO
Tunicamycin results in increased expression of LAMB2 mRNA
CTD
PMID:22378314
NCBI chr 8:118,056,899...118,069,090
Ensembl chr 8:109,178,409...109,190,549
G
Lamp3
lysosomal-associated membrane protein 3
increases expression
ISO
Tunicamycin results in increased expression of LAMP3 mRNA
CTD
PMID:38498338
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Lamp5
lysosomal-associated membrane protein family, member 5
decreases expression
ISO
Tunicamycin results in decreased expression of LAMP5 mRNA
CTD
PMID:22378314
NCBI chr 3:123,372,462...123,384,973
Ensembl chr 3:123,372,462...123,384,952
G
Lancl2
LanC like glutathione S-transferase 2
increases expression
ISO
Tunicamycin results in increased expression of LANCL2 mRNA
CTD
PMID:29453283
NCBI chr 4:87,441,821...87,483,707
Ensembl chr 4:87,441,823...87,482,800
G
Larp1b
La ribonucleoprotein 1B
increases expression
ISO
Tunicamycin results in increased expression of LARP1B mRNA
CTD
PMID:22378314
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Larp6
La ribonucleoprotein 6, translational regulator
increases expression
ISO
Tunicamycin results in increased expression of LARP6 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:70,079,753...70,101,175
Ensembl chr 8:61,184,116...61,205,535
G
Lars2
leucyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
Tunicamycin results in decreased expression of LARS2 mRNA
CTD
PMID:22378314
NCBI chr 8:123,010,271...123,106,395
Ensembl chr 8:123,010,293...123,106,395
G
Lcat
lecithin cholesterol acyltransferase
increases expression
ISO
Tunicamycin results in increased expression of LCAT mRNA
CTD
PMID:22378314
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:33,834,403...33,838,231
G
Lcmt1
leucine carboxyl methyltransferase 1
decreases expression
ISO
Tunicamycin results in decreased expression of LCMT1 mRNA
CTD
PMID:17127020
NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:177,904,139...177,960,112
G
Lcmt2
leucine carboxyl methyltransferase 2
decreases expression
ISO
Tunicamycin results in decreased expression of LCMT2 mRNA
CTD
PMID:22378314
NCBI chr 3:128,553,707...128,555,831
Ensembl chr 3:108,099,961...108,102,084
G
Lcn2
lipocalin 2
increases expression affects response to substance
ISO
Tunicamycin results in increased expression of LCN2 mRNA LCN2 mRNA affects the susceptibility to Tunicamycin
CTD
PMID:22800509 PMID:38498338
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ldha
lactate dehydrogenase A
decreases expression increases expression multiple interactions
ISO
Tunicamycin results in decreased expression of LDHA mRNA Tunicamycin results in increased expression of LDHA protein PHGDH protein affects the reaction [Tunicamycin results in increased expression of LDHA protein]
CTD
PMID:22378314 PMID:36473502 PMID:39427783
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Ldlr
low density lipoprotein receptor
decreases expression
ISO
Tunicamycin results in decreased expression of LDLR mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Leo1
LEO1 homolog, Paf1/RNA polymerase II complex component
decreases expression
ISO
Tunicamycin results in decreased expression of LEO1 mRNA
CTD
PMID:22378314
NCBI chr 8:85,080,036...85,104,471
Ensembl chr 8:76,199,099...76,223,983
G
Letm1
leucine zipper and EF-hand containing transmembrane protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of LETM1 mRNA
CTD
PMID:22378314
NCBI chr14:81,167,268...81,206,776
Ensembl chr14:76,942,729...76,984,904
G
Letmd1
LETM1 domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of LETMD1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:133,461,920...133,476,592
Ensembl chr 7:131,584,259...131,597,796
G
Lfng
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
decreases expression
ISO
Tunicamycin results in decreased expression of LFNG mRNA
CTD
PMID:22378314
NCBI chr12:19,144,474...19,152,951
Ensembl chr12:14,018,333...14,039,008
G
Lgals3
galectin 3
increases expression
ISO
Tunicamycin results in increased expression of LGALS3 mRNA
CTD
PMID:17127020
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Lgals3bp
galectin 3 binding protein
decreases expression
ISO
Tunicamycin results in decreased expression of LGALS3BP mRNA
CTD
PMID:22378314
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lhfpl2
LHFPL tetraspan subfamily member 2
decreases expression
ISO
Tunicamycin results in decreased expression of LHFPL2 mRNA
CTD
PMID:22378314
NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950
G
Lias
lipoic acid synthetase
increases expression
ISO
Tunicamycin results in increased expression of LIAS mRNA
CTD
PMID:22378314
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
G
Lima1
LIM domain and actin binding 1
decreases expression
ISO
Tunicamycin results in decreased expression of LIMA1 mRNA
CTD
PMID:22378314
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
G
Lin28b
lin-28 homolog B
decreases expression
ISO
Tunicamycin results in decreased expression of LIN28B mRNA
CTD
PMID:29453283
NCBI chr20:48,865,329...48,964,769
Ensembl chr20:48,869,485...48,955,077
G
Lingo1
leucine rich repeat and Ig domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of LINGO1 mRNA
CTD
PMID:22378314
NCBI chr 8:65,907,275...66,089,485
Ensembl chr 8:57,010,007...57,196,544
G
Lipa
lipase A, lysosomal acid type
increases expression
ISO
Tunicamycin results in increased expression of LIPA mRNA
CTD
PMID:22378314
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:232,024,356...232,057,633
G
Lman1
lectin, mannose-binding, 1
increases expression
ISO
Tunicamycin results in increased expression of LMAN1 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr18:61,778,971...61,800,960
Ensembl chr18:59,508,996...59,530,851
G
Lman2
lectin, mannose-binding 2
increases expression
ISO
Tunicamycin results in increased expression of LMAN2 mRNA
CTD
PMID:22378314
NCBI chr17:9,269,236...9,286,923
Ensembl chr17:9,269,022...9,287,265
G
Lman2l
lectin, mannose-binding 2-like
decreases expression
ISO
Tunicamycin results in decreased expression of LMAN2L mRNA
CTD
PMID:17127020
NCBI chr 9:38,661,709...38,685,244
Ensembl chr 9:38,661,712...38,685,337
G
Lmna
lamin A/C
increases expression
ISO
Tunicamycin results in increased expression of LMNA mRNA
CTD
PMID:22378314
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lmnb2
lamin B2
decreases expression
ISO
Tunicamycin results in decreased expression of LMNB2 mRNA
CTD
PMID:22378314
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
G
Lmo3
LIM domain only 3
decreases expression
ISO
Tunicamycin results in decreased expression of LMO3 mRNA
CTD
PMID:22378314
NCBI chr 4:171,234,686...171,297,677
Ensembl chr 4:171,234,696...171,292,222
G
Lmo4
LIM domain only 4
increases expression
ISO
Tunicamycin results in increased expression of LMO4 mRNA
CTD
PMID:22378314
NCBI chr 2:233,264,180...233,280,881
Ensembl chr 2:233,264,182...233,280,880
G
Lonp1
lon peptidase 1, mitochondrial
increases expression
ISO
Tunicamycin results in increased expression of LONP1 mRNA; Tunicamycin results in increased expression of LONP1 protein
CTD
PMID:22378314 PMID:28942281 PMID:29453283
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Loxl3
lysyl oxidase-like 3
decreases expression
ISO
Tunicamycin results in decreased expression of LOXL3 mRNA
CTD
PMID:22378314
NCBI chr 4:117,098,358...117,114,673
Ensembl chr 4:115,540,685...115,557,466
G
Lpcat1
lysophosphatidylcholine acyltransferase 1
decreases expression
ISO
Tunicamycin results in decreased expression of LPCAT1 mRNA
CTD
PMID:22378314
NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:29,766,071...29,816,401
G
Lpxn
leupaxin
increases expression
ISO
Tunicamycin results in increased expression of LPXN mRNA
CTD
PMID:22378314
NCBI chr 1:209,928,297...209,963,085
Ensembl chr 1:209,929,202...209,963,084
G
Lrp4
LDL receptor related protein 4
decreases expression
ISO
Tunicamycin results in decreased expression of LRP4 mRNA
CTD
PMID:22378314
NCBI chr 3:77,429,600...77,483,593
Ensembl chr 3:77,429,798...77,483,593
G
Lrp8
LDL receptor related protein 8
decreases expression
ISO
Tunicamycin results in decreased expression of LRP8 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:122,563,468...122,635,434
Ensembl chr 5:122,563,453...122,631,352
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
decreases expression
ISO
Tunicamycin results in decreased expression of LRRC8C mRNA
CTD
PMID:22378314
NCBI chr14:4,528,721...4,621,259
Ensembl chr14:4,227,832...4,315,249
G
Lrrc8d
leucine rich repeat containing 8 VRAC subunit D
increases expression
ISO
Tunicamycin results in increased expression of LRRC8D mRNA
CTD
PMID:29453283
NCBI chr14:4,335,114...4,411,549
Ensembl chr14:4,029,473...4,135,877
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
Tunicamycin results in decreased expression of LSM4 mRNA
CTD
PMID:22378314
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
G
Lsr
lipolysis stimulated lipoprotein receptor
decreases expression
ISO
Tunicamycin results in decreased expression of LSR mRNA
CTD
PMID:22414386
NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:86,186,431...86,201,952
G
Lss
lanosterol synthase
decreases expression
ISO
Tunicamycin results in decreased expression of LSS mRNA
CTD
PMID:22378314
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,092,774...12,118,762
G
Ltn1
listerin E3 ubiquitin protein ligase 1
increases expression
ISO
Tunicamycin results in increased expression of LTN1 mRNA
CTD
PMID:22378314
NCBI chr11:40,090,169...40,147,159
Ensembl chr11:26,603,903...26,660,886
G
Lum
lumican
decreases expression
ISO
Tunicamycin results in decreased expression of LUM mRNA
CTD
PMID:22378314
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:32,358,614...32,365,793
G
Ly6g6d
lymphocyte antigen 6 family member G6D
decreases expression
ISO
Tunicamycin results in decreased expression of LY6G6D mRNA
CTD
PMID:29453283
NCBI chr20:3,741,973...3,752,378
Ensembl chr20:3,737,459...3,752,248
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Tunicamycin results in decreased expression of LYN mRNA
CTD
PMID:22378314
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:16,639,466...16,756,868
G
Lztfl1
leucine zipper transcription factor-like 1
increases expression
ISO
Tunicamycin results in increased expression of LZTFL1 mRNA
CTD
PMID:22378314
NCBI chr 8:123,344,085...123,360,245
Ensembl chr 8:123,344,925...123,360,192
G
Lzts1
leucine zipper tumor suppressor 1
decreases expression
ISO
Tunicamycin results in decreased expression of LZTS1 mRNA
CTD
PMID:22378314
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
G
Maco1
macoilin 1
increases expression
ISO
Tunicamycin results in increased expression of MACO1 mRNA
CTD
PMID:29453283
NCBI chr 5:147,012,416...147,075,265
Ensembl chr 5:147,012,867...147,075,001
G
Macrod1
mono-ADP ribosylhydrolase 1
increases expression
ISO
Tunicamycin results in increased expression of MACROD1 mRNA
CTD
PMID:29453283
NCBI chr 1:204,246,238...204,387,027
Ensembl chr 1:204,246,166...204,389,716
G
Mad2l1
mitotic arrest deficient 2 like 1
decreases expression
ISO
Tunicamycin results in decreased expression of MAD2L1 mRNA
CTD
PMID:22378314
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:95,906,817...95,913,470
G
Mafb
MAF bZIP transcription factor B
increases expression
ISO
Tunicamycin results in increased expression of MAFB mRNA
CTD
PMID:29453283
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:148,998,122...149,000,031
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Tunicamycin results in increased expression of MAFF mRNA
CTD
PMID:17127020 PMID:33545341
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
Tunicamycin results in increased expression of MAFG mRNA
CTD
PMID:36586010
NCBI chr10:106,401,633...106,410,159
Ensembl chr10:105,903,237...105,912,026
G
Mal2
mal, T-cell differentiation protein 2
increases expression
ISO
Tunicamycin results in increased expression of MAL2 mRNA
CTD
PMID:29453283
NCBI chr 7:85,900,453...85,933,433
Ensembl chr 7:85,900,453...85,933,429
G
Man1a1
mannosidase, alpha, class 1A, member 1
decreases expression
ISO
Tunicamycin results in decreased expression of MAN1A mRNA
CTD
PMID:17127020
NCBI chr20:33,202,509...33,385,747
Ensembl chr20:33,202,517...33,385,824
G
Man2a1
mannosidase, alpha, class 2A, member 1
increases expression
ISO
Tunicamycin results in increased expression of MAN2A1 mRNA
CTD
PMID:22378314
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
Tunicamycin results in increased expression of MANF mRNA Tunicamycin results in increased expression of MANF mRNA; Tunicamycin results in increased expression of MANF protein
CTD
PMID:22001960 PMID:22378314 PMID:29453283 PMID:33545341 PMID:38498338
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression increases prenylation increases lipidation multiple interactions
ISO EXP
Tunicamycin results in increased expression of MAP1LC3B mRNA; Tunicamycin results in increased expression of MAP1LC3B protein; Tunicamycin results in increased expression of MAP1LC3B protein modified form Tunicamycin results in increased prenylation of MAP1LC3B protein Tunicamycin results in increased lipidation of MAP1LC3B protein ATG5 protein mutant form inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein]; spautin-1 inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein] Curcumin inhibits the reaction [Tunicamycin results in increased expression of MAP1LC3B protein]
CTD
PMID:20593179 PMID:20962572 PMID:29793971 PMID:36640941 PMID:37654027 PMID:38498338 More...
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k7
mitogen activated protein kinase kinase 7
decreases expression
ISO
Tunicamycin results in decreased expression of MAP2K7 mRNA
CTD
PMID:17127020
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:2,591,219...2,604,222
G
Map3k13
mitogen-activated protein kinase kinase kinase 13
decreases expression
ISO
Tunicamycin results in decreased expression of MAP3K13 mRNA
CTD
PMID:22378314
NCBI chr11:92,596,436...92,741,717
Ensembl chr11:79,097,247...79,235,181
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
multiple interactions
ISO
Tunicamycin results in increased phosphorylation of and results in increased activity of MAP3K5 protein
CTD
PMID:19735704
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
increases expression
ISO
Tunicamycin results in increased expression of MAP3K7 mRNA
CTD
PMID:17127020
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Map4k2
mitogen activated protein kinase kinase kinase kinase 2
increases expression decreases expression
ISO
Tunicamycin results in increased expression of MAP4K2 mRNA Tunicamycin results in decreased expression of MAP4K2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:213,074,360...213,090,042
Ensembl chr 1:203,645,153...203,660,331
G
Map7d1
MAP7 domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of MAP7D1 mRNA
CTD
PMID:29453283
NCBI chr 5:138,527,944...138,552,537
Ensembl chr 5:138,527,401...138,552,499
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions decreases phosphorylation
EXP ISO
Tunicamycin results in increased phosphorylation of MAPK1 protein [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK1 protein Arsenic Trioxide inhibits the reaction [Tunicamycin results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:21147958 PMID:24898257 PMID:36509116
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
decreases expression
ISO
Tunicamycin results in decreased expression of MAPK14 mRNA
CTD
PMID:17127020
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions decreases phosphorylation
EXP ISO
Tunicamycin results in increased phosphorylation of MAPK3 protein [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK3 protein Tunicamycin results in decreased phosphorylation of MAPK3 protein Arsenic Trioxide inhibits the reaction [Tunicamycin results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:21147958 PMID:24898257 PMID:36509116
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases expression increases phosphorylation
ISO EXP
Tunicamycin results in increased expression of MAPK8 mRNA Tunicamycin results in increased phosphorylation of MAPK8 protein
CTD
PMID:17127020 PMID:21147958
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
EXP
Tunicamycin results in increased phosphorylation of MAPK9 protein
CTD
PMID:21147958
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Mapkapk5
MAPK activated protein kinase 5
decreases expression
ISO
Tunicamycin results in decreased expression of MAPKAPK5 mRNA
CTD
PMID:17127020
NCBI chr12:40,654,220...40,673,740
Ensembl chr12:34,994,092...35,013,052
G
Marchf2
membrane associated ring-CH-type finger 2
decreases expression
ISO
Tunicamycin results in decreased expression of MARCHF2 mRNA
CTD
PMID:17127020
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
G
Marchf4
membrane associated ring-CH-type finger 4
decreases expression
ISO
Tunicamycin results in decreased expression of MARCHF4 mRNA
CTD
PMID:22378314
NCBI chr 9:74,078,437...74,196,070
Ensembl chr 9:74,078,434...74,198,199
G
Marcksl1
MARCKS-like 1
decreases expression
ISO
Tunicamycin results in decreased expression of MARCKSL1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:141,850,110...141,853,817
G
Mars1
methionyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of MARS1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495
G
Mast4
microtubule associated serine/threonine kinase family member 4
increases expression
ISO
Tunicamycin results in increased expression of MAST4 mRNA
CTD
PMID:17127020
NCBI chr 2:33,893,241...34,483,682
Ensembl chr 2:33,894,436...34,483,723
G
Mbtps2
membrane-bound transcription factor peptidase, site 2
increases expression
ISO
Tunicamycin results in increased expression of MBTPS2 mRNA
CTD
PMID:22378314
NCBI chr X:37,410,914...37,461,130
Ensembl chr X:37,410,811...37,464,430
G
Mccc2
methylcrotonyl-CoA carboxylase subunit 2
decreases expression
ISO
Tunicamycin results in decreased expression of MCCC2 mRNA
CTD
PMID:22378314
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
G
Mcee
methylmalonyl CoA epimerase
increases expression
ISO
Tunicamycin results in increased expression of MCEE mRNA
CTD
PMID:22378314
NCBI chr 1:117,964,576...117,987,779
Ensembl chr 1:117,964,576...117,988,484
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
increases expression
ISO
Tunicamycin results in increased expression of MCFD2 mRNA
CTD
PMID:22378314
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression multiple interactions
ISO
Tunicamycin results in decreased expression of MCL1 protein [Tunicamycin results in increased phosphorylation of EIF2S1 protein] which results in decreased expression of MCL1 protein
CTD
PMID:17553788
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
G
Mcm10
minichromosome maintenance 10 replication initiation factor
decreases expression
ISO
Tunicamycin results in decreased expression of MCM10 mRNA
CTD
PMID:22378314
NCBI chr17:78,172,049...78,197,644
Ensembl chr17:73,266,095...73,287,364
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
Tunicamycin results in decreased expression of MCM2 mRNA
CTD
PMID:22378314
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
Tunicamycin results in decreased expression of MCM3 mRNA
CTD
PMID:22378314
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
Tunicamycin results in decreased expression of MCM4 mRNA
CTD
PMID:22378314
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
Tunicamycin results in decreased expression of MCM5 mRNA
CTD
PMID:22378314
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
Tunicamycin results in decreased expression of MCM6 mRNA
CTD
PMID:22378314
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:39,826,763...39,851,960
G
Mcrip1
MAPK regulated co-repressor interacting protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of MCRIP1 mRNA
CTD
PMID:22378314
NCBI chr10:105,820,656...105,828,146
Ensembl chr10:105,820,656...105,828,271
G
Mcrip2
MAPK regulated co-repressor interacting protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of MCRIP2 mRNA
CTD
PMID:29453283
NCBI chr10:15,388,325...15,393,302
Ensembl chr10:14,883,813...14,894,021
G
Mdm4
MDM4 regulator of p53
increases expression
ISO
Tunicamycin results in increased expression of MDM4 mRNA
CTD
PMID:22378314
NCBI chr13:46,922,236...47,068,241
Ensembl chr13:44,406,213...44,474,226
G
Mecom
MDS1 and EVI1 complex locus
decreases expression
ISO
Tunicamycin results in decreased expression of MECOM mRNA
CTD
PMID:22378314
NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:112,909,321...113,464,590
G
Med1
mediator complex subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of MED1 mRNA
CTD
PMID:17127020
NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,145,568...83,189,299
G
Med10
mediator complex subunit 10
increases expression
ISO
Tunicamycin results in increased expression of MED10 mRNA
CTD
PMID:22378314
NCBI chr 1:33,470,064...33,481,698
Ensembl chr 1:33,470,066...33,475,767
G
Med29
mediator complex subunit 29
increases expression
ISO
Tunicamycin results in increased expression of MED29 mRNA
CTD
PMID:29453283
NCBI chr 1:83,677,961...83,683,365
Ensembl chr 1:83,677,961...83,683,365
G
Med8
mediator complex subunit 8
increases expression
ISO
Tunicamycin results in increased expression of MED8 mRNA
CTD
PMID:22378314
NCBI chr 5:131,948,632...131,949,516
Ensembl chr 5:131,943,982...131,950,305
G
Mef2d
myocyte enhancer factor 2D
increases expression
ISO
Tunicamycin results in increased expression of MEF2D mRNA
CTD
PMID:22378314
NCBI chr 2:175,904,332...175,933,451
Ensembl chr 2:173,606,490...173,634,457
G
Meis1
Meis homeobox 1
decreases expression
ISO
Tunicamycin results in decreased expression of MEIS1 mRNA
CTD
PMID:22378314
NCBI chr14:97,356,949...97,499,646
Ensembl chr14:93,155,419...93,294,265
G
Mettl22
methyltransferase 22, Kin17 lysine
increases expression
ISO
Tunicamycin results in increased expression of METTL22 mRNA
CTD
PMID:29453283
NCBI chr10:7,113,602...7,130,715
Ensembl chr10:7,113,660...7,130,654
G
Mettl25b
methyltransferase like 25B
increases expression
ISO
Tunicamycin results in increased expression of METTL25B mRNA
CTD
PMID:29453283
NCBI chr 2:173,388,625...173,397,279
Ensembl chr 2:173,388,625...173,397,279
G
Mex3d
mex-3 RNA binding family member D
decreases expression
ISO
Tunicamycin results in decreased expression of MEX3D mRNA
CTD
PMID:22378314
NCBI chr 7:9,325,575...9,332,705
Ensembl chr 7:9,325,488...9,332,096
G
Mfap4
microfibril associated protein 4
increases expression
ISO
Tunicamycin results in increased expression of MFAP4 mRNA
CTD
PMID:22378314
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
decreases expression
ISO
Tunicamycin results in decreased expression of MFSD2A mRNA
CTD
PMID:22378314
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mgst1
microsomal glutathione S-transferase 1
decreases expression
ISO
Tunicamycin results in decreased expression of MGST1 mRNA
CTD
PMID:17127020
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression
ISO
Tunicamycin results in decreased expression of MGST3 mRNA
CTD
PMID:17127020
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
G
Mib1
MIB E3 ubiquitin protein ligase 1
decreases expression
ISO
Tunicamycin results in decreased expression of MIB1 mRNA
CTD
PMID:22378314
NCBI chr18:1,802,519...1,926,988
Ensembl chr18:1,802,519...1,920,689
G
Mid1ip1
MID1 interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of MID1IP1 mRNA
CTD
PMID:29453283
NCBI chr X:14,733,539...14,735,859
Ensembl chr X:12,060,883...12,065,774
G
Midn
midnolin
decreases expression
ISO
Tunicamycin results in decreased expression of MIDN mRNA
CTD
PMID:29453283
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Mif4gd
MIF4G domain containing
increases expression
ISO
Tunicamycin results in increased expression of MIF4GD mRNA
CTD
PMID:29453283
NCBI chr10:100,847,168...100,852,166
G
Mir181c
microRNA 181c
increases expression
ISO
Tunicamycin results in increased expression of MIR181C mRNA
CTD
PMID:29453283
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
G
Mis12
MIS12 kinetochore complex component
increases expression
ISO
Tunicamycin results in increased expression of MIS12 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:55,739,741...55,747,915
Ensembl chr10:55,739,564...55,751,068
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
Tunicamycin results in decreased expression of MKI67 mRNA
CTD
PMID:22378314
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mlec
malectin
increases expression
ISO
Tunicamycin results in increased expression of MLEC mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
G
Mllt11
MLLT11, transcription factor 7 cofactor
decreases expression
ISO
Tunicamycin results in decreased expression of MLLT11 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
G
Mmab
metabolism of cobalamin associated B
decreases expression
ISO
Tunicamycin results in decreased expression of MMAB mRNA
CTD
PMID:22378314
NCBI chr12:42,159,109...42,172,518
Ensembl chr12:42,159,089...42,172,490
G
Mmadhc
metabolism of cobalamin associated D
increases expression
ISO
Tunicamycin results in increased expression of MMADHC mRNA
CTD
PMID:22378314
NCBI chr 3:34,708,649...34,726,554
Ensembl chr 3:34,708,649...34,726,771
G
Mmp1
matrix metallopeptidase 1
increases expression
ISO
Tunicamycin results in increased expression of MMP1 mRNA
CTD
PMID:33545341
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp15
matrix metallopeptidase 15
decreases expression
ISO
Tunicamycin results in decreased expression of MMP15 mRNA
CTD
PMID:17127020
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,663,449...9,684,943
G
Mmp17
matrix metallopeptidase 17
increases expression
ISO
Tunicamycin results in increased expression of MMP17 mRNA
CTD
PMID:17127020
NCBI chr12:27,074,398...27,099,317
Ensembl chr12:27,074,409...27,099,316
G
Mmp3
matrix metallopeptidase 3
increases expression
ISO
Tunicamycin results in increased expression of MMP3 mRNA
CTD
PMID:33545341 PMID:38498338
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mogs
mannosyl-oligosaccharide glucosidase
increases expression
ISO
Tunicamycin results in increased expression of MOGS mRNA
CTD
PMID:22378314
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
G
Mon2
MON2 homolog, regulator of endosome-to-Golgi trafficking
increases expression
ISO
Tunicamycin results in increased expression of MON2 mRNA
CTD
PMID:22378314
NCBI chr 7:58,649,378...58,728,102
Ensembl chr 7:58,651,075...58,728,064
G
Mpc1
mitochondrial pyruvate carrier 1
multiple interactions decreases expression
ISO
HMGA2 protein affects the reaction [Tunicamycin results in decreased expression of MPC1 protein]
CTD
PMID:38992767
NCBI chr 1:52,437,745...52,449,399
Ensembl chr 1:52,437,741...52,449,400
G
Mphosph6
M phase phosphoprotein 6
decreases expression
ISO
Tunicamycin results in decreased expression of MPHOSPH6 mRNA
CTD
PMID:22378314
NCBI chr19:45,860,152...45,870,117
Ensembl chr19:45,860,154...45,870,170
G
Mpp2
MAGUK p55 scaffold protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of MPP2 mRNA
CTD
PMID:29453283
NCBI chr10:87,011,434...87,043,883
Ensembl chr10:87,011,434...87,043,896
G
Mprip
myosin phosphatase Rho interacting protein
decreases expression
ISO
Tunicamycin results in decreased expression of MPRIP mRNA
CTD
PMID:22378314
NCBI chr10:44,453,949...44,573,843
Ensembl chr10:44,453,929...44,569,118
G
Mpv17l2
MPV17 mitochondrial inner membrane protein like 2
increases expression
ISO
Tunicamycin results in increased expression of MPV17L2 mRNA
CTD
PMID:22378314
NCBI chr16:18,713,690...18,718,191
Ensembl chr16:18,681,826...18,684,212
G
Mrap2
melanocortin 2 receptor accessory protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of MRAP2 mRNA
CTD
PMID:22378314
NCBI chr 8:96,968,239...97,024,581
Ensembl chr 8:88,088,272...88,143,886
G
Mrpl1
mitochondrial ribosomal protein L1
increases expression
ISO
Tunicamycin results in increased expression of MRPL1 mRNA
CTD
PMID:22378314
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
G
Mrpl11
mitochondrial ribosomal protein L11
decreases expression
ISO
Tunicamycin results in decreased expression of MRPL11 mRNA
CTD
PMID:22378314
NCBI chr 1:211,693,807...211,696,667
Ensembl chr 1:202,264,471...202,267,756
G
Mrpl12
mitochondrial ribosomal protein L12
decreases expression
ISO
Tunicamycin results in decreased expression of MRPL12 mRNA
CTD
PMID:22378314
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrpl13
mitochondrial ribosomal protein L13
decreases expression
ISO
Tunicamycin results in decreased expression of MRPL13 mRNA
CTD
PMID:22378314
NCBI chr 7:86,951,541...86,973,147
Ensembl chr 7:86,951,541...86,973,577
G
Mrpl20
mitochondrial ribosomal protein L20
decreases expression
ISO
Tunicamycin results in decreased expression of MRPL20 mRNA
CTD
PMID:22378314
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
G
Mrpl23
mitochondrial ribosomal protein L23
decreases expression
ISO
Tunicamycin results in decreased expression of MRPL23 mRNA
CTD
PMID:22378314
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
G
Mrpl42
mitochondrial ribosomal protein L42
decreases expression
ISO
Tunicamycin results in decreased expression of MRPL42 mRNA
CTD
PMID:22378314
NCBI chr 7:30,117,977...30,141,757
Ensembl chr 7:30,117,977...30,141,639
G
Mrpl45
mitochondrial ribosomal protein L45
increases expression
ISO
Tunicamycin results in increased expression of MRPL45 mRNA
CTD
PMID:22378314
NCBI chr10:82,308,650...82,320,474
Ensembl chr10:82,308,427...82,320,474
G
Mrps12
mitochondrial ribosomal protein S12
decreases expression
ISO
Tunicamycin results in decreased expression of MRPS12 mRNA
CTD
PMID:22378314
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
G
Mrps17
mitochondrial ribosomal protein S17
decreases expression
ISO
Tunicamycin results in decreased expression of MRPS17 mRNA
CTD
PMID:29453283
NCBI chr12:26,948,535...26,951,828
Ensembl chr12:26,948,730...26,951,737 Ensembl chr12:26,948,730...26,951,737
G
Mrps18b
mitochondrial ribosomal protein S18B
increases expression
ISO
Tunicamycin results in increased expression of MRPS18B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
G
Mrps22
mitochondrial ribosomal protein S22
increases expression
ISO
Tunicamycin results in increased expression of MRPS22 mRNA
CTD
PMID:22378314
NCBI chr 8:99,184,110...99,197,278
Ensembl chr 8:99,184,109...99,197,291
G
Mrps25
mitochondrial ribosomal protein S25
decreases expression
ISO
Tunicamycin results in decreased expression of MRPS25 mRNA
CTD
PMID:22378314
NCBI chr 4:124,668,320...124,680,086
Ensembl chr 4:124,668,094...124,680,057
G
Mrps28
mitochondrial ribosomal protein S28
decreases expression
ISO
Tunicamycin results in decreased expression of MRPS28 mRNA
CTD
PMID:22378314
NCBI chr 2:92,820,676...92,951,302
Ensembl chr 2:92,820,606...92,951,284
G
Mrps31
mitochondrial ribosomal protein S31
increases expression
ISO
Tunicamycin results in increased expression of MRPS31 mRNA
CTD
PMID:22378314
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
G
Mrps5
mitochondrial ribosomal protein S5
increases expression
ISO
Tunicamycin results in increased expression of MRPS5 mRNA
CTD
PMID:22378314
NCBI chr 3:114,821,046...114,837,291
Ensembl chr 3:114,821,046...114,837,291
G
Mrps6
mitochondrial ribosomal protein S6
decreases expression
ISO
Tunicamycin results in decreased expression of MRPS6 mRNA
CTD
PMID:22378314
NCBI chr11:31,295,358...31,348,483
Ensembl chr11:31,295,614...31,348,484
G
Mrrf
mitochondrial ribosome recycling factor
increases expression
ISO
Tunicamycin results in increased expression of MRRF mRNA
CTD
PMID:22378314
NCBI chr 3:39,884,530...39,941,317
Ensembl chr 3:19,487,182...19,543,908
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
Tunicamycin results in decreased expression of MSMO1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msra
methionine sulfoxide reductase A
increases expression
ISO
Tunicamycin results in increased expression of MSRA mRNA
CTD
PMID:29453283
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
G
Msrb2
methionine sulfoxide reductase B2
decreases expression
ISO
Tunicamycin results in decreased expression of MSRB2 mRNA
CTD
PMID:22378314
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
G
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
decreases expression
ISO
Tunicamycin results in decreased expression of ATP6 mRNA
CTD
PMID:22378314
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
decreases expression
ISO
Tunicamycin results in decreased expression of ATP8 mRNA
CTD
PMID:22378314
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
decreases expression
ISO
Tunicamycin results in decreased expression of COX1 mRNA
CTD
PMID:22378314
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
decreases expression
ISO
Tunicamycin results in decreased expression of COX2 mRNA
CTD
PMID:22378314
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
decreases expression
ISO
Tunicamycin results in decreased expression of COX3 mRNA
CTD
PMID:22378314
NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Mt-cyb
mitochondrially encoded cytochrome b
decreases expression
ISO
Tunicamycin results in decreased expression of CYTB mRNA
CTD
PMID:22378314
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of ND1 mRNA; Tunicamycin results in decreased expression of ND1 protein
CTD
PMID:22378314 PMID:36473502
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
G
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
decreases expression
ISO
Tunicamycin results in decreased expression of ND2 mRNA
CTD
PMID:22378314
NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
Mt-nd3
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3
decreases expression
ISO
Tunicamycin results in decreased expression of ND3 mRNA
CTD
PMID:22378314
NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
G
Mt-nd4
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4
decreases expression
ISO
Tunicamycin results in decreased expression of ND4 mRNA
CTD
PMID:22378314
NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
G
Mt-nd4l
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L
decreases expression
ISO
Tunicamycin results in decreased expression of ND4L mRNA
CTD
PMID:22378314
NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
G
Mt-nd5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
decreases expression
ISO
Tunicamycin results in decreased expression of ND5 mRNA
CTD
PMID:22378314
NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression
ISO
Tunicamycin results in decreased expression of ND6 mRNA
CTD
PMID:22378314
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mt1
metallothionein 1
increases expression
ISO
Tunicamycin results in increased expression of MT1 mRNA
CTD
PMID:15019097 PMID:17127020
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
increases expression multiple interactions decreases expression
ISO EXP
Tunicamycin results in increased expression of MT2 mRNA MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; MT2A protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [MT2A protein inhibits the reaction [Tunicamycin results in decreased phosphorylation of AKT1 protein]] Tunicamycin results in decreased expression of MT2A mRNA
CTD
PMID:15019097 PMID:17127020 PMID:24680926 PMID:36586010
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Mt4
metallothionein 4
decreases expression
ISO
Tunicamycin results in decreased expression of MT4 mRNA
CTD
PMID:17127020
NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909
G
Mtarc2
mitochondrial amidoxime reducing component 2
increases expression
ISO
Tunicamycin results in increased expression of MTARC2 mRNA
CTD
PMID:22378314
NCBI chr13:96,362,810...96,397,284
G
Mtch2
mitochondrial carrier 2
decreases expression
ISO
Tunicamycin results in decreased expression of MTCH2 mRNA
CTD
PMID:22378314
NCBI chr 3:76,830,549...76,850,189
Ensembl chr 3:76,830,413...76,850,189
G
Mtdh
metadherin
increases expression
ISO
Tunicamycin results in increased expression of MTDH mRNA
CTD
PMID:29453283
NCBI chr 7:67,192,592...67,250,819
Ensembl chr 7:65,306,400...65,364,413
G
Mtfmt
mitochondrial methionyl-tRNA formyltransferase
decreases expression
ISO
Tunicamycin results in decreased expression of MTFMT mRNA
CTD
PMID:22378314
NCBI chr 8:65,953,787...65,971,841
Ensembl chr 8:65,953,767...65,971,841
G
Mtfr1
mitochondrial fission regulator 1
increases expression
ISO
Tunicamycin results in increased expression of MTFR1 mRNA
CTD
PMID:22378314
NCBI chr 2:101,678,331...101,713,547
Ensembl chr 2:101,679,265...101,713,544
G
Mthfd1
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
decreases expression
ISO
Tunicamycin results in decreased expression of MTHFD1 mRNA
CTD
PMID:22378314
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
increases expression
ISO
Tunicamycin results in increased expression of MTHFD1L mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
ISO
Tunicamycin results in increased expression of MTHFD2 mRNA; Tunicamycin results in increased expression of MTHFD2 protein
CTD
PMID:22378314 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mthfs
methenyltetrahydrofolate synthetase
increases expression
ISO
Tunicamycin results in increased expression of MTHFS mRNA
CTD
PMID:29453283
NCBI chr 8:89,729,498...89,801,998
Ensembl chr 8:89,729,508...89,799,089
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
[resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; [resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; [resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form] Curcumin inhibits the reaction [Tunicamycin results in increased expression of and results in increased phosphorylation of MTOR protein]; Tunicamycin results in increased expression of and results in increased phosphorylation of MTOR protein
CTD
PMID:21321189 PMID:36640941
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Mtrf1
mitochondrial translation release factor 1
increases expression
ISO
Tunicamycin results in increased expression of MTRF1 mRNA
CTD
PMID:22378314
NCBI chr15:54,776,885...54,804,699
Ensembl chr15:54,776,937...54,804,704
G
Mttp
microsomal triglyceride transfer protein
decreases expression
ISO
Tunicamycin results in decreased expression of MTTP mRNA
CTD
PMID:32535746
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Mtx3
metaxin 3
increases expression
ISO
Tunicamycin results in increased expression of MTX3 mRNA
CTD
PMID:29453283
NCBI chr 2:24,066,332...24,079,708
Ensembl chr 2:24,066,365...24,079,670
G
Muc20
mucin 20, cell surface associated
increases expression
ISO
Tunicamycin results in increased expression of MUC20 mRNA
CTD
PMID:17127020
NCBI chr11:67,987,816...68,001,496
Ensembl chr11:67,987,800...68,001,495
G
Mvd
mevalonate diphosphate decarboxylase
increases expression
ISO
Tunicamycin results in increased expression of MVD mRNA
CTD
PMID:17127020
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
G
Mvp
major vault protein
increases expression
ISO
Tunicamycin results in increased expression of MVP mRNA
CTD
PMID:22378314
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:181,594,734...181,622,380
G
Mx1
MX dynamin like GTPase 1
increases expression
ISO
Tunicamycin results in increased expression of MX1 mRNA
CTD
PMID:38498338
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Myb
MYB proto-oncogene, transcription factor
decreases expression
ISO
Tunicamycin results in decreased expression of MYB mRNA
CTD
PMID:22378314
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:15,939,761...15,973,057
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of MYC mRNA Tunicamycin results in increased expression of MYC mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Mycbp
Myc binding protein
decreases expression
ISO
Tunicamycin results in decreased expression of MYCBP mRNA
CTD
PMID:22378314
NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616
G
Mycbpap
Mycbp associated protein
increases expression
ISO
Tunicamycin results in increased expression of MYCBPAP mRNA
CTD
PMID:17127020
NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828
G
Mycn
MYCN proto-oncogene, bHLH transcription factor
decreases expression
ISO
Tunicamycin results in decreased expression of MYCN mRNA
CTD
PMID:22378314
NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:35,717,764...35,723,590
G
Mydgf
myeloid-derived growth factor
increases expression
ISO
Tunicamycin results in increased expression of MYDGF mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 9:999,659...1,008,804
Ensembl chr 9:1,000,722...1,008,822
G
Myg1
MYG1 exonuclease
increases expression
ISO
Tunicamycin results in increased expression of MYG1 mRNA
CTD
PMID:22378314
NCBI chr 7:133,456,778...133,463,985
Ensembl chr 7:133,456,750...133,466,969
G
Myh10
myosin heavy chain 10
decreases expression
ISO
Tunicamycin results in decreased expression of MYH10 mRNA
CTD
PMID:22378314
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
G
Mylip
myosin regulatory light chain interacting protein
decreases expression
ISO
Tunicamycin results in decreased expression of MYLIP mRNA
CTD
PMID:22378314
NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295
G
Myo1d
myosin ID
increases expression
ISO
Tunicamycin results in increased expression of MYO1D mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
G
Myo5c
myosin VC
increases expression
ISO
Tunicamycin results in increased expression of MYO5C mRNA
CTD
PMID:29453283
NCBI chr 8:75,989,497...76,066,485
Ensembl chr 8:75,989,528...76,066,483
G
Mypop
Myb-related transcription factor, partner of profilin
decreases expression
ISO
Tunicamycin results in decreased expression of MYPOP mRNA
CTD
PMID:29453283
NCBI chr 1:78,639,699...78,650,555
Ensembl chr 1:78,639,769...78,650,552
G
N4bp2
NEDD4 binding protein 2
increases expression
ISO
Tunicamycin results in increased expression of N4BP2 mRNA
CTD
PMID:22378314
NCBI chr14:42,342,690...42,479,861
Ensembl chr14:42,409,510...42,483,960
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression
ISO
Tunicamycin results in increased expression of N4BP2L1 mRNA
CTD
PMID:22378314
NCBI chr12:4,938,199...4,965,003
Ensembl chr12:102,573...127,257
G
N4bp2l2
NEDD4 binding protein 2-like 2
increases expression
ISO
Tunicamycin results in increased expression of N4BP2L2 mRNA
CTD
PMID:22378314
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
Nans
N-acetylneuraminate synthase
increases expression
ISO
Tunicamycin results in increased expression of NANS mRNA; Tunicamycin results in increased expression of NANS protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:60,780,441...60,797,583
Ensembl chr 5:60,780,392...60,814,950
G
Nap1l2
nucleosome assembly protein 1-like 2
increases expression
ISO
Tunicamycin results in increased expression of NAP1L2 mRNA
CTD
PMID:17127020
NCBI chr X:68,174,051...68,176,449
Ensembl chr X:68,173,987...68,176,666
G
Nars1
asparaginyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of NARS1 mRNA
CTD
PMID:22378314
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:57,989,308...58,005,622
G
Nat8f2
N-acetyltransferase 8 (GCN5-related) family member 2
decreases expression
ISO
Tunicamycin results in decreased expression of NAT8F2 mRNA
CTD
PMID:17127020
NCBI chr 4:118,319,984...118,323,159
Ensembl chr 4:118,319,988...118,324,395
G
Ncald
neurocalcin delta
decreases expression
ISO
Tunicamycin results in decreased expression of NCALD mRNA
CTD
PMID:22378314
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
G
Ncam2
neural cell adhesion molecule 2
decreases expression
ISO
Tunicamycin results in decreased expression of NCAM2 mRNA
CTD
PMID:22378314
NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
Tunicamycin results in decreased expression of NCAPG mRNA
CTD
PMID:22378314
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:65,404,163...65,432,902
G
Ncoa5
nuclear receptor coactivator 5
increases expression
ISO
Tunicamycin results in increased expression of NCOA5 mRNA
CTD
PMID:17127020
NCBI chr 3:174,155,731...174,188,862
Ensembl chr 3:153,736,420...153,769,553
G
Ncr3lg1
natural killer cell cytotoxicity receptor 3 ligand 1
increases expression
ISO
Tunicamycin results in increased expression of NCR3LG1 mRNA
CTD
PMID:29453283
NCBI chr 1:96,565,664...96,581,825
Ensembl chr 1:96,574,455...96,580,466
G
Ncs1
neuronal calcium sensor 1
decreases expression
ISO
Tunicamycin results in decreased expression of NCS1 mRNA
CTD
PMID:22378314
NCBI chr 3:34,920,949...34,966,554
Ensembl chr 3:14,523,220...14,568,829
G
Ndor1
NADPH dependent diflavin oxidoreductase 1
decreases expression
ISO
Tunicamycin results in decreased expression of NDOR1 mRNA
CTD
PMID:17127020
NCBI chr 3:28,460,787...28,469,018
Ensembl chr 3:8,062,630...8,070,860
G
Ndrg1
N-myc downstream regulated 1
multiple interactions increases expression
ISO
NDRG1 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Tunicamycin results in increased expression of NDRG1 mRNA
CTD
PMID:24532803 PMID:29453283
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880
G
Ndufa11
NADH:ubiquinone oxidoreductase subunit A11
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA11 mRNA
CTD
PMID:22378314
NCBI chr 9:1,637,614...1,641,673
Ensembl chr 9:1,550,468...1,555,601
G
Ndufa12
NADH:ubiquinone oxidoreductase subunit A12
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA12 mRNA
CTD
PMID:22378314
NCBI chr 7:30,658,316...30,685,302
Ensembl chr 7:28,771,330...28,798,315
G
Ndufa13
NADH:ubiquinone oxidoreductase subunit A13
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA13 mRNA
CTD
PMID:22378314
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726 Ensembl chr 7:19,526,565...19,535,726
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA3 mRNA
CTD
PMID:22378314
NCBI chr 1:74,512,928...74,515,558
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa4
Ndufa4, mitochondrial complex associated
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA4 mRNA
CTD
PMID:22378314
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,002,216...40,023,920
G
Ndufa5
NADH:ubiquinone oxidoreductase subunit A5
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA5 mRNA
CTD
PMID:17127020
NCBI chr 4:53,962,877...53,971,235
Ensembl chr 4:52,995,546...53,005,598 Ensembl chr 5:52,995,546...53,005,598
G
Ndufa6
NADH:ubiquinone oxidoreductase subunit A6
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA6 mRNA
CTD
PMID:22378314
NCBI chr 7:115,746,460...115,750,317
Ensembl chr 7:113,866,382...113,870,239
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFA7 mRNA
CTD
PMID:22378314
NCBI chr 7:15,311,446...15,324,226
Ensembl chr 7:14,609,146...14,631,976
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFAB1 mRNA
CTD
PMID:22378314
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:176,644,703...176,658,099
G
Ndufaf1
NADH:ubiquinone oxidoreductase complex assembly factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFAF1 mRNA
CTD
PMID:22378314
NCBI chr 3:106,639,025...106,650,549
Ensembl chr 3:106,639,851...106,650,212
G
Ndufaf2
NADH:ubiquinone oxidoreductase complex assembly factor 2
increases expression
ISO
Tunicamycin results in increased expression of NDUFAF2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:39,535,680...39,647,378
Ensembl chr 2:39,535,689...39,647,316
G
Ndufb2
NADH:ubiquinone oxidoreductase subunit B2
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFB2 mRNA
CTD
PMID:22378314
NCBI chr 4:69,334,307...69,341,394
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
G
Ndufb3
NADH:ubiquinone oxidoreductase subunit B3
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFB3 mRNA
CTD
PMID:22378314
NCBI chr 9:67,623,417...67,633,629
Ensembl chr 9:60,129,154...60,139,446
G
Ndufb4
NADH:ubiquinone oxidoreductase subunit B4
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFB4 mRNA
CTD
PMID:17127020
NCBI chr11:76,569,178...76,575,879
Ensembl chr11:63,063,795...63,070,425
G
Ndufb6
NADH:ubiquinone oxidoreductase subunit B6
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFB6 mRNA
CTD
PMID:22378314
NCBI chr 5:60,196,585...60,206,152
Ensembl chr 5:55,400,543...55,410,181
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFB8 mRNA
CTD
PMID:22378314
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:243,408,619...243,413,817
G
Ndufc1
NADH:ubiquinone oxidoreductase subunit C1
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFC1 mRNA
CTD
PMID:22378314
NCBI chr 2:137,597,944...137,601,819
Ensembl chr 2:135,447,119...135,450,874
G
Ndufs4
NADH:ubiquinone oxidoreductase subunit S4
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFS4 mRNA
CTD
PMID:17127020
NCBI chr 2:47,684,420...47,794,914
Ensembl chr 2:45,951,313...46,061,846
G
Ndufs5
NADH:ubiquinone oxidoreductase subunit S5
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFS5 mRNA
CTD
PMID:22378314
NCBI chr 5:141,258,828...141,264,552
Ensembl chr 5:135,974,034...135,979,603 Ensembl chr14:135,974,034...135,979,603 Ensembl chr 2:135,974,034...135,979,603
G
Ndufs7
NADH:ubiquinone oxidoreductase core subunit S7
increases expression
ISO
Tunicamycin results in increased expression of NDUFS7 mRNA
CTD
PMID:29453283
NCBI chr 7:10,103,226...10,110,862
Ensembl chr 7:9,450,392...9,460,195
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
decreases expression
ISO
Tunicamycin results in decreased expression of NDUFV2 mRNA
CTD
PMID:22378314
NCBI chr 9:113,137,305...113,157,571
Ensembl chr 9:105,690,455...105,710,713
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
increases expression
ISO
Tunicamycin results in increased expression of NEDD4 mRNA
CTD
PMID:22378314
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
G
Nefh
neurofilament heavy chain
decreases expression
ISO
Tunicamycin results in decreased expression of NEFH mRNA
CTD
PMID:22378314
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nek6
NIMA-related kinase 6
decreases expression
ISO
Tunicamycin results in decreased expression of NEK6 mRNA
CTD
PMID:22378314
NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:22,284,279...22,395,990
G
Nes
nestin
decreases expression
ISO
Tunicamycin results in decreased expression of NES mRNA
CTD
PMID:22378314
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Neto2
neuropilin and tolloid like 2
decreases expression
ISO
Tunicamycin results in decreased expression of NETO2 mRNA
CTD
PMID:22378314
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
G
Nfe2l1
NFE2 like bZIP transcription factor 1
multiple interactions
ISO
Tunicamycin affects the reaction [sodium arsenite affects the localization of NFE2L1 protein]
CTD
PMID:20805060
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions affects response to substance increases expression affects localization increases activity
ISO
Tunicamycin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased phosphorylation of NFE2L2 protein; Exenatide inhibits the reaction [Tunicamycin affects the localization of NFE2L2 protein]; Exenatide inhibits the reaction [Tunicamycin results in increased expression of NFE2L2 mRNA]; NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA]; NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GSR mRNA]; NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of NQO1 mRNA]; NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB5 mRNA]; NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB6 mRNA] NFE2L2 mRNA affects the susceptibility to Tunicamycin Tunicamycin results in increased expression of NFE2L2 mRNA; Tunicamycin results in increased expression of NFE2L2 protein modified form Tunicamycin results in increased activity of NFE2L2 protein
CTD
PMID:20805060 PMID:22959925 PMID:29289645 PMID:30203046 PMID:30253173 PMID:36586010 More...
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfe2l3
NFE2 like bZIP transcription factor 3
decreases expression
ISO
Tunicamycin results in decreased expression of NFE2L3 mRNA
CTD
PMID:22378314
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
ISO
Tunicamycin results in increased expression of NFIL3 mRNA
CTD
PMID:17127020
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,280,484...12,295,858
G
Nfkbiz
NFKB inhibitor zeta
increases expression
ISO
Tunicamycin results in increased expression of NFKBIZ mRNA
CTD
PMID:17127020
NCBI chr11:58,251,720...58,279,767
Ensembl chr11:44,782,676...44,810,723
G
Nfxl1
nuclear transcription factor, X-box binding-like 1
increases expression
ISO
Tunicamycin results in increased expression of NFXL1 mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr14:35,626,086...35,667,505
Ensembl chr14:35,626,066...35,667,498
G
Niban1
niban apoptosis regulator 1
increases expression
ISO
Tunicamycin results in increased expression of NIBAN1 mRNA
CTD
PMID:29453283
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Ninj1
ninjurin 1
increases expression
ISO
Tunicamycin results in increased expression of NINJ1 mRNA
CTD
PMID:22378314
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nipal1
NIPA-like domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of NIPAL1 mRNA
CTD
PMID:22378314
NCBI chr14:35,537,641...35,561,656
Ensembl chr14:35,540,324...35,561,659
G
Nipsnap1
nipsnap homolog 1
decreases expression
ISO
Tunicamycin results in decreased expression of NIPSNAP1 mRNA
CTD
PMID:22378314
NCBI chr14:79,734,234...79,758,101
Ensembl chr14:79,734,209...79,758,098
G
Nktr
natural killer cell triggering receptor
increases expression
ISO
Tunicamycin results in increased expression of NKTR mRNA
CTD
PMID:17127020
NCBI chr 8:130,255,541...130,298,001
Ensembl chr 8:121,382,436...121,418,314
G
Nkx1-2
NK1 homeobox 2
increases expression
ISO
Tunicamycin results in increased expression of NKX1-2 mRNA
CTD
PMID:17127020
NCBI chr 1:187,386,370...187,391,252
Ensembl chr 1:187,388,711...187,391,149
G
Nln
neurolysin
decreases expression
ISO
Tunicamycin results in decreased expression of NLN mRNA
CTD
PMID:22378314
NCBI chr 2:35,133,634...35,232,927
Ensembl chr 2:35,134,145...35,232,914
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions increases expression
ISO EXP
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of NLRP3 protein]] Tunicamycin results in increased expression of NLRP3 protein
CTD
PMID:37394652 PMID:37654027
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
G
Nmb
neuromedin B
decreases expression
ISO
Tunicamycin results in decreased expression of NMB mRNA
CTD
PMID:22378314
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of NME1 mRNA
CTD
PMID:22378314
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:78,906,083...78,916,408
G
Nme4
NME/NM23 nucleoside diphosphate kinase 4
decreases expression
ISO
Tunicamycin results in decreased expression of NME4 mRNA
CTD
PMID:22378314
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
G
Nmt2
N-myristoyltransferase 2
decreases expression
ISO
Tunicamycin results in decreased expression of NMT2 mRNA
CTD
PMID:17127020
NCBI chr17:74,917,833...74,964,788
Ensembl chr17:74,917,833...74,961,080
G
Nmu
neuromedin U
decreases expression
ISO
Tunicamycin results in decreased expression of NMU mRNA
CTD
PMID:22378314
NCBI chr14:32,198,789...32,226,397
Ensembl chr14:31,844,728...31,872,192
G
Nnat
neuronatin
decreases expression
ISO
Tunicamycin results in decreased expression of NNAT mRNA
CTD
PMID:22378314
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:146,226,407...146,228,834
G
Nop53
NOP53 ribosome biogenesis factor
increases expression
ISO
Tunicamycin results in increased expression of NOP53 mRNA
CTD
PMID:29453283
NCBI chr 1:85,757,271...85,765,089
Ensembl chr 1:76,629,069...76,636,902
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of NOS2 protein]]
CTD
PMID:37394652
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
increases cleavage multiple interactions
ISO
Tunicamycin results in increased cleavage of NOTCH1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased cleavage of NOTCH1 protein]
CTD
PMID:22115781
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Npas1
neuronal PAS domain protein 1
increases expression
ISO
Tunicamycin results in increased expression of NPAS1 mRNA
CTD
PMID:29453283
NCBI chr 1:77,167,375...77,187,887
Ensembl chr 1:77,167,381...77,186,762
G
Nppa
natriuretic peptide A
decreases expression
ISO
Tunicamycin results in decreased expression of NPPA mRNA
CTD
PMID:22378314
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nptx2
neuronal pentraxin 2
decreases expression
ISO
Tunicamycin results in decreased expression of NPTX2 mRNA
CTD
PMID:22378314
NCBI chr12:10,037,435...10,048,345
Ensembl chr12:10,037,435...10,048,345
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of NQO1 mRNA; Tunicamycin results in increased expression of NQO1 protein [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of NQO1 mRNA; Exenatide inhibits the reaction [Tunicamycin results in increased expression of NQO1 mRNA]; NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of NQO1 mRNA]
CTD
PMID:22959925 PMID:29289645 PMID:30253173 PMID:36586010
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
ISO
Tunicamycin results in increased expression of NR1D2 mRNA
CTD
PMID:22378314
NCBI chr15:9,955,034...9,981,329
Ensembl chr15:7,524,257...7,550,553
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases activity
ISO
Tunicamycin results in decreased activity of NR1I3 protein
CTD
PMID:30203046
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:83,632,899...83,637,906
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
decreases expression
ISO
Tunicamycin results in decreased expression of NR2F2 mRNA
CTD
PMID:17127020
NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:124,009,181...124,022,031
G
Nrcam
neuronal cell adhesion molecule
increases expression
ISO
Tunicamycin results in increased expression of NRCAM mRNA
CTD
PMID:22378314
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
Tunicamycin results in decreased expression of NREP mRNA
CTD
PMID:22378314
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nrf1
nuclear respiratory factor 1
decreases expression
ISO
Tunicamycin results in decreased expression of NRF1 mRNA
CTD
PMID:22378314
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
G
Nrip1
nuclear receptor interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of NRIP1 mRNA
CTD
PMID:17127020
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
G
Nrm
nurim
decreases expression
ISO
Tunicamycin results in decreased expression of NRM mRNA
CTD
PMID:22378314
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
G
Nsmce1
NSE1 homolog, SMC5-SMC6 complex component
increases expression
ISO
Tunicamycin results in increased expression of NSMCE1 mRNA
CTD
PMID:29453283
NCBI chr 1:180,030,355...180,058,541
Ensembl chr 1:180,030,160...180,058,417
G
Nt5c3a
5'-nucleotidase, cytosolic IIIA
increases expression
ISO
Tunicamycin results in increased expression of NT5C3A mRNA
CTD
PMID:29453283
NCBI chr 4:86,161,642...86,204,656
Ensembl chr 4:86,161,643...86,204,628
G
Nt5dc2
5'-nucleotidase domain containing 2
increases expression
ISO
Tunicamycin results in increased expression of NT5DC2 mRNA
CTD
PMID:22378314
NCBI chr16:6,322,485...6,330,538
Ensembl chr16:6,322,236...6,330,537
G
Nucb1
nucleobindin 1
increases expression
ISO
Tunicamycin results in increased expression of NUCB1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
G
Nucb2
nucleobindin 2
increases expression
ISO
Tunicamycin results in increased expression of NUCB2 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:38498338
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
G
Nudt1
nudix hydrolase 1
decreases expression
ISO
Tunicamycin results in decreased expression of NUDT1 mRNA
CTD
PMID:22378314
NCBI chr12:19,416,411...19,423,448
Ensembl chr12:14,302,694...14,305,826
G
Nudt11
nudix hydrolase 11
decreases expression
ISO
Tunicamycin results in decreased expression of NUDT11 mRNA
CTD
PMID:22378314
NCBI chr X:18,998,587...19,005,208
Ensembl chr X:16,326,598...16,333,145
G
Nudt13
nudix hydrolase 13
increases expression
ISO
Tunicamycin results in increased expression of NUDT13 mRNA
CTD
PMID:29453283
NCBI chr15:4,001,787...4,022,404
Ensembl chr15:4,001,794...4,022,293
G
Nudt8
nudix hydrolase 8
decreases expression
ISO
Tunicamycin results in decreased expression of NUDT8 mRNA
CTD
PMID:22378314
NCBI chr 1:201,293,660...201,295,233
Ensembl chr 1:201,292,619...201,295,224
G
Nup107
nucleoporin 107
decreases expression
ISO
Tunicamycin results in decreased expression of NUP107 mRNA
CTD
PMID:29453283
NCBI chr 7:53,353,740...53,398,345
Ensembl chr 7:53,353,743...53,398,370
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of NUSAP1 mRNA
CTD
PMID:22378314
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:106,603,289...106,633,624
G
Nxn
nucleoredoxin
decreases expression
ISO
Tunicamycin results in decreased expression of NXN mRNA
CTD
PMID:22378314
NCBI chr10:61,109,322...61,247,578
Ensembl chr10:61,110,020...61,248,251
G
Oas1a
2'-5' oligoadenylate synthetase 1A
increases expression
ISO
Tunicamycin results in increased expression of OAS1 mRNA
CTD
PMID:38498338
NCBI chr12:41,330,423...41,341,130
Ensembl chr12:35,669,801...35,680,517
G
Oat
ornithine aminotransferase
decreases expression
ISO
Tunicamycin results in decreased expression of OAT mRNA
CTD
PMID:22378314
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Odad4
outer dynein arm docking complex subunit 4
increases expression
ISO
Tunicamycin results in increased expression of ODAD4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:85,480,089...85,508,603
Ensembl chr10:85,480,094...85,508,603
G
Ogdh
oxoglutarate dehydrogenase
decreases expression
ISO
Tunicamycin results in decreased expression of OGDH mRNA
CTD
PMID:17127020
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:81,150,091...81,217,479
G
Os9
OS9, endoplasmic reticulum lectin
increases expression
ISO
Tunicamycin results in increased expression of OS9 mRNA
CTD
PMID:22378314
NCBI chr 7:64,802,517...64,829,185
Ensembl chr 7:62,915,515...62,943,745
G
Osbp
oxysterol binding protein
increases expression
ISO
Tunicamycin results in increased expression of OSBP mRNA
CTD
PMID:22378314
NCBI chr 1:208,888,697...208,918,511
Ensembl chr 1:208,887,895...208,918,506
G
Osbpl6
oxysterol binding protein-like 6
increases expression
ISO
Tunicamycin results in increased expression of OSBPL6 mRNA
CTD
PMID:22378314
NCBI chr 3:61,343,776...61,541,170
Ensembl chr 3:61,343,809...61,537,102
G
Ostc
oligosaccharyltransferase complex non-catalytic subunit
increases expression
ISO
Tunicamycin results in increased expression of OSTC mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
G
Oxa1l
OXA1L, mitochondrial inner membrane protein
increases expression
ISO
Tunicamycin results in increased expression of OXA1L mRNA
CTD
PMID:22378314
NCBI chr15:31,783,725...31,791,353
Ensembl chr15:27,813,625...27,821,319
G
P4hb
prolyl 4-hydroxylase subunit beta
increases expression
ISO
Tunicamycin results in increased expression of P4HB mRNA; Tunicamycin results in increased expression of P4HB protein
CTD
PMID:15049342 PMID:22378314 PMID:28975502 PMID:29453283 PMID:32535746 PMID:32740777 More...
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pacsin2
protein kinase C and casein kinase substrate in neurons 2
increases expression
ISO
Tunicamycin results in increased expression of PACSIN2 mRNA
CTD
PMID:22378314
NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546
G
Pacsin3
protein kinase C and casein kinase substrate in neurons 3
increases expression
ISO
Tunicamycin results in increased expression of PACSIN3 mRNA
CTD
PMID:17127020
NCBI chr 3:77,227,187...77,235,820
Ensembl chr 3:77,222,710...77,235,811
G
Pafah1b3
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
decreases expression
ISO
Tunicamycin results in decreased expression of PAFAH1B3 mRNA
CTD
PMID:22378314
NCBI chr 1:80,881,263...80,883,789
Ensembl chr 1:80,881,309...80,883,893
G
Pam16
presequence translocase associated motor 16
decreases expression
ISO
Tunicamycin results in decreased expression of PAM16 mRNA
CTD
PMID:22378314
NCBI chr10:10,942,534...10,950,654
Ensembl chr10:10,943,001...10,950,649
G
Pan2
poly(A) specific ribonuclease subunit PAN2
increases expression
ISO
Tunicamycin results in increased expression of PAN2 mRNA
CTD
PMID:29453283
NCBI chr 7:729,146...747,744
Ensembl chr 7:729,562...747,744
G
Pank1
pantothenate kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of PANK1 mRNA
CTD
PMID:17127020
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Pank3
pantothenate kinase 3
decreases expression
ISO
Tunicamycin results in decreased expression of PANK3 mRNA
CTD
PMID:17127020
NCBI chr10:20,229,129...20,252,955
Ensembl chr10:20,229,129...20,252,955
G
Panx2
pannexin 2
decreases expression
ISO
Tunicamycin results in decreased expression of PANX2 mRNA
CTD
PMID:29453283
NCBI chr 7:120,139,259...120,153,056
Ensembl chr 7:120,139,294...120,152,361
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
decreases expression
ISO
Tunicamycin results in decreased expression of PAPSS2 mRNA
CTD
PMID:29453283
NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:230,454,426...230,539,331
G
Parp1
poly (ADP-ribose) polymerase 1
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of PARP1 protein modified form 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of PARP1 protein modified form]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of PARP1 protein modified form]
CTD
PMID:31330229 PMID:32407927
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Parp12
poly (ADP-ribose) polymerase family, member 12
increases expression
ISO
Tunicamycin results in increased expression of PARP12 mRNA
CTD
PMID:29453283
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
G
Pbx2
PBX homeobox 2
increases expression
ISO
Tunicamycin results in increased expression of PBX2 mRNA
CTD
PMID:17127020
NCBI chr20:4,156,107...4,161,503
Ensembl chr20:4,151,500...4,156,425
G
Pcca
propionyl-CoA carboxylase subunit alpha
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of PCCA mRNA Tunicamycin results in increased expression of PCCA mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
G
Pccb
propionyl-CoA carboxylase subunit beta
decreases expression
ISO
Tunicamycin results in decreased expression of PCCB mRNA
CTD
PMID:22378314
NCBI chr 8:101,591,218...101,641,213
Ensembl chr 8:101,590,737...101,641,234
G
Pcdh18
protocadherin 18
increases expression
ISO
Tunicamycin results in increased expression of PCDH18 mRNA
CTD
PMID:22378314
NCBI chr 2:133,831,996...133,845,992
Ensembl chr 2:133,832,001...133,845,883
G
Pcdh7
protocadherin 7
decreases expression
ISO
Tunicamycin results in decreased expression of PCDH7 mRNA
CTD
PMID:17127020
NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051 Ensembl chr14:52,475,610...52,902,051
G
Pcdh9
protocadherin 9
increases expression
ISO
Tunicamycin results in increased expression of PCDH9 mRNA
CTD
PMID:17127020
NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538
G
Pcdhac2
protocadherin alpha subfamily C, 2
increases expression
ISO
Tunicamycin results in increased expression of PCDHAC2 mRNA
CTD
PMID:38498338
Ensembl chr18:28,581,225...28,846,211
G
Pcdhb3
protocadherin beta 3
decreases expression
ISO
Tunicamycin results in decreased expression of PCDHB3 mRNA
CTD
PMID:22378314
NCBI chr18:29,011,667...29,014,221
Ensembl chr18:29,011,816...29,015,188
G
Pcdhga12
protocadherin gamma subfamily A, 12
decreases expression
ISO
Tunicamycin results in decreased expression of PCDHGA12 mRNA
CTD
PMID:17127020
NCBI chr18:29,592,664...29,667,865
Ensembl chr18:29,493,954...29,667,868
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of PCK2 mRNA Tunicamycin results in increased expression of PCK2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
Tunicamycin results in decreased expression of PCLAF mRNA
CTD
PMID:22378314
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcna
proliferating cell nuclear antigen
decreases expression multiple interactions
ISO
Tunicamycin results in decreased expression of PCNA mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein]; [Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein
CTD
PMID:22378314 PMID:24898257
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pcolce2
procollagen C-endopeptidase enhancer 2
decreases expression
ISO
Tunicamycin results in decreased expression of PCOLCE2 mRNA
CTD
PMID:22378314
NCBI chr 8:96,193,461...96,251,116
Ensembl chr 8:96,193,461...96,251,114
G
Pdap1
PDGFA associated protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of PDAP1 mRNA
CTD
PMID:17127020
NCBI chr12:9,470,652...9,480,880
Ensembl chr12:9,470,574...9,535,374
G
Pdcd10
programmed cell death 10
decreases expression
ISO
Tunicamycin results in decreased expression of PDCD10 mRNA
CTD
PMID:17127020
NCBI chr 2:162,602,516...162,644,690
Ensembl chr 2:160,303,449...160,346,018
G
Pde4b
phosphodiesterase 4B
decreases expression
ISO
Tunicamycin results in decreased expression of PDE4B mRNA
CTD
PMID:22378314
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pde4d
phosphodiesterase 4D
increases expression
ISO
Tunicamycin results in increased expression of PDE4D mRNA
CTD
PMID:17127020
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
G
Pde8b
phosphodiesterase 8B
increases expression
ISO
Tunicamycin results in increased expression of PDE8B mRNA
CTD
PMID:22378314
NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209
G
Pdgfd
platelet derived growth factor D
increases expression
ISO
Tunicamycin results in increased expression of PDGFD mRNA
CTD
PMID:17127020
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Pdgfra
platelet derived growth factor receptor alpha
decreases expression
ISO
Tunicamycin results in decreased expression of PDGFRA mRNA
CTD
PMID:22378314
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
decreases expression
ISO
Tunicamycin results in decreased expression of PDGFRB mRNA
CTD
PMID:22378314
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Pdia2
protein disulfide isomerase family A, member 2
decreases expression
ISO
Tunicamycin results in decreased expression of PDIA2 mRNA
CTD
PMID:17127020
NCBI chr10:15,215,824...15,218,937
Ensembl chr10:15,215,824...15,220,931
G
Pdia3
protein disulfide isomerase family A, member 3
increases expression
ISO
Tunicamycin results in increased expression of PDIA3 mRNA
CTD
PMID:17127020 PMID:29723631
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:108,388,245...108,413,236
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
ISO
Tunicamycin results in increased expression of PDIA4 mRNA Tunicamycin results in increased expression of PDIA4 mRNA; Tunicamycin results in increased expression of PDIA4 protein
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdia5
protein disulfide isomerase family A, member 5
increases expression
ISO
Tunicamycin results in increased expression of PDIA5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdia6
protein disulfide isomerase family A, member 6
increases expression
ISO
Tunicamycin results in increased expression of PDIA6 mRNA Tunicamycin results in increased expression of PDIA6 mRNA; Tunicamycin results in increased expression of PDIA6 protein
CTD
PMID:17127020 PMID:22378314 PMID:29453283 PMID:36586010 PMID:38498338
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pdik1l
PDLIM1 interacting kinase 1 like
increases expression
ISO
Tunicamycin results in increased expression of PDIK1L mRNA
CTD
PMID:29453283
NCBI chr 5:146,495,115...146,507,363
Ensembl chr 5:146,495,115...146,506,835
G
Pdk2
pyruvate dehydrogenase kinase 2
increases expression
ISO
Tunicamycin results in increased expression of PDK2 mRNA
CTD
PMID:22378314
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
G
Pdk3
pyruvate dehydrogenase kinase 3
decreases expression
ISO
Tunicamycin results in decreased expression of PDK3 mRNA
CTD
PMID:22378314
NCBI chr X:62,480,535...62,547,371
Ensembl chr X:58,486,554...58,553,557
G
Pdk4
pyruvate dehydrogenase kinase 4
decreases expression
ISO
Tunicamycin results in decreased expression of PDK4 mRNA
CTD
PMID:17127020
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pdss1
decaprenyl diphosphate synthase subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of PDSS1 mRNA
CTD
PMID:22378314
NCBI chr17:85,059,953...85,098,739
Ensembl chr17:85,060,106...85,098,730
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
ISO
Tunicamycin results in increased expression of PEA15 mRNA
CTD
PMID:22378314
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Pebp1
phosphatidylethanolamine binding protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of PEBP1 mRNA
CTD
PMID:22378314
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:39,302,840...39,307,862
G
Peg3
paternally expressed 3
increases expression
ISO
Tunicamycin results in increased expression of PEG3 mRNA
CTD
PMID:22378314
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
G
Per3
period circadian regulator 3
increases expression
ISO
Tunicamycin results in increased expression of PER3 mRNA
CTD
PMID:22378314
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
G
Pfas
phosphoribosylformylglycinamidine synthase
decreases expression
ISO
Tunicamycin results in decreased expression of PFAS mRNA
CTD
PMID:22378314
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:53,691,626...53,708,420
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
decreases expression
ISO
Tunicamycin results in decreased expression of PFKFB3 mRNA
CTD
PMID:22378314
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
decreases expression
ISO
Tunicamycin results in decreased expression of PFKFB4 mRNA
CTD
PMID:22378314
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pfkp
phosphofructokinase, platelet
decreases expression
ISO
Tunicamycin results in decreased expression of PFKP mRNA
CTD
PMID:22378314
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pfn2
profilin 2
decreases expression
ISO
Tunicamycin results in decreased expression of PFN2 mRNA
CTD
PMID:22378314
NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:142,067,104...142,072,938
G
Pgam1
phosphoglycerate mutase 1
decreases expression
ISO
Tunicamycin results in decreased expression of PGAM1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgf
placental growth factor
decreases expression
ISO
Tunicamycin results in decreased expression of PGF mRNA
CTD
PMID:24370435
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Pgk1
phosphoglycerate kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of PGK1 mRNA
CTD
PMID:22378314
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:71,271,440...71,287,418
G
Pgls
6-phosphogluconolactonase
increases expression
ISO
Tunicamycin results in increased expression of PGLS mRNA
CTD
PMID:29453283
NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,300,317...18,305,803
G
Pgm3
phosphoglucomutase 3
increases expression
ISO
Tunicamycin results in increased expression of PGM3 mRNA
CTD
PMID:22378314 PMID:38498338
NCBI chr 8:87,518,317...87,536,021
Ensembl chr 8:87,517,701...87,536,022
G
Phb1
prohibitin 1
decreases expression
ISO
Tunicamycin results in decreased expression of PHB1 mRNA
CTD
PMID:22378314
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Phf5a
PHD finger protein 5A
decreases expression
ISO
Tunicamycin results in decreased expression of PHF5A mRNA
CTD
PMID:29453283
NCBI chr 7:113,378,469...113,385,035
Ensembl chr 7:113,378,471...113,385,460
G
Phgdh
phosphoglycerate dehydrogenase
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of PHGDH mRNA; Tunicamycin results in increased expression of PHGDH protein ATF4 protein affects the reaction [Tunicamycin results in increased expression of PHGDH protein]; PHGDH protein affects the reaction [Tunicamycin results in decreased expression of SQSTM1 protein]; PHGDH protein affects the reaction [Tunicamycin results in increased expression of LDHA protein]; PHGDH protein affects the reaction [Tunicamycin results in increased expression of PKM protein]
CTD
PMID:22378314 PMID:29453283 PMID:39427783
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phkb
phosphorylase kinase regulatory subunit beta
increases expression
ISO
Tunicamycin results in increased expression of PHKB mRNA
CTD
PMID:17127020
NCBI chr19:37,179,937...37,383,979
Ensembl chr19:21,025,733...21,210,633
G
Phlda3
pleckstrin homology-like domain, family A, member 3
increases expression
ISO
Tunicamycin results in increased expression of PHLDA3 mRNA
CTD
PMID:22378314
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
G
Phyhipl
phytanoyl-CoA 2-hydroxylase interacting protein-like
decreases expression
ISO
Tunicamycin results in decreased expression of PHYHIPL mRNA
CTD
PMID:22378314
NCBI chr20:18,024,744...18,065,822
Ensembl chr20:18,024,666...18,065,478
G
Pidd1
p53-induced death domain protein 1
increases expression
ISO
Tunicamycin results in increased expression of PIDD1 mRNA
CTD
PMID:22378314
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Pierce1
piercer of microtubule wall 1
increases expression
ISO
Tunicamycin results in increased expression of PIERCE1 mRNA
CTD
PMID:29453283
NCBI chr 3:11,797,031...11,801,568
Ensembl chr 3:11,797,031...11,801,568
G
Piezo1
piezo-type mechanosensitive ion channel component 1
increases expression
ISO
Tunicamycin results in increased expression of PIEZO1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr19:50,544,580...50,606,812
Ensembl chr19:50,544,582...50,606,501
G
Pigk
phosphatidylinositol glycan anchor biosynthesis, class K
increases expression
ISO
Tunicamycin results in increased expression of PIGK mRNA
CTD
PMID:22378314
NCBI chr 2:241,630,021...241,715,493
Ensembl chr 2:241,630,053...241,716,134
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of PIK3R1 mRNA
CTD
PMID:17127020
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pimreg
PICALM interacting mitotic regulator
decreases expression
ISO
Tunicamycin results in decreased expression of PIMREG mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791
G
Pin4
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
decreases expression
ISO
Tunicamycin results in decreased expression of PIN4 mRNA
CTD
PMID:22378314
NCBI chr X:67,232,066...67,238,709
Ensembl chr X:67,232,081...67,238,702
G
Pink1
PTEN induced kinase 1
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of PINK1 mRNA Tunicamycin results in increased expression of PINK1 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:150,530,523...150,542,635
G
Pir
pirin
decreases expression
ISO
Tunicamycin results in decreased expression of PIR mRNA
CTD
PMID:29453283
NCBI chr X:33,740,428...33,851,049
Ensembl chr X:30,108,538...30,219,218
G
Pitpnm1
phosphatidylinositol transfer protein, membrane-associated 1
increases expression
ISO
Tunicamycin results in increased expression of PITPNM1 mRNA
CTD
PMID:22378314
NCBI chr 1:201,394,099...201,407,523
Ensembl chr 1:201,394,149...201,407,522
G
Piwil1
piwi-like RNA-mediated gene silencing 1
increases expression
ISO
Tunicamycin results in increased expression of PIWIL1 mRNA
CTD
PMID:22378314
NCBI chr12:27,949,743...27,970,645
Ensembl chr12:27,949,744...27,970,580
G
Pja2
praja ring finger ubiquitin ligase 2
increases expression
ISO
Tunicamycin results in increased expression of PJA2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 9:103,956,678...104,006,763
Ensembl chr 9:103,956,678...104,006,783
G
Pkd2
polycystin 2, transient receptor potential cation channel
increases expression
ISO
Tunicamycin results in increased expression of PKD2 mRNA
CTD
PMID:22378314
NCBI chr14:5,237,135...5,280,455
Ensembl chr14:5,237,135...5,280,825
G
Pkia
cAMP-dependent protein kinase inhibitor alpha
decreases expression
ISO
Tunicamycin results in decreased expression of PKIA mRNA
CTD
PMID:22378314
NCBI chr 2:94,398,869...94,473,638
Ensembl chr 2:94,398,869...94,414,282
G
Pkm
pyruvate kinase M1/2
decreases expression increases expression multiple interactions
ISO
Tunicamycin results in decreased expression of PKM mRNA Tunicamycin results in increased expression of PKM protein PHGDH protein affects the reaction [Tunicamycin results in increased expression of PKM protein]
CTD
PMID:22378314 PMID:36473502 PMID:39427783
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:60,057,402...60,079,599
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
decreases expression
ISO
Tunicamycin results in decreased expression of PKMYT1 mRNA
CTD
PMID:22378314
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
G
Pla2g4a
phospholipase A2 group 4A
multiple interactions
EXP
Taurodeoxycholic Acid inhibits the reaction [Tunicamycin results in increased expression of and results in increased activity of PLA2G4A protein]; Tunicamycin results in increased expression of and results in increased activity of PLA2G4A protein
CTD
PMID:33527851
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
G
Pla2g4b
phospholipase A2 group IVB
increases expression
ISO
Tunicamycin results in increased expression of PLA2G4B mRNA
CTD
PMID:22378314
NCBI chr 3:127,458,022...127,467,637
Ensembl chr 3:107,005,489...107,013,853
G
Plaat3
phospholipase A and acyltransferase 3
increases expression
ISO
Tunicamycin results in increased expression of PLAAT3 mRNA
CTD
PMID:22378314
NCBI chr 1:204,782,608...204,816,397
Ensembl chr 1:204,782,729...204,817,667
G
Plekhg4
pleckstrin homology and RhoGEF domain containing G4
increases expression
ISO
Tunicamycin results in increased expression of PLEKHG4 mRNA
CTD
PMID:29453283
NCBI chr19:50,161,722...50,176,491
Ensembl chr19:33,249,706...33,266,357
G
Plekhh3
pleckstrin homology, MyTH4 and FERM domain containing H3
increases expression
ISO
Tunicamycin results in increased expression of PLEKHH3 mRNA
CTD
PMID:22378314
NCBI chr10:86,098,461...86,106,931
Ensembl chr10:86,098,469...86,106,880
G
Plin2
perilipin 2
increases expression
ISO
Tunicamycin results in increased expression of PLIN2 mRNA
CTD
PMID:22414386
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plpp3
phospholipid phosphatase 3
decreases expression
ISO
Tunicamycin results in decreased expression of PLPP3 mRNA
CTD
PMID:22378314
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:119,927,085...120,002,205
G
Plpp5
phospholipid phosphatase 5
increases expression
ISO
Tunicamycin results in increased expression of PLPP5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr16:66,349,483...66,353,887
Ensembl chr16:66,349,502...66,464,797
G
Pls3
plastin 3
increases expression
ISO
Tunicamycin results in increased expression of PLS3 mRNA
CTD
PMID:22378314
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Plscr1
phospholipid scramblase 1
increases expression
ISO
Tunicamycin results in increased expression of PLSCR1 mRNA
CTD
PMID:38498338
NCBI chr 8:101,662,512...101,684,474
Ensembl chr 8:92,784,356...92,804,692
G
Pmm1
phosphomannomutase 1
increases expression
ISO
Tunicamycin results in increased expression of PMM1 mRNA
CTD
PMID:22378314
NCBI chr 7:113,466,632...113,477,004
Ensembl chr 7:113,466,632...113,477,022
G
Pmpca
peptidase, mitochondrial processing subunit alpha
decreases expression
ISO
Tunicamycin results in decreased expression of PMPCA mRNA
CTD
PMID:22378314
NCBI chr 3:9,207,731...9,216,846
Ensembl chr 3:9,207,717...9,216,844
G
Pmpcb
peptidase, mitochondrial processing subunit beta
increases expression
ISO
Tunicamycin results in increased expression of PMPCB mRNA
CTD
PMID:22378314
NCBI chr 4:13,297,583...13,310,363
Ensembl chr 4:13,297,559...13,310,367
G
Pnpla7
patatin-like phospholipase domain containing 7
increases expression
ISO
Tunicamycin results in increased expression of PNPLA7 mRNA
CTD
PMID:22378314
NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
G
Pnrc2
proline-rich nuclear receptor coactivator 2
increases expression
ISO
Tunicamycin results in increased expression of PNRC2 mRNA
CTD
PMID:17127020
NCBI chr 5:148,103,966...148,106,950
Ensembl chr 5:148,095,699...148,107,242 Ensembl chr 5:148,095,699...148,107,242
G
Podxl2
podocalyxin-like 2
decreases expression
ISO
Tunicamycin results in decreased expression of PODXL2 mRNA
CTD
PMID:22378314
NCBI chr 4:121,306,224...121,338,070
Ensembl chr 4:121,306,224...121,338,112
G
Pofut2
protein O-fucosyltransferase 2
increases expression
ISO
Tunicamycin results in increased expression of POFUT2 mRNA
CTD
PMID:22378314
NCBI chr20:11,367,073...11,377,788
Ensembl chr20:11,367,096...11,377,743
G
Polg2
DNA polymerase gamma 2, accessory subunit
increases expression
ISO
Tunicamycin results in increased expression of POLG2 mRNA
CTD
PMID:22378314
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
G
Polr2c
RNA polymerase II subunit C
decreases expression
ISO
Tunicamycin results in decreased expression of POLR2C mRNA
CTD
PMID:29453283
NCBI chr19:10,158,153...10,164,935
Ensembl chr19:10,157,823...10,164,945
G
Polr2f
RNA polymerase II, I and III subunit F
decreases expression
ISO
Tunicamycin results in decreased expression of POLR2F mRNA
CTD
PMID:22378314
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:110,712,572...110,724,234
G
Polr3c
RNA polymerase III subunit C
increases expression
ISO
Tunicamycin results in increased expression of POLR3C mRNA
CTD
PMID:22378314
NCBI chr 2:184,246,201...184,262,150
Ensembl chr 2:184,246,204...184,262,208
G
Polr3h
RNA polymerase III subunit H
decreases expression
ISO
Tunicamycin results in decreased expression of POLR3H mRNA
CTD
PMID:22378314
NCBI chr 7:113,429,434...113,439,743
Ensembl chr 7:113,429,451...113,439,778
G
Polr3k
RNA polymerase III subunit K
decreases expression
ISO
Tunicamycin results in decreased expression of POLR3K mRNA
CTD
PMID:22378314
NCBI chr 3:168,982,846...168,987,043
Ensembl chr 3:168,982,812...168,987,040
G
Pon2
paraoxonase 2
decreases expression
ISO
Tunicamycin results in decreased expression of PON2 mRNA
CTD
PMID:22378314
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Pop1
POP1 homolog, ribonuclease P/MRP subunit
decreases expression
ISO
Tunicamycin results in decreased expression of POP1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:65,705,348...65,733,143
Ensembl chr 7:65,705,368...65,733,141
G
Potem
POTE ankyrin domain family member M
decreases expression
ISO
Tunicamycin results in decreased expression of POTEM mRNA
CTD
PMID:33770205
NCBI chr16:20,193,646...20,311,924
Ensembl chr16:19,949,230...19,976,541
G
Ppan
peter pan homolog
increases expression
ISO
Tunicamycin results in increased expression of PPAN mRNA
CTD
PMID:17127020
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
Tunicamycin results in decreased expression of PPARA mRNA
CTD
PMID:22414386
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
increases response to substance multiple interactions
ISO
PPARD gene mutant form results in increased susceptibility to Tunicamycin [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of NQO1 mRNA; [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of VLDLR mRNA; [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased phosphorylation of NFE2L2 protein; [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased uptake of Triglycerides; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]]; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]]; PPARD gene mutant form promotes the reaction [Tunicamycin results in increased expression of TRIB3 mRNA]; PPARD gene mutant form promotes the reaction [Tunicamycin results in increased uptake of Triglycerides]; Tunicamycin inhibits the reaction [FGF21 protein inhibits the reaction [PPARD gene mutant form results in increased uptake of Triglycerides]]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of TRIB3 mRNA]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR protein]
CTD
PMID:29289645
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression decreases expression multiple interactions
ISO
Tunicamycin results in increased expression of PPARGC1A mRNA Tunicamycin results in decreased expression of PPARGC1A mRNA; Tunicamycin results in decreased expression of PPARGC1A protein CEBPB protein inhibits the reaction [Tunicamycin results in decreased expression of PPARGC1A protein]
CTD
PMID:22414386 PMID:28482072
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
G
Ppargc1b
PPARG coactivator 1 beta
increases expression
ISO
Tunicamycin results in increased expression of PPARGC1B mRNA
CTD
PMID:22414386
NCBI chr18:57,029,264...57,131,466
Ensembl chr18:54,758,902...54,861,194
G
Ppef1
protein phosphatase with EF-hand domain 1
decreases expression
ISO
Tunicamycin results in decreased expression of PPEF1 mRNA
CTD
PMID:22378314
NCBI chr X:33,994,503...34,151,704
Ensembl chr X:34,021,350...34,151,701
G
Ppfia4
PTPRF interacting protein alpha 4
decreases expression
ISO
Tunicamycin results in decreased expression of PPFIA4 mRNA
CTD
PMID:22378314
NCBI chr13:45,753,827...45,802,305
Ensembl chr13:45,753,827...45,802,261
G
Ppib
peptidylprolyl isomerase B
increases expression
ISO
Tunicamycin results in increased expression of PPIB mRNA; Tunicamycin results in increased expression of PPIB protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:66,603,877...66,609,734
Ensembl chr 8:66,603,861...66,630,428
G
Ppic
peptidylprolyl isomerase C
increases expression
ISO
Tunicamycin results in increased expression of PPIC mRNA
CTD
PMID:22378314
NCBI chr18:46,842,410...46,855,016
Ensembl chr18:46,842,409...46,855,017
G
Ppie
peptidylprolyl isomerase E
increases expression
ISO
Tunicamycin results in increased expression of PPIE mRNA
CTD
PMID:22378314
NCBI chr 5:135,406,172...135,419,332
Ensembl chr 5:135,406,176...135,419,235
G
Ppm1e
protein phosphatase, Mg2+/Mn2+ dependent, 1E
increases expression
ISO
Tunicamycin results in increased expression of PPM1E mRNA
CTD
PMID:22378314
NCBI chr10:72,051,643...72,187,439
Ensembl chr10:72,055,208...72,187,282
G
Ppm1m
protein phosphatase, Mg2+/Mn2+ dependent, 1M
increases expression
ISO
Tunicamycin results in increased expression of PPM1M mRNA
CTD
PMID:22378314
NCBI chr 8:106,836,221...106,843,472
Ensembl chr 8:106,837,037...106,842,057
G
Ppox
protoporphyrinogen oxidase
increases expression
ISO
Tunicamycin results in increased expression of PPOX mRNA
CTD
PMID:22378314
NCBI chr13:83,697,661...83,701,998
Ensembl chr13:83,664,891...83,701,805
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
decreases expression
ISO
Tunicamycin results in decreased expression of PPP1R10 mRNA
CTD
PMID:22378314
NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,822,995...2,837,611
G
Ppp1r14c
protein phosphatase 1, regulatory (inhibitor) subunit 14c
increases expression
ISO
Tunicamycin results in increased expression of PPP1R14C mRNA
CTD
PMID:17127020
NCBI chr 1:39,773,403...39,886,970
Ensembl chr 1:39,773,403...39,886,956
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression multiple interactions
ISO EXP
Tunicamycin results in increased expression of PPP1R15A mRNA Tunicamycin results in increased expression of PPP1R15A mRNA; Tunicamycin results in increased expression of PPP1R15A protein [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of PPP1R15A mRNA 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Tunicamycin results in increased expression of PPP1R15A mRNA]
CTD
PMID:22378314 PMID:23741617 PMID:24291486 PMID:24892553 PMID:29453283 PMID:29793971 PMID:33545341 PMID:36586010 More...
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r16b
protein phosphatase 1, regulatory subunit 16B
decreases expression
ISO
Tunicamycin results in decreased expression of PPP1R16B mRNA
CTD
PMID:22378314
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
Tunicamycin results in decreased expression of PPP1R3C mRNA
CTD
PMID:22378314
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r3e
protein phosphatase 1, regulatory subunit 3E
increases expression
ISO
Tunicamycin results in increased expression of PPP1R3E mRNA
CTD
PMID:29453283
NCBI chr15:28,348,443...28,349,603
Ensembl chr15:28,347,854...28,349,603
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
decreases expression
ISO
Tunicamycin results in decreased expression of PPP2CB mRNA
CTD
PMID:17127020
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:58,558,122...58,579,576
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
decreases expression
ISO
Tunicamycin results in decreased expression of PPP2R1A mRNA
CTD
PMID:22378314
NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:60,540,194...60,560,129
G
Ppp2r2b
protein phosphatase 2, regulatory subunit B, beta
affects localization
EXP
Tunicamycin affects the localization of PPP2R2B protein
CTD
PMID:18940801
NCBI chr18:34,904,686...35,357,299
Ensembl chr18:34,653,721...35,081,025
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
increases expression
ISO
Tunicamycin results in increased expression of PPP2R5E mRNA
CTD
PMID:17127020
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of PPP3CA mRNA
CTD
PMID:17127020
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974
G
Ppp3cb
protein phosphatase 3 catalytic subunit beta
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of PPP3CB mRNA Tunicamycin results in increased expression of PPP3CB mRNA
CTD
PMID:17127020 PMID:20138156
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,760,030...3,804,981
G
Pramex1
PRAME like, X-linked 1
decreases expression
ISO
Tunicamycin results in decreased expression of PRAME mRNA
CTD
PMID:22378314
NCBI chr X:98,567,994...98,574,654
Ensembl chr X:98,569,415...98,572,096
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
Tunicamycin results in decreased expression of PRC1 mRNA
CTD
PMID:22378314
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdx1
peroxiredoxin 1
decreases expression
ISO
Tunicamycin results in decreased expression of PRDX1 mRNA
CTD
PMID:29453283
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:130,147,204...130,162,856
G
Prdx3
peroxiredoxin 3
decreases expression
ISO
Tunicamycin results in decreased expression of PRDX3 mRNA
CTD
PMID:22378314
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
G
Prdx5
peroxiredoxin 5
increases expression
ISO
Tunicamycin results in increased expression of PRDX5 mRNA
CTD
PMID:22378314
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:204,099,826...204,114,268
G
Prdx6
peroxiredoxin 6
decreases expression
ISO
Tunicamycin results in decreased expression of PRDX6 mRNA
CTD
PMID:17127020
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Preb
prolactin regulatory element binding
increases expression
ISO
Tunicamycin results in increased expression of PREB mRNA
CTD
PMID:22378314
NCBI chr 6:25,418,805...25,422,594
Ensembl chr 6:25,418,776...25,422,590
G
Prep
prolyl endopeptidase
decreases expression
ISO
Tunicamycin results in decreased expression of PREP mRNA
CTD
PMID:22378314
NCBI chr20:48,556,211...48,653,165
Ensembl chr20:48,556,280...48,654,466
G
Prickle1
prickle planar cell polarity protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of PRICKLE1 mRNA
CTD
PMID:22378314
NCBI chr 7:126,518,587...126,614,581
Ensembl chr 7:124,639,142...124,658,113
G
Prickle4
prickle planar cell polarity protein 4
decreases expression
ISO
Tunicamycin results in decreased expression of PRICKLE4 mRNA
CTD
PMID:22378314
NCBI chr 9:13,297,494...13,305,635
Ensembl chr 9:13,297,758...13,305,630
G
Prim1
DNA primase subunit 1
increases expression
ISO
Tunicamycin results in increased expression of PRIM1 mRNA
CTD
PMID:29453283
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
decreases expression
ISO
Tunicamycin results in decreased expression of PRKAA1 mRNA
CTD
PMID:17127020
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of PRKAG2 mRNA Tunicamycin results in increased expression of PRKAG2 mRNA
CTD
PMID:17127020 PMID:33545341
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,010,890...10,252,142
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of PRKAR1A mRNA
CTD
PMID:17127020
NCBI chr10:95,120,537...95,139,028
Ensembl chr10:94,620,039...94,639,041
G
Prkca
protein kinase C, alpha
increases expression
ISO
Tunicamycin results in increased expression of PRKCA mRNA
CTD
PMID:17127020
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Prkce
protein kinase C, epsilon
increases expression
ISO
Tunicamycin results in increased expression of PRKCE mRNA
CTD
PMID:17127020
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Prkch
protein kinase C, eta
decreases expression
ISO
Tunicamycin results in decreased expression of PRKCH mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:92,292,000...92,490,654
G
Prkrip1
PRKR interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of PRKRIP1 mRNA
CTD
PMID:22378314
NCBI chr12:20,470,802...20,491,789
Ensembl chr12:20,470,820...20,489,115
G
Prkx
protein kinase cAMP-dependent X-linked catalytic subunit
increases expression
ISO
Tunicamycin results in increased expression of PRKX mRNA
CTD
PMID:17127020
NCBI chr X:45,701,747...45,745,210
Ensembl chr X:41,823,355...41,866,669
G
Prmt6
protein arginine methyltransferase 6
decreases expression
ISO
Tunicamycin results in decreased expression of PRMT6 mRNA
CTD
PMID:22378314
NCBI chr 2:197,927,750...197,932,760
Ensembl chr 2:197,927,220...197,933,648
G
Prnp
prion protein
increases expression
ISO
Tunicamycin results in increased expression of PRNP mRNA
CTD
PMID:22378314
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:119,177,485...119,203,937
G
Procr
protein C receptor
decreases expression
ISO
Tunicamycin results in decreased expression of PROCR mRNA
CTD
PMID:29453283
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Prorp
protein only RNase P catalytic subunit
decreases expression
ISO
Tunicamycin results in decreased expression of PRORP mRNA
CTD
PMID:22378314
NCBI chr 6:72,669,659...72,762,419
Ensembl chr 6:72,670,847...72,762,416
G
Pros1
protein S
decreases expression
ISO
Tunicamycin results in decreased expression of PROS1 mRNA
CTD
PMID:22378314
NCBI chr11:13,676,310...13,757,858
Ensembl chr11:230,696...311,286
G
Prph
peripherin
increases expression
ISO
Tunicamycin results in increased expression of PRPH mRNA
CTD
PMID:29453283
NCBI chr 7:130,218,149...130,222,136
Ensembl chr 7:130,218,357...130,222,136
G
Prps1
phosphoribosyl pyrophosphate synthetase 1
decreases expression
ISO
Tunicamycin results in decreased expression of PRPS1 mRNA
CTD
PMID:22378314
NCBI chr X:104,132,139...104,154,191
Ensembl chr X:104,132,141...104,154,187
G
Prr16
proline rich 16
decreases expression
ISO
Tunicamycin results in decreased expression of PRR16 mRNA
CTD
PMID:22378314
NCBI chr18:44,424,348...44,764,796
Ensembl chr18:44,424,616...44,632,329
G
Prr4
proline rich 4
increases expression
ISO
Tunicamycin results in increased expression of PRR4 mRNA
CTD
PMID:22378314
NCBI chr 4:166,605,104...166,608,903
Ensembl chr 4:166,543,755...166,607,586
G
Prrt2
proline-rich transmembrane protein 2
increases expression
ISO
Tunicamycin results in increased expression of PRRT2 mRNA
CTD
PMID:22378314
NCBI chr 1:181,625,243...181,628,833
Ensembl chr 1:181,604,545...181,628,850
G
Prss16
serine protease 16
increases expression
ISO
Tunicamycin results in increased expression of PRSS16 mRNA
CTD
PMID:29453283
NCBI chr17:42,514,306...42,521,885
Ensembl chr17:42,514,306...42,521,884
G
Prss21
serine protease 21
decreases expression
ISO
Tunicamycin results in decreased expression of PRSS21 mRNA
CTD
PMID:17127020
NCBI chr10:12,899,820...12,905,612
Ensembl chr10:12,900,535...12,905,618
G
Psat1
phosphoserine aminotransferase 1
increases expression
ISO
Tunicamycin results in increased expression of PSAT1 mRNA; Tunicamycin results in increased expression of PSAT1 protein
CTD
PMID:29453283 PMID:33545341 PMID:36586010
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psen1
presenilin 1
multiple interactions increases expression
ISO
[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA; ATF4 protein affects the reaction [[Tunicamycin co-treated with APP protein modified form] results in increased expression of PSEN1 mRNA] Tunicamycin results in increased expression of PSEN1 protein
CTD
PMID:22115781
NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:103,323,120...103,371,650
G
Psen2
presenilin 2
increases expression
ISO
Tunicamycin results in increased expression of PSEN2 mRNA
CTD
PMID:29453283
NCBI chr13:94,499,451...94,528,419
Ensembl chr13:91,967,983...91,993,174
G
Psma2
proteasome 20S subunit alpha 2
decreases expression
ISO
Tunicamycin results in decreased expression of PSMA2 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
ISO
Tunicamycin results in decreased expression of PSMB10 mRNA
CTD
PMID:17127020
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psmb5
proteasome 20S subunit beta 5
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of PSMB5 mRNA NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB5 mRNA]
CTD
PMID:22959925
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
G
Psmb6
proteasome 20S subunit beta 6
multiple interactions increases expression
ISO
NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of PSMB6 mRNA]
CTD
PMID:22959925
NCBI chr10:55,239,256...55,241,586
Ensembl chr10:55,239,241...55,241,586
G
Psmd1
proteasome 26S subunit, non-ATPase 1
decreases expression
ISO
Tunicamycin results in decreased expression of PSMD1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 9:86,709,714...86,785,213
Ensembl chr 9:86,709,947...86,785,211
G
Psmd11
proteasome 26S subunit, non-ATPase 11
decreases expression
ISO
Tunicamycin results in decreased expression of PSMD11 mRNA
CTD
PMID:29453283
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
G
Psmd7
proteasome 26S subunit, non-ATPase 7
decreases expression
ISO
Tunicamycin results in decreased expression of PSMD7 mRNA
CTD
PMID:29453283
NCBI chr19:35,494,317...35,501,605
Ensembl chr19:35,494,316...35,501,588
G
Psme3
proteasome activator subunit 3
decreases expression
ISO
Tunicamycin results in decreased expression of PSME3 mRNA
CTD
PMID:29453283
NCBI chr10:86,757,933...86,765,719
Ensembl chr10:86,257,668...86,333,804
G
Psph
phosphoserine phosphatase
increases expression
ISO
Tunicamycin results in increased expression of PSPH mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Psrc1
proline and serine rich coiled-coil 1
decreases expression
ISO
Tunicamycin results in decreased expression of PSRC1 mRNA
CTD
PMID:22378314
NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
G
Pstk
phosphoseryl-tRNA kinase
increases expression
ISO
Tunicamycin results in increased expression of PSTK mRNA
CTD
PMID:29453283
NCBI chr 1:186,157,730...186,168,145
Ensembl chr 1:186,157,707...186,168,145
G
Ptchd1
patched domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of PTCHD1 mRNA
CTD
PMID:22378314
NCBI chr X:39,681,910...39,733,416
Ensembl chr X:39,681,910...39,733,519
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO EXP
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of PTGS2 protein]] Taurodeoxycholic Acid inhibits the reaction [Tunicamycin results in increased expression of and results in increased activity of PTGS2 protein]; Tunicamycin results in increased expression of and results in increased activity of PTGS2 protein
CTD
PMID:33527851 PMID:37394652
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Pth2r
parathyroid hormone 2 receptor
increases expression
ISO
Tunicamycin results in increased expression of PTH2R mRNA
CTD
PMID:17127020
NCBI chr 9:66,706,050...66,810,601
Ensembl chr 9:66,706,050...66,810,036
G
Ptk6
protein tyrosine kinase 6
decreases expression
ISO
Tunicamycin results in decreased expression of PTK6 mRNA
CTD
PMID:17127020
NCBI chr 3:168,307,073...168,315,664
Ensembl chr 3:168,307,073...168,315,664
G
Ptms
parathymosin
decreases expression
ISO
Tunicamycin results in decreased expression of PTMS mRNA
CTD
PMID:22378314
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Ptpdc1
protein tyrosine phosphatase domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of PTPDC1 mRNA
CTD
PMID:22378314
NCBI chr17:16,028,964...16,076,512
Ensembl chr17:16,049,382...16,076,512
G
Ptpmt1
protein tyrosine phosphatase, mitochondrial 1
increases expression
ISO
Tunicamycin results in increased expression of PTPMT1 mRNA
CTD
PMID:29453283
NCBI chr 3:76,889,922...76,899,427
Ensembl chr 3:76,889,922...76,899,427
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
multiple interactions increases response to substance decreases expression
ISO
PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein]; PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of HSPA5 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to EIF2AK3 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to ERN1 protein]; Tunicamycin promotes the reaction [PTPN1 protein binds to HSPA5 protein] PTPN1 gene mutant form results in increased susceptibility to Tunicamycin PTPN1 protein affects the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein] Tunicamycin results in decreased expression of PTPN1 mRNA
CTD
PMID:22509299 PMID:28359145 PMID:29453283 PMID:29894845
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:156,638,769...156,687,504
G
Ptpn9
protein tyrosine phosphatase, non-receptor type 9
decreases expression
ISO
Tunicamycin results in decreased expression of PTPN9 mRNA
CTD
PMID:17127020
NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
ISO
Tunicamycin results in decreased expression of PTPRF mRNA
CTD
PMID:17127020
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:131,742,754...131,810,023
G
Ptprh
protein tyrosine phosphatase, receptor type, H
increases expression
ISO
Tunicamycin results in increased expression of PTPRH mRNA
CTD
PMID:22378314
NCBI chr 1:78,272,414...78,318,977
Ensembl chr 1:69,242,321...69,285,077
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
ISO
Tunicamycin results in decreased expression of PTTG1 mRNA
CTD
PMID:22378314
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837
G
Pycard
PYD and CARD domain containing
multiple interactions
ISO
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of PYCARD protein]]
CTD
PMID:37394652
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
G
Pycr1
pyrroline-5-carboxylate reductase 1
increases expression
ISO
Tunicamycin results in increased expression of PYCR1 mRNA
CTD
PMID:22378314
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Pym1
PYM homolog 1, exon junction complex associated factor
increases expression
ISO
Tunicamycin results in increased expression of PYM1 mRNA
CTD
PMID:33770205
NCBI chr 7:1,761,556...1,785,318
Ensembl chr 7:1,178,008...1,198,937
G
Qdpr
quinoid dihydropteridine reductase
decreases expression
ISO
Tunicamycin results in decreased expression of QDPR mRNA
CTD
PMID:22378314
NCBI chr14:69,882,776...69,896,378
Ensembl chr14:65,670,131...65,683,854
G
Rab11fip5
RAB11 family interacting protein 5
increases expression
ISO
Tunicamycin results in increased expression of RAB11FIP5 mRNA
CTD
PMID:22378314
NCBI chr 4:117,871,301...117,908,819
Ensembl chr 4:117,871,308...117,908,741
G
Rab24
RAB24, member RAS oncogene family
increases expression
ISO
Tunicamycin results in increased expression of RAB24 mRNA
CTD
PMID:22378314
NCBI chr17:9,308,471...9,310,553
Ensembl chr17:9,308,525...9,310,553
G
Rab32
RAB32, member RAS oncogene family
increases expression
ISO
Tunicamycin results in increased expression of RAB32 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:4,946,193...4,961,003
Ensembl chr 1:4,945,036...4,960,934
G
Rab3il1
RAB3A interacting protein-like 1
increases expression
ISO
Tunicamycin results in increased expression of RAB3IL1 mRNA
CTD
PMID:22378314
NCBI chr 1:216,071,043...216,107,609
Ensembl chr 1:206,646,155...206,679,972
G
Rab5a
RAB5A, member RAS oncogene family
increases expression
ISO
Tunicamycin results in increased expression of RAB5A mRNA
CTD
PMID:22378314
NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,484,469...6,512,873
G
Rab9a
RAB9A, member RAS oncogene family
increases expression
ISO
Tunicamycin results in increased expression of RAB9A mRNA
CTD
PMID:29453283
NCBI chr X:27,955,552...28,009,870
Ensembl chr X:27,952,204...28,001,622
G
Rab9b
RAB9B, member RAS oncogene family
increases expression
ISO
Tunicamycin results in increased expression of RAB9B mRNA
CTD
PMID:29453283
NCBI chr X:100,220,897...100,231,591
Ensembl chr X:100,220,894...100,231,701
G
Rabac1
Rab acceptor 1
increases expression
ISO
Tunicamycin results in increased expression of RABAC1 mRNA
CTD
PMID:29453283
NCBI chr 1:80,564,029...80,567,164
Ensembl chr 1:80,564,033...80,567,163
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
Tunicamycin results in decreased expression of RAD23A mRNA
CTD
PMID:29453283
NCBI chr19:40,219,235...40,225,543
Ensembl chr19:23,314,797...23,320,695
G
Rad54l
RAD54 like
decreases expression
ISO
Tunicamycin results in decreased expression of RAD54L mRNA
CTD
PMID:22378314
NCBI chr 5:134,812,158...134,841,821
Ensembl chr 5:129,575,378...129,605,070
G
Rad9a
RAD9 checkpoint clamp component A
increases expression
ISO
Tunicamycin results in increased expression of RAD9A mRNA
CTD
PMID:29453283
NCBI chr 1:201,488,511...201,553,582
Ensembl chr 1:201,487,136...201,553,608
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
decreases expression
ISO
Tunicamycin results in decreased expression of RAF1 mRNA
CTD
PMID:22378314
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Rai2
retinoic acid induced 2
decreases expression
ISO
Tunicamycin results in decreased expression of RAI2 mRNA
CTD
PMID:29453283
NCBI chr X:32,948,656...33,011,222
Ensembl chr X:32,948,656...33,011,264
G
Ramp1
receptor activity modifying protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of RAMP1 mRNA
CTD
PMID:22378314
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
G
Ran
RAN, member RAS oncogene family
decreases expression
ISO
Tunicamycin results in decreased expression of RAN mRNA
CTD
PMID:22378314
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:27,674,050...27,678,276
G
Ranbp1
RAN binding protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of RANBP1 mRNA
CTD
PMID:22378314
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:82,742,600...82,750,838
G
Rapgef3
Rap guanine nucleotide exchange factor 3
increases expression
ISO
Tunicamycin results in increased expression of RAPGEF3 mRNA
CTD
PMID:29453283
NCBI chr 7:128,875,772...128,898,203
Ensembl chr 7:128,875,773...128,898,521
G
Rasl11a
RAS-like family 11 member A
decreases expression
ISO
Tunicamycin results in decreased expression of RASL11A mRNA
CTD
PMID:29453283
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576
G
Rasl11b
RAS-like family 11 member B
decreases expression
ISO
Tunicamycin results in decreased expression of RASL11B mRNA
CTD
PMID:22378314
NCBI chr14:34,014,924...34,019,146
Ensembl chr14:34,014,509...34,019,152
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein]
CTD
PMID:24898257
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rbck1
RANBP2-type and C3HC4-type zinc finger containing 1
increases expression
ISO
Tunicamycin results in increased expression of RBCK1 mRNA
CTD
PMID:22378314
NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005
G
Rbfa
ribosome binding factor A
decreases expression
ISO
Tunicamycin results in decreased expression of RBFA mRNA
CTD
PMID:22378314
NCBI chr18:73,639,264...73,648,914
Ensembl chr18:73,639,260...73,648,915
G
Rbm12
RNA binding motif protein 12
decreases expression
ISO
Tunicamycin results in decreased expression of RBM12 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915
G
Rbm14
RNA binding motif protein 14
decreases expression
ISO
Tunicamycin results in decreased expression of RBM14 mRNA
CTD
PMID:29453283
NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:202,078,287...202,105,665 Ensembl chr 1:202,078,287...202,105,665
G
Rbm33
RNA binding motif protein 33
increases expression
ISO
Tunicamycin results in increased expression of RBM33 mRNA
CTD
PMID:22378314
NCBI chr 4:6,980,807...7,088,334
Ensembl chr 4:6,983,970...7,089,918
G
Rbp1
retinol binding protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of RBP1 mRNA
CTD
PMID:22378314
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rcc1
regulator of chromosome condensation 1
decreases expression
ISO
Tunicamycin results in decreased expression of RCC1 mRNA
CTD
PMID:22378314
NCBI chr 5:144,526,025...144,544,445
Ensembl chr 5:144,526,025...144,544,577
G
Rcn1
reticulocalbin 1
increases expression
ISO
Tunicamycin results in increased expression of RCN1 mRNA
CTD
PMID:22378314
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rcor2
REST corepressor 2
decreases expression
ISO
Tunicamycin results in decreased expression of RCOR2 mRNA
CTD
PMID:22378314
NCBI chr 1:213,882,585...213,890,022
Ensembl chr 1:204,454,360...204,460,838
G
Rcor3
REST corepressor 3
increases expression
ISO
Tunicamycin results in increased expression of RCOR3 mRNA
CTD
PMID:22378314
NCBI chr13:103,624,966...103,665,565
Ensembl chr13:103,624,971...103,665,565
G
Rec8
REC8 meiotic recombination protein
decreases expression
ISO
Tunicamycin results in decreased expression of REC8 mRNA
CTD
PMID:22378314
NCBI chr15:29,109,862...29,117,327
Ensembl chr15:29,109,863...29,117,326
G
Rel
REL proto-oncogene, NF-kB subunit
increases expression
ISO
Tunicamycin results in increased expression of REL mRNA
CTD
PMID:17127020
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
increases response to substance
ISO
RELA gene mutant form results in increased susceptibility to Tunicamycin
CTD
PMID:11360202
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Ret
ret proto-oncogene
decreases expression
ISO
Tunicamycin results in decreased expression of RET mRNA
CTD
PMID:22378314
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Rfc3
replication factor C subunit 3
decreases expression
ISO
Tunicamycin results in decreased expression of RFC3 mRNA
CTD
PMID:22378314
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
G
Rfk
riboflavin kinase
decreases expression
ISO
Tunicamycin results in decreased expression of RFK mRNA
CTD
PMID:17127020
NCBI chr 1:214,799,880...214,807,440
Ensembl chr 1:214,799,825...214,807,438 Ensembl chr X:214,799,825...214,807,438
G
Rfng
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
ISO
Tunicamycin results in increased expression of RFNG mRNA
CTD
PMID:22378314
NCBI chr10:106,545,543...106,548,644
Ensembl chr10:106,047,221...106,050,345
G
Rgcc
regulator of cell cycle
increases expression
ISO
Tunicamycin results in increased expression of RGCC mRNA
CTD
PMID:33545341
NCBI chr15:61,071,574...61,084,408
Ensembl chr15:54,662,483...54,681,141
G
Rgs11
regulator of G-protein signaling 11
increases expression
ISO
Tunicamycin results in increased expression of RGS11 mRNA
CTD
PMID:22378314
NCBI chr10:15,222,804...15,231,062
Ensembl chr10:15,222,803...15,231,060
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
Tunicamycin results in increased expression of RGS16 mRNA
CTD
PMID:29453283
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs18
regulator of G-protein signaling 18
increases expression
ISO
Tunicamycin results in increased expression of RGS18 mRNA
CTD
PMID:17127020
NCBI chr13:56,493,134...56,516,045
Ensembl chr13:56,494,010...56,516,098
G
Rgs4
regulator of G-protein signaling 4
decreases expression
ISO
Tunicamycin results in decreased expression of RGS4 mRNA
CTD
PMID:22378314
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:81,936,775...81,943,068
G
Rgs5
regulator of G-protein signaling 5
decreases expression
ISO
Tunicamycin results in decreased expression of RGS5 mRNA
CTD
PMID:22378314
NCBI chr13:84,381,077...84,417,875
Ensembl chr13:81,836,304...81,885,518
G
Rhbdd2
rhomboid domain containing 2
increases expression
ISO
Tunicamycin results in increased expression of RHBDD2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:21,043,605...21,054,305
Ensembl chr12:21,043,608...21,054,289
G
Rhbdf1
rhomboid 5 homolog 1
increases expression
ISO
Tunicamycin results in increased expression of RHBDF1 mRNA
CTD
PMID:22378314
NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763
G
Rhoc
ras homolog family member C
decreases expression
ISO
Tunicamycin results in decreased expression of RHOC mRNA
CTD
PMID:29453283
NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:192,287,130...192,295,306
G
Rhoq
ras homolog family member Q
increases expression
ISO
Tunicamycin results in increased expression of RHOQ mRNA
CTD
PMID:22378314
NCBI chr 6:13,368,499...13,403,929
Ensembl chr 1:106,622,141...106,623,699
G
Rims3
regulating synaptic membrane exocytosis 3
increases expression
ISO
Tunicamycin results in increased expression of RIMS3 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:134,429,092...134,468,935
Ensembl chr 5:134,435,829...134,640,489
G
Rin1
Ras and Rab interactor 1
increases expression
ISO
Tunicamycin results in increased expression of RIN1 mRNA
CTD
PMID:17127020
NCBI chr 1:211,785,107...211,789,755
Ensembl chr 1:202,355,890...202,362,729
G
Rint1
RAD50 interactor 1
increases expression
ISO
Tunicamycin results in increased expression of RINT1 mRNA
CTD
PMID:22378314
NCBI chr 4:11,319,416...11,355,740
Ensembl chr 4:11,320,955...11,355,736
G
Riox1
ribosomal oxygenase 1
decreases expression
ISO
Tunicamycin results in decreased expression of RIOX1 mRNA
CTD
PMID:22378314
NCBI chr 6:103,579,642...103,582,260
Ensembl chr 6:103,579,642...103,582,250
G
Ripk1
receptor interacting serine/threonine kinase 1
increases expression
ISO
Tunicamycin results in increased expression of RIPK1 mRNA
CTD
PMID:29453283
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:30,839,650...30,871,824
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
Tunicamycin results in increased expression of RIPK2 mRNA
CTD
PMID:22378314
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:29,631,570...29,662,657
G
Rmi1
RecQ mediated genome instability 1
decreases expression
ISO
Tunicamycin results in decreased expression of RMI1 mRNA
CTD
PMID:22378314
NCBI chr17:6,256,533...6,264,523
Ensembl chr17:6,256,450...6,264,695
G
Rmi2
RecQ mediated genome instability 2
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of RMI2 mRNA Tunicamycin results in increased expression of RMI2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
G
Rnase4
ribonuclease A family member 4
increases expression
ISO
Tunicamycin results in increased expression of RNASE4 mRNA
CTD
PMID:38498338
NCBI chr15:26,786,287...26,803,634
Ensembl chr15:24,312,464...24,330,117
G
Rnaset2
ribonuclease T2
increases expression
ISO
Tunicamycin results in increased expression of RNASET2 mRNA
CTD
PMID:29453283
NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147
G
Rnd3
Rho family GTPase 3
decreases expression
ISO
Tunicamycin results in decreased expression of RND3 mRNA
CTD
PMID:22378314
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rnf113a1
ring finger protein 113A1
increases expression
ISO
Tunicamycin results in increased expression of RNF113A mRNA
CTD
PMID:22378314
NCBI chr X:116,427,941...116,429,164
Ensembl chr X:116,427,684...116,433,762
G
Rnf122
ring finger protein 122
increases expression
ISO
Tunicamycin results in increased expression of RNF122 mRNA
CTD
PMID:29453283
NCBI chr16:67,712,936...67,730,479
Ensembl chr16:61,009,879...61,027,448
G
Rnf144b
ring finger protein 144B
increases expression
ISO
Tunicamycin results in increased expression of RNF144B mRNA
CTD
PMID:17127020
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
G
Rnf145
ring finger protein 145
decreases expression
ISO
Tunicamycin results in decreased expression of RNF145 mRNA
CTD
PMID:22378314
NCBI chr10:29,006,391...29,050,788
Ensembl chr10:29,011,548...29,050,781
G
Rnf181
ring finger protein 181
increases expression
ISO
Tunicamycin results in increased expression of RNF181 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:104,414,586...104,421,433
Ensembl chr 4:104,414,605...104,421,309
G
Rnf207
ring finger protein 207
decreases expression
ISO
Tunicamycin results in decreased expression of RNF207 mRNA
CTD
PMID:22378314
NCBI chr 5:162,815,351...162,828,325
Ensembl chr 5:162,815,357...162,828,375
G
Rnf227
ring finger protein 227
increases expression
ISO
Tunicamycin results in increased expression of RNF227 mRNA
CTD
PMID:29453283
NCBI chr10:54,559,862...54,561,823
Ensembl chr10:54,059,947...54,063,010
G
Rnf24
ring finger protein 24
decreases expression
ISO
Tunicamycin results in decreased expression of RNF24 mRNA
CTD
PMID:22378314
NCBI chr 3:138,973,492...138,987,354
Ensembl chr 3:118,525,349...118,541,080
G
Rnft2
ring finger protein, transmembrane 2
decreases expression
ISO
Tunicamycin results in decreased expression of RNFT2 mRNA
CTD
PMID:22378314
NCBI chr12:38,329,217...38,387,303
Ensembl chr12:38,329,269...38,387,290
G
Ror1
receptor tyrosine kinase-like orphan receptor 1
decreases expression
ISO
Tunicamycin results in decreased expression of ROR1 mRNA
CTD
PMID:17127020
NCBI chr 5:114,744,311...115,088,155
Ensembl chr 5:114,744,304...115,088,155
G
Rora
RAR-related orphan receptor A
increases expression
ISO
Tunicamycin results in increased expression of RORA mRNA; Tunicamycin results in increased expression of RORA protein
CTD
PMID:28698385
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:69,301,733...70,025,931
G
Rp9
RP9, pre-mRNA splicing factor
increases expression
ISO
Tunicamycin results in increased expression of RP9 mRNA
CTD
PMID:29453283
NCBI chr 8:20,955,447...21,005,225
Ensembl chr 8:20,941,362...21,005,175
G
Rpap2
RNA polymerase II associated protein 2
increases expression
ISO
Tunicamycin results in increased expression of RPAP2 mRNA
CTD
PMID:22378314
NCBI chr14:2,109,044...2,187,343
Ensembl chr14:2,109,053...2,187,350
G
Rpf2
ribosome production factor 2 homolog
increases expression
ISO
Tunicamycin results in increased expression of RPF2 mRNA
CTD
PMID:22378314
NCBI chr20:43,630,003...43,651,477
Ensembl chr20:43,629,951...43,651,509
G
Rpl13a
ribosomal protein L13A
increases expression
ISO
Tunicamycin results in increased expression of RPL13A mRNA
CTD
PMID:29453283
NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:95,609,370...95,620,463
G
Rpl28
ribosomal protein L28
increases expression
ISO
Tunicamycin results in increased expression of RPL28 mRNA
CTD
PMID:29453283
NCBI chr 1:69,052,148...69,054,735
Ensembl chr 1:69,053,203...69,055,032
G
Rpl29
ribosomal protein L29
decreases expression
ISO
Tunicamycin results in decreased expression of RPL29 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:107,068,929...107,070,963
Ensembl chr 8:107,068,480...107,070,914 Ensembl chr12:107,068,480...107,070,914
G
Rpl37
ribosomal protein L37
increases expression
ISO
Tunicamycin results in increased expression of RPL37 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:54,215,469...54,217,429
Ensembl chr 2:54,215,469...54,217,442
G
Rpn1
ribophorin I
increases expression
ISO
Tunicamycin results in increased expression of RPN1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:120,543,667...120,565,069
Ensembl chr 4:120,543,667...120,565,069
G
Rpn2
ribophorin II
increases expression
ISO
Tunicamycin results in increased expression of RPN2 mRNA
CTD
PMID:29453283
NCBI chr 3:166,361,955...166,409,272
Ensembl chr 3:145,941,839...145,989,543
G
Rpp40
ribonuclease P/MRP subunit p40
increases expression
ISO
Tunicamycin results in increased expression of RPP40 mRNA
CTD
PMID:22378314
NCBI chr17:28,947,752...28,956,788
Ensembl chr17:28,947,734...28,956,788
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
Tunicamycin results in increased expression of RPS27L mRNA
CTD
PMID:22378314
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
G
Rps6ka4
ribosomal protein S6 kinase A4
decreases expression
ISO
Tunicamycin results in decreased expression of RPS6KA4 mRNA
CTD
PMID:17127020
NCBI chr 1:213,451,026...213,461,982
Ensembl chr 1:204,021,806...204,032,761
G
Rps6kb1
ribosomal protein S6 kinase B1
increases expression multiple interactions
ISO
Tunicamycin results in increased expression of RPS6KB1 mRNA Tunicamycin inhibits the reaction [[EIF2AK4 gene mutant form affects the susceptibility to Amino Acids deficiency] which results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:17127020 PMID:29449374
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
Tunicamycin results in decreased expression of RRM2 mRNA
CTD
PMID:22378314
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
Tunicamycin results in increased expression of RRM2B mRNA
CTD
PMID:22378314
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:69,078,291...69,108,633
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression
ISO
Tunicamycin results in increased expression of RSAD2 mRNA
CTD
PMID:33545341 PMID:38498338
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:43,047,658...43,059,699
G
Rsl24d1
ribosomal L24 domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of RSL24D1 mRNA
CTD
PMID:29453283
NCBI chr 8:73,852,991...73,861,996
Ensembl chr 8:73,852,996...73,862,001
G
RT1-DMa
RT1 class II, locus DMa
increases expression
ISO
Tunicamycin results in increased expression of HLA-DMA mRNA
CTD
PMID:22378314
NCBI chr20:4,708,932...4,712,335
Ensembl chr20:4,707,028...4,710,432
G
Rtn1
reticulon 1
decreases expression
ISO
Tunicamycin results in decreased expression of RTN1 mRNA
CTD
PMID:22378314
NCBI chr 6:90,763,212...90,983,436
Ensembl chr 6:90,763,216...90,983,436
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression
ISO
Tunicamycin results in decreased expression of RUNX1T1 mRNA
CTD
PMID:22378314
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
G
Rusf1
RUS family member 1
increases expression
ISO
Tunicamycin results in increased expression of RUSF1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:182,852,257...182,881,652
Ensembl chr 1:182,852,262...182,880,732
G
Rwdd2a
RWD domain containing 2A
increases expression
ISO
Tunicamycin results in increased expression of RWDD2A mRNA
CTD
PMID:22378314
NCBI chr 8:87,536,153...87,539,301
Ensembl chr 8:87,536,176...87,539,300
G
S100a10
S100 calcium binding protein A10
decreases expression
ISO
Tunicamycin results in decreased expression of S100A10 mRNA
CTD
PMID:29453283
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a14
S100 calcium binding protein A14
increases expression
ISO
Tunicamycin results in increased expression of S100A14 mRNA
CTD
PMID:29453283
NCBI chr 2:176,008,395...176,010,423
Ensembl chr 2:176,008,395...176,010,423
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
Tunicamycin results in decreased expression of S100A4 mRNA
CTD
PMID:22378314
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:176,091,804...176,093,254
G
Samm50
SAMM50 sorting and assembly machinery component
increases expression
ISO
Tunicamycin results in increased expression of SAMM50 mRNA
CTD
PMID:22378314
NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682
G
Sapcd2
suppressor APC domain containing 2
decreases expression
ISO
Tunicamycin results in decreased expression of SAPCD2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
Tunicamycin results in increased expression of SAR1B mRNA
CTD
PMID:22378314
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
G
Sarm1
sterile alpha and TIR motif containing 1
increases expression
ISO
Tunicamycin results in increased expression of SARM1 mRNA
CTD
PMID:29453283
NCBI chr10:63,369,456...63,393,016
Ensembl chr10:63,369,456...63,392,822
G
Sars1
seryl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of SARS1 mRNA; Tunicamycin results in increased expression of SARS1 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Sars2
seryl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
Tunicamycin results in decreased expression of SARS2 mRNA
CTD
PMID:22378314
NCBI chr 1:84,028,972...84,040,725
Ensembl chr 1:84,028,986...84,040,725
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
Tunicamycin results in increased expression of SAT1 mRNA
CTD
PMID:22378314
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Scd
stearoyl-CoA desaturase
increases expression decreases expression
ISO
Tunicamycin results in increased expression of SCD1 mRNA Tunicamycin results in increased expression of SCD mRNA Tunicamycin results in decreased expression of SCD mRNA
CTD
PMID:17127020 PMID:22378314 PMID:22414386
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Scg3
secretogranin III
increases expression
ISO
Tunicamycin results in increased expression of SCG3 mRNA
CTD
PMID:29453283
NCBI chr 8:76,399,777...76,442,015
Ensembl chr 8:76,399,777...76,442,015
G
Sco1
synthesis of cytochrome C oxidase 1
decreases expression
ISO
Tunicamycin results in decreased expression of SCO1 mRNA
CTD
PMID:22378314
NCBI chr10:51,744,656...51,757,246
Ensembl chr10:51,744,656...51,757,237
G
Sdc4
syndecan 4
increases expression
ISO
Tunicamycin results in increased expression of SDC4 mRNA
CTD
PMID:33545341
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:153,154,896...153,173,580
G
Sdccag8
SHH signaling and ciliogenesis regulator SDCCAG8
increases expression
ISO
Tunicamycin results in increased expression of SDCCAG8 mRNA
CTD
PMID:22378314
NCBI chr13:88,754,521...88,979,363
Ensembl chr13:88,754,626...89,097,111
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
Tunicamycin results in increased expression of SDF2L1 mRNA; Tunicamycin results in increased expression of SDF2L1 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
increases expression
ISO
Tunicamycin results in increased expression of SDHA mRNA
CTD
PMID:22378314
NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:28,940,164...28,961,535
G
Sdhc
succinate dehydrogenase complex subunit C
decreases expression
ISO
Tunicamycin results in decreased expression of SDHC mRNA
CTD
PMID:22378314
NCBI chr13:86,077,133...86,098,025
Ensembl chr13:83,544,652...83,566,253
G
Sdhd
succinate dehydrogenase complex subunit D
decreases expression
ISO
Tunicamycin results in decreased expression of SDHD mRNA
CTD
PMID:17127020
NCBI chr 8:59,841,090...59,850,641
Ensembl chr 8:50,944,704...50,954,238
G
Sdsl
serine dehydratase-like
increases expression
ISO
Tunicamycin results in increased expression of SDSL mRNA
CTD
PMID:29453283
NCBI chr12:36,099,693...36,109,914
Ensembl chr12:36,099,693...36,109,906
G
Sec11c
SEC11 homolog C, signal peptidase complex subunit
increases expression
ISO
Tunicamycin results in increased expression of SEC11C mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr18:59,320,932...59,337,272
Ensembl chr18:59,320,884...59,337,364
G
Sec13
SEC13 homolog, nuclear pore and COPII coat complex component
increases expression
ISO
Tunicamycin results in increased expression of SEC13 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:148,433,344...148,446,735
Ensembl chr 4:146,875,524...146,891,173
G
Sec23a
Sec23 homolog A, COPII coat complex component
increases expression
ISO
Tunicamycin results in increased expression of SEC23A mRNA
CTD
PMID:22378314
NCBI chr 6:76,658,793...76,706,125
Ensembl chr 6:76,658,427...76,706,035
G
Sec23b
Sec23 homolog B, COPII coat complex component
increases expression
ISO
Tunicamycin results in increased expression of SEC23B mRNA
CTD
PMID:22378314
NCBI chr 3:131,939,011...131,981,489
Ensembl chr 3:131,939,337...131,981,489
G
Sec24d
SEC24 homolog D, COPII coat complex component
increases expression
ISO
Tunicamycin results in increased expression of SEC24D mRNA; Tunicamycin results in increased expression of SEC24D protein
CTD
PMID:29453283
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
G
Sec31a
SEC31 homolog A, COPII coat complex component
increases expression
ISO
Tunicamycin results in increased expression of SEC31A mRNA
CTD
PMID:22378314
NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273
G
Sec61a1
SEC61 translocon subunit alpha 1
increases expression
ISO
Tunicamycin results in increased expression of SEC61A1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:122,530,785...122,545,141
Ensembl chr 4:120,960,626...120,987,925
G
Sec61b
SEC61 translocon subunit beta
increases expression
ISO
Tunicamycin results in increased expression of SEC61B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:66,569,184...66,577,394
Ensembl chr 5:61,773,594...61,781,804
G
Sec63
SEC63 homolog, protein translocation regulator
increases expression
ISO
Tunicamycin results in increased expression of SEC63 mRNA; Tunicamycin results in increased expression of SEC63 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
G
Sel1l
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
increases expression
ISO
Tunicamycin results in increased expression of SEL1L mRNA
CTD
PMID:38498338
NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:110,735,450...110,779,648
G
Sel1l3
SEL1L family member 3
increases expression
ISO
Tunicamycin results in increased expression of SEL1L3 mRNA
CTD
PMID:29453283
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
G
Selenok
selenoprotein K
increases expression
ISO
Tunicamycin results in increased expression of SELK mRNA
CTD
PMID:29453283
NCBI chr16:5,152,066...5,160,648
Ensembl chr16:5,152,066...5,159,188
G
Selenom
selenoprotein M
increases expression
ISO
Tunicamycin results in increased expression of SELENOM mRNA
CTD
PMID:22378314
NCBI chr14:78,395,826...78,398,429
Ensembl chr14:78,395,826...78,398,429
G
Selenon
selenoprotein N
decreases expression
ISO
Tunicamycin results in decreased expression of SELENON mRNA
CTD
PMID:22378314
NCBI chr 5:146,748,638...146,764,656
Ensembl chr 5:146,748,652...146,763,059
G
Selenos
selenoprotein S
increases expression
ISO
Tunicamycin results in increased expression of SELENOS mRNA; Tunicamycin results in increased expression of SELS mRNA
CTD
PMID:16227999 PMID:22378314 PMID:29453283 PMID:38498338
NCBI chr 1:129,070,240...129,080,007
Ensembl chr 1:119,659,751...119,669,833
G
Selenow
selenoprotein W
decreases expression
ISO
Tunicamycin results in decreased expression of SEPW1 mRNA
CTD
PMID:29453283
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sema4f
semaphorin 4F
decreases expression
ISO
Tunicamycin results in decreased expression of SEMA4F mRNA
CTD
PMID:22378314
NCBI chr 4:115,411,411...115,437,721
Ensembl chr 4:115,411,417...115,437,721
G
Sephs2
selenophosphate synthetase 2
increases expression
ISO
Tunicamycin results in increased expression of SEPHS2 mRNA
CTD
PMID:22378314
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
G
Serp1
stress-associated endoplasmic reticulum protein 1
increases expression
ISO
Tunicamycin results in increased expression of SERP1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:142,757,270...142,761,116
G
Serpine2
serpin family E member 2
increases expression
ISO
Tunicamycin results in increased expression of SERPINE2 mRNA
CTD
PMID:22378314 PMID:33545341
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826
G
Serpinf1
serpin family F member 1
increases expression
ISO
Tunicamycin results in increased expression of SERPINF1 mRNA
CTD
PMID:22378314
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Serpinh1
serpin family H member 1
increases expression multiple interactions decreases glycosylation
ISO
Tunicamycin results in increased expression of SERPINH1 mRNA Ketoconazole inhibits the reaction [Tunicamycin results in decreased glycosylation of SERPINH1 protein]
CTD
PMID:16330322 PMID:22378314
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:153,643,510...153,650,801
G
Sertad1
SERTA domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of SERTAD1 mRNA
CTD
PMID:29453283
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
G
Sesn2
sestrin 2
increases expression multiple interactions
ISO EXP
Tunicamycin results in increased expression of SESN2 mRNA SESN2 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; SESN2 protein promotes the reaction [Luteolin inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]] 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of SESN2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of SESN2 protein]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Tunicamycin results in increased expression of SESN2 protein]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of SESN2 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of SESN2 protein] Tunicamycin results in increased expression of SESN2 mRNA; Tunicamycin results in increased expression of SESN2 protein 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Tunicamycin results in increased expression of SESN2 protein]; ATF4 protein affects the reaction [Tunicamycin results in increased expression of SESN2 protein]
CTD
PMID:22378314 PMID:29453283 PMID:32407927 PMID:32740777 PMID:33545341 PMID:38498338 More...
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Setd9-ps1
SET domain containing, pseudogene 1
decreases expression
ISO
Tunicamycin results in decreased expression of SETD9 mRNA
CTD
PMID:22378314
NCBI chr 2:43,319,359...43,322,764
G
Setmar
SET domain and mariner transposase fusion gene
decreases expression
ISO
Tunicamycin results in decreased expression of SETMAR mRNA
CTD
PMID:22378314
NCBI chr 4:141,046,058...141,058,183
Ensembl chr 4:141,046,069...141,058,197
G
Setx
senataxin
increases expression
ISO
Tunicamycin results in increased expression of SETX mRNA
CTD
PMID:22378314
NCBI chr 3:12,428,091...12,480,801
Ensembl chr 3:12,427,635...12,480,803
G
Sez6
seizure related 6 homolog
increases expression
ISO
Tunicamycin results in increased expression of SEZ6 mRNA
CTD
PMID:22378314
NCBI chr10:62,818,931...62,868,686
Ensembl chr10:62,819,069...62,868,671
G
Sf3a1
splicing factor 3A subunit 1
increases expression
ISO
Tunicamycin results in increased expression of SF3A1 mRNA
CTD
PMID:17127020
NCBI chr14:79,031,394...79,052,144
Ensembl chr14:79,031,394...79,052,144
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
ISO
Tunicamycin results in decreased expression of SFPQ mRNA
CTD
PMID:22378314
NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:139,338,075...139,353,472
G
Sfxn1
sideroflexin 1
decreases expression
ISO
Tunicamycin results in decreased expression of SFXN1 mRNA
CTD
PMID:22378314
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
G
Sfxn2
sideroflexin 2
decreases expression
ISO
Tunicamycin results in decreased expression of SFXN2 mRNA
CTD
PMID:22378314
NCBI chr 1:255,388,428...255,400,724
Ensembl chr 1:245,447,015...245,468,411 Ensembl chr 1:245,447,015...245,468,411
G
Sfxn3
sideroflexin 3
decreases expression
ISO
Tunicamycin results in decreased expression of SFXN3 mRNA
CTD
PMID:22378314
NCBI chr 1:243,907,958...243,917,065
Ensembl chr 1:243,907,751...243,917,073
G
Sfxn5
sideroflexin 5
increases expression
ISO
Tunicamycin results in increased expression of SFXN5 mRNA
CTD
PMID:22378314
NCBI chr 4:117,750,213...117,869,826
Ensembl chr 4:117,752,806...117,869,794
G
Sgf29
SAGA complex associated factor 29
increases expression
ISO
Tunicamycin results in increased expression of SGF29 mRNA
CTD
PMID:29453283
NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781
G
Sh3bgr
SH3 domain binding glutamate-rich protein
increases expression
ISO
Tunicamycin results in increased expression of SH3BGR mRNA
CTD
PMID:29453283
NCBI chr11:35,503,663...35,527,853
Ensembl chr11:35,503,725...35,527,853
G
Sh3bgrl1
SH3 domain binding glutamate rich protein like 1
decreases expression
ISO
Tunicamycin results in decreased expression of SH3BGRL mRNA
CTD
PMID:22378314
NCBI chr X:78,242,704...78,343,633
Ensembl chr X:74,166,871...74,263,783
G
Sh3kbp1
SH3 domain-containing kinase-binding protein 1
increases expression
ISO
Tunicamycin results in increased expression of SH3KBP1 mRNA
CTD
PMID:29453283
NCBI chr X:34,877,862...35,223,013
Ensembl chr X:34,877,866...35,222,747
G
Shmt2
serine hydroxymethyltransferase 2
increases expression
ISO
Tunicamycin results in increased expression of SHMT2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:63,358,961...63,364,236
G
Shroom3
shroom family member 3
decreases expression
ISO
Tunicamycin results in decreased expression of SHROOM3 mRNA
CTD
PMID:22378314
NCBI chr14:15,099,415...15,396,832
Ensembl chr14:15,099,423...15,396,915
G
Siah2
siah E3 ubiquitin protein ligase 2
increases expression
ISO
Tunicamycin results in increased expression of SIAH2 mRNA
CTD
PMID:17127020
NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950
G
Sidt2
SID1 transmembrane family, member 2
increases expression
ISO
Tunicamycin results in increased expression of SIDT2 mRNA
CTD
PMID:22378314
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
G
Sil1
SIL1 nucleotide exchange factor
increases expression
ISO
Tunicamycin results in increased expression of SIL1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr18:26,872,423...27,104,365
Ensembl chr18:26,872,429...27,104,332
G
Sirt3
sirtuin 3
decreases expression
ISO
Tunicamycin results in decreased expression of SIRT3 mRNA
CTD
PMID:22378314
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Sirt7
sirtuin 7
multiple interactions increases expression
ISO
SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA] Tunicamycin results in increased expression of SIRT7 mRNA; Tunicamycin results in increased expression of SIRT7 protein
CTD
PMID:24210820
NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
G
Six4
SIX homeobox 4
decreases expression
ISO
Tunicamycin results in decreased expression of SIX4 mRNA
CTD
PMID:29453283
NCBI chr 6:91,802,328...91,816,002
Ensembl chr 6:91,802,329...91,815,992
G
Skap2
src kinase associated phosphoprotein 2
decreases expression
ISO
Tunicamycin results in decreased expression of SKAP2 mRNA
CTD
PMID:17127020
NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891
G
Skida1
SKI/DACH domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of SKIDA1 mRNA
CTD
PMID:29453283
NCBI chr17:80,798,241...80,809,062
Ensembl chr17:80,803,716...80,806,463
G
Slc11a2
solute carrier family 11 member 2
decreases expression
ISO
Tunicamycin results in decreased expression of SLC11A2 mRNA
CTD
PMID:29453283
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:131,503,081...131,540,145
G
Slc12a6
solute carrier family 12, member 6
decreases expression
ISO
Tunicamycin results in decreased expression of SLC12A6 mRNA
CTD
PMID:33770205
NCBI chr 3:119,525,521...119,624,655
Ensembl chr 3:99,071,391...99,170,258
G
Slc13a1
solute carrier family 13 member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC13A1 mRNA
CTD
PMID:17127020
NCBI chr 4:52,569,179...52,647,126
Ensembl chr 4:52,569,375...52,647,099
G
Slc13a5
solute carrier family 13 member 5
increases expression
ISO
Tunicamycin results in increased expression of SLC13A5 mRNA
CTD
PMID:17127020
NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945
G
Slc16a9
solute carrier family 16, member 9
increases expression
ISO
Tunicamycin results in increased expression of SLC16A9 mRNA
CTD
PMID:29453283
NCBI chr20:18,334,946...18,376,195
Ensembl chr20:18,335,862...18,377,022
G
Slc1a1
solute carrier family 1 member 1
decreases expression
ISO
Tunicamycin results in decreased expression of SLC1A1 mRNA
CTD
PMID:22378314
NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a3
solute carrier family 1 member 3
increases expression
ISO
Tunicamycin results in increased expression of SLC1A3 mRNA
CTD
PMID:17127020
NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:57,755,497...57,830,605
G
Slc1a4
solute carrier family 1 member 4
increases expression
ISO
Tunicamycin results in increased expression of SLC1A4 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
increases expression
ISO
Tunicamycin results in increased expression of SLC1A5 mRNA
CTD
PMID:29453283
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a17
solute carrier family 22, member 17
increases expression
ISO
Tunicamycin results in increased expression of SLC22A17 mRNA
CTD
PMID:22378314
NCBI chr15:28,382,285...28,389,435
Ensembl chr15:28,382,292...28,388,799
G
Slc22a3
solute carrier family 22 member 3
increases expression
ISO
Tunicamycin results in increased expression of SLC22A3 mRNA
CTD
PMID:17127020
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc22a5
solute carrier family 22 member 5
increases expression
ISO
Tunicamycin results in increased expression of SLC22A5 mRNA
CTD
PMID:29453283
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc23a1
solute carrier family 23 member 1
decreases expression
ISO
Tunicamycin results in decreased expression of SLC23A1 mRNA
CTD
PMID:17127020
NCBI chr18:27,214,940...27,230,564
Ensembl chr18:27,216,281...27,230,697
G
Slc23a2
solute carrier family 23 member 2
decreases expression
ISO
Tunicamycin results in decreased expression of SLC23A2 mRNA
CTD
PMID:17127020
NCBI chr 3:139,755,583...139,913,304
Ensembl chr 3:119,302,666...119,460,343
G
Slc25a1
solute carrier family 25 member 1
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A1 mRNA
CTD
PMID:22378314
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a10
solute carrier family 25 member 10
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A10 mRNA
CTD
PMID:22378314
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Slc25a11
solute carrier family 25 member 11
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A11 mRNA
CTD
PMID:22378314
NCBI chr10:55,357,590...55,360,441
Ensembl chr10:55,357,597...55,360,410
G
Slc25a13
solute carrier family 25 member 13
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A13 mRNA
CTD
PMID:22378314
NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902
G
Slc25a14
solute carrier family 25 member 14
increases expression
ISO
Tunicamycin results in increased expression of SLC25A14 mRNA
CTD
PMID:22378314
NCBI chr X:127,807,630...127,845,823
Ensembl chr X:127,807,449...127,845,823
G
Slc25a15
solute carrier family 25 member 15
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A15 mRNA
CTD
PMID:22378314
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
G
Slc25a20
solute carrier family 25 member 20
increases expression
ISO
Tunicamycin results in increased expression of SLC25A20 mRNA
CTD
PMID:22378314
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:109,365,002...109,386,512
G
Slc25a22
solute carrier family 25 member 22
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A22 mRNA
CTD
PMID:22378314
NCBI chr 1:196,528,471...196,536,398
Ensembl chr 1:196,528,472...196,536,331
G
Slc25a23
solute carrier family 25 member 23
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A23 mRNA
CTD
PMID:22378314
NCBI chr 9:1,882,636...1,898,369
Ensembl chr 9:1,882,621...1,898,561
G
Slc25a27
solute carrier family 25, member 27
increases expression
ISO
Tunicamycin results in increased expression of SLC25A27 mRNA
CTD
PMID:22378314 PMID:38498338
NCBI chr 9:24,804,183...24,831,219
Ensembl chr 9:17,307,023...17,332,731
G
Slc25a28
solute carrier family 25 member 28
increases expression
ISO
Tunicamycin results in increased expression of SLC25A28 mRNA
CTD
PMID:22378314
NCBI chr 1:252,480,106...252,491,365
Ensembl chr 1:242,530,899...242,542,115
G
Slc25a38
solute carrier family 25, member 38
increases expression
ISO
Tunicamycin results in increased expression of SLC25A38 mRNA
CTD
PMID:22378314
NCBI chr 8:119,835,546...119,848,334
Ensembl chr 8:119,835,634...119,848,332
G
Slc25a39
solute carrier family 25, member 39
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A39 mRNA
CTD
PMID:22378314
NCBI chr10:87,362,494...87,367,358
Ensembl chr10:87,362,490...87,367,260
G
Slc25a4
solute carrier family 25 member 4
decreases expression
ISO
Tunicamycin results in decreased expression of SLC25A4 mRNA
CTD
PMID:22378314
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:46,072,939...46,076,733
G
Slc25a44
solute carrier family 25, member 44
increases expression
ISO
Tunicamycin results in increased expression of SLC25A44 mRNA
CTD
PMID:22378314
NCBI chr 2:173,868,317...173,883,137
Ensembl chr 2:173,868,320...173,883,020
G
Slc27a2
solute carrier family 27 member 2
increases expression
ISO
Tunicamycin results in increased expression of SLC27A2 mRNA
CTD
PMID:29453283
NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:113,804,728...113,842,208
G
Slc28a2
solute carrier family 28 member 2
increases expression
ISO
Tunicamycin results in increased expression of SLC28A2 mRNA
CTD
PMID:17127020
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc2a1
solute carrier family 2 member 1
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of SLC2A1 mRNA Tunicamycin results in increased expression of SLC2A1 protein
CTD
PMID:22378314 PMID:24370435 PMID:36473502
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a3
solute carrier family 2 member 3
increases expression
ISO
Tunicamycin results in increased expression of SLC2A3 mRNA
CTD
PMID:24370435
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
G
Slc2a6
solute carrier family 2 member 6
decreases expression
ISO
Tunicamycin results in decreased expression of SLC2A6 mRNA
CTD
PMID:22378314
NCBI chr 3:10,348,395...10,355,208
Ensembl chr 3:10,348,395...10,355,208
G
Slc30a10
solute carrier family 30, member 10
increases expression
ISO
Tunicamycin results in increased expression of SLC30A10 mRNA
CTD
PMID:28688763
NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103
G
Slc30a7
solute carrier family 30 member 7
increases expression
ISO
Tunicamycin results in increased expression of SLC30A7 mRNA
CTD
PMID:22378314
NCBI chr 2:206,544,800...206,607,087
Ensembl chr 2:203,859,175...203,922,132
G
Slc33a1
solute carrier family 33 member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC33A1 mRNA
CTD
PMID:22378314
NCBI chr 2:148,415,660...148,438,182
Ensembl chr 2:148,415,666...148,437,758
G
Slc35a2
solute carrier family 35 member A2
increases expression
ISO
Tunicamycin results in increased expression of SLC35A2 mRNA
CTD
PMID:17127020
NCBI chr X:17,280,072...17,288,928
Ensembl chr X:14,608,055...14,616,678
G
Slc35b1
solute carrier family 35, member B1
increases expression
ISO
Tunicamycin results in increased expression of SLC35B1 mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274
G
Slc35b3
solute carrier family 35 member B3
increases expression
ISO
Tunicamycin results in increased expression of SLC35B3 mRNA
CTD
PMID:22378314
NCBI chr17:25,846,590...25,873,115
Ensembl chr17:25,846,748...25,872,557
G
Slc35f6
solute carrier family 35, member F6
increases expression
ISO
Tunicamycin results in increased expression of SLC35F6 mRNA
CTD
PMID:29453283
NCBI chr 6:25,725,822...25,737,720
Ensembl chr 6:25,725,819...25,737,730
G
Slc35g1
solute carrier family 35, member G1
decreases expression
ISO
Tunicamycin results in decreased expression of SLC35G1 mRNA
CTD
PMID:29453283
NCBI chr 1:236,163,593...236,172,115
Ensembl chr 1:236,163,175...236,170,262
G
Slc36a1
solute carrier family 36 member 1
decreases expression
ISO
Tunicamycin results in decreased expression of SLC36A1 mRNA
CTD
PMID:22378314
NCBI chr10:39,819,753...39,858,068
Ensembl chr10:39,324,337...39,354,217
G
Slc37a4
solute carrier family 37 member 4
decreases expression
ISO
Tunicamycin results in decreased expression of SLC37A4 mRNA
CTD
PMID:17127020
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc38a1
solute carrier family 38, member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC38A1 mRNA
CTD
PMID:29453283
NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:127,738,226...127,802,218
G
Slc38a2
solute carrier family 38, member 2
increases expression
ISO
Tunicamycin results in increased expression of SLC38A2 mRNA
CTD
PMID:29453283
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:127,851,267...127,863,436
G
Slc38a9
solute carrier family 38, member 9
increases expression
ISO
Tunicamycin results in increased expression of SLC38A9 mRNA
CTD
PMID:29453283
NCBI chr 2:46,024,731...46,102,419
Ensembl chr 2:44,291,989...44,368,955
G
Slc39a14
solute carrier family 39 member 14
increases expression
ISO
Tunicamycin results in increased expression of SLC39A14 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:51,786,517...51,833,260
Ensembl chr15:45,376,917...45,423,524
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
Tunicamycin results in increased expression of SLC3A2 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:33545341
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Slc40a1
solute carrier family 40 member 1
decreases expression
ISO
Tunicamycin results in decreased expression of SLC40A1 mRNA
CTD
PMID:17127020
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:48,033,526...48,051,481
G
Slc43a1
solute carrier family 43 member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC43A1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:69,920,649...69,946,768
G
Slc46a1
solute carrier family 46 member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC46A1 mRNA
CTD
PMID:29453283
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
G
Slc4a4
solute carrier family 4 member 4
decreases expression
ISO
Tunicamycin results in decreased expression of SLC4A4 mRNA
CTD
PMID:17127020
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc50a1
solute carrier family 50 member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC50A1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:174,677,985...174,680,366
Ensembl chr 2:174,677,708...174,680,366
G
Slc52a2
solute carrier family 52 member 2
increases expression
ISO
Tunicamycin results in increased expression of SLC52A2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:108,246,003...108,267,642
Ensembl chr 7:108,262,612...108,268,034
G
Slc6a9
solute carrier family 6 member 9
increases expression
ISO
Tunicamycin results in increased expression of SLC6A9 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
increases expression
ISO
Tunicamycin results in increased expression of SLC7A1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Tunicamycin results in increased expression of SLC7A11 mRNA
CTD
PMID:17127020 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a12
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12
increases expression
ISO
Tunicamycin results in increased expression of SLC7A12 mRNA
CTD
PMID:17127020
NCBI chr 2:87,079,724...87,146,875
Ensembl chr 2:87,079,749...87,146,875
G
Slc7a5
solute carrier family 7 member 5
increases expression
ISO
Tunicamycin results in increased expression of SLC7A5 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Slc8a1
solute carrier family 8 member A1
increases expression
ISO
Tunicamycin results in increased expression of SLC8A1 mRNA
CTD
PMID:17127020
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a3
solute carrier family 9 member A3
decreases expression
ISO
Tunicamycin results in decreased expression of SLC9A3 mRNA
CTD
PMID:17127020
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
G
Slco2a1
solute carrier organic anion transporter family, member 2a1
increases expression
ISO
Tunicamycin results in increased expression of SLCO2A1 mRNA
CTD
PMID:29453283
NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546
G
Slit2
slit guidance ligand 2
decreases expression
ISO
Tunicamycin results in decreased expression of SLIT2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Slit3
slit guidance ligand 3
decreases expression
ISO
Tunicamycin results in decreased expression of SLIT3 mRNA
CTD
PMID:22378314
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
G
Slx4
SLX4 structure-specific endonuclease subunit
decreases expression
ISO
Tunicamycin results in decreased expression of SLX4 mRNA
CTD
PMID:22378314
NCBI chr10:11,526,623...11,549,313
Ensembl chr10:11,528,424...11,549,295
G
Smad6
SMAD family member 6
decreases expression
ISO
Tunicamycin results in decreased expression of SMAD6 mRNA
CTD
PMID:29453283
NCBI chr 8:73,345,457...73,414,985
Ensembl chr 8:64,450,114...64,519,763
G
Smap1
small ArfGAP 1
increases expression
ISO
Tunicamycin results in increased expression of SMAP1 mRNA
CTD
PMID:22378314
NCBI chr 9:26,250,178...26,342,151
Ensembl chr 9:26,249,978...26,342,170
G
Smarca4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
decreases expression
ISO
Tunicamycin results in decreased expression of SMARCA4 mRNA
CTD
PMID:22378314
NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
G
Smdt1
single-pass membrane protein with aspartate-rich tail 1
increases expression
ISO
Tunicamycin results in increased expression of SMDT1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:113,862,162...113,865,245
Ensembl chr 7:113,860,611...113,865,226
G
Smim14
small integral membrane protein 14
increases expression
ISO
Tunicamycin results in increased expression of SMIM14 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr14:43,136,754...43,180,622
Ensembl chr14:42,783,332...42,829,760
G
Smim19
small integral membrane protein 19
increases expression
ISO
Tunicamycin results in increased expression of SMIM19 mRNA
CTD
PMID:29453283
NCBI chr16:69,551,507...69,564,323
Ensembl chr16:69,553,916...69,567,245
G
Smpd2
sphingomyelin phosphodiesterase 2
increases activity multiple interactions
EXP
Tunicamycin results in increased activity of SMPD2 protein Taurodeoxycholic Acid inhibits the reaction [Tunicamycin results in increased activity of SMPD2 protein]
CTD
PMID:33527851
NCBI chr20:44,986,229...44,989,343
Ensembl chr20:44,986,231...44,989,441
G
Snap25
synaptosome associated protein 25
decreases expression
ISO
Tunicamycin results in decreased expression of SNAP25 mRNA
CTD
PMID:22378314
NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:124,041,898...124,123,760
G
Snd1
staphylococcal nuclease and tudor domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of SND1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:58,060,689...58,459,926
Ensembl chr 4:57,095,208...57,530,843
G
Snhg11
small nucleolar RNA host gene 11
increases expression
ISO
Tunicamycin results in increased expression of SNHG11 mRNA
CTD
PMID:29453283
NCBI chr 3:147,031,367...147,037,043
G
Snip1
Smad nuclear interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of SNIP1 mRNA
CTD
PMID:17127020
NCBI chr 5:137,328,371...137,335,846
Ensembl chr 5:137,328,371...137,335,845
G
Snord96a
small nucleolar RNA, C/D box 96A
decreases expression
ISO
Tunicamycin results in decreased expression of SNORD96A mRNA
CTD
PMID:29453283
NCBI chr10:33,171,093...33,171,172
Ensembl chr10:33,171,093...33,171,172
G
Snrnp25
small nuclear ribonucleoprotein U11/U12 subunit 25
decreases expression
ISO
Tunicamycin results in decreased expression of SNRNP25 mRNA
CTD
PMID:29453283
NCBI chr10:15,420,482...15,423,806
Ensembl chr10:15,420,486...15,423,804
G
Snrnp70
small nuclear ribonucleoprotein U1 subunit 70
decreases expression
ISO
Tunicamycin results in decreased expression of SNRNP70 mRNA
CTD
PMID:29453283
NCBI chr 1:104,992,518...105,012,851
Ensembl chr 1:95,856,036...95,876,392
G
Snrpd1
small nuclear ribonucleoprotein D1 polypeptide
decreases expression
ISO
Tunicamycin results in decreased expression of SNRPD1 mRNA
CTD
PMID:22378314
NCBI chr18:1,969,351...1,980,207
Ensembl chr18:1,696,852...1,708,256
G
Sntb1
syntrophin, beta 1
increases expression
ISO
Tunicamycin results in increased expression of SNTB1 mRNA
CTD
PMID:29453283
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:87,060,926...87,329,315
G
Snx10
sorting nexin 10
decreases expression
ISO
Tunicamycin results in decreased expression of SNX10 mRNA
CTD
PMID:22378314
NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
G
Socs2
suppressor of cytokine signaling 2
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of SOCS2 mRNA Tunicamycin results in increased expression of SOCS2 mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:30,008,578...30,043,548
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
Tunicamycin results in increased expression of SOCS3 mRNA
CTD
PMID:17127020
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Socs4
suppressor of cytokine signaling 4
increases expression
ISO
Tunicamycin results in increased expression of SOCS4 mRNA
CTD
PMID:17127020
NCBI chr15:23,003,130...23,017,615
Ensembl chr15:20,523,183...20,542,494
G
Sod1
superoxide dismutase 1
decreases expression
ISO
Tunicamycin results in decreased expression of SOD1 mRNA
CTD
PMID:17127020
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases expression
ISO
Tunicamycin results in decreased expression of SOD2 mRNA
CTD
PMID:22378314
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sox18
SRY-box transcription factor 18
decreases expression
ISO
Tunicamycin results in decreased expression of SOX18 mRNA
CTD
PMID:29453283
NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290
G
Sox4
SRY-box transcription factor 4
decreases expression
ISO
Tunicamycin results in decreased expression of SOX4 mRNA
CTD
PMID:22378314
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,667,537...35,673,665
G
Sp1
Sp1 transcription factor
decreases expression
EXP
Tunicamycin results in decreased expression of SP1 mRNA
CTD
PMID:25398788
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:133,541,491...133,571,961
G
Spaca9
sperm acrosome associated 9
increases expression
ISO
Tunicamycin results in increased expression of SPACA9 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:12,019,376...12,028,801
Ensembl chr 3:12,019,363...12,029,119
G
Spag5
sperm associated antigen 5
decreases expression
ISO
Tunicamycin results in decreased expression of SPAG5 mRNA
CTD
PMID:22378314
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,198,768...63,216,745
G
Spata18
spermatogenesis associated 18
increases expression
ISO
Tunicamycin results in increased expression of SPATA18 mRNA
CTD
PMID:22378314
NCBI chr14:34,531,931...34,558,671
Ensembl chr14:34,531,061...34,558,687
G
Spc25
SPC25 component of NDC80 kinetochore complex
decreases expression
ISO
Tunicamycin results in decreased expression of SPC25 mRNA
CTD
PMID:22378314
NCBI chr 3:53,930,013...53,988,940
Ensembl chr 3:53,975,704...53,988,959
G
Spcs2
signal peptidase complex subunit 2
increases expression
ISO
Tunicamycin results in increased expression of SPCS2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186
G
Spcs3
signal peptidase complex subunit 3
increases expression
ISO
Tunicamycin results in increased expression of SPCS3 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr16:44,038,421...44,043,855
Ensembl chr16:37,305,305...37,331,746
G
Spen
spen family transcriptional repressor
decreases expression
ISO
Tunicamycin results in decreased expression of SPEN mRNA
CTD
PMID:29453283
NCBI chr 5:153,775,287...153,848,677
Ensembl chr 5:153,776,234...153,848,811
G
Spock1
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1
decreases expression
ISO
Tunicamycin results in decreased expression of SPOCK1 mRNA
CTD
PMID:22378314
NCBI chr17:6,741,504...7,221,685
Ensembl chr17:6,742,273...7,224,935
G
Spred1
sprouty-related, EVH1 domain containing 1
decreases expression
ISO
Tunicamycin results in decreased expression of SPRED1 mRNA
CTD
PMID:29453283
NCBI chr 3:124,437,230...124,504,358
Ensembl chr 3:103,983,072...104,049,718
G
Spred2
sprouty-related, EVH1 domain containing 2
decreases expression
ISO
Tunicamycin results in decreased expression of SPRED2 mRNA
CTD
PMID:29453283
NCBI chr14:98,350,577...98,452,143
Ensembl chr14:94,148,837...94,249,162
G
Spry2
sprouty RTK signaling antagonist 2
decreases expression
ISO
Tunicamycin results in decreased expression of SPRY2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:89,106,809...89,111,926
Ensembl chr15:82,692,143...82,698,009
G
Spsb3
splA/ryanodine receptor domain and SOCS box containing 3
increases expression
ISO
Tunicamycin results in increased expression of SPSB3 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:13,907,175...13,912,841
Ensembl chr10:13,907,253...13,912,841
G
Spty2d1
SPT2 chromatin protein domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of SPTY2D1 mRNA
CTD
PMID:22378314
NCBI chr 1:97,531,495...97,549,616
Ensembl chr 1:97,531,508...97,549,581
G
Sqle
squalene epoxidase
decreases expression
ISO
Tunicamycin results in decreased expression of SQLE mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Sqstm1
sequestosome 1
increases expression multiple interactions decreases expression
ISO
Tunicamycin results in increased expression of SQSTM1 mRNA [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of SQSTM1 protein Tunicamycin results in decreased expression of SQSTM1 mRNA; Tunicamycin results in decreased expression of SQSTM1 protein Curcumin inhibits the reaction [Tunicamycin results in decreased expression of SQSTM1 protein]; PHGDH protein affects the reaction [Tunicamycin results in decreased expression of SQSTM1 protein]
CTD
PMID:22378314 PMID:25979647 PMID:29793971 PMID:36586010 PMID:36640941 PMID:39427783 More...
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
increases cleavage multiple interactions increases expression increases expression
ISO EXP
Tunicamycin results in increased cleavage of SREBF1 protein HNRNPA1 mutant form inhibits the reaction [Tunicamycin results in increased expression of SREBF1 protein]; Tunicamycin promotes the reaction [HNRNPA1 protein binds to SREBF1 5' UTR] HNRNPA1 mutant form inhibits the reaction [Tunicamycin results in increased expression of SREBF1 protein]; Tunicamycin promotes the reaction [SREBF1 protein binds to TGFB1 promoter] Luteolin inhibits the reaction [Tunicamycin results in increased expression of SREBF1 mRNA] tunicamycin increases expression of Srebf1 mRNA and protein in liver naltrexone inhibits the reaction [tunicamycin increases expression of Srebf1 mRNA and protein in liver]
CTD RGD
PMID:22414386 PMID:23106379 PMID:25398788 PMID:32407927 PMID:27813192 PMID:27813192 More...
RGD:401842386 , RGD:401842386
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
decreases expression
ISO
Tunicamycin results in decreased expression of SREBF2 mRNA
CTD
PMID:22378314
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
G
Srp19
signal recognition particle 19
increases expression
ISO
Tunicamycin results in increased expression of SRP19 mRNA
CTD
PMID:22378314
NCBI chr18:26,205,888...26,212,171
Ensembl chr18:25,931,589...25,938,017
G
Srp54a
signal recognition particle 54A
increases expression
ISO
Tunicamycin results in increased expression of SRP54 mRNA
CTD
PMID:22378314
NCBI chr 6:78,322,308...78,362,017
Ensembl chr 6:72,587,605...72,625,189
G
Srp68
signal recognition particle 68
increases expression
ISO
Tunicamycin results in increased expression of SRP68 mRNA
CTD
PMID:22378314
NCBI chr10:101,980,089...102,006,913
Ensembl chr10:101,481,212...101,508,035
G
Srpra
SRP receptor subunit alpha
increases expression
ISO
Tunicamycin results in increased expression of SRPRA mRNA
CTD
PMID:22378314
NCBI chr 8:41,818,199...41,824,292
Ensembl chr 8:33,560,348...33,566,470
G
Srprb
SRP receptor subunit beta
increases expression
ISO
Tunicamycin results in increased expression of SRPRB mRNA; Tunicamycin results in increased expression of SRPRB protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:103,768,685...103,782,632
G
Srpx
sushi-repeat-containing protein, X-linked
decreases expression
ISO
Tunicamycin results in decreased expression of SRPX mRNA
CTD
PMID:22378314
NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882
G
Srsf2
serine and arginine rich splicing factor 2
decreases expression
ISO
Tunicamycin results in decreased expression of SRSF2 mRNA
CTD
PMID:22378314
NCBI chr10:102,550,962...102,554,200
Ensembl chr10:102,052,314...102,055,338
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
Tunicamycin results in decreased expression of SRSF3 mRNA
CTD
PMID:22378314
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srsf6
serine and arginine rich splicing factor 6
increases expression
ISO
Tunicamycin results in increased expression of SRSF6 mRNA
CTD
PMID:29453283
NCBI chr 3:172,009,072...172,014,395
Ensembl chr 3:151,589,535...151,594,860
G
Srsf7
serine and arginine rich splicing factor 7
decreases expression
ISO
Tunicamycin results in decreased expression of SRSF7 mRNA
CTD
PMID:22378314
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Tunicamycin results in increased expression of SRXN1 protein Tunicamycin results in increased expression of SRXN1 mRNA
CTD
PMID:27358234 PMID:36586010
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Ssr1
signal sequence receptor subunit 1
increases expression
ISO
Tunicamycin results in increased expression of SSR1 mRNA
CTD
PMID:22378314
NCBI chr17:26,833,720...26,861,821
Ensembl chr17:26,833,741...26,861,821
G
Ssr4
signal sequence receptor subunit 4
increases expression
ISO
Tunicamycin results in increased expression of SSR4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr X:151,524,191...151,528,218
Ensembl chr X:151,524,009...151,528,202
G
St3gal2
ST3 beta-galactoside alpha-2,3-sialyltransferase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ST3GAL2 mRNA
CTD
PMID:17127020
NCBI chr19:38,888,851...38,939,874
Ensembl chr19:38,923,999...38,939,869
G
St3gal4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
increases expression
ISO
Tunicamycin results in increased expression of ST3GAL4 mRNA
CTD
PMID:17127020
NCBI chr 8:41,673,510...41,723,158
Ensembl chr 8:33,415,671...33,524,389
G
St3gal5
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
decreases expression
ISO
Tunicamycin results in decreased expression of ST3GAL5 mRNA
CTD
PMID:22378314
NCBI chr 4:104,134,613...104,192,558
Ensembl chr 4:104,134,613...104,192,558
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
increases expression
ISO
Tunicamycin results in increased expression of ST6GALNAC4 mRNA
CTD
PMID:22378314
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
G
St8sia2
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
decreases expression
ISO
Tunicamycin results in decreased expression of ST8SIA2 mRNA
CTD
PMID:22378314
NCBI chr 1:127,762,573...127,838,017
Ensembl chr 1:127,762,573...127,838,091
G
Stac2
SH3 and cysteine rich domain 2
increases expression
ISO
Tunicamycin results in increased expression of STAC2 mRNA
CTD
PMID:22378314
NCBI chr10:83,528,741...83,544,583
Ensembl chr10:83,032,417...83,048,260
G
Stambpl1
STAM binding protein-like 1
increases expression
ISO
Tunicamycin results in increased expression of STAMBPL1 mRNA
CTD
PMID:22378314
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
G
Stat5b
signal transducer and activator of transcription 5B
increases activity
ISO
Tunicamycin results in increased activity of STAT5B protein
CTD
PMID:30114225
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:85,705,670...85,775,668
G
Stc1
stanniocalcin 1
increases expression
ISO
Tunicamycin results in increased expression of STC1 mRNA
CTD
PMID:29453283
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
increases expression
ISO
Tunicamycin results in increased expression of STC2 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:36586010
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Steap2
STEAP2 metalloreductase
increases expression
ISO
Tunicamycin results in increased expression of STEAP2 mRNA
CTD
PMID:17127020
NCBI chr 4:28,347,769...28,368,177
Ensembl chr 4:28,348,362...28,375,791
G
Stip1
stress-induced phosphoprotein 1
decreases expression
ISO
Tunicamycin results in decreased expression of STIP1 mRNA
CTD
PMID:29453283
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Stk17b
serine/threonine kinase 17b
increases expression
ISO
Tunicamycin results in increased expression of STK17B mRNA
CTD
PMID:17127020
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
G
Stmn1
stathmin 1
decreases expression
ISO
Tunicamycin results in decreased expression of STMN1 mRNA
CTD
PMID:22378314
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:146,681,436...146,687,154
G
Stmnd1
stathmin domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of STMND1 mRNA
CTD
PMID:29453283
NCBI chr17:18,393,312...18,420,655
Ensembl chr17:18,394,346...18,437,412
G
Stox2
storkhead box 2
increases expression
ISO
Tunicamycin results in increased expression of STOX2 mRNA
CTD
PMID:22378314
NCBI chr16:44,848,179...45,087,238
Ensembl chr16:44,848,078...45,085,105
G
Stt3a
STT3 oligosaccharyltransferase complex catalytic subunit A
increases expression
ISO
Tunicamycin results in increased expression of STT3A mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr 8:36,443,623...36,483,111
Ensembl chr 8:36,446,788...36,483,293
G
Stt3b
STT3 oligosaccharyltransferase complex catalytic subunit B
increases expression
ISO
Tunicamycin results in increased expression of STT3B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:114,928,678...114,994,027
Ensembl chr 8:114,917,824...114,994,028
G
Stx3
syntaxin 3
increases expression
ISO
Tunicamycin results in increased expression of STX3 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:217,940,697...218,114,865
Ensembl chr 1:208,639,115...208,685,805
G
Stx5
syntaxin 5
increases expression
ISO
Tunicamycin results in increased expression of STX5 mRNA
CTD
PMID:22378314
NCBI chr 1:205,637,401...205,653,563
Ensembl chr 1:205,637,413...205,653,563
G
Styxl1
serine/threonine/tyrosine interacting-like 1
increases expression
ISO
Tunicamycin results in increased expression of STYXL1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:20,907,410...20,940,232
Ensembl chr12:20,907,435...20,939,752
G
Sult1b1
sulfotransferase family 1B member 1
decreases expression
ISO
Tunicamycin results in decreased expression of SULT1B1 mRNA
CTD
PMID:17127020
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
G
Sumf2
sulfatase modifying factor 2
increases expression
ISO
Tunicamycin results in increased expression of SUMF2 mRNA
CTD
PMID:29453283
NCBI chr12:26,853,561...26,871,835
Ensembl chr12:26,853,200...26,871,816
G
Suox
sulfite oxidase
decreases expression
ISO
Tunicamycin results in decreased expression of SUOX mRNA
CTD
PMID:22378314
NCBI chr 7:1,687,666...1,691,759
Ensembl chr 7:1,103,151...1,107,038
G
Surf4
surfeit 4
increases expression
ISO
Tunicamycin results in increased expression of SURF4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:30,646,435...30,659,641
Ensembl chr 3:10,241,837...10,263,315
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Tunicamycin results in decreased expression of SYNCRIP mRNA
CTD
PMID:22378314
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Synj2bp
synaptojanin 2 binding protein
decreases expression
ISO
Tunicamycin results in decreased expression of SYNJ2BP mRNA
CTD
PMID:22378314
NCBI chr 6:106,920,970...106,958,653
Ensembl chr 6:101,189,714...101,227,406
G
Syp
synaptophysin
increases expression
ISO
Tunicamycin results in increased expression of SYP mRNA
CTD
PMID:29453283
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
G
Sypl1
synaptophysin-like 1
increases expression
ISO
Tunicamycin results in increased expression of SYPL1 mRNA
CTD
PMID:22378314
NCBI chr 6:49,565,111...49,585,205
Ensembl chr 6:49,565,154...49,585,330
G
Syt17
synaptotagmin 17
increases expression
ISO
Tunicamycin results in increased expression of SYT17 mRNA
CTD
PMID:22378314
NCBI chr 1:182,129,491...182,195,827
Ensembl chr 1:172,696,120...172,761,960
G
Syvn1
synoviolin 1
increases expression
ISO
Tunicamycin results in increased expression of SYVN1 mRNA
CTD
PMID:17127020 PMID:22378314 PMID:29453283
NCBI chr 1:212,766,736...212,775,426
Ensembl chr 1:203,339,619...203,346,152
G
Tac1
tachykinin, precursor 1
increases expression
ISO
Tunicamycin results in increased expression of TAC1 mRNA
CTD
PMID:29453283
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
G
Tacc3
transforming, acidic coiled-coil containing protein 3
decreases expression
ISO
Tunicamycin results in decreased expression of TACC3 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr14:81,275,755...81,289,894
Ensembl chr14:77,051,215...77,065,219
G
Taf4
TATA-box binding protein associated factor 4
decreases expression
ISO
Tunicamycin results in decreased expression of TAF4 mRNA
CTD
PMID:29453283
NCBI chr 3:167,017,992...167,083,413
Ensembl chr 3:167,017,993...167,083,356
G
Tagln3
transgelin 3
decreases expression
ISO
Tunicamycin results in decreased expression of TAGLN3 mRNA
CTD
PMID:22378314
NCBI chr11:55,099,887...55,113,457
Ensembl chr11:55,099,743...55,113,485
G
Tars1
threonyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of TARS1 mRNA
CTD
PMID:22378314
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tatdn1
TatD DNase domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of TATDN1 mRNA
CTD
PMID:22378314
NCBI chr 7:90,449,979...90,481,000
Ensembl chr 7:90,441,079...90,481,133
G
Tax1bp1
Tax1 binding protein 1
increases expression
ISO
Tunicamycin results in increased expression of TAX1BP1 mRNA
CTD
PMID:22378314
NCBI chr 4:81,821,991...81,877,906
Ensembl chr 4:81,821,989...81,879,100
G
Tax1bp3
Tax1 binding protein 3
decreases expression
ISO
Tunicamycin results in decreased expression of TAX1BP3 mRNA
CTD
PMID:22378314
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
G
Tbc1d15
TBC1 domain family, member 15
increases expression
ISO
Tunicamycin results in increased expression of TBC1D15 mRNA
CTD
PMID:22378314
NCBI chr 7:50,804,553...50,860,272
Ensembl chr 7:50,804,012...50,860,175
G
Tbc1d16
TBC1 domain family, member 16
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of TBC1D16 mRNA Tunicamycin results in increased expression of TBC1D16 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:104,400,963...104,486,698
Ensembl chr10:104,402,398...104,486,670
G
Tbc1d23
TBC1 domain family, member 23
increases expression decreases expression
ISO
Tunicamycin results in increased expression of TBC1D23 mRNA Tunicamycin results in decreased expression of TBC1D23 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr11:43,303,355...43,361,507
Ensembl chr11:43,303,355...43,361,503
G
Tbcd
tubulin folding cofactor D
decreases expression
ISO
Tunicamycin results in decreased expression of TBCD mRNA
CTD
PMID:22378314
NCBI chr10:107,215,626...107,372,398
Ensembl chr10:106,717,367...106,874,122
G
Tbk1
TANK-binding kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of TBK1 mRNA
CTD
PMID:17127020 PMID:29453283
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:57,077,830...57,110,892
G
Tbl1x
transducin (beta)-like 1 X-linked
increases expression
ISO
Tunicamycin results in increased expression of TBL1X mRNA
CTD
PMID:29453283
NCBI chr X:41,574,558...41,731,117
Ensembl chr X:41,576,047...41,731,101
G
Tcea3
transcription elongation factor A3
increases expression
ISO
Tunicamycin results in increased expression of TCEA3 mRNA
CTD
PMID:29453283
NCBI chr 5:148,476,941...148,509,452
Ensembl chr 5:148,476,941...148,509,448
G
Tcf25
TCF25 ribosome quality control complex subunit
increases expression
ISO
Tunicamycin results in increased expression of TCF25 mRNA
CTD
PMID:22378314
NCBI chr19:51,415,341...51,449,725
Ensembl chr19:51,415,543...51,449,723
G
Tcf3
transcription factor 3
decreases expression
ISO
Tunicamycin results in decreased expression of TCF3 mRNA
CTD
PMID:22378314
NCBI chr 7:9,931,251...9,952,994
Ensembl chr 7:9,280,571...9,302,314
G
Tcf4
transcription factor 4
decreases expression
ISO
Tunicamycin results in decreased expression of TCF4 mRNA
CTD
PMID:22378314
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
G
Tctn1
tectonic family member 1
increases expression
ISO
Tunicamycin results in increased expression of TCTN1 mRNA
CTD
PMID:29453283
NCBI chr12:34,309,795...34,347,190
Ensembl chr12:34,309,897...34,342,267
G
Tead2
TEA domain transcription factor 2
decreases expression
ISO
Tunicamycin results in decreased expression of TEAD2 mRNA
CTD
PMID:22378314
NCBI chr 1:95,702,366...95,719,186
Ensembl chr 1:95,703,005...95,719,186
G
Tes
testin LIM domain protein
increases expression
ISO
Tunicamycin results in increased expression of TES mRNA
CTD
PMID:38498338
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
G
Tfam
transcription factor A, mitochondrial
decreases expression
ISO
Tunicamycin results in decreased expression of TFAM mRNA
CTD
PMID:22378314
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Tfap2b
transcription factor AP-2 beta
decreases expression
ISO
Tunicamycin results in decreased expression of TFAP2B mRNA
CTD
PMID:22378314
NCBI chr 9:29,282,703...29,312,568
Ensembl chr 9:21,786,258...21,814,520
G
Tfrc
transferrin receptor
decreases expression
ISO
Tunicamycin results in decreased expression of TFRC mRNA
CTD
PMID:22378314
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgds
TDP-glucose 4,6-dehydratase
increases expression
ISO
Tunicamycin results in increased expression of TGDS mRNA
CTD
PMID:22378314
NCBI chr15:95,175,064...95,195,555
Ensembl chr15:95,174,608...95,195,554
G
Tgfb1
transforming growth factor, beta 1
multiple interactions decreases expression
EXP
TGFB1 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; Tunicamycin promotes the reaction [SREBF1 protein binds to TGFB1 promoter] Tunicamycin results in decreased expression of TGFB1 mRNA
CTD
PMID:25398788 PMID:33127435
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression
ISO
Tunicamycin results in increased expression of TGFB1I1 mRNA
CTD
PMID:17127020
NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:182,828,544...182,837,080
G
Tgfbr3
transforming growth factor beta receptor 3
decreases expression
ISO
Tunicamycin results in decreased expression of TGFBR3 mRNA
CTD
PMID:29453283
NCBI chr14:2,634,294...2,810,269
Ensembl chr14:2,489,397...2,663,341
G
Tgfbrap1
transforming growth factor, beta receptor associated protein 1
increases expression
ISO
Tunicamycin results in increased expression of TGFBRAP1 mRNA
CTD
PMID:17127020
NCBI chr 9:45,320,975...45,371,329
Ensembl chr 9:45,320,930...45,371,311
G
Thop1
thimet oligopeptidase 1
decreases expression
ISO
Tunicamycin results in decreased expression of THOP1 mRNA
CTD
PMID:22378314
NCBI chr 7:8,632,911...8,645,339
Ensembl chr 7:8,632,916...8,645,275
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
decreases expression
ISO
Tunicamycin results in decreased expression of TIAL1 mRNA
CTD
PMID:17127020
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
G
Ticam2
TIR domain containing adaptor molecule 2
increases expression
ISO
Tunicamycin results in increased expression of TICAM2 mRNA
CTD
PMID:22378314
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
decreases expression
ISO
Tunicamycin results in decreased expression of TICRR mRNA
CTD
PMID:22378314
NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523
G
Tigar
TP53 induced glycolysis regulatory phosphatase
increases expression decreases expression
ISO
Tunicamycin results in increased expression of TIGAR mRNA Tunicamycin results in decreased expression of TIGAR mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 4:161,613,306...161,632,248
Ensembl chr 4:159,927,139...159,946,029 Ensembl chr 6:159,927,139...159,946,029
G
Timm44
translocase of inner mitochondrial membrane 44
increases expression
ISO
Tunicamycin results in increased expression of TIMM44 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:2,612,581...2,629,374
Ensembl chr12:2,612,581...2,629,351
G
Timm8a1
translocase of inner mitochondrial membrane 8A1
decreases expression
ISO
Tunicamycin results in decreased expression of TIMM8A mRNA
CTD
PMID:22378314
NCBI chr X:97,717,932...97,722,170
Ensembl chr X:97,717,920...97,721,960
G
Timm9
translocase of inner mitochondrial membrane 9
increases expression
ISO
Tunicamycin results in increased expression of TIMM9 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Tinf2
TERF1 interacting nuclear factor 2
increases expression
ISO
Tunicamycin results in increased expression of TINF2 mRNA
CTD
PMID:22378314
NCBI chr15:29,170,663...29,178,015
Ensembl chr15:29,170,652...29,176,984
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
Tunicamycin results in increased expression of TIPARP mRNA
CTD
PMID:17127020
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tk1
thymidine kinase 1
decreases expression
ISO
Tunicamycin results in decreased expression of TK1 mRNA
CTD
PMID:22378314
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
G
Tlcd1
TLC domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of TLCD1 mRNA
CTD
PMID:29453283
NCBI chr10:63,074,469...63,076,502
Ensembl chr10:63,074,469...63,076,501
G
Tm4sf1
transmembrane 4 L six family member 1
increases expression
ISO
Tunicamycin results in increased expression of TM4SF1 mRNA
CTD
PMID:33545341
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
G
Tm4sf4
transmembrane 4 L six family member 4
decreases expression
ISO
Tunicamycin results in decreased expression of TM4SF4 mRNA
CTD
PMID:22378314
NCBI chr 2:143,720,220...143,771,283
Ensembl chr 2:141,481,902...141,621,200
G
Tm9sf1
transmembrane 9 superfamily member 1
increases expression
ISO
Tunicamycin results in increased expression of TM9SF1 mRNA
CTD
PMID:22378314
NCBI chr15:29,127,585...29,135,334
Ensembl chr15:29,127,584...29,135,349
G
Tmbim4
transmembrane BAX inhibitor motif containing 4
increases expression
ISO
Tunicamycin results in increased expression of TMBIM4 mRNA
CTD
PMID:29453283
NCBI chr 7:55,718,690...55,733,277
Ensembl chr 7:55,718,699...55,742,773
G
Tmco3
transmembrane and coiled-coil domains 3
increases expression
ISO
Tunicamycin results in increased expression of TMCO3 mRNA
CTD
PMID:29453283
NCBI chr16:76,217,146...76,254,309
Ensembl chr16:76,217,201...76,254,107
G
Tmed10
transmembrane p24 trafficking protein 10
increases expression
ISO
Tunicamycin results in increased expression of TMED10 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmed2
transmembrane p24 trafficking protein 2
increases expression
ISO
Tunicamycin results in increased expression of TMED2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:32,052,542...32,061,628
Ensembl chr12:32,052,543...32,071,903
G
Tmed5
transmembrane p24 trafficking protein 5
increases expression
ISO
Tunicamycin results in increased expression of TMED5 mRNA
CTD
PMID:22378314
NCBI chr14:1,607,895...1,619,028
Ensembl chr14:1,607,819...1,628,426
G
Tmed7
transmembrane p24 trafficking protein 7
increases expression
ISO
Tunicamycin results in increased expression of TMED7 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr18:39,318,564...39,325,640
Ensembl chr18:39,297,351...39,325,640
G
Tmed9
transmembrane p24 trafficking protein 9
increases expression
ISO
Tunicamycin results in increased expression of TMED9 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,029,646...9,034,176
G
Tmem100
transmembrane protein 100
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM100 mRNA
CTD
PMID:22378314
NCBI chr10:74,854,779...74,861,147
Ensembl chr10:74,854,468...74,862,941
G
Tmem108
transmembrane protein 108
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM108 mRNA
CTD
PMID:22378314
NCBI chr 8:104,066,081...104,360,172
Ensembl chr 8:104,066,078...104,360,094
G
Tmem116
transmembrane protein 116
increases expression
ISO
Tunicamycin results in increased expression of TMEM116 mRNA
CTD
PMID:29453283
NCBI chr12:35,021,912...35,089,409
Ensembl chr12:35,041,572...35,089,430
G
Tmem119
transmembrane protein 119
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM119 mRNA
CTD
PMID:22378314
NCBI chr12:42,828,621...42,835,678
Ensembl chr12:42,828,418...42,835,689
G
Tmem120a
transmembrane protein 120A
increases expression
ISO
Tunicamycin results in increased expression of TMEM120A mRNA
CTD
PMID:22378314
NCBI chr12:20,942,243...20,950,908
Ensembl chr12:20,942,439...20,990,316
G
Tmem144
transmembrane protein 144
increases expression
ISO
Tunicamycin results in increased expression of TMEM144 mRNA
CTD
PMID:29453283
NCBI chr 2:164,960,649...164,993,562
Ensembl chr 2:164,961,247...164,992,368
G
Tmem14a
transmembrane protein 14A
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM14A mRNA
CTD
PMID:22378314
NCBI chr 9:23,640,594...23,652,379
Ensembl chr 9:23,733,039...23,734,463 Ensembl chr 9:23,733,039...23,734,463
G
Tmem158
transmembrane protein 158
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM158 mRNA
CTD
PMID:22378314
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
G
Tmem175
transmembrane protein 175
increases expression
ISO
Tunicamycin results in increased expression of TMEM175 mRNA
CTD
PMID:22378314
NCBI chr14:1,073,410...1,089,764
Ensembl chr14:1,073,523...1,089,819
G
Tmem177
transmembrane protein 177
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM177 mRNA
CTD
PMID:22378314
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem18
transmembrane protein 18
increases expression
ISO
Tunicamycin results in increased expression of TMEM18 mRNA
CTD
PMID:29453283
NCBI chr 6:47,206,845...47,214,294
Ensembl chr 6:47,206,845...47,214,294
G
Tmem205
transmembrane protein 205
increases expression
ISO
Tunicamycin results in increased expression of TMEM205 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 8:20,452,092...20,458,011
Ensembl chr 8:20,452,092...20,457,828
G
Tmem209
transmembrane protein 209
increases expression
ISO
Tunicamycin results in increased expression of TMEM209 mRNA
CTD
PMID:29453283
NCBI chr 4:59,102,943...59,128,636
Ensembl chr 4:59,101,550...59,128,630
G
Tmem241
transmembrane protein 241
increases expression
ISO
Tunicamycin results in increased expression of TMEM241 mRNA
CTD
PMID:22378314
NCBI chr18:3,168,072...3,318,340
Ensembl chr18:3,168,067...3,318,293
G
Tmem243
transmembrane protein 243
increases expression
ISO
Tunicamycin results in increased expression of TMEM243 mRNA
CTD
PMID:22378314
NCBI chr 4:24,950,791...24,968,642
Ensembl chr 4:24,950,791...24,968,642
G
Tmem254
transmembrane protein 254
increases expression
ISO
Tunicamycin results in increased expression of TMEM254 mRNA
CTD
PMID:29453283
NCBI chr16:1,503,931...1,507,819
Ensembl chr16:1,503,933...1,507,895
G
Tmem268
transmembrane protein 268
increases expression
ISO
Tunicamycin results in increased expression of TMEM268 mRNA
CTD
PMID:29453283
NCBI chr 5:76,974,827...77,001,457
Ensembl chr 5:76,977,310...77,001,452
G
Tmem35a
transmembrane protein 35A
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM35A mRNA
CTD
PMID:22378314
NCBI chr X:97,503,350...97,514,198
Ensembl chr X:97,503,350...97,514,197
G
Tmem39a
transmembrane protein 39a
increases expression
ISO
Tunicamycin results in increased expression of TMEM39A mRNA
CTD
PMID:22378314
NCBI chr11:62,160,631...62,189,964
Ensembl chr11:62,160,631...62,189,964
G
Tmem41b
transmembrane protein 41B
increases expression
ISO
Tunicamycin results in increased expression of TMEM41B mRNA
CTD
PMID:22378314
NCBI chr 1:164,012,585...164,026,967
Ensembl chr 1:164,012,592...164,026,933
G
Tmem42
transmembrane protein 42
increases expression
ISO
Tunicamycin results in increased expression of TMEM42 mRNA
CTD
PMID:29453283
NCBI chr 8:131,551,616...131,554,749
Ensembl chr 8:122,674,070...122,677,276
G
Tmem50b
transmembrane protein 50B
increases expression
ISO
Tunicamycin results in increased expression of TMEM50B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr11:44,290,805...44,323,650
Ensembl chr11:30,804,837...30,837,661
G
Tmem79
transmembrane protein 79
increases expression
ISO
Tunicamycin results in increased expression of TMEM79 mRNA
CTD
PMID:29453283
NCBI chr 2:173,798,267...173,803,151
Ensembl chr 2:173,798,267...173,803,046
G
Tmem97
transmembrane protein 97
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM97 mRNA
CTD
PMID:22378314
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
G
Tmem98
transmembrane protein 98
decreases expression
ISO
Tunicamycin results in decreased expression of TMEM98 mRNA
CTD
PMID:22378314
NCBI chr10:66,293,895...66,304,806
Ensembl chr10:65,796,145...65,807,079
G
Tmf1
TATA element modulatory factor 1
increases expression
ISO
Tunicamycin results in increased expression of TMF1 mRNA
CTD
PMID:22378314
NCBI chr 4:129,759,952...129,785,705
Ensembl chr 4:129,763,114...129,785,629
G
Tmlhe
trimethyllysine hydroxylase, epsilon
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of TMLHE mRNA Tunicamycin results in increased expression of TMLHE mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr20:91,234...138,942
Ensembl chr20:91,272...140,386
G
Tmod1
tropomodulin 1
increases expression
ISO
Tunicamycin results in increased expression of TMOD1 mRNA
CTD
PMID:17127020
NCBI chr 5:60,316,445...60,393,957
Ensembl chr 5:60,338,512...60,393,956
G
Tmsb10
thymosin, beta 10
decreases expression
ISO
Tunicamycin results in decreased expression of TMSB10 mRNA
CTD
PMID:22378314
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tmsb15b2
thymosin beta 15B2
decreases expression
ISO
Tunicamycin results in decreased expression of TMSB15A mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr X:100,298,705...100,300,820
Ensembl chr X:100,298,514...100,300,886
G
Tmsb4x
thymosin beta 4, X-linked
increases expression
ISO
Tunicamycin results in increased expression of TMSB4X mRNA
CTD
PMID:29453283
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667 Ensembl chr10:27,128,610...27,146,667
G
Tmx3
thioredoxin-related transmembrane protein 3
increases expression
ISO
Tunicamycin results in increased expression of TMX3 mRNA
CTD
PMID:17127020
NCBI chr18:83,731,777...83,764,719
Ensembl chr18:83,731,868...83,762,263
G
Tnc
tenascin C
decreases expression
ISO
Tunicamycin results in decreased expression of TNC mRNA
CTD
PMID:22378314
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO
Tunicamycin inhibits the reaction [corilagin inhibits the reaction [Morphine results in increased expression of TNF protein]]; Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] Tunicamycin results in increased expression of TNF mRNA
CTD
PMID:18799549 PMID:22414386 PMID:37394652
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
decreases expression
ISO
Tunicamycin results in decreased expression of TNFAIP6 mRNA
CTD
PMID:22378314
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
ISO
Tunicamycin results in increased expression of TNFRSF12A mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf19
TNF receptor superfamily member 19
increases expression
ISO
Tunicamycin results in increased expression of TNFRSF19 mRNA
CTD
PMID:17127020
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfrsf21
TNF receptor superfamily member 21
decreases expression
ISO
Tunicamycin results in decreased expression of TNFRSF21 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 9:25,376,400...25,451,323
Ensembl chr 9:17,879,156...17,954,085
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
Tunicamycin results in increased expression of TNFRSF9 mRNA
CTD
PMID:38498338
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
Tunicamycin results in decreased expression of TNFSF10 mRNA
CTD
PMID:17127020
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf4
TNF superfamily member 4
increases expression
ISO
Tunicamycin results in increased expression of TNFSF4 mRNA
CTD
PMID:22378314
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788
G
Tnip1
TNFAIP3 interacting protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of TNIP1 mRNA
CTD
PMID:22378314
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
G
Tnk1
tyrosine kinase, non-receptor, 1
increases expression
ISO
Tunicamycin results in increased expression of TNK1 mRNA
CTD
PMID:17127020
NCBI chr10:54,571,396...54,580,547
Ensembl chr10:54,571,117...54,579,940
G
Tnnc2
troponin C2, fast skeletal type
increases expression
ISO
Tunicamycin results in increased expression of TNNC2 mRNA
CTD
PMID:17127020
NCBI chr 3:153,513,272...153,516,033
Ensembl chr 3:153,513,271...153,516,029
G
Tns3
tensin 3
decreases expression
ISO
Tunicamycin results in decreased expression of TNS3 mRNA
CTD
PMID:22378314
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:83,173,649...83,405,998
G
Tomm22
translocase of outer mitochondrial membrane 22
decreases expression
ISO
Tunicamycin results in decreased expression of TOMM22 mRNA
CTD
PMID:22378314
NCBI chr 7:113,103,863...113,109,056
Ensembl chr 7:111,216,571...111,246,799
G
Tomm34
translocase of outer mitochondrial membrane 34
decreases expression
ISO
Tunicamycin results in decreased expression of TOMM34 mRNA
CTD
PMID:22378314
NCBI chr 3:152,729,345...152,746,295
Ensembl chr 3:152,729,349...152,746,373
G
Tomm5
translocase of outer mitochondrial membrane 5
decreases expression
ISO
Tunicamycin results in decreased expression of TOMM5 mRNA
CTD
PMID:29453283
NCBI chr 5:64,158,026...64,160,857
Ensembl chr 5:59,362,240...59,365,269
G
Top1
DNA topoisomerase I
increases expression
ISO
Tunicamycin results in increased expression of TOP1 mRNA
CTD
PMID:17127020
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
G
Top1mt
DNA topoisomerase I mitochondrial
increases expression
ISO
Tunicamycin results in increased expression of TOP1MT mRNA
CTD
PMID:22378314
NCBI chr 7:107,338,092...107,368,125
Ensembl chr 7:107,342,527...107,366,049
G
Top2b
DNA topoisomerase II beta
increases expression
ISO
Tunicamycin results in increased expression of TOP2B mRNA
CTD
PMID:17127020
NCBI chr15:11,482,089...11,542,464
Ensembl chr15:9,051,341...9,112,085
G
Tp53
tumor protein p53
multiple interactions
ISO EXP
Tunicamycin promotes the reaction [Capsaicin results in increased degradation of TP53 protein] HR protein inhibits the reaction [Tunicamycin results in increased expression of TP53 protein] TRP53 protein affects the reaction [HR protein affects the reaction [Tunicamycin results in increased activity of CASP3 protein]]
CTD
PMID:19699254 PMID:20886113
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp2
tumor protein p53 binding protein, 2
increases expression
ISO
Tunicamycin results in increased expression of TP53BP2 mRNA
CTD
PMID:33545341
NCBI chr13:94,088,769...94,145,436
Ensembl chr13:94,088,709...94,145,432
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
Tunicamycin results in increased expression of TRP53INP1 mRNA
CTD
PMID:17127020
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tp53inp2
tumor protein p53 inducible nuclear protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of TRP53INP2 mRNA
CTD
PMID:17127020
NCBI chr 3:143,881,427...143,890,104
Ensembl chr 3:143,882,021...143,890,097
G
Tpi1
triosephosphate isomerase 1
decreases expression
ISO
Tunicamycin results in decreased expression of TPI1 mRNA
CTD
PMID:22378314
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:157,615,386...157,619,541
G
Tprg1l
tumor protein p63 regulated 1-like
decreases expression
ISO
Tunicamycin results in decreased expression of TPRG1L mRNA
CTD
PMID:29453283
NCBI chr 5:164,722,151...164,725,358
Ensembl chr 5:164,710,285...164,725,425
G
Tpt1
tumor protein, translationally-controlled 1
increases expression
ISO
Tunicamycin results in increased expression of TPT1 mRNA
CTD
PMID:29453283
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
G
Tpx2
TPX2, microtubule nucleation factor
decreases expression
ISO
Tunicamycin results in decreased expression of TPX2 mRNA
CTD
PMID:29453283
NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:141,318,455...141,360,468
G
Tram1
translocation associated membrane protein 1
increases expression
ISO
Tunicamycin results in increased expression of TRAM1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971
G
Tram2
translocation associated membrane protein 2
increases expression
ISO
Tunicamycin results in increased expression of TRAM2 mRNA
CTD
PMID:29453283
NCBI chr 9:23,419,204...23,498,745
Ensembl chr 9:23,424,232...23,498,689
G
Trap1
TNF receptor-associated protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of TRAP1 mRNA
CTD
PMID:22378314
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981
G
Trappc1
trafficking protein particle complex subunit 1
decreases expression
ISO
Tunicamycin results in decreased expression of TRAPPC1 mRNA
CTD
PMID:22378314
NCBI chr10:54,045,598...54,047,184
Ensembl chr10:54,045,537...54,047,331
G
Trappc6a
trafficking protein particle complex subunit 6A
increases expression
ISO
Tunicamycin results in increased expression of TRAPPC6A mRNA
CTD
PMID:29453283
NCBI chr 1:79,158,587...79,165,502
Ensembl chr 1:79,158,529...79,165,493
G
Trappc6b
trafficking protein particle complex subunit 6B
increases expression
ISO
Tunicamycin results in increased expression of TRAPPC6B mRNA
CTD
PMID:22378314
NCBI chr 6:76,740,898...76,752,035
Ensembl chr 6:76,740,898...76,752,024
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
EXP ISO
Tunicamycin results in increased expression of TRIB3 mRNA PPARD gene mutant form promotes the reaction [Tunicamycin results in increased expression of TRIB3 mRNA]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of TRIB3 mRNA]
CTD
PMID:22378314 PMID:24291486 PMID:29289645 PMID:29453283 PMID:33545341 PMID:36586010 PMID:38498338 More...
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:140,809,043...140,814,497
G
Trim11
tripartite motif-containing 11
increases expression
ISO
Tunicamycin results in increased expression of TRIM11 mRNA
CTD
PMID:22378314
NCBI chr10:43,758,299...43,771,138
Ensembl chr10:43,758,354...43,771,138
G
Trim8
tripartite motif-containing 8
increases expression
ISO
Tunicamycin results in increased expression of TRIM8 mRNA
CTD
PMID:33770205
NCBI chr 1:245,369,632...245,384,513
Ensembl chr 1:245,369,632...245,384,513
G
Trip13
thyroid hormone receptor interactor 13
decreases expression
ISO
Tunicamycin results in decreased expression of TRIP13 mRNA
CTD
PMID:29453283
NCBI chr 1:31,185,700...31,230,638
Ensembl chr 1:29,357,130...29,402,074
G
Trmt112
tRNA methyltransferase activator subunit 11-2
decreases expression
ISO
Tunicamycin results in decreased expression of TRMT112 mRNA
CTD
PMID:29453283
NCBI chr 1:213,532,507...213,533,360
G
Trmu
tRNA mitochondrial 2-thiouridylase
increases expression
ISO
Tunicamycin results in increased expression of TRMU mRNA
CTD
PMID:22378314
NCBI chr 7:116,969,750...116,987,704
Ensembl chr 7:116,969,756...116,986,355
G
Trnp1
TMF1-regulated nuclear protein 1
increases expression
ISO
Tunicamycin results in increased expression of TRNP1 mRNA
CTD
PMID:29453283
NCBI chr 5:145,706,427...145,713,279
Ensembl chr 5:145,706,094...145,713,272
G
Trub1
TruB pseudouridine synthase family member 1
decreases expression
ISO
Tunicamycin results in decreased expression of TRUB1 mRNA
CTD
PMID:29453283
NCBI chr 1:256,513,418...256,554,549
Ensembl chr 1:256,515,562...256,552,814
G
Tsc22d3
TSC22 domain family, member 3
increases expression
ISO
Tunicamycin results in increased expression of TSC22D3 mRNA
CTD
PMID:29453283 PMID:33545341
NCBI chr X:109,006,410...109,066,389
Ensembl chr X:104,217,925...104,276,861
G
Tsen15
tRNA splicing endonuclease subunit 15
increases expression
ISO
Tunicamycin results in increased expression of TSEN15 mRNA
CTD
PMID:29453283
NCBI chr13:64,490,216...64,505,591
Ensembl chr13:64,490,218...64,505,617
G
Tsks
testis-specific serine kinase substrate
increases expression
ISO
Tunicamycin results in increased expression of TSKS mRNA
CTD
PMID:17127020
NCBI chr 1:95,414,312...95,441,670
Ensembl chr 1:95,414,157...95,441,662
G
Tspan33
tetraspanin 33
increases expression
ISO
Tunicamycin results in increased expression of TSPAN33 mRNA
CTD
PMID:22378314
NCBI chr 4:58,305,378...58,330,013
Ensembl chr 4:58,305,437...58,328,940
G
Tspo
translocator protein
decreases expression
ISO
Tunicamycin results in decreased expression of TSPO mRNA
CTD
PMID:22378314
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
G
Ttc17
tetratricopeptide repeat domain 17
increases expression
ISO
Tunicamycin results in increased expression of TTC17 mRNA
CTD
PMID:29453283
NCBI chr 3:80,263,488...80,374,137
Ensembl chr 3:80,263,495...80,373,812
G
Ttc19
tetratricopeptide repeat domain 19
increases expression
ISO
Tunicamycin results in increased expression of TTC19 mRNA
CTD
PMID:29453283
NCBI chr10:46,969,723...46,997,607
Ensembl chr10:46,969,727...46,997,789
G
Ttll12
tubulin tyrosine ligase like 12
decreases expression
ISO
Tunicamycin results in decreased expression of TTLL12 mRNA
CTD
PMID:22378314
NCBI chr 7:114,731,890...114,751,237
Ensembl chr 7:114,731,892...114,751,356
G
Ttyh3
tweety family member 3
decreases expression
ISO
Tunicamycin results in decreased expression of TTYH3 mRNA
CTD
PMID:22378314
NCBI chr12:13,996,831...14,025,457
Ensembl chr12:13,997,045...14,025,459
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
Tunicamycin results in decreased expression of TUBA1A mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO
Tunicamycin results in decreased expression of TUBA1B mRNA
CTD
PMID:22378314
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1c
tubulin, alpha 1C
decreases expression
ISO
Tunicamycin results in decreased expression of TUBA1C mRNA
CTD
PMID:22378314
NCBI chr 7:130,192,050...130,199,655
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba3a
tubulin, alpha 3A
decreases expression
ISO
Tunicamycin results in decreased expression of TUBA3E mRNA
CTD
PMID:22378314
NCBI chr 4:158,075,083...158,083,972
Ensembl chr 4:158,075,083...158,083,972
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
Tunicamycin results in decreased expression of TUBB3 mRNA
CTD
PMID:22378314
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243
G
Tubb4a
tubulin, beta 4A class IVa
decreases expression
ISO
Tunicamycin results in decreased expression of TUBB4A mRNA
CTD
PMID:22378314
NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:1,917,845...1,925,291
G
Tubb4b
tubulin, beta 4B class IVb
decreases expression
ISO
Tunicamycin results in decreased expression of TUBB4B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
Tunicamycin results in decreased expression of TUBB mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubg1
tubulin, gamma 1
decreases expression
ISO
Tunicamycin results in decreased expression of TUBG1 mRNA
CTD
PMID:22378314
NCBI chr10:86,052,845...86,059,436
Ensembl chr10:86,052,743...86,059,433
G
Txn1
thioredoxin 1
decreases expression
ISO
Tunicamycin results in decreased expression of TXN mRNA
CTD
PMID:22378314
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
increases expression
ISO
Tunicamycin results in increased expression of TXN2 mRNA
CTD
PMID:22378314
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txndc11
thioredoxin domain containing 11
increases expression
ISO
Tunicamycin results in increased expression of TXNDC11 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr10:4,515,457...4,572,999
Ensembl chr10:4,515,478...4,572,989
G
Txnip
thioredoxin interacting protein
increases expression
ISO
Tunicamycin results in increased expression of TXNIP mRNA
CTD
PMID:29453283
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd2
thioredoxin reductase 2
decreases expression
ISO
Tunicamycin results in decreased expression of TXNRD2 mRNA
CTD
PMID:17127020
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
U2af1l4
U2 small nuclear RNA auxiliary factor 1-like 4
increases expression
ISO
Tunicamycin results in increased expression of U2AF1L4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 1:85,816,268...85,818,462
Ensembl chr 1:85,815,101...85,818,462
G
Uba5
ubiquitin-like modifier activating enzyme 5
increases expression
ISO
Tunicamycin results in increased expression of UBA5 mRNA
CTD
PMID:17127020
NCBI chr 8:104,665,241...104,680,915
Ensembl chr 8:104,665,046...104,680,894
G
Ubash3b
ubiquitin associated and SH3 domain containing, B
decreases expression
ISO
Tunicamycin results in decreased expression of UBASH3B mRNA
CTD
PMID:29453283
NCBI chr 8:50,282,510...50,430,034
Ensembl chr 8:41,388,341...41,532,201
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
Tunicamycin results in decreased expression of UBE2C mRNA
CTD
PMID:22378314
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:153,506,636...153,513,339
G
Ube2d2b
ubiquitin-conjugating enzyme E2D 2B
decreases expression
ISO
Tunicamycin results in decreased expression of UBE2D4 mRNA
CTD
PMID:22378314
NCBI chr14:1,915,999...1,917,473
Ensembl chr14:1,916,845...1,917,416
G
Ube2j1
ubiquitin-conjugating enzyme E2, J1
increases expression
ISO
Tunicamycin results in increased expression of UBE2J1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:52,218,807...52,237,805
Ensembl chr 5:47,422,587...47,441,461
G
Ube2n
ubiquitin-conjugating enzyme E2N
decreases expression
ISO
Tunicamycin results in decreased expression of UBE2N mRNA
CTD
PMID:22378314
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
G
Ube2q1
ubiquitin conjugating enzyme E2 Q1
decreases expression
ISO
Tunicamycin results in decreased expression of UBE2Q1 mRNA
CTD
PMID:29453283
NCBI chr 2:175,198,793...175,209,152
Ensembl chr 2:175,198,873...175,207,942
G
Ube2t
ubiquitin-conjugating enzyme E2T
decreases expression
ISO
Tunicamycin results in decreased expression of UBE2T mRNA
CTD
PMID:22378314
NCBI chr13:46,403,352...46,413,854
Ensembl chr13:46,403,375...46,414,835
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
increases expression
ISO
Tunicamycin results in increased expression of UBR4 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:151,635,825...151,743,931
Ensembl chr 5:151,635,868...151,743,784
G
Ucp2
uncoupling protein 2
decreases expression
ISO
Tunicamycin results in decreased expression of UCP2 mRNA
CTD
PMID:22378314
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Ufl1
Ufm1-specific ligase 1
increases expression
ISO
Tunicamycin results in increased expression of UFL1 mRNA
CTD
PMID:22378314
NCBI chr 5:38,962,721...38,995,134
Ensembl chr 5:38,962,171...38,995,199
G
Ufm1
ubiquitin-fold modifier 1
increases expression
ISO
Tunicamycin results in increased expression of UFM1 mRNA
CTD
PMID:22378314
NCBI chr 2:137,969,476...137,977,620
Ensembl chr 2:137,966,678...137,978,089 Ensembl chr 2:137,966,678...137,978,089
G
Ufsp2
UFM1-specific peptidase 2
increases expression
ISO
Tunicamycin results in increased expression of UFSP2 mRNA
CTD
PMID:29453283
NCBI chr16:46,272,016...46,291,080
Ensembl chr16:46,272,016...46,291,059
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
Tunicamycin results in increased expression of UGDH mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Uggt2
UDP-glucose glycoprotein glucosyltransferase 2
increases expression
ISO
Tunicamycin results in increased expression of UGGT2 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
Tunicamycin results in increased expression of UGT1A1 mRNA
CTD
PMID:35341795
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
decreases expression
ISO
Tunicamycin results in decreased expression of UHRF1 mRNA
CTD
PMID:22378314
NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,134,909...1,154,631
G
Ulbp1
UL16 binding protein 1
increases expression
ISO
Tunicamycin results in increased expression of ULBP1 mRNA
CTD
PMID:29453283
NCBI chr 1:1,694,255...1,716,160
G
Umps
uridine monophosphate synthetase
decreases expression
ISO
Tunicamycin results in decreased expression of UMPS mRNA
CTD
PMID:17127020
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
Tunicamycin results in decreased expression of UNG mRNA
CTD
PMID:22378314
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:42,485,276...42,494,206
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
Tunicamycin results in decreased expression of UPB1 mRNA
CTD
PMID:17127020
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Upp1
uridine phosphorylase 1
increases expression
ISO
Tunicamycin results in increased expression of UPP1 mRNA
CTD
PMID:29453283
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:83,809,960...83,829,462
G
Uqcr10
ubiquinol-cytochrome c reductase, complex III subunit X
decreases expression
ISO
Tunicamycin results in decreased expression of UQCR10 mRNA
CTD
PMID:22378314
NCBI chr14:79,566,151...79,569,017
Ensembl chr14:79,566,157...79,569,003
G
Uqcr11
ubiquinol-cytochrome c reductase, complex III subunit XI
decreases expression
ISO
Tunicamycin results in decreased expression of UQCR11 mRNA
CTD
PMID:22378314
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
G
Uqcrb
ubiquinol-cytochrome c reductase binding protein
decreases expression
ISO
Tunicamycin results in decreased expression of UQCRB mRNA
CTD
PMID:22378314
NCBI chr 7:65,700,016...65,705,382
Ensembl chr 7:63,814,797...63,820,150
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
decreases expression
ISO
Tunicamycin results in decreased expression of UQCRC1 mRNA
CTD
PMID:22378314
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:109,589,706...109,601,480
G
Uqcrh
ubiquinol-cytochrome c reductase hinge protein
decreases expression
ISO
Tunicamycin results in decreased expression of UQCRH mRNA
CTD
PMID:22378314
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:129,545,984...129,554,242
G
Usb1
U6 snRNA biogenesis phosphodiesterase 1
decreases expression
ISO
Tunicamycin results in decreased expression of USB1 mRNA
CTD
PMID:29453283
NCBI chr19:9,689,313...9,702,306
Ensembl chr19:9,689,316...9,702,302
G
Use1
unconventional SNARE in the ER 1
increases expression
ISO
Tunicamycin results in increased expression of USE1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr16:18,038,284...18,041,826
Ensembl chr16:18,039,173...18,041,826
G
Uso1
USO1 vesicle transport factor
increases expression
ISO
Tunicamycin results in increased expression of USO1 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:36586010
NCBI chr14:15,866,638...15,932,185
Ensembl chr14:15,866,638...15,932,171
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
Tunicamycin results in increased expression of USP18 mRNA
CTD
PMID:38498338
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp25
ubiquitin specific peptidase 25
decreases expression
ISO
Tunicamycin results in decreased expression of USP25 mRNA
CTD
PMID:17127020
NCBI chr11:15,603,654...15,711,356
Ensembl chr11:15,603,881...15,711,348
G
Usp34
ubiquitin specific peptidase 34
decreases expression
ISO
Tunicamycin results in decreased expression of USP34 mRNA
CTD
PMID:17127020
NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376
G
Usp36
ubiquitin specific peptidase 36
increases expression
ISO
Tunicamycin results in increased expression of USP36 mRNA
CTD
PMID:22378314
NCBI chr10:103,497,349...103,528,877
Ensembl chr10:103,497,349...103,528,877
G
Vamp4
vesicle-associated membrane protein 4
increases expression
ISO
Tunicamycin results in increased expression of VAMP4 mRNA
CTD
PMID:22378314
NCBI chr13:77,453,135...77,475,909
Ensembl chr13:74,919,880...74,933,686
G
Vcan
versican
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of VCAN mRNA Tunicamycin results in increased expression of VCAN mRNA
CTD
PMID:17127020
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vcpip1
valosin containing protein interacting protein 1
increases expression
ISO
Tunicamycin results in increased expression of VCPIP1 mRNA
CTD
PMID:17127020
NCBI chr 5:9,534,247...9,560,889
Ensembl chr 5:9,534,129...9,562,040
G
Vdac1
voltage-dependent anion channel 1
decreases expression
ISO
Tunicamycin results in decreased expression of VDAC1 mRNA
CTD
PMID:22378314
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
G
Vdac3
voltage-dependent anion channel 3
decreases expression
ISO
Tunicamycin results in decreased expression of VDAC3 mRNA
CTD
PMID:22378314
NCBI chr16:76,137,489...76,153,933
Ensembl chr16:69,435,005...69,451,471
G
Vegfa
vascular endothelial growth factor A
increases secretion increases expression multiple interactions
ISO EXP
Tunicamycin results in increased secretion of VEGFA protein Tunicamycin results in increased expression of VEGFA mRNA Tunicamycin results in increased expression of VEGFA mRNA; Tunicamycin results in increased expression of VEGFA protein 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of VEGFA protein]
CTD
PMID:12147617 PMID:23383089 PMID:28844859 PMID:29453283
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vgf
VGF nerve growth factor inducible
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of VGF mRNA Tunicamycin results in increased expression of VGF mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:25,274,004...25,281,803
Ensembl chr12:19,637,320...19,640,341
G
Vgll4
vestigial-like family member 4
increases expression
ISO
Tunicamycin results in increased expression of VGLL4 mRNA
CTD
PMID:29453283
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:147,927,034...148,038,471
G
Vipr1
vasoactive intestinal peptide receptor 1
decreases expression
ISO
Tunicamycin results in decreased expression of VIPR1 mRNA
CTD
PMID:17127020
NCBI chr 8:130,181,219...130,217,098
Ensembl chr 8:121,310,248...121,339,585
G
Vipr2
vasoactive intestinal peptide receptor 2
increases expression
ISO
Tunicamycin results in increased expression of VIPR2 mRNA
CTD
PMID:22378314
NCBI chr 6:136,996,664...137,070,599
Ensembl chr 6:137,001,511...137,070,597
G
Vldlr
very low density lipoprotein receptor
multiple interactions increases expression
ISO
[PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of VLDLR mRNA; FGF21 protein inhibits the reaction [Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR mRNA]; FGF21 protein inhibits the reaction [Tunicamycin results in increased expression of VLDLR protein]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR mRNA]; Tunicamycin promotes the reaction [PPARD gene mutant form results in increased expression of VLDLR protein] Tunicamycin results in increased expression of VLDLR mRNA; Tunicamycin results in increased expression of VLDLR protein
CTD
PMID:29289645
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vom1r86
vomeronasal 1 receptor 86
decreases expression
ISO
Tunicamycin results in decreased expression of VMN1R13 mRNA
CTD
PMID:17127020
NCBI chr 4:87,198,525...87,199,433
Ensembl chr 4:87,192,378...87,204,465
G
Vstm2l
V-set and transmembrane domain containing 2 like
decreases expression
ISO
Tunicamycin results in decreased expression of VSTM2L mRNA
CTD
PMID:22378314
NCBI chr 3:146,571,099...146,600,930
Ensembl chr 3:146,571,278...146,600,325
G
Vwce
von Willebrand factor C and EGF domains
increases expression
ISO
Tunicamycin results in increased expression of VWCE mRNA
CTD
PMID:22378314
NCBI chr 1:207,280,714...207,327,215
Ensembl chr 1:207,282,356...207,312,986
G
Wars1
tryptophanyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of WARS1 mRNA; Tunicamycin results in increased expression of WARS1 protein
CTD
PMID:22378314 PMID:29453283 PMID:33545341 PMID:38498338
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Washc3
WASH complex subunit 3
increases expression
ISO
Tunicamycin results in increased expression of CCDC53 mRNA
CTD
PMID:29453283
NCBI chr 7:22,621,078...22,665,550
Ensembl chr 7:22,621,078...22,690,696
G
Wdr13
WD repeat domain 13
increases expression
ISO
Tunicamycin results in increased expression of WDR13 mRNA
CTD
PMID:29453283
NCBI chr X:17,034,779...17,045,682
Ensembl chr X:14,362,860...14,373,727
G
Wdr25
WD repeat domain 25
increases expression
ISO
Tunicamycin results in increased expression of WDR25 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 6:127,807,347...127,939,795
Ensembl chr 6:127,807,421...127,938,929
G
Wdr45
WD repeat domain 45
increases expression
ISO
Tunicamycin results in increased expression of WDR45 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr X:17,448,195...17,454,117
Ensembl chr X:14,776,293...14,782,202
G
Wdr59
WD repeat domain 59
decreases expression
ISO
Tunicamycin results in decreased expression of WDR59 mRNA
CTD
PMID:29453283
NCBI chr19:39,416,432...39,483,773
Ensembl chr19:39,416,429...39,483,698
G
Wdr83
WD repeat domain 83
increases expression
ISO
Tunicamycin results in increased expression of WDR83 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr19:23,076,948...23,082,569
Ensembl chr19:23,077,010...23,082,563
G
Wdsub1
WD repeat, sterile alpha motif and U-box domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of WDSUB1 mRNA
CTD
PMID:29453283
NCBI chr 3:44,340,415...44,370,890
Ensembl chr 3:44,340,415...44,370,891
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
Tunicamycin results in decreased expression of WEE1 mRNA
CTD
PMID:22378314
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wfs1
wolframin ER transmembrane glycoprotein
increases expression
ISO
Tunicamycin results in increased expression of WFS1 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr14:73,810,478...73,834,993
Ensembl chr14:73,810,404...73,835,602
G
Whr1
winged helix repair factor 1
increases expression
ISO
Tunicamycin results in increased expression of WHR1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr20:3,995,590...4,005,117
Ensembl chr20:3,995,587...4,005,116
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Tunicamycin results in increased expression of WIPI1 mRNA
CTD
PMID:22378314 PMID:29453283 PMID:33545341 PMID:38498338
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:94,542,946...94,579,846
G
Wnk4
WNK lysine deficient protein kinase 4
increases expression
ISO
Tunicamycin results in increased expression of WNK4 mRNA
CTD
PMID:17127020
NCBI chr10:86,202,552...86,219,655
Ensembl chr10:86,188,812...86,231,829
G
Wnt5a
Wnt family member 5A
increases expression decreases expression
ISO
Tunicamycin results in increased expression of WNT5A mRNA Tunicamycin results in decreased expression of WNT5A mRNA
CTD
PMID:17127020 PMID:29453283 PMID:38498338
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,697,032...3,718,234
G
Xaf1
XIAP associated factor 1
increases expression
ISO
Tunicamycin results in increased expression of XAF1 mRNA
CTD
PMID:38498338
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xbp1
X-box binding protein 1
multiple interactions increases expression increases splicing
ISO EXP
[ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of XBP1 mRNA; [Resveratrol results in decreased activity of MTOR protein] inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form]; Amiloride inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Particulate Matter inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Tunicamycin inhibits the reaction [mevastatin results in increased cleavage of XBP1 protein] ibutilide inhibits the reaction [Tunicamycin results in increased expression of XBP1 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA] Tunicamycin results in increased expression of XBP1 mRNA; Tunicamycin results in increased expression of XBP1 mRNA alternative form; Tunicamycin results in increased expression of XBP1 protein alternative form Tunicamycin results in increased expression of XBP1 mRNA; Tunicamycin results in increased expression of XBP1 mRNA alternative form; Tunicamycin results in increased expression of XBP1 protein; Tunicamycin results in increased expression of XBP1 protein alternative form 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; Acetylcysteine inhibits the reaction [toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]]; cinnamaldehyde inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Doxorubicin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of XBP1 mRNA alternative form]; shikonin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; toxoflavin inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]; Tunicamycin inhibits the reaction [Thapsigargin results in increased expression of XBP1 mRNA]; Tunicamycin results in increased splicing of and results in increased expression of XBP1 mRNA alternative form
CTD
PMID:16330322 PMID:17917237 PMID:18477628 PMID:19135031 PMID:20015086 PMID:20554909 PMID:21321189 PMID:22001960 PMID:22378314 PMID:22414386 PMID:22509299 PMID:22959463 PMID:23741617 PMID:24210820 PMID:24291486 PMID:24312631 PMID:25160872 PMID:25324550 PMID:27358234 PMID:28399139 PMID:29380555 PMID:29453283 PMID:29793971 PMID:29956773 PMID:31022492 PMID:32407927 PMID:32574669 PMID:33454823 PMID:34560123 PMID:35840659 PMID:36030031 PMID:36586010 More...
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693
G
Xk
X-linked Kx blood group antigen, Kell and VPS13A binding protein
increases expression
ISO
Tunicamycin results in increased expression of XK mRNA
CTD
PMID:29453283
NCBI chr X:13,436,412...13,472,830
Ensembl chr X:13,436,418...13,472,830
G
Xpot
exportin for tRNA
increases expression
ISO
Tunicamycin results in increased expression of XPOT mRNA; Tunicamycin results in increased expression of XPOT protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 7:57,111,536...57,152,013
Ensembl chr 7:57,111,536...57,152,099
G
Xrcc1
X-ray repair cross complementing 1
increases expression
ISO
Tunicamycin results in increased expression of XRCC1 mRNA
CTD
PMID:22378314
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Yars1
tyrosyl-tRNA synthetase 1
increases expression
ISO
Tunicamycin results in increased expression of YARS1 mRNA; Tunicamycin results in increased expression of YARS1 protein
CTD
PMID:22378314 PMID:29453283
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Yars2
tyrosyl-tRNA synthetase 2
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of YARS2 mRNA Tunicamycin results in increased expression of YARS2 mRNA
CTD
PMID:22378314 PMID:33770205
NCBI chr11:84,632,350...84,638,138
Ensembl chr11:84,624,369...84,638,125
G
Yju2b
YJU2 splicing factor homolog B
increases expression
ISO
Tunicamycin results in increased expression of YJU2B mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr19:23,894,587...23,906,084
Ensembl chr19:23,894,649...23,906,077
G
Yme1l1
YME1-like 1 ATPase
increases expression
ISO
Tunicamycin results in increased expression of YME1L1 mRNA
CTD
PMID:22378314
NCBI chr17:85,287,607...85,326,068
Ensembl chr17:85,287,554...85,326,335
G
Ypel4
yippee-like 4
increases expression
ISO
Tunicamycin results in increased expression of YPEL4 mRNA
CTD
PMID:22378314
NCBI chr 3:90,222,060...90,227,395
Ensembl chr 3:69,816,175...69,820,707
G
Ypel5
yippee-like 5
increases expression
ISO
Tunicamycin results in increased expression of YPEL5 mRNA
CTD
PMID:22378314
NCBI chr 6:28,408,079...28,423,536
Ensembl chr 6:22,656,285...22,671,691
G
Ywhae
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
decreases expression
ISO
Tunicamycin results in decreased expression of YWHAE mRNA
CTD
PMID:22378314
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
G
Ywhag
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
decreases expression
ISO
Tunicamycin results in decreased expression of YWHAG mRNA
CTD
PMID:22378314
NCBI chr12:20,744,500...20,772,828
Ensembl chr12:20,744,535...20,772,827
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
decreases expression
ISO
Tunicamycin results in decreased expression of YWHAH mRNA
CTD
PMID:22378314
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
G
Zbtb21
zinc finger and BTB domain containing 21
increases expression
ISO
Tunicamycin results in increased expression of ZBTB21 mRNA
CTD
PMID:29453283
NCBI chr11:37,312,337...37,327,040
Ensembl chr11:37,312,378...37,326,996
G
Zc3h7a
zinc finger CCCH type containing 7 A
increases expression
ISO
Tunicamycin results in increased expression of ZC3H7A mRNA
CTD
PMID:22378314
NCBI chr10:4,473,177...4,512,668
Ensembl chr10:4,473,203...4,512,665
G
Zcchc12
zinc finger CCHC-type containing 12
decreases expression
ISO
Tunicamycin results in decreased expression of ZCCHC12 mRNA
CTD
PMID:22378314
NCBI chr X:115,433,444...115,436,691
Ensembl chr X:115,433,259...115,436,692
G
Zcchc7
zinc finger CCHC-type containing 7
increases expression
ISO
Tunicamycin results in increased expression of ZCCHC7 mRNA
CTD
PMID:22378314
NCBI chr 5:63,787,292...63,968,960
Ensembl chr 5:58,993,290...59,173,300
G
Zcwpw1
zinc finger CW-type and PWWP domain containing 1
increases expression
ISO
Tunicamycin results in increased expression of ZCWPW1 mRNA
CTD
PMID:29453283
NCBI chr12:18,880,625...18,910,713
Ensembl chr12:18,880,633...18,910,711
G
Zdhhc12
zinc finger DHHC-type palmitoyltransferase 12
decreases expression
ISO
Tunicamycin results in decreased expression of ZDHHC12 mRNA
CTD
PMID:22378314
NCBI chr 3:13,363,504...13,366,383
Ensembl chr 3:13,363,504...13,366,474
G
Zfand1
zinc finger AN1-type containing 1
increases expression
ISO
Tunicamycin results in increased expression of ZFAND1 mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr 2:91,444,497...91,457,540
Ensembl chr 2:91,444,508...91,453,246
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
ISO
Tunicamycin results in increased expression of ZFAND2A mRNA
CTD
PMID:22378314 PMID:29453283
NCBI chr12:20,275,435...20,286,513
Ensembl chr12:15,161,639...15,172,677
G
Zfand3
zinc finger AN1-type containing 3
increases expression
ISO
Tunicamycin results in increased expression of ZFAND3 mRNA
CTD
PMID:22378314
NCBI chr20:8,083,407...8,279,617
Ensembl chr20:8,082,200...8,279,616
G
Zfhx2
zinc finger homeobox 2
decreases expression
ISO
Tunicamycin results in decreased expression of ZFHX2 mRNA
CTD
PMID:22378314
NCBI chr15:28,533,155...28,565,667
Ensembl chr15:28,533,156...28,565,128
G
Zfhx3
zinc finger homeobox 3
decreases expression
ISO
Tunicamycin results in decreased expression of ZFHX3 mRNA
CTD
PMID:22378314
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
G
Zfp106
zinc finger protein 106
decreases expression
ISO
Tunicamycin results in decreased expression of ZFP106 mRNA
CTD
PMID:17127020
NCBI chr 3:107,459,232...107,510,507
Ensembl chr 3:107,462,096...107,510,481
G
Zfp34
zinc finger protein 34
increases expression
ISO
Tunicamycin results in increased expression of ZNF34 mRNA
CTD
PMID:22378314
NCBI chr 5:157,509,762...157,513,970
Ensembl chr 5:157,509,451...157,599,926
G
Zfp423
zinc finger protein 423
decreases expression
ISO
Tunicamycin results in decreased expression of ZNF423 mRNA
CTD
PMID:22378314
NCBI chr19:19,111,213...19,407,373
Ensembl chr19:19,110,238...19,407,373
G
Zfp462
zinc finger protein 462
decreases expression
ISO
Tunicamycin results in decreased expression of ZNF462 mRNA
CTD
PMID:22378314
NCBI chr 5:69,670,085...69,810,729
Ensembl chr 5:69,670,328...69,810,327
G
Zfp467
zinc finger protein 467
increases expression
ISO
Tunicamycin results in increased expression of ZNF467 mRNA
CTD
PMID:22378314
NCBI chr 4:78,716,473...78,725,829
Ensembl chr 4:77,385,758...77,392,229
G
Zfp524
zinc finger protein 524
increases expression
ISO
Tunicamycin results in increased expression of ZNF524 mRNA
CTD
PMID:29453283
NCBI chr 1:68,824,803...68,828,363
Ensembl chr 1:68,824,803...68,828,594
G
Zfp536
zinc finger protein 536
decreases expression
ISO
Tunicamycin results in decreased expression of ZNF536 mRNA
CTD
PMID:22378314
NCBI chr 1:90,000,359...90,463,423
Ensembl chr 1:90,002,858...90,462,990
G
Zfp618
zinc finger protein 618
decreases expression
ISO
Tunicamycin results in decreased expression of ZNF618 mRNA
CTD
PMID:22378314
NCBI chr 5:76,398,514...76,564,837
Ensembl chr 5:76,398,366...76,564,834
G
Zfp622
zinc finger protein 622
increases expression
ISO
Tunicamycin results in increased expression of ZNF622 mRNA
CTD
PMID:22378314
NCBI chr 2:78,205,655...78,224,888
Ensembl chr 2:76,335,609...76,493,898
G
Zfp638
zinc finger protein 638
increases expression
ISO
Tunicamycin results in increased expression of ZFP638 mRNA
CTD
PMID:17127020
NCBI chr 4:116,355,934...116,475,051
Ensembl chr 4:116,402,428...116,479,845
G
Zfp668
zinc finger protein 668
decreases expression
ISO
Tunicamycin results in decreased expression of ZNF668 mRNA
CTD
PMID:22378314
NCBI chr 1:182,474,633...182,484,957
Ensembl chr 1:182,474,633...182,492,878
G
Zfp90
zinc finger protein 90
increases expression
ISO
Tunicamycin results in increased expression of ZFP90 mRNA
CTD
PMID:29453283
NCBI chr19:34,321,980...34,333,195
Ensembl chr19:34,321,940...34,333,194
G
Zfyve21
zinc finger FYVE-type containing 21
decreases expression
ISO
Tunicamycin results in decreased expression of ZFYVE21 mRNA
CTD
PMID:29453283
NCBI chr 6:130,873,979...130,894,618
Ensembl chr 6:130,873,912...130,894,411
G
Zhx2
zinc fingers and homeoboxes 2
increases expression
ISO
Tunicamycin results in increased expression of ZHX2 mRNA
CTD
PMID:22378314
NCBI chr 7:89,226,358...89,374,266
Ensembl chr 7:89,226,463...89,374,378
G
Zmat3
zinc finger, matrin type 3
decreases expression increases expression
ISO
Tunicamycin results in decreased expression of ZMAT3 mRNA Tunicamycin results in increased expression of ZMAT3 mRNA
CTD
PMID:17127020 PMID:22378314
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Zmiz2
zinc finger, MIZ-type containing 2
decreases expression
ISO
Tunicamycin results in decreased expression of ZMIZ2 mRNA
CTD
PMID:22378314
NCBI chr14:81,251,391...81,267,936
Ensembl chr14:81,251,417...81,267,936
G
Zmym5
zinc finger MYM-type containing 5
increases expression
ISO
Tunicamycin results in increased expression of ZMYM5 mRNA
CTD
PMID:22378314
NCBI chr15:30,920,479...30,941,249
Ensembl chr15:30,923,241...30,941,240
G
Zmynd8
zinc finger, MYND-type containing 8
decreases expression
ISO
Tunicamycin results in decreased expression of ZMYND8 mRNA
CTD
PMID:17127020
NCBI chr 3:154,528,917...154,629,532
Ensembl chr 3:154,529,043...154,628,463
G
Znf773
zinc finger protein 773
increases expression
ISO
Tunicamycin results in increased expression of ZNF773 mRNA
CTD
PMID:29453283
NCBI chr 1:66,789,930...66,802,405
Ensembl chr 1:66,788,479...66,802,623
G
Zyx
zyxin
increases expression
ISO
Tunicamycin results in increased expression of ZYX mRNA
CTD
PMID:22378314
NCBI chr 4:71,236,767...71,246,553
Ensembl chr 4:71,237,451...71,246,553
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all